data_1jhb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jhb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.61 -45.77 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -55.79 -50.18 71.18 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.361 0.664 . . . . 0.0 111.34 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.22 -25.72 36.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.941 0.896 . . . . 0.0 111.781 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -65.58 -38.45 89.55 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.811 1.187 . . . . 0.0 110.621 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.91 154.84 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 120.63 1.559 . . . . 0.0 107.9 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.9 166.93 14.89 Favored Pre-proline 0 C--O 1.241 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 107.175 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.56 158.59 52.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 159.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.77 84.24 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 113.968 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.62 151.56 38.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.174 2.19 . . . . 0.0 108.961 163.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.68 79.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.203 1.401 . . . . 0.0 107.476 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.09 140.7 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.02 115.82 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -81.54 131.94 35.29 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 171.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 126.294 1.838 . . . . 0.0 111.235 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' NZ ' ' SG ' ' A' ' 23' ' ' CYS . 3.1 ptmm? -140.15 143.94 35.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 162.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.14 -10.99 24.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.602 1.535 . . . . 0.0 110.985 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 p -89.46 -9.31 50.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.472 1.509 . . . . 0.0 111.882 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.569 ' CB ' ' HG ' ' A' ' 26' ' ' CYS . 1.8 m -78.33 123.62 85.78 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.527 1.058 . . . . 0.0 109.092 161.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.67 -23.67 48.79 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.672 1.581 . . . . 0.0 110.291 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.37 -28.92 62.3 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.673 0.789 . . . . 0.0 110.369 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.569 ' HG ' ' CB ' ' A' ' 23' ' ' CYS . 63.0 m -68.02 -32.08 72.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -65.89 -38.28 88.33 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.932 0.787 . . . . 0.0 111.833 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -59.56 4.97 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.91 -35.88 58.86 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 124.051 0.845 . . . . 0.0 111.343 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -45.96 92.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.117 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.93 -50.9 25.12 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -46.05 -50.39 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.738 1.215 . . . . 0.0 110.563 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mt -79.59 -48.39 13.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -70.63 -6.18 34.93 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.8 -21.25 60.22 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.456 1.025 . . . . 0.0 110.725 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.91 142.09 24.58 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.797 . . . . 0.0 109.964 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.11 109.75 2.78 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.64 2.894 . . . . 0.0 110.075 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.2 mt -133.68 149.84 31.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -53.0 127.69 24.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 118.195 0.452 . . . . 0.0 110.995 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.12 131.08 49.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.757 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.86 52.73 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.287 1.422 . . . . 0.0 111.841 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.95 -34.44 64.3 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.951 1.375 . . . . 0.0 110.665 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.36 111.32 18.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -129.08 108.75 10.63 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -83.93 102.49 12.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.77 137.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.506 1.923 . . . . 0.0 106.965 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.12 149.5 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.728 -0.608 . . . . 0.0 110.816 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.65 10.19 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.102 1.761 . . . . 0.0 112.27 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 CA--C 1.541 0.618 0 CA-C-N 120.581 1.537 . . . . 0.0 111.882 171.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.5 m170 . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -42.14 -63.31 0.77 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -43.85 -33.1 1.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.921 2.488 . . . . 0.0 113.758 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.36 -60.68 1.93 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.76 -33.85 28.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 124.972 1.309 . . . . 0.0 111.173 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -73.63 -40.68 63.6 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.31 -44.63 87.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.077 1.751 . . . . 0.0 110.496 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.53 -48.15 81.81 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.035 -0.416 . . . . 0.0 110.469 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.78 -36.41 69.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.096 0.959 . . . . 0.0 110.288 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -50.47 68.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.509 0.724 . . . . 0.0 110.418 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -68.73 -45.28 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.084 0.553 . . . . 0.0 110.279 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.79 -30.79 59.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 p -123.72 -12.78 7.58 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.65 59.66 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.292 1.405 . . . . 0.0 113.178 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.46 149.47 18.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.357 1.079 . . . . 0.0 109.935 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -102.9 -25.29 13.53 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.811 0.844 . . . . 0.0 112.649 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -71.29 144.31 50.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.95 165.99 11.81 Favored Pre-proline 0 C--O 1.244 0.777 0 C-N-CA 126.372 1.869 . . . . 0.0 109.21 -170.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.58 161.91 51.53 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 119.287 0.781 . . . . 0.0 111.424 -3.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -137.81 97.11 3.35 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.14 127.49 39.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.23 96.03 5.59 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.836 2.454 . . . . 0.0 107.879 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.61 107.84 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 38.37 81.48 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 127.432 2.444 . . . . 0.0 113.135 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 16.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.37 2.268 . . . . 0.0 116.996 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.96 110.81 18.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 119.024 0.829 . . . . 0.0 108.836 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.28 117.12 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.54 -21.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.53 -155.76 21.3 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.64 -168.75 31.2 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.982 1.753 . . . . 0.0 110.253 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.75 -24.66 64.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.578 -1.201 . . . . 0.0 112.126 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m -60.63 -49.22 78.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 120.231 1.378 . . . . 0.0 109.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -41.29 84.86 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.692 0.797 . . . . 0.0 109.57 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.7 tp -56.59 -39.25 73.22 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.367 0.667 . . . . 0.0 112.004 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -61.92 -46.08 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.044 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.58 -56.47 21.73 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.73 -27.15 68.71 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.912 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -68.05 -54.07 21.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.586 1.539 . . . . 0.0 109.454 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -40.8 77.37 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.702 1.201 . . . . 0.0 111.775 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -70.61 -20.52 62.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.529 2.732 . . . . 0.0 110.262 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.9 6.63 82.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.722 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.61 -31.98 72.91 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 120.273 2.036 . . . . 0.0 109.514 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.43 -40.9 75.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.191 1.796 . . . . 0.0 110.445 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.11 -47.72 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.592 0.633 . . . . 0.0 109.339 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m -60.82 -49.52 77.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.279 0.632 . . . . 0.0 109.351 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -48.77 61.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.598 1.159 . . . . 0.0 110.688 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -49.3 70.88 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.334 1.054 . . . . 0.0 112.734 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -67.43 -25.11 65.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 117.088 -1.845 . . . . 0.0 112.717 -166.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -48.16 -46.22 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.764 0.665 . . . . 0.0 110.448 168.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.71 8.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.903 0.774 . . . . 0.0 112.078 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.67 34.21 44.64 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.602 1.096 . . . . 0.0 111.701 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.31 -74.52 0.38 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.39 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.59 133.75 55.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.773 1.169 . . . . 0.0 110.578 -159.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 131.144 3.778 . . . . 0.0 104.858 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.9 t80 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 118.896 -0.574 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.43 -49.29 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.322 0.51 . . . . 0.0 109.895 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.86 -53.12 55.6 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.547 0.612 . . . . 0.0 111.262 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.9 m -68.76 -5.4 20.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.214 1.406 . . . . 0.0 112.659 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.6 -26.4 45.4 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.508 167.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.26 167.45 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 165.08 18.98 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 128.194 2.598 . . . . 0.0 105.735 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.6 61.47 7.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.709 2.273 . . . . 0.0 111.951 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.74 16.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.745 -1.031 . . . . 0.0 115.513 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -119.05 160.11 22.66 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.486 1.643 . . . . 0.0 108.002 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.96 98.78 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.59 151.68 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.56 115.22 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -74.81 120.42 20.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.07 176.04 7.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 127.462 2.305 . . . . 0.0 110.268 -171.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -122.89 158.69 56.49 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 164.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.95 9.75 2.26 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.759 2.972 . . . . 0.0 112.971 -168.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.306 0.1 OUTLIER -133.35 -106.17 0.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -173.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t 33.83 115.06 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 130.975 3.71 . . . . 0.0 113.702 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -61.75 -20.32 68.62 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.96 1.107 . . . . 0.0 112.602 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -81.8 -42.6 19.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.76 -43.13 99.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -54.35 -53.42 54.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.31 1.044 . . . . 0.0 110.204 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -55.81 27.8 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.1 69.89 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.677 0.611 . . . . 0.0 110.868 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -54.6 -51.98 63.61 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.81 1.244 . . . . 0.0 112.557 172.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.8 -47.61 45.12 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 126.342 1.857 . . . . 0.0 110.178 -171.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -50.21 -56.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.207 1.803 . . . . 0.0 108.079 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.83 -43.25 62.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.268 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.3 m -70.39 -4.43 22.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.8 -26.75 60.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.431 1.469 . . . . 0.0 111.874 172.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.83 150.51 65.88 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 119.137 0.881 . . . . 0.0 110.787 -171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.47 72.95 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.613 2.876 . . . . 0.0 108.731 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.61 147.57 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -50.21 124.21 9.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.941 0.496 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -65.14 140.87 58.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.1 -3.5 85.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.109 -1.384 . . . . 0.0 112.418 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -92.23 -28.88 16.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.201 2.001 . . . . 0.0 112.674 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.63 109.64 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.858 2.117 . . . . 0.0 108.193 -171.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -121.43 112.6 18.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.46 1.027 . . . . 0.0 109.885 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 74.5 m-85 -96.03 91.76 6.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.832 1.253 . . . . 0.0 108.963 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.67 104.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.299 1.84 . . . . 0.0 108.708 -168.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.73 104.79 2.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.69 1.596 . . . . 0.0 112.235 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.23 -8.98 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.639 1.175 . . . . 0.0 113.087 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.453 -0.289 0 CA-C-N 119.427 1.012 . . . . 0.0 110.79 -173.928 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.0 m170 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.87 -63.4 0.98 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 120.397 1.453 . . . . 0.0 109.864 170.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -47.02 -49.7 20.63 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.373 -0.822 . . . . 0.0 113.01 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -60.9 -44.61 96.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.708 1.203 . . . . 0.0 110.06 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -68.31 -42.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.801 1.64 . . . . 0.0 107.32 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -48.92 70.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.567 2.347 . . . . 0.0 105.421 -172.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -52.91 -59.01 5.05 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 126.022 1.729 . . . . 0.0 109.942 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.97 -38.7 79.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.644 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.37 -32.1 72.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.462 1.028 . . . . 0.0 111.213 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -61.72 -38.69 88.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.277 0.944 . . . . 0.0 110.372 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -51.54 12.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.728 0.695 . . . . 0.0 111.395 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.59 -22.76 63.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.611 1.164 . . . . 0.0 110.533 -171.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.9 p -116.09 -71.67 0.73 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.608 1.095 . . . . 0.0 108.083 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.66 0.23 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.108 1.337 . . . . 0.0 110.811 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -134.89 144.95 47.8 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 108.871 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -21.66 51.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.117 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.5 p -63.05 133.37 54.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.493 0.496 . . . . 0.0 110.007 -158.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.76 155.57 61.69 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.39 166.28 64.93 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 CA-C-N 119.927 1.01 . . . . 0.0 111.419 -5.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -133.84 96.11 3.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 169.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.4 126.31 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -113.99 101.83 9.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.877 1.671 . . . . 0.0 107.477 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.04 115.26 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.554 -2.388 . . . . 0.0 104.554 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.35 72.38 0.48 Allowed Glycine 0 C--N 1.337 0.611 0 C-N-CA 124.621 1.105 . . . . 0.0 111.873 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 46.67 22.1 0.16 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.58 130.52 38.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.397 1.453 . . . . 0.0 110.854 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 t -71.58 115.96 11.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.776 0.83 . . . . 0.0 110.068 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.2 -6.65 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 118.442 0.565 . . . . 0.0 111.256 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.54 -175.93 19.68 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.561 1.553 . . . . 0.0 109.519 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.66 -91.82 1.2 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.43 -55.7 0.96 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.611 0.705 . . . . 0.0 112.457 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -61.18 -33.56 73.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.171 0.896 . . . . 0.0 111.107 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.12 -63.21 1.21 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.098 1.759 . . . . 0.0 107.766 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -37.25 23.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.683 2.393 . . . . 0.0 113.126 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.33 -36.03 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.341 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -49.39 66.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 121.3 1.864 . . . . 0.0 107.383 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.54 -37.48 75.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.36 -63.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.465 1.03 . . . . 0.0 109.692 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -51.64 58.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.155 1.782 . . . . 0.0 112.25 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -75.01 -36.73 61.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.594 1.157 . . . . 0.0 109.889 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.21 35.34 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.799 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -63.06 -26.97 69.09 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.621 2.21 . . . . 0.0 110.872 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -39.66 84.94 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 125.206 1.402 . . . . 0.0 109.172 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -39.71 84.93 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.526 0.73 . . . . 0.0 109.234 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 m -59.7 -57.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -34.51 78.3 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.888 -0.508 . . . . 0.0 112.174 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 mt -57.04 -53.73 54.71 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.946 1.298 . . . . 0.0 109.793 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -25.34 68.03 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.368 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -56.55 -30.31 62.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.42 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.74 8.78 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 112.53 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.59 30.95 59.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.305 -0.872 . . . . 0.0 112.858 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.74 -70.47 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 110.195 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.93 134.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -166.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--O 1.247 0.944 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 -174.041 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.0 t80 . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 18' ' ' PHE . 24.8 t -80.6 -56.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -60.47 -28.42 68.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -158.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -109.34 -16.66 13.98 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.398 1.079 . . . . 0.0 112.662 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -65.6 -39.07 91.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 0.0 110.149 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -69.9 144.86 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.26 160.27 37.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 163.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 71.5 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.499 3.466 . . . . 0.0 111.931 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.31 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.922 2.201 . . . . 0.0 110.555 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -151.24 162.92 40.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.76 2.424 . . . . 0.0 106.361 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.44 87.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 165.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -88.16 135.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.58 114.27 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' HG11 ' A' ' 6' ' ' VAL . 69.3 m-85 -84.11 130.04 34.87 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 167.77 18.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.005 1.322 . . . . 0.0 110.659 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.7 149.33 58.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 161.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.49 -19.68 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.617 2.878 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -75.58 31.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.758 2.423 . . . . 0.0 110.802 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.9 t -144.19 121.5 6.6 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.87 1.668 . . . . 0.0 111.289 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.98 -19.97 19.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.018 1.812 . . . . 0.0 111.238 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.409 ' HB3' ' HG ' ' A' ' 83' ' ' CYS . 26.4 m-85 -76.8 -41.18 45.46 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.38 -46.65 88.07 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.3 ttm-85 -57.17 -42.66 81.52 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.467 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -58.62 -56.91 16.14 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 120.321 1.418 . . . . 0.0 108.529 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.45 -32.7 51.09 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 123.722 0.639 . . . . 0.0 111.141 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -60.52 3.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.46 1.504 . . . . 0.0 112.474 169.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -66.11 -45.94 79.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.692 1.133 . . . . 0.0 109.243 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.12 -48.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.424 1.49 . . . . 0.0 110.494 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.96 -52.29 11.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -64.42 -14.43 56.75 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.47 1.508 . . . . 0.0 113.531 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.64 -24.25 59.98 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.073 1.306 . . . . 0.0 111.28 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.77 150.83 84.3 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.178 0.899 . . . . 0.0 110.714 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.88 67.69 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.565 2.843 . . . . 0.0 110.47 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -90.33 154.25 3.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -55.38 128.75 35.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.57 1.148 . . . . 0.0 109.469 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.93 136.22 57.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.26 -3.66 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.481 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mt -73.66 -41.15 63.08 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.888 1.844 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.79 110.04 18.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -121.52 120.25 34.33 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.79 94.76 9.95 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.585 1.554 . . . . 0.0 107.324 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -85.29 107.96 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.895 2.078 . . . . 0.0 107.988 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -70.92 107.86 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.97 1.308 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 pt -68.47 -15.19 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.605 0.762 . . . . 0.0 112.644 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 124.274 1.03 . . . . 0.0 110.952 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.7 m170 . . . . . 0 N--CA 1.456 -0.125 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -63.44 1.11 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.988 0.915 . . . . 0.0 109.53 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -27.24 32.71 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.58 -29.67 15.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.831 1.196 . . . . 0.0 111.448 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.77 -37.16 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -62.89 -51.67 66.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.38 1.872 . . . . 0.0 106.472 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -52.65 -53.84 41.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 111.054 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -41.44 80.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.92 -35.83 81.94 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.749 -1.22 . . . . 0.0 110.321 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.23 -39.02 92.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.373 0.533 . . . . 0.0 111.201 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -63.22 -52.45 62.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.805 . . . . 0.0 110.25 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -75.7 -52.95 9.35 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 p -97.57 -15.95 20.27 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.73 1.67 57.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.079 -0.845 . . . . 0.0 111.748 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.44 151.94 10.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.186 1.493 . . . . 0.0 110.756 169.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -87.9 -26.38 22.76 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 p -58.61 133.35 55.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -158.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.88 22.46 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.896 0.879 . . . . 0.0 110.007 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -60.53 155.33 51.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 CA-C-N 119.833 0.976 . . . . 0.0 110.111 -10.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.83 113.6 20.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.21 123.92 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 119.712 1.142 . . . . 0.0 109.08 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.87 104.09 13.72 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 121.93 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 160.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.4 80.58 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 127.736 2.589 . . . . 0.0 114.934 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.26 21.14 0.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.27 125.39 34.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 121.206 1.821 . . . . 0.0 111.722 158.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.6 t -65.56 113.46 4.21 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.592 1.957 . . . . 0.0 109.761 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.68 -21.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 O-C-N 122.935 0.147 . . . . 0.0 110.611 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.39 -165.44 24.72 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.65 -167.11 36.43 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.985 0.802 . . . . 0.0 111.312 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' HG ' ' HB3' ' A' ' 25' ' ' TYR . 5.2 p -60.87 -34.89 75.32 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.303 1.051 . . . . 0.0 111.707 -171.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -74.45 -42.98 58.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.543 0.611 . . . . 0.0 109.524 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.77 -46.97 82.85 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.95 -41.07 67.37 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.318 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.93 -48.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 116.827 -1.559 . . . . 0.0 109.9 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -47.02 87.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.206 1.821 . . . . 0.0 108.037 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.7 -40.56 83.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.933 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.36 -67.01 0.47 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.842 1.655 . . . . 0.0 110.211 172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -43.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.981 2.113 . . . . 0.0 113.294 -170.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.9 -4.17 50.41 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.73 1.212 . . . . 0.0 111.482 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.9 5.53 87.76 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 117.271 -1.849 . . . . 0.0 115.146 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.2 -29.08 69.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 121.495 2.648 . . . . 0.0 110.937 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -53.54 -38.1 63.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.88 1.672 . . . . 0.0 111.619 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.76 -50.67 48.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.5 m -60.5 -47.36 86.48 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.721 0.808 . . . . 0.0 110.132 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -52.05 41.1 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 110.213 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.3 -46.17 84.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -66.3 -26.84 67.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 117.995 -1.003 . . . . 0.0 113.031 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -54.84 -33.1 61.33 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.504 0.593 . . . . 0.0 110.558 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.45 9.38 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.438 1.017 . . . . 0.0 112.199 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.16 17.8 79.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.311 0.96 . . . . 0.0 114.181 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.32 -61.83 1.63 Allowed 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.123 1.769 . . . . 0.0 111.468 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.35 133.29 46.79 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.249 1.077 0 O-C-N 126.227 2.204 . . . . 0.0 112.195 -152.431 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 CA--C 1.53 0.212 0 CA-C-O 120.579 0.228 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.75 -33.29 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.96 -30.86 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.861 -0.525 . . . . 0.0 111.541 -162.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -89.18 -19.22 25.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.091 1.757 . . . . 0.0 110.61 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -47.09 82.46 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.493 -1.38 . . . . 0.0 109.012 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -71.28 148.03 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -136.25 145.97 54.24 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.133 0.973 . . . . 0.0 108.878 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 61.21 7.62 Favored 'Trans proline' 0 CA--C 1.537 0.661 1 C-N-CA 125.324 4.016 . . . . 0.0 112.924 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.06 23.09 0.03 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 125.809 1.671 . . . . 0.0 111.723 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -137.94 154.04 49.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 127.003 2.121 . . . . 0.0 107.006 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.04 93.13 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.58 129.94 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.18 155.98 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.75 125.59 50.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.54 175.63 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.048 2.139 . . . . 0.0 110.005 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -129.73 152.96 80.68 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.11 1.764 . . . . 0.0 106.688 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.79 -13.62 26.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.235 2.623 . . . . 0.0 113.145 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -102.3 -10.68 19.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.816 2.047 . . . . 0.0 112.209 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -90.95 127.57 51.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.653 0.781 . . . . 0.0 109.381 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.89 -23.05 16.78 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.86 1.707 . . . . 0.0 111.293 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.38 -35.04 47.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -58.19 -54.08 51.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.581 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -51.11 -45.15 61.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.306 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -61.59 2.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.96 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.895 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -55.11 -58.74 6.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.38 1.472 . . . . 0.0 112.683 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.87 -41.49 82.75 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 118.549 0.613 . . . . 0.0 109.802 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -53.75 -52.82 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.443 1.497 . . . . 0.0 109.101 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.31 -44.77 64.51 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -55.73 -15.67 3.4 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.5 -23.02 59.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.802 2.092 . . . . 0.0 111.745 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.29 137.12 39.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 119.071 0.851 . . . . 0.0 109.682 -169.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.72 85.17 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.847 3.031 . . . . 0.0 111.032 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.34 151.63 7.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.474 1.51 . . . . 0.0 107.196 -165.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -49.24 126.65 13.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.026 0.93 . . . . 0.0 109.988 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.46 130.02 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.67 84.35 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 117.623 -1.654 . . . . 0.0 113.16 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.12 -37.72 64.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.594 2.197 . . . . 0.0 111.022 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 110.37 18.26 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.403 1.456 . . . . 0.0 107.589 -175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -124.53 98.61 5.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.221 1.408 . . . . 0.0 108.549 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -83.97 105.99 15.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.59 127.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.963 1.305 . . . . 0.0 107.568 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.842 1.257 . . . . 0.0 111.119 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.0 pt -68.6 -16.76 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.722 -1.237 . . . . 0.0 112.243 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.315 174.514 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.89 -63.28 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.764 2.026 . . . . 0.0 109.96 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -45.19 -48.49 12.47 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.952 1.701 . . . . 0.0 113.719 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -40.19 73.51 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.58 0.627 . . . . 0.0 110.498 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 mt -63.31 -42.27 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -58.01 -51.32 70.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.17 2.988 . . . . 0.0 109.27 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.23 -62.16 1.9 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.041 1.737 . . . . 0.0 110.442 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -53.17 -41.02 64.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.07 -27.57 69.19 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.753 1.221 . . . . 0.0 112.423 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -44.3 96.66 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.026 0.83 . . . . 0.0 110.049 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.45 -46.76 37.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.211 0.605 . . . . 0.0 110.359 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.69 -23.82 66.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 111.464 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 1.5 p -127.22 -72.22 0.65 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.741 1.609 . . . . 0.0 109.45 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.16 -21.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.492 -1.171 . . . . 0.0 114.864 -172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.71 156.94 45.09 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.861 1.831 . . . . 0.0 110.24 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -71.63 -30.49 65.82 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.692 -0.63 . . . . 0.0 110.01 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 p -61.16 133.54 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -165.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 165.64 22.28 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.354 1.462 . . . . 0.0 107.487 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.4 171.1 18.13 Favored 'Cis proline' 0 C--N 1.345 0.352 0 CA-C-N 120.883 1.351 . . . . 0.0 111.815 -6.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -142.37 108.01 5.1 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.85 133.27 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -114.75 140.4 48.92 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 113.08 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.59 58.53 13.94 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.353 -0.842 . . . . 0.0 112.008 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.256 1.0 OUTLIER 46.21 27.73 0.59 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -174.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -129.85 135.23 48.15 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.65 1.114 . . . . 0.0 109.187 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -71.11 150.03 45.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -105.51 -12.46 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 122.924 0.49 . . . . 0.0 111.39 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.18 -165.44 18.34 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -166.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.65 -95.57 2.41 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 119.006 -0.886 . . . . 0.0 110.921 -174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.89 -56.78 2.19 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.133 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -59.35 -39.04 81.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.861 1.664 . . . . 0.0 112.126 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -42.86 81.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.827 0.451 . . . . 0.0 109.871 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.16 -37.0 85.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.558 0.743 . . . . 0.0 110.479 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.39 -49.56 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 115.494 -2.193 . . . . 0.0 109.738 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -61.93 -39.95 93.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 122.939 2.608 . . . . 0.0 112.051 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -54.47 -46.18 73.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.41 -51.95 25.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 121.375 1.898 . . . . 0.0 110.959 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.2 -53.15 53.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.897 1.679 . . . . 0.0 112.01 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.4 t -71.59 -5.19 31.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.845 1.258 . . . . 0.0 110.775 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.93 9.29 59.44 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.016 -1.435 . . . . 0.0 112.968 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.38 -21.6 66.24 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.264 2.032 . . . . 0.0 111.842 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.49 -37.9 65.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 111.047 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.41 -48.69 74.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.667 0.667 . . . . 0.0 109.65 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -46.57 85.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.199 1.0 . . . . 0.0 110.236 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -47.7 -53.51 14.84 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.512 1.525 . . . . 0.0 110.392 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 mp -72.27 -34.85 68.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -58.95 -30.75 68.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.435 1.471 . . . . 0.0 111.419 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -54.62 -19.01 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 112.979 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.01 11.08 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.716 1.143 . . . . 0.0 112.384 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.23 46.9 7.27 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 118.703 0.683 . . . . 0.0 112.431 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.34 -72.49 0.58 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.842 1.257 . . . . 0.0 111.875 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.58 137.19 55.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 120.182 1.355 . . . . 0.0 109.528 -159.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 163.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.226 -0.177 0 CA-C-O 120.02 -0.038 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.79 -62.85 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.86 -43.65 98.41 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -159.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.37 -15.13 60.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.273 -0.87 . . . . 0.0 113.296 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -71.99 -38.76 69.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.426 1.466 . . . . 0.0 111.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.05 126.36 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -106.88 162.32 20.07 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 123.42 0.688 . . . . 0.0 109.357 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.5 79.18 0.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.636 2.89 . . . . 0.0 109.658 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.79 19.7 0.49 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 127.313 2.387 . . . . 0.0 113.54 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -111.96 159.02 18.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.782 1.791 . . . . 0.0 108.467 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -113.07 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.8 t -84.06 147.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.98 113.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.52 126.28 30.71 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.11 168.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.791 1.236 . . . . 0.0 110.399 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -117.5 149.57 45.07 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 158.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.28 4.83 5.54 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.188 1.926 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -124.21 -17.25 6.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 132.33 89.12 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 168.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -64.85 -21.26 64.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.766 1.644 . . . . 0.0 109.78 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -74.34 -42.9 58.65 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.953 0.901 . . . . 0.0 109.609 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.64 -45.13 94.25 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -54.55 -44.93 73.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.103 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -57.74 10.27 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 118.793 0.724 . . . . 0.0 109.654 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.96 55.84 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -69.58 -37.62 77.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 117.558 -1.21 . . . . 0.0 114.113 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.51 -49.25 27.56 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 120.111 1.323 . . . . 0.0 108.464 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -49.28 -53.33 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.531 1.532 . . . . 0.0 109.982 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.46 -46.43 17.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -74.79 6.25 4.16 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.156 1.343 . . . . 0.0 114.196 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.1 -12.73 60.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.47 1.508 . . . . 0.0 112.572 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.4 148.66 56.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.55 1.068 . . . . 0.0 111.199 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.64 96.62 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.181 2.588 . . . . 0.0 109.911 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.82 145.98 30.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -47.32 134.34 11.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.272 0.629 . . . . 0.0 111.998 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -49.42 115.39 1.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.381 1.473 . . . . 0.0 109.137 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.92 86.75 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.404 -1.22 . . . . 0.0 114.126 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.73 -33.07 64.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 121.215 2.507 . . . . 0.0 109.962 165.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.46 109.59 17.47 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -171.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -129.25 102.72 6.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.51 90.4 8.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.128 1.371 . . . . 0.0 107.938 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.5 111.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.475 1.51 . . . . 0.0 109.212 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -71.31 115.01 9.97 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.314 1.046 . . . . 0.0 112.929 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 pt -70.82 -35.0 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.688 1.595 . . . . 0.0 112.494 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.232 0.177 0 C-N-CA 124.297 1.039 . . . . 0.0 111.63 -166.732 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m170 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -63.68 1.2 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -67.7 -23.69 65.32 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.95 -48.62 73.43 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.061 1.744 . . . . 0.0 111.009 165.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.3 mt -60.86 -38.28 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.102 0.961 . . . . 0.0 109.066 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -59.96 -49.86 76.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.02 -44.09 85.74 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.5 1.143 . . . . 0.0 112.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -58.11 -43.64 87.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.624 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 mt -61.89 -33.24 73.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.116 0.966 . . . . 0.0 111.081 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.27 -51.0 69.75 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 119.15 0.886 . . . . 0.0 110.39 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.29 -49.54 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.209 0.528 . . . . 0.0 109.609 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tp -73.53 -17.9 61.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.792 0.837 . . . . 0.0 111.114 -167.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -129.25 -25.91 2.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 114.451 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.51 23.1 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.071 -1.405 . . . . 0.0 112.183 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.86 147.52 22.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 121.069 2.435 . . . . 0.0 110.698 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -21.09 61.05 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 p -70.24 133.75 47.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.806 0.73 . . . . 0.0 110.457 -159.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 161.74 22.54 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.483 1.913 . . . . 0.0 107.813 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.85 125.01 6.2 Favored 'Cis proline' 0 C--N 1.345 0.394 0 CA-C-N 120.344 1.158 . . . . 0.0 111.571 -1.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -95.61 91.25 6.04 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.64 125.07 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 94.03 4.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.142 2.577 . . . . 0.0 107.38 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.27 112.37 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.47 63.39 5.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.291 0.948 . . . . 0.0 113.41 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 46.48 15.28 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.838 2.455 . . . . 0.0 115.703 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -126.96 144.5 50.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 120.074 1.306 . . . . 0.0 109.887 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -86.57 134.96 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.974 0.91 . . . . 0.0 110.896 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pp -83.86 -18.41 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 119.104 0.866 . . . . 0.0 110.556 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.06 -141.3 12.48 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.8 -158.05 14.37 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.898 1.713 . . . . 0.0 108.838 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -22.03 59.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.756 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -65.32 -45.09 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.847 1.203 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.32 -57.62 12.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.162 1.785 . . . . 0.0 107.112 170.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.9 tp -52.0 -40.09 60.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.14 -50.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 117.266 -1.349 . . . . 0.0 108.382 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -43.24 99.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 120.82 1.645 . . . . 0.0 110.28 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -51.82 -47.48 64.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.097 0.862 . . . . 0.0 109.537 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.79 -52.58 42.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.515 1.052 . . . . 0.0 110.785 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -58.73 3.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.947 1.699 . . . . 0.0 111.244 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -11.46 59.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.463 1.505 . . . . 0.0 109.889 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.51 -2.53 49.76 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.569 161.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -59.27 -28.87 67.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.797 1.799 . . . . 0.0 111.435 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 tt -44.17 -57.89 3.17 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.359 1.863 . . . . 0.0 110.514 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.73 -42.09 98.5 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.864 0.756 . . . . 0.0 109.532 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -61.29 -54.23 46.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.791 0.836 . . . . 0.0 110.358 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.52 76.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.436 1.094 . . . . 0.0 111.021 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.66 -47.4 60.19 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.31 -26.34 67.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.174 1.352 . . . . 0.0 112.468 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -52.3 -33.04 40.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.346 1.458 . . . . 0.0 110.738 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.04 11.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.126 0.876 . . . . 0.0 112.674 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 37.9 26.68 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.2 -0.938 . . . . 0.0 112.328 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.99 -69.83 0.56 Allowed 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 112.131 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.84 136.58 52.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.991 0.814 . . . . 0.0 110.839 -158.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.664 3.185 . . . . 0.0 105.219 -175.245 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.96 -55.12 23.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.32 1.448 . . . . 0.0 109.448 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.66 -39.87 95.28 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 t -81.4 38.6 0.49 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.803 2.041 . . . . 0.0 111.772 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -130.91 -47.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.626 0.771 . . . . 0.0 109.647 159.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.17 133.76 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.21 165.07 34.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.58 156.77 40.22 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.008 -1.574 . . . . 0.0 108.008 159.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.69 17.1 77.94 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.191 -0.943 . . . . 0.0 115.08 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -135.78 162.04 33.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.684 1.593 . . . . 0.0 108.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.88 79.58 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.19 132.95 33.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.06 110.79 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.3 130.07 38.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.08 179.73 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 C-N-CA 126.362 1.865 . . . . 0.0 109.843 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -140.37 151.27 63.73 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 158.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.22 -15.01 20.49 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.588 2.192 . . . . 0.0 111.527 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -50.57 43.57 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.703 1.201 . . . . 0.0 110.131 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.41 ' H ' ' HG3' ' A' ' 20' ' ' LYS . 16.0 m -61.1 109.59 2.25 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.401 1.481 . . . . 0.0 111.398 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.75 -20.84 58.98 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.992 1.795 . . . . 0.0 110.898 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -73.2 -22.32 60.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.926 -1.109 . . . . 0.0 111.294 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.96 -33.12 74.05 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.47 -0.769 . . . . 0.0 109.755 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -63.17 -30.04 71.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.764 0.826 . . . . 0.0 111.774 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.76 4.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.22 51.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 124.365 1.041 . . . . 0.0 111.785 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.6 -56.53 16.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.549 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.46 -41.33 63.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 123.741 0.651 . . . . 0.0 110.263 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -50.21 -57.42 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.732 1.213 . . . . 0.0 108.737 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.96 -43.25 45.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.303 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.2 p -65.65 -20.83 66.45 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 120.03 1.286 . . . . 0.0 113.915 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -73.51 -21.77 60.31 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.626 1.103 . . . . 0.0 110.697 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.78 142.24 56.53 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -64.56 127.56 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -146.36 157.61 11.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 128.02 34.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.173 0.989 . . . . 0.0 109.646 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -64.43 126.24 27.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.985 -168.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.92 71.29 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.962 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.68 -37.58 65.19 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 119.847 1.824 . . . . 0.0 109.002 164.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 100.03 10.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -170.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -122.1 101.49 7.57 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 108.92 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -84.55 93.82 8.44 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.774 1.23 . . . . 0.0 108.638 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.56 112.22 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.809 1.244 . . . . 0.0 109.363 -171.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.83 121.29 13.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.506 1.523 . . . . 0.0 112.793 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.5 pt -85.18 -21.35 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.17 1.388 . . . . 0.0 113.382 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 119.071 0.85 . . . . 0.0 110.134 -179.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -37.13 -63.02 0.46 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.417 2.287 . . . . 0.0 109.792 164.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -43.74 -49.34 7.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.031 1.333 . . . . 0.0 113.372 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.68 -43.39 80.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.935 0.894 . . . . 0.0 111.458 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.2 mt -62.87 -31.75 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -69.35 -54.24 15.51 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.9 -55.8 17.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 123.679 1.704 . . . . 0.0 111.004 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 4.67 13.71 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.764 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -91.41 -37.7 13.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 118.122 -2.861 . . . . 0.0 109.907 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.83 -49.79 47.72 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.336 1.455 . . . . 0.0 108.142 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -57.49 5.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.412 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.86 -23.86 67.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 111.01 -163.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.1 p -126.45 -17.31 5.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.75 50.0 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.645 1.111 . . . . 0.0 112.155 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.28 158.16 31.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.336 1.854 . . . . 0.0 107.869 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -22.08 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -55.41 133.54 49.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.41 0.684 . . . . 0.0 111.139 -161.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.82 153.8 39.96 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -60.3 147.17 43.24 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.122 1.079 . . . . 0.0 110.043 -10.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -130.46 103.1 6.46 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.09 124.45 40.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 123.022 0.529 . . . . 0.0 109.92 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -103.37 105.5 15.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.605 1.562 . . . . 0.0 107.772 160.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.97 116.57 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 161.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 41.46 69.67 0.51 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 126.193 1.854 . . . . 0.0 114.019 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 47.31 21.37 0.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -116.82 120.67 39.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.908 1.283 . . . . 0.0 108.632 165.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -83.99 104.26 13.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.201 0.6 . . . . 0.0 110.088 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -83.85 -8.74 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.462 0.574 . . . . 0.0 112.008 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.97 -167.19 24.15 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.843 0.735 . . . . 0.0 112.606 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.7 -162.15 34.81 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.032 1.301 . . . . 0.0 110.373 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -37.93 71.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.652 1.226 . . . . 0.0 110.104 -165.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 m -68.43 -36.09 78.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.557 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.33 -49.76 58.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.607 1.163 . . . . 0.0 108.618 173.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -44.32 62.74 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.016 1.726 . . . . 0.0 111.821 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.17 -44.84 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-O 117.113 -1.422 . . . . 0.0 109.694 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.99 -48.79 75.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -173.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.12 -42.34 85.56 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.222 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -64.1 -56.84 12.04 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.371 0.987 . . . . 0.0 110.305 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -51.52 55.07 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.739 1.616 . . . . 0.0 111.364 -172.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.0 t -71.49 -7.23 46.19 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.325 1.45 . . . . 0.0 110.934 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.09 77.93 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.662 -1.632 . . . . 0.0 114.062 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.04 -33.66 73.64 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.742 2.271 . . . . 0.0 110.707 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -38.18 86.61 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.904 1.282 . . . . 0.0 109.545 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.25 -37.72 86.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.364 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -48.57 72.51 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.589 1.086 . . . . 0.0 109.736 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -50.73 62.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 110.593 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -60.11 -48.21 82.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.49 1.516 . . . . 0.0 110.715 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.59 -35.22 77.23 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.903 -1.123 . . . . 0.0 111.811 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -54.0 -32.42 54.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.007 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.96 5.5 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 119.484 1.038 . . . . 0.0 113.377 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.89 39.44 13.5 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.747 1.158 . . . . 0.0 112.87 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 106' ' ' GLN . . . -84.93 -74.86 0.38 Allowed 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 125.876 1.67 . . . . 0.0 112.602 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -53.13 -23.38 8.0 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.24 1.816 . . . . 0.0 114.872 -159.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 130.377 3.471 . . . . 0.0 110.523 -173.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.51 -60.26 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.524 -0.735 . . . . 0.0 110.263 166.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.617 ' ND2' ' HH ' ' A' ' 60' ' ' TYR . 22.3 m-20 -63.38 -27.29 69.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -163.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.2 t -87.35 -24.15 24.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.087 0.955 . . . . 0.0 111.349 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -73.95 -37.84 64.43 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 121.074 -1.016 . . . . 0.0 111.406 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.61 149.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 160.05 34.92 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 72.0 Cg_endo -75.94 111.36 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.412 2.741 . . . . 0.0 108.733 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 9.12 21.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.42 1.486 . . . . 0.0 113.646 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -123.47 166.04 16.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.09 1.756 . . . . 0.0 109.241 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.0 110.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.01 139.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.43 112.91 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -78.4 119.91 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.42 161.28 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.629 1.172 . . . . 0.0 111.602 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -120.33 141.96 32.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.58 -20.12 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.903 1.736 . . . . 0.0 110.996 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 26.52 0.97 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.798 2.039 . . . . 0.0 111.44 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -130.92 134.97 26.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.622 2.369 . . . . 0.0 108.706 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.98 -25.87 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.179 2.586 . . . . 0.0 112.265 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -74.34 -29.98 61.83 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.37 -48.0 83.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.562 -0.711 . . . . 0.0 109.836 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -59.5 -41.51 90.06 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.518 -0.739 . . . . 0.0 110.164 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -58.67 6.53 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -39.85 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.154 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.449 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -56.46 -54.3 47.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.503 172.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -69.47 -41.93 75.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.288 0.949 . . . . 0.0 109.752 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.73 -52.28 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 125.727 1.611 . . . . 0.0 110.159 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.22 -48.97 16.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -69.83 -13.58 62.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.923 0.489 . . . . 0.0 112.269 -169.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.08 -23.33 60.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.035 0.834 . . . . 0.0 110.951 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.08 149.65 85.14 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.12 113.99 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 106.631 -2.103 . . . . 0.0 106.631 164.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.66 138.44 54.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 124.34 7.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.968 1.307 . . . . 0.0 108.687 -169.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.61 122.33 13.81 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -162.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.19 -12.96 58.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.082 1.325 . . . . 0.0 113.875 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.67 -28.29 61.68 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 120.697 2.249 . . . . 0.0 110.458 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 120.67 26.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 120.229 1.377 . . . . 0.0 107.482 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -131.61 104.71 7.09 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.473 1.109 . . . . 0.0 109.338 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 20.3 m-85 -84.6 100.76 11.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.07 107.39 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -67.06 104.45 1.41 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.1 pt -69.44 -18.25 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.64 0.776 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 CA--C 1.535 0.366 0 O-C-N 121.386 -0.821 . . . . 0.0 111.382 179.216 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m170 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.41 -63.68 0.78 Allowed 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.558 1.943 . . . . 0.0 109.053 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -52.34 -43.27 64.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.196 1.398 . . . . 0.0 109.801 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.87 -36.1 69.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 112.246 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.7 -51.74 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -57.25 10.04 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.291 0.567 . . . . 0.0 110.822 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.67 -42.33 62.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.242 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' HH ' ' ND2' ' A' ' 7' ' ' ASN . 33.6 t80 -61.13 -43.43 98.9 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.682 0.673 . . . . 0.0 110.709 175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.78 -27.51 68.05 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.333 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -56.69 14.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 120.739 1.609 . . . . 0.0 109.67 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.79 -49.13 71.7 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.839 0.712 . . . . 0.0 109.972 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.3 -29.74 57.48 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.116 1.366 . . . . 0.0 111.606 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 p -125.63 -29.08 3.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.55 13.96 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.179 -1.345 . . . . 0.0 113.982 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.99 150.97 9.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.649 2.224 . . . . 0.0 110.68 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptt-85 -96.61 -7.87 33.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.738 0.815 . . . . 0.0 112.571 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -65.05 133.98 52.84 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 108.649 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.88 147.0 34.61 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 126.618 1.967 . . . . 0.0 105.794 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -66.35 155.1 81.97 Favored 'Cis proline' 0 N--CA 1.461 -0.436 0 CA-C-N 120.353 1.162 . . . . 0.0 111.666 3.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -140.29 106.48 5.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.89 127.46 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.73 93.98 4.3 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.598 2.359 . . . . 0.0 106.85 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.5 121.6 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.75 63.44 3.84 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.231 0.919 . . . . 0.0 113.425 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.406 ' HE3' ' HD3' ' A' ' 12' ' ' PRO . 3.5 ttmt 46.13 19.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.369 2.267 . . . . 0.0 117.056 -173.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.74 133.38 50.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.069 1.304 . . . . 0.0 110.571 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -81.11 121.99 26.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.106 -0.996 . . . . 0.0 109.899 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.31 -11.81 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 119.616 1.098 . . . . 0.0 111.502 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.83 -163.69 19.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.322 0.963 . . . . 0.0 111.137 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.19 -155.26 29.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.303 0.954 . . . . 0.0 111.076 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -41.96 95.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.465 0.633 . . . . 0.0 111.269 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -65.94 -44.63 84.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.444 0.566 . . . . 0.0 110.897 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.47 -58.13 9.34 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.0 tp -50.51 -42.13 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.436 1.094 . . . . 0.0 112.051 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.28 -51.02 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 116.347 -1.787 . . . . 0.0 109.229 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.47 54.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.448 1.931 . . . . 0.0 107.14 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.33 -40.98 83.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.111 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -74.67 -47.58 30.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.197 1.362 . . . . 0.0 107.806 -172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -35.85 60.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.373 1.069 . . . . 0.0 111.073 -169.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 t -94.13 -2.8 52.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.838 1.255 . . . . 0.0 111.15 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.76 0.32 87.74 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.082 -1.954 . . . . 0.0 115.075 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.54 -33.63 74.17 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 121.295 2.548 . . . . 0.0 110.37 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 tp -54.69 -37.64 66.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.48 -48.15 57.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -56.58 -49.87 73.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.981 0.913 . . . . 0.0 109.283 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.4 91.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.101 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -50.34 62.79 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.183 173.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.37 1.441 . . . . 0.0 111.801 -164.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.35 -39.08 14.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.304 1.441 . . . . 0.0 113.02 168.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.18 0.58 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 119.304 0.956 . . . . 0.0 111.936 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.34 55.2 2.94 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.7 1.143 . . . . 0.0 110.925 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.46 -75.65 0.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.79 1.636 . . . . 0.0 111.892 -167.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.89 133.73 52.49 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.235 -0.888 . . . . 0.0 108.826 -172.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.8 t80 . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.94 -47.05 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.949 0.9 . . . . 0.0 109.976 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.84 -44.19 86.22 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.006 -0.434 . . . . 0.0 111.355 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.22 -23.52 65.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.703 1.601 . . . . 0.0 112.168 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.05 -44.33 69.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.913 1.233 . . . . 0.0 110.268 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 136.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.23 153.02 55.51 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.08 80.54 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.178 2.586 . . . . 0.0 109.361 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.51 18.54 0.27 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.074 1.797 . . . . 0.0 115.323 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -132.17 171.82 13.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.568 1.684 . . . . 0.0 108.074 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.87 110.39 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.0 t -126.73 126.16 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.81 112.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -81.83 120.16 24.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.22 164.52 34.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.391 1.477 . . . . 0.0 111.402 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -123.55 139.54 32.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 165.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.58 -9.55 21.42 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.373 2.049 . . . . 0.0 112.104 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 p -79.23 -18.81 52.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.581 2.352 . . . . 0.0 113.592 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -122.4 134.54 24.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -158.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.86 -14.25 26.67 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.805 2.337 . . . . 0.0 112.304 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -73.27 -35.17 66.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.566 1.075 . . . . 0.0 108.739 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.27 -47.07 74.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -52.05 -49.96 62.42 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.157 0.983 . . . . 0.0 113.049 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -57.03 14.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.582 1.083 . . . . 0.0 109.02 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -35.94 64.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.412 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -53.65 54.34 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.561 1.144 . . . . 0.0 112.435 174.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.69 -52.26 46.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.1 mt -46.73 -53.64 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.763 2.025 . . . . 0.0 109.413 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.94 -47.16 63.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.9 p -63.45 -19.14 64.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.538 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -73.28 -33.22 65.12 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 120.254 1.388 . . . . 0.0 109.966 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.12 136.05 95.28 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.81 76.98 3.87 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.493 2.795 . . . . 0.0 110.046 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.7 mt -87.76 145.51 7.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -53.25 123.39 11.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -66.3 122.87 18.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 -8.04 40.89 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.192 1.377 . . . . 0.0 111.801 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -78.04 -33.7 50.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.812 1.806 . . . . 0.0 111.489 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 120.73 29.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.433 1.015 . . . . 0.0 109.782 -171.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.67 130.68 47.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.481 0.712 . . . . 0.0 109.605 168.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.0 101.42 11.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.7 113.97 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.005 2.122 . . . . 0.0 108.485 -167.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -69.9 109.97 4.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.529 0.732 . . . . 0.0 110.532 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.43 13.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.316 1.046 . . . . 0.0 112.857 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.234 0.253 0 O-C-N 120.449 -1.407 . . . . 0.0 111.45 179.702 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 CA--C 1.515 -0.383 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -63.53 0.99 Allowed 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 125.465 1.506 . . . . 0.0 107.495 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -44.14 -48.89 9.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.525 1.13 . . . . 0.0 113.013 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -52.64 64.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.552 1.141 . . . . 0.0 111.411 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.96 -31.82 54.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.75 1.22 . . . . 0.0 111.675 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.536 ' HA ' HH22 ' A' ' 72' ' ' ARG . 7.1 mt-30 -68.31 -45.31 73.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -64.64 -52.27 58.27 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.703 2.801 . . . . 0.0 110.405 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -55.05 -47.82 74.28 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.148 0.979 . . . . 0.0 111.205 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.66 -36.95 85.16 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.73 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.71 -44.31 96.76 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.53 1.059 . . . . 0.0 110.725 172.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -42.39 98.83 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.829 0.452 . . . . 0.0 110.597 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.05 -29.69 58.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.421 1.089 . . . . 0.0 109.399 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -125.06 -76.03 0.59 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.202 0.91 . . . . 0.0 109.072 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.31 -8.31 0.05 OUTLIER Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.728 -1.596 . . . . 0.0 116.715 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.43 146.26 48.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.572 2.686 . . . . 0.0 111.19 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.12 -28.29 15.15 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.302 1.441 . . . . 0.0 112.238 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 p -61.14 133.82 56.4 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 159.02 56.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.43 170.28 32.85 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 CA-C-N 118.763 0.594 . . . . 0.0 111.88 -11.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.536 HH22 ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -121.11 113.14 19.59 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 159.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.7 t -83.22 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.96 121.93 43.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 164.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.88 118.57 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 166.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.65 58.96 11.46 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.387 0.994 . . . . 0.0 112.689 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.285 3.6 tmtt? 45.49 30.73 0.78 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.58 1.952 . . . . 0.0 116.192 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.02 149.95 49.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.71 130.39 34.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.88 -26.08 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.14 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.17 -174.2 21.83 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.636 1.589 . . . . 0.0 112.057 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 -167.67 42.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.31 1.433 . . . . 0.0 112.042 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.42 -38.11 89.89 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.811 1.306 . . . . 0.0 111.598 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -64.99 -40.18 94.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.399 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.84 -51.65 45.97 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.421 1.088 . . . . 0.0 109.316 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.1 tp -51.89 -38.91 57.98 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 125.515 1.526 . . . . 0.0 111.652 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.42 -47.87 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 116.53 -1.7 . . . . 0.0 109.8 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -46.79 88.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.636 2.017 . . . . 0.0 108.615 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.155 -174.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.07 -52.54 23.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.385 1.448 . . . . 0.0 110.234 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.79 49.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.928 1.691 . . . . 0.0 111.399 -170.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -63.66 -33.55 75.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.76 2.024 . . . . 0.0 109.951 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.32 64.81 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.951 -1.472 . . . . 0.0 112.034 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.75 -32.04 65.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.089 1.945 . . . . 0.0 110.835 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.29 -36.23 70.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.846 1.659 . . . . 0.0 110.648 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.77 -50.67 61.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.916 0.487 . . . . 0.0 109.829 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 m -60.41 -49.29 78.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.883 0.873 . . . . 0.0 109.551 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -49.35 60.0 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.433 1.093 . . . . 0.0 110.348 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.4 mt -66.99 -45.09 78.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.32 -24.44 64.84 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.34 -1.475 . . . . 0.0 112.832 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.08 -39.34 59.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.861 0.755 . . . . 0.0 110.323 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.11 10.93 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.919 0.888 . . . . 0.0 111.914 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.45 76.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.411 -0.806 . . . . 0.0 113.571 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.0 -67.7 0.45 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 118.467 1.133 . . . . 0.0 110.142 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.92 134.01 45.75 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 118.163 -1.415 . . . . 0.0 107.669 -162.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 125.11 1.506 . . . . 0.0 108.668 -157.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.85 -54.19 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.851 0.861 . . . . 0.0 109.954 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.81 -38.22 75.16 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.051 0.94 . . . . 0.0 110.971 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.22 -29.76 64.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.736 0.815 . . . . 0.0 111.702 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -76.65 -45.6 29.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.797 1.635 . . . . 0.0 111.484 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.65 148.29 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -144.5 145.96 30.71 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.19 129.44 28.5 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.701 1.601 . . . . 0.0 108.617 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.54 77.88 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.372 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.6 169.91 8.99 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.237 2.019 . . . . 0.0 110.041 172.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.86 109.49 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.63 111.35 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.82 121.14 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.79 130.14 34.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.48 173.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 110.399 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.41 144.53 43.08 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 161.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.83 -15.04 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.749 1.633 . . . . 0.0 111.433 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -66.65 -49.03 67.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.106 2.162 . . . . 0.0 110.943 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 122.35 87.28 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.806 1.242 . . . . 0.0 110.257 -172.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.29 -11.5 31.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.272 2.648 . . . . 0.0 112.31 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.8 -31.46 63.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.241 -0.912 . . . . 0.0 109.588 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -72.82 -38.77 67.04 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -46.55 67.06 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.138 0.575 . . . . 0.0 110.068 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.92 -56.05 23.84 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.287 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.91 -38.85 65.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.238 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -48.64 79.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.37 0.986 . . . . 0.0 113.644 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.09 -44.57 53.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -49.3 -54.83 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.969 1.307 . . . . 0.0 110.323 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.97 -41.56 20.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.813 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.7 t -70.65 -18.71 62.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.543 1.519 . . . . 0.0 112.498 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.83 -11.01 60.24 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.729 1.149 . . . . 0.0 111.827 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.12 133.06 39.77 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 163.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.44 62.52 8.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.011 2.474 . . . . 0.0 111.791 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.16 147.84 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -55.77 124.31 17.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -62.61 113.38 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.09 -12.9 9.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.744 1.164 . . . . 0.0 111.741 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.15 -39.81 15.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.691 1.745 . . . . 0.0 111.63 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 115.91 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.482 1.113 . . . . 0.0 109.465 -167.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -137.74 107.54 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.52 1.055 . . . . 0.0 109.078 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -85.93 105.12 16.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.842 1.257 . . . . 0.0 108.175 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.08 111.01 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -63.45 127.93 33.52 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 162.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 pt -93.04 -2.23 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 112.195 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 119.847 1.203 . . . . 0.0 111.372 179.323 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.21 -63.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.468 1.507 . . . . 0.0 110.384 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -40.63 59.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.78 0.832 . . . . 0.0 110.969 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.5 -11.91 56.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.615 1.966 . . . . 0.0 114.425 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 mt -85.03 -47.49 16.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 125.379 1.472 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -40.98 70.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.521 0.677 . . . . 0.0 110.78 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.89 -36.86 72.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.918 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -66.36 -33.87 76.71 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.311 -1.493 . . . . 0.0 112.703 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.92 -29.62 70.78 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 120.186 1.357 . . . . 0.0 110.135 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.79 -38.5 78.67 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 120.354 1.434 . . . . 0.0 110.681 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -55.54 6.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.405 0.682 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.13 -25.79 55.71 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.1 p -122.9 -36.74 2.83 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.813 -1.18 . . . . 0.0 111.977 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.95 -17.69 5.15 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.378 -1.234 . . . . 0.0 114.211 168.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.91 148.33 38.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.899 1.85 . . . . 0.0 110.216 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -11.95 59.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.59 143.11 25.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.805 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 151.55 43.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.9 1.68 . . . . 0.0 106.573 164.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.28 165.45 43.8 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 CA-C-N 120.139 1.086 . . . . 0.0 111.33 -4.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -142.57 109.11 5.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.9 t -88.31 126.78 41.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.935 0.494 . . . . 0.0 110.145 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -105.06 130.47 53.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.82 111.78 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.43 73.39 0.42 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 125.145 1.355 . . . . 0.0 113.213 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.55 -9.18 0.0 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 130.658 3.583 . . . . 0.0 118.107 -173.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -91.73 163.82 13.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.923 1.238 . . . . 0.0 108.877 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 t -125.02 129.13 49.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.828 1.651 . . . . 0.0 109.006 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -106.48 -16.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -162.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.68 178.66 23.96 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.73 -89.54 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 125.206 1.384 . . . . 0.0 110.391 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.45 -62.15 1.05 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 111.642 -169.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.2 t -65.53 -36.79 84.85 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.108 0.867 . . . . 0.0 110.183 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.47 -55.61 29.25 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.5 tp -49.07 -45.49 43.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.995 1.318 . . . . 0.0 111.689 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -46.74 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 116.628 -1.653 . . . . 0.0 109.789 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -49.08 75.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.64 -33.11 69.7 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.489 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -71.4 -51.57 23.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 121.148 1.794 . . . . 0.0 109.784 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -47.73 60.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.015 1.326 . . . . 0.0 110.045 -166.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.98 -34.08 74.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.424 1.89 . . . . 0.0 110.436 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 19.65 57.78 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-O 118.156 -1.358 . . . . 0.0 112.043 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.54 -42.51 83.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.732 2.266 . . . . 0.0 110.381 170.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -35.27 63.55 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.23 1.812 . . . . 0.0 110.473 -174.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.31 -52.58 64.1 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.681 0.793 . . . . 0.0 111.945 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.1 m -65.71 -41.53 92.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.449 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -44.72 73.14 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.771 0.828 . . . . 0.0 110.167 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.93 -44.44 89.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.974 1.31 . . . . 0.0 112.752 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 105' ' ' LEU . 68.0 mttt -63.18 -27.08 69.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.696 1.135 . . . . 0.0 112.434 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -56.03 -15.89 4.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 112.878 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.59 12.3 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.141 1.337 . . . . 0.0 112.351 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.74 36.14 58.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.174 -0.954 . . . . 0.0 113.005 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.72 -66.05 0.96 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.253 1.421 . . . . 0.0 112.757 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . 17.1 mt -75.27 133.57 41.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 121.352 1.887 . . . . 0.0 107.572 -167.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.771 1.229 . . . . 0.0 109.315 -167.269 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.4 t80 . . . . . 0 C--O 1.225 -0.201 0 CA-C-O 119.643 -0.218 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -68.99 -59.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.51 -49.41 74.83 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -161.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 t -76.76 -26.44 54.54 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.79 0.836 . . . . 0.0 112.367 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -66.47 -39.18 88.64 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.322 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.81 132.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.18 155.49 71.07 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.83 26.08 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 125.302 4.001 . . . . 0.0 115.054 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.23 21.16 0.11 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.603 1.573 . . . . 0.0 113.169 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -120.79 168.24 11.65 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.84 120.55 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.07 135.1 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.73 118.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -82.19 124.53 29.99 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.51 177.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.384 1.474 . . . . 0.0 111.257 -166.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 158.98 64.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.009 1.724 . . . . 0.0 107.289 169.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.88 2.09 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.264 2.643 . . . . 0.0 114.592 -163.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -133.04 -25.3 1.82 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -158.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 156.41 77.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.32 1.448 . . . . 0.0 114.12 -158.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.27 -29.5 21.34 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.431 2.087 . . . . 0.0 110.666 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -73.92 -46.74 42.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.7 m -70.09 -44.23 69.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -48.56 -46.71 39.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.217 -0.927 . . . . 0.0 111.969 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -60.4 -60.54 3.64 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.891 0.769 . . . . 0.0 109.572 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.69 69.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 124.244 0.965 . . . . 0.0 111.968 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -47.54 85.93 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 117.827 -1.082 . . . . 0.0 111.503 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.77 -53.55 31.9 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 119.08 0.855 . . . . 0.0 109.9 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.04 -49.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.442 1.497 . . . . 0.0 109.763 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.27 -51.96 13.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -66.33 -23.44 66.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -73.84 -23.61 59.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.248 0.931 . . . . 0.0 110.044 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.98 138.15 69.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.1 65.79 8.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.303 2.668 . . . . 0.0 111.663 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.02 150.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -55.82 123.97 16.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.502 1.121 . . . . 0.0 109.516 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -65.29 151.31 46.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.322 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.61 -18.83 10.28 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.671 -1.627 . . . . 0.0 112.255 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -46.14 47.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 120.649 2.224 . . . . 0.0 109.803 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 116.08 22.69 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.044 0.84 . . . . 0.0 109.866 -169.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -124.48 150.67 45.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.987 1.315 . . . . 0.0 108.949 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -124.24 130.31 52.31 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.54 101.39 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.801 1.64 . . . . 0.0 107.82 -160.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -64.16 119.67 10.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 pt -89.77 -8.22 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.072 0.949 . . . . 0.0 113.196 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 124.556 1.142 . . . . 0.0 110.964 -175.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.738 0.78 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -62.46 1.56 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 125.377 1.471 . . . . 0.0 107.376 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -47.8 -45.42 29.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.494 1.118 . . . . 0.0 112.537 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.261 9.9 tm-20 -63.87 -44.47 93.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.751 2.02 . . . . 0.0 112.668 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 mt -62.99 -37.75 80.18 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 125.243 1.417 . . . . 0.0 110.335 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.63 -38.56 70.75 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.33 -50.47 72.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.267 1.427 . . . . 0.0 111.057 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.09 -43.31 82.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.9 mt -64.15 -34.85 79.01 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 111.543 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -57.89 -46.0 85.56 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -53.73 30.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.63 -29.77 69.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.708 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -121.8 -27.31 4.69 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.34 -33.99 3.97 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.405 1.479 . . . . 0.0 110.867 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.74 43.59 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.729 1.264 . . . . 0.0 112.077 -172.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.49 -5.89 28.52 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.299 1.039 . . . . 0.0 113.175 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.6 p -68.1 133.78 49.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.99 154.56 37.27 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 132.23 14.57 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.169 1.096 . . . . 0.0 111.716 -9.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -93.03 111.1 22.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.37 126.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -111.23 136.76 49.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 159.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.62 115.51 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 102.501 -3.148 . . . . 0.0 102.501 171.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.46 72.35 0.43 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.661 1.601 . . . . 0.0 114.183 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp 46.58 9.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.002 2.521 . . . . 0.0 116.12 -171.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -114.58 113.21 24.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.994 1.27 . . . . 0.0 108.848 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.94 123.93 21.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.71 -26.04 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 118.714 0.688 . . . . 0.0 109.707 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.38 -161.35 24.67 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.328 0.966 . . . . 0.0 111.133 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.42 -161.47 31.42 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.455 1.026 . . . . 0.0 111.444 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -33.59 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.326 1.063 . . . . 0.0 110.119 -165.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 t -71.42 -36.59 71.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.63 -53.8 30.22 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.3 tp -51.72 -46.42 63.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.313 1.445 . . . . 0.0 112.132 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.39 -44.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 117.357 -1.306 . . . . 0.0 108.892 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -50.02 63.9 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.45 -38.88 72.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.13 -57.32 6.99 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.381 1.446 . . . . 0.0 110.505 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -29.7 65.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.49 1.516 . . . . 0.0 112.486 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 t -87.17 -14.5 41.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.434 2.294 . . . . 0.0 110.638 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.3 89.39 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -25.31 67.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.246 2.523 . . . . 0.0 110.77 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.41 -34.32 76.51 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.605 1.962 . . . . 0.0 111.449 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.16 -50.24 66.74 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 m -61.55 -46.49 89.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.188 0.449 . . . . 0.0 109.808 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -47.0 72.26 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.234 0.47 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.44 -53.48 23.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 111.24 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -58.27 -29.19 65.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.655 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -51.34 -42.58 61.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.715 0.689 . . . . 0.0 110.093 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.31 6.05 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.027 0.831 . . . . 0.0 112.354 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.31 38.01 19.41 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.289 0.95 . . . . 0.0 112.821 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.87 -69.47 0.69 Allowed 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.801 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.46 133.84 49.24 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -172.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.253 1.276 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.934 -160.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.07 -58.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.219 1.007 . . . . 0.0 109.549 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -68.41 -17.74 64.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -159.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.3 t -101.97 -26.42 13.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.983 1.313 . . . . 0.0 110.31 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -64.14 -45.75 87.11 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.659 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.2 143.75 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.682 1.128 . . . . 0.0 108.076 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.7 140.36 35.15 Favored Pre-proline 0 C--O 1.238 0.454 0 CA-C-N 119.296 0.953 . . . . 0.0 109.716 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.86 89.94 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.24 2.627 . . . . 0.0 108.714 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.53 17.04 2.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.896 1.712 . . . . 0.0 113.882 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -128.6 162.23 27.77 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.875 2.07 . . . . 0.0 109.636 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.29 81.45 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.43 134.93 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 t -134.3 111.71 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -78.46 128.36 33.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 pt -138.53 179.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.3 1.84 . . . . 0.0 109.24 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -144.79 147.6 36.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 158.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.34 -14.97 38.33 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.579 2.186 . . . . 0.0 113.042 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p -77.16 -28.82 54.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.333 0.97 . . . . 0.0 111.672 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -74.8 121.52 85.44 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.583 0.629 . . . . 0.0 110.382 -164.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.74 -15.62 33.43 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.012 1.808 . . . . 0.0 111.823 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.98 -33.55 24.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.772 1.169 . . . . 0.0 109.341 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.2 m -62.63 -41.52 99.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -53.49 -42.76 67.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.474 0.579 . . . . 0.0 112.29 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -55.82 23.19 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.02 -36.08 62.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.307 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.92 83.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.777 169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.81 -46.58 65.38 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 120.543 1.519 . . . . 0.0 109.414 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -52.09 -58.34 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 126.504 1.921 . . . . 0.0 107.7 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.47 -33.34 58.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.598 -170.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 m -67.33 -35.13 78.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 0.0 112.138 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.98 -9.43 58.63 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.904 1.229 . . . . 0.0 112.079 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.57 135.52 43.41 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.058 1.299 . . . . 0.0 109.392 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.12 75.96 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.515 3.477 . . . . 0.0 110.481 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.93 151.3 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -169.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -48.25 130.53 16.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.383 1.073 . . . . 0.0 110.485 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.1 140.27 56.01 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.66 -7.81 57.18 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.814 -1.548 . . . . 0.0 113.733 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.57 -37.19 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 121.066 2.433 . . . . 0.0 110.966 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 103.29 13.26 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.26 103.68 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.377 1.071 . . . . 0.0 108.58 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -84.09 117.49 23.48 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.67 109.2 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.995 2.118 . . . . 0.0 108.834 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -64.02 104.95 0.78 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.494 2.318 . . . . 0.0 114.015 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.67 -22.38 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.757 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.262 3.0 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 117.877 -1.058 . . . . 0.0 111.135 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 C--O 1.232 0.144 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -63.51 1.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.462 1.105 . . . . 0.0 108.914 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.46 -29.96 70.29 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -167.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.24 -46.57 83.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.484 1.114 . . . . 0.0 110.985 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -59.26 -38.57 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -169.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -49.21 -55.31 12.94 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.211 1.404 . . . . 0.0 110.548 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -56.84 -45.12 82.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.169 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.06 -44.83 96.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.889 1.222 . . . . 0.0 111.032 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.8 -34.75 69.97 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 123.151 0.282 . . . . 0.0 111.034 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -76.29 -48.23 20.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.935 0.494 . . . . 0.0 111.567 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.28 -47.01 63.17 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.941 1.296 . . . . 0.0 108.5 -158.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 p -102.63 -44.9 5.19 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.34 -13.35 4.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.667 1.127 . . . . 0.0 113.001 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.78 160.28 41.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.486 1.643 . . . . 0.0 108.875 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -118.65 -24.16 6.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 117.394 -1.289 . . . . 0.0 114.221 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 p -64.16 133.24 52.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 160.73 56.16 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.783 1.233 . . . . 0.0 108.497 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.16 159.99 61.4 Favored 'Cis proline' 0 C--N 1.344 0.323 0 CA-C-N 120.314 1.148 . . . . 0.0 110.591 -4.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -123.27 101.2 7.24 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.07 126.56 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -114.25 97.86 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 123.12 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 168.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 42.6 68.79 0.69 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.924 1.25 . . . . 0.0 113.23 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.22 -2.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.813 2.845 . . . . 0.0 118.645 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.4 115.74 28.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.094 1.316 . . . . 0.0 107.87 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -63.74 117.26 6.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.32 -16.89 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.19 -146.79 17.88 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.26 -153.43 18.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.934 0.741 . . . . 0.0 111.783 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.2 p -65.64 -38.47 89.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.044 0.938 . . . . 0.0 110.653 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -75.92 -31.39 59.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.662 0.601 . . . . 0.0 111.62 -176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.05 -52.5 41.54 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 23.0 tp -57.01 -34.36 68.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.451 0.7 . . . . 0.0 111.351 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.65 -48.44 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 115.419 -2.229 . . . . 0.0 109.723 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -55.1 37.64 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.441 1.928 . . . . 0.0 107.256 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.54 -35.86 72.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.689 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -68.47 -47.77 66.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.335 1.425 . . . . 0.0 110.51 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -63.8 1.15 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.999 2.52 . . . . 0.0 109.818 -168.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -79.22 -12.54 59.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 119.253 -0.404 . . . . 0.0 110.523 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.7 18.81 53.92 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-O 117.228 -1.873 . . . . 0.0 113.282 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.52 -23.02 67.13 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 121.099 2.449 . . . . 0.0 111.049 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.44 -38.86 63.94 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.294 1.438 . . . . 0.0 111.09 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.57 -48.38 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.161 0.984 . . . . 0.0 109.182 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.2 m -66.69 -44.66 81.15 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.976 1.31 . . . . 0.0 110.658 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -47.76 64.33 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.6 0.76 . . . . 0.0 109.392 174.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.83 -50.67 40.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.126 0.57 . . . . 0.0 111.438 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -57.95 -29.94 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.362 -0.836 . . . . 0.0 112.627 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -47.96 -40.52 22.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.361 1.064 . . . . 0.0 111.601 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.4 8.17 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.646 0.657 . . . . 0.0 112.764 -168.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.4 50.81 5.54 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.694 0.679 . . . . 0.0 111.671 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.86 -74.17 0.65 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 126.508 1.923 . . . . 0.0 112.507 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.74 150.95 43.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.599 1.999 . . . . 0.0 106.93 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.964 -172.294 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.574 0.702 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.26 -48.67 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.726 -0.609 . . . . 0.0 110.033 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -70.95 -32.03 68.8 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.161 -0.962 . . . . 0.0 113.199 -167.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -18.12 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.973 -1.08 . . . . 0.0 110.818 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HE3' ' OE2' ' A' ' 44' ' ' GLU . 32.1 mmtm -76.46 -59.87 2.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.479 172.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.05 144.81 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.623 1.101 . . . . 0.0 108.928 -172.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -138.27 157.04 73.35 Favored Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 126.982 2.113 . . . . 0.0 106.559 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.26 66.76 7.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.518 2.812 . . . . 0.0 110.7 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.86 40.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.109 1.814 . . . . 0.0 111.21 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -143.49 168.99 18.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.22 1.808 . . . . 0.0 107.128 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.7 95.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.68 144.66 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 t -132.22 117.59 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -77.16 120.79 22.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.29 -178.15 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.745 2.418 . . . . 0.0 109.664 -172.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -136.27 164.48 42.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 126.496 1.918 . . . . 0.0 107.673 170.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.74 -1.97 12.14 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.452 2.101 . . . . 0.0 112.773 -165.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -118.67 -99.99 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.794 1.637 . . . . 0.0 107.426 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 t 32.48 100.94 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.599 2.76 . . . . 0.0 114.995 169.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.56 -10.0 26.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.247 1.298 . . . . 0.0 111.637 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.85 -35.1 15.85 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.727 -1.233 . . . . 0.0 108.169 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.7 -55.18 33.08 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -57.58 -41.4 81.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.845 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -56.89 -61.41 2.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 118.865 0.757 . . . . 0.0 109.69 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.13 -33.54 27.03 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.049 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.418 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.18 -55.52 33.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.56 1.544 . . . . 0.0 111.968 171.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.43 -38.58 77.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.078 1.763 . . . . 0.0 110.243 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.41 -50.33 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.291 1.436 . . . . 0.0 108.971 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.86 -53.0 9.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -63.21 -24.55 67.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.397 0.679 . . . . 0.0 112.098 -166.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -74.01 0.85 12.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.055 0.843 . . . . 0.0 112.392 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 120.796 -1.19 . . . . 0.0 109.207 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.35 57.24 6.16 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.159 3.24 . . . . 0.0 111.383 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.2 mt -74.52 151.2 7.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -53.92 123.93 13.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.06 133.33 50.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -171.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -14.33 63.9 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.571 -1.127 . . . . 0.0 113.005 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.16 -39.5 63.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.706 1.753 . . . . 0.0 110.754 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 104.18 14.14 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -168.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' OE2' ' HE3' ' A' ' 9' ' ' LYS . 42.5 tt0 -122.35 113.9 20.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 22.1 m-85 -83.84 133.28 34.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -125.03 100.2 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.369 1.468 . . . . 0.0 107.052 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -64.65 112.86 3.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.708 1.203 . . . . 0.0 111.131 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.7 pt -68.04 -9.39 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.113 -0.992 . . . . 0.0 112.689 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 CA--C 1.54 0.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.623 172.731 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.86 -63.0 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.674 1.99 . . . . 0.0 110.237 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.62 -22.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.629 1.572 . . . . 0.0 114.81 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.74 -30.71 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.155 1.343 . . . . 0.0 111.522 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mt -69.76 -33.68 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.896 1.279 . . . . 0.0 108.299 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -52.27 54.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -52.48 -54.96 25.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.199 1.8 . . . . 0.0 110.424 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -51.55 -46.0 63.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.608 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.97 -35.46 81.25 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.617 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.53 -54.91 28.79 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.973 1.26 . . . . 0.0 109.412 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -36.76 76.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.137 0.975 . . . . 0.0 110.393 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -76.34 -52.48 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 0.0 109.161 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -97.49 -75.89 0.53 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -168.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.06 -13.93 0.06 OUTLIER Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.022 1.296 . . . . 0.0 114.005 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.68 146.47 41.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.091 1.945 . . . . 0.0 108.97 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -29.43 45.8 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.861 171.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -62.41 133.29 54.83 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -159.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.03 153.91 52.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.32 156.85 80.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.24 0.764 . . . . 0.0 111.684 -7.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.48 106.69 10.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.2 129.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -118.53 93.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.912 2.485 . . . . 0.0 107.479 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.91 118.15 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 168.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 40.13 67.97 0.61 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.492 1.996 . . . . 0.0 114.489 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.61 24.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.89 97.75 5.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -67.84 118.1 10.62 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.806 -1.184 . . . . 0.0 108.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -83.76 -21.58 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -168.77 24.34 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -170.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.14 -85.62 1.79 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 -64.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.813 1.245 . . . . 0.0 108.157 -170.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m -58.77 -39.41 80.94 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.533 0.733 . . . . 0.0 111.721 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.83 -56.73 18.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.0 -39.35 74.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.099 1.36 . . . . 0.0 110.856 -168.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.8 t -64.85 -40.87 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 117.256 -1.354 . . . . 0.0 111.119 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -50.91 69.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -56.06 -37.65 69.58 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 117.743 -1.122 . . . . 0.0 109.613 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -63.64 -57.58 9.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.453 1.479 . . . . 0.0 109.613 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -42.9 83.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.299 1.44 . . . . 0.0 111.57 -166.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.1 t -65.06 -51.99 58.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.593 1.957 . . . . 0.0 107.845 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.73 1.77 27.3 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.259 -1.301 . . . . 0.0 111.475 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.7 -22.66 66.67 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.936 1.868 . . . . 0.0 110.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -54.51 -46.45 73.5 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 110.348 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.68 -51.14 68.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.478 0.711 . . . . 0.0 109.234 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -53.73 -45.62 70.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.009 0.924 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -56.23 21.36 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 110.678 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.22 -30.72 60.65 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.944 -1.097 . . . . 0.0 112.15 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.19 -30.15 66.21 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.396 -1.44 . . . . 0.0 112.474 169.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -60.17 -8.8 2.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.157 1.383 . . . . 0.0 113.773 171.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.16 8.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.437 1.895 . . . . 0.0 110.866 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.51 36.86 89.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.968 1.27 . . . . 0.0 112.951 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.45 -62.32 1.48 Allowed 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.71 1.204 . . . . 0.0 110.742 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -72.28 142.62 48.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.464 -161.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.319 -0.741 0 C-N-CA 127.994 2.518 . . . . 0.0 107.5 -178.199 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.7 t80 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.79 -69.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.458 1.503 . . . . 0.0 110.687 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -65.79 -43.56 88.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.1 0.863 . . . . 0.0 111.834 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.1 t -72.83 -18.19 61.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.814 0.445 . . . . 0.0 111.009 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -71.2 -46.86 60.35 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.615 -1.184 . . . . 0.0 112.109 171.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.5 144.21 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 120.245 1.384 . . . . 0.0 108.526 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.74 168.18 14.62 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 125.372 1.469 . . . . 0.0 107.416 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.3 157.55 30.19 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.295 1.141 . . . . 0.0 109.399 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.63 79.55 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.575 -1.125 . . . . 0.0 115.372 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -132.39 158.58 41.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.656 1.728 . . . . 0.0 107.905 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.05 123.3 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.06 136.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.12 114.58 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -77.68 122.66 25.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -133.71 166.91 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.056 1.342 . . . . 0.0 109.758 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -132.33 125.18 19.66 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 158.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.4 -15.32 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.66 1.573 . . . . 0.0 111.414 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -83.0 -0.17 47.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.914 2.086 . . . . 0.0 113.356 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.13 132.49 21.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.159 1.345 . . . . 0.0 108.23 161.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.91 -17.72 56.2 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.479 2.786 . . . . 0.0 110.952 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -74.04 -38.21 64.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.457 ' HG ' ' HB3' ' A' ' 71' ' ' PRO . 64.0 m -61.95 -44.51 96.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 117.72 -1.134 . . . . 0.0 109.027 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -53.43 -50.35 65.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.606 1.094 . . . . 0.0 111.783 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -54.45 -59.21 4.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 119.202 -0.427 . . . . 0.0 110.187 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.06 60.84 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.604 1.19 . . . . 0.0 111.231 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.67 80.62 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 117.855 -1.069 . . . . 0.0 111.206 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -41.33 69.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 120.557 1.526 . . . . 0.0 109.336 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.17 -54.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.429 1.892 . . . . 0.0 109.263 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.43 -42.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -171.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 t -65.91 -25.11 67.0 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.247 0.476 . . . . 0.0 111.131 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.69 -22.72 59.84 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.355 0.98 . . . . 0.0 112.407 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.95 154.47 92.58 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 119.329 0.968 . . . . 0.0 109.496 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.57 77.93 3.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.853 2.369 . . . . 0.0 109.876 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mt -102.43 153.46 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' A' ' 39' ' ' LYS . 6.2 mmmt -51.97 124.27 12.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.033 0.933 . . . . 0.0 109.083 174.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.61 137.83 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.77 -14.07 64.13 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.841 -1.533 . . . . 0.0 112.247 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mt -73.81 -36.8 65.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.802 2.301 . . . . 0.0 111.78 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.04 118.02 23.79 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -170.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -122.04 123.6 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.627 1.171 . . . . 0.0 109.193 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.53 127.26 45.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.96 105.09 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.935 1.294 . . . . 0.0 108.735 -165.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.35 100.76 3.26 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.576 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -63.94 -14.46 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 113.18 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.871 1.268 . . . . 0.0 111.666 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 CA--C 1.513 -0.452 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -63.47 1.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.275 1.43 . . . . 0.0 108.323 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.47 -30.64 60.95 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.61 -52.31 61.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.839 1.199 . . . . 0.0 110.747 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.03 -39.24 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -57.2 -50.07 74.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.406 2.282 . . . . 0.0 107.459 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.27 -42.32 93.34 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 110.518 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -58.41 -47.42 83.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.9 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.19 -36.78 84.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.792 0.724 . . . . 0.0 110.581 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.83 -51.04 70.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.538 0.735 . . . . 0.0 109.945 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.91 -49.93 72.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.003 0.521 . . . . 0.0 109.851 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.49 -40.58 66.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.116 0.966 . . . . 0.0 109.373 -166.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 p -108.38 -15.37 14.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.255 0.934 . . . . 0.0 113.356 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.19 6.78 64.5 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.625 -1.097 . . . . 0.0 112.158 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.52 22.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.236 1.518 . . . . 0.0 109.265 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -94.67 -8.89 36.56 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.92 133.82 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.685 1.129 . . . . 0.0 110.66 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.11 161.11 29.27 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 160.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' A' ' 26' ' ' CYS . 43.6 Cg_endo -62.24 141.79 37.46 Favored 'Cis proline' 0 N--CA 1.463 -0.275 0 N-CA-C 110.158 -0.747 . . . . 0.0 110.158 -13.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.94 93.1 4.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.85 130.79 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.86 109.02 18.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.378 1.871 . . . . 0.0 106.927 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.5 108.66 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 163.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 67.48 1.91 Allowed Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.264 1.411 . . . . 0.0 112.849 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.0 mttt 46.06 20.39 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.166 1.787 . . . . 0.0 115.393 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.29 110.91 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 164.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -67.26 107.99 2.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.48 -14.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.485 0.584 . . . . 0.0 111.456 -170.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.47 -171.35 22.94 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 124.478 1.037 . . . . 0.0 111.355 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.81 -160.23 31.82 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.896 1.713 . . . . 0.0 110.251 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -37.78 86.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.026 0.913 . . . . 0.0 110.334 -170.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.6 m -67.36 -48.32 67.79 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.987 -172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 -51.94 67.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.7 tp -54.28 -37.33 64.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.074 -0.965 . . . . 0.0 112.231 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -60.85 -53.41 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 116.777 -1.582 . . . . 0.0 108.982 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.22 87.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 121.848 2.113 . . . . 0.0 108.692 -174.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.3 -32.03 71.88 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.745 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.34 -55.11 8.66 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 121.055 1.752 . . . . 0.0 111.087 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -51.91 34.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.635 2.374 . . . . 0.0 110.631 -168.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 t -70.34 -24.59 63.01 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.945 1.298 . . . . 0.0 109.977 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 11.06 65.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.166 173.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.55 -25.93 68.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.36 2.08 . . . . 0.0 111.726 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.73 -32.23 69.02 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.536 1.134 . . . . 0.0 111.513 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.09 -46.52 61.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.65 0.659 . . . . 0.0 109.656 -168.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.9 m -64.45 -40.49 95.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -40.97 85.37 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.54 -0.725 . . . . 0.0 111.687 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.75 -46.09 84.96 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.713 1.205 . . . . 0.0 110.503 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -62.12 -31.02 71.44 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.958 -1.089 . . . . 0.0 112.331 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -63.64 -10.99 21.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.92 11.75 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 119.474 1.034 . . . . 0.0 111.854 170.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.12 26.09 62.69 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.341 0.972 . . . . 0.0 112.887 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.616 1.166 . . . . 0.0 111.487 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.7 mt -77.55 134.32 38.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.802 -1.559 . . . . 0.0 110.944 -158.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 . . . . . 0 N--CA 1.428 -1.526 0 C-N-CA 130.134 3.374 . . . . 0.0 106.161 -179.273 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 . . . . . 0 N--CA 1.461 0.104 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.09 -58.93 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -55.32 -37.39 67.36 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.19 0.996 . . . . 0.0 113.573 -161.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.0 m -101.91 -8.87 21.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.971 0.908 . . . . 0.0 112.815 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.87 -45.26 90.24 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.966 1.257 . . . . 0.0 107.7 159.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.75 155.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 152.52 47.48 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.61 125.22 14.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 N-CA-C 104.763 -2.822 . . . . 0.0 104.763 158.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.49 35.58 25.63 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.737 0.684 . . . . 0.0 113.302 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -142.31 161.31 38.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.099 2.159 . . . . 0.0 109.341 166.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.33 109.25 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.56 132.25 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 120.555 -1.341 . . . . 0.0 108.289 -166.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.23 111.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -166.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -79.29 119.26 22.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.86 169.5 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.989 1.716 . . . . 0.0 109.921 -174.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 22' ' ' THR . 4.2 ptmm? -127.29 141.28 40.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 162.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.06 28.77 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.6 3.533 . . . . 0.0 111.315 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 20' ' ' LYS 0.323 9.6 t -147.23 29.48 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.813 2.045 . . . . 0.0 108.929 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.63 123.84 26.87 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.035 1.734 . . . . 0.0 108.595 167.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.98 -24.92 52.4 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.486 1.457 . . . . 0.0 111.984 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -78.98 -28.72 43.54 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.953 0.797 . . . . 0.0 109.353 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.2 m -66.11 -46.9 75.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -51.92 -48.15 64.33 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.166 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -55.5 -57.87 10.13 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 119.014 0.825 . . . . 0.0 109.938 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.42 62.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.328 1.018 . . . . 0.0 111.472 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -45.69 78.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.388 0.994 . . . . 0.0 113.295 172.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.66 -53.21 16.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt -44.34 -53.22 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.39 1.876 . . . . 0.0 110.442 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.64 -46.47 19.13 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.186 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -6.51 59.26 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.367 0.985 . . . . 0.0 112.608 -167.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -73.83 -16.16 61.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.66 1.118 . . . . 0.0 110.992 167.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -78.0 151.29 78.89 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 120.885 -1.134 . . . . 0.0 108.748 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 42.23 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.303 2.669 . . . . 0.0 111.295 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.1 145.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -58.38 123.06 14.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.27 146.66 54.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.78 10.22 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.589 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.49 -30.5 63.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.883 1.842 . . . . 0.0 109.68 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 119.72 25.18 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 120.515 1.507 . . . . 0.0 107.684 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -128.72 110.41 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.688 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -84.19 103.74 13.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -90.82 114.96 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 126.519 1.927 . . . . 0.0 107.231 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.57 110.58 3.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.591 1.156 . . . . 0.0 110.942 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.6 pt -70.45 -2.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.369 1.068 . . . . 0.0 113.006 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.261 3.3 t . . . . . 0 N--CA 1.443 -0.824 0 CA-C-N 118.775 0.716 . . . . 0.0 110.41 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -63.66 0.86 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.581 1.152 . . . . 0.0 111.817 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -46.63 -54.68 9.02 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.901 0.75 . . . . 0.0 111.15 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -41.66 93.63 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.554 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.4 -39.99 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.03 -41.45 74.25 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -42.05 35.9 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.49 1.916 . . . . 0.0 111.423 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.5 -50.99 66.49 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.753 1.221 . . . . 0.0 110.338 171.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.42 -30.71 65.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.789 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.485 ' NE2' HH21 ' A' ' 68' ' ' ARG . 22.7 tt0 -66.56 -37.79 85.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.627 1.558 . . . . 0.0 111.695 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -67.66 -47.54 69.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.53 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.27 -24.33 57.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.211 -168.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 p -133.51 -2.85 3.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.283 1.401 . . . . 0.0 114.101 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.13 -10.23 61.42 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 120.061 1.301 . . . . 0.0 112.857 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.62 137.33 54.48 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.126 -1.22 . . . . 0.0 110.587 -172.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' A' ' 62' ' ' GLN . 5.1 ptp85 -102.02 -31.31 10.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.475 174.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 133.33 41.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.285 0.564 . . . . 0.0 109.716 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.27 159.49 39.27 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.369 1.467 . . . . 0.0 108.458 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.54 167.77 22.72 Favored 'Cis proline' 0 C--N 1.347 0.457 0 CA-C-N 120.379 1.171 . . . . 0.0 111.881 -8.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 110.15 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.062 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.9 t -91.98 125.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 119.426 1.012 . . . . 0.0 108.761 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -102.21 114.68 29.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 158.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -93.18 123.68 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 160.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 43.78 72.43 0.33 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.301 1.429 . . . . 0.0 113.811 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 46.65 14.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.17 120.22 36.44 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.471 1.487 . . . . 0.0 110.658 170.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.71 114.66 4.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.706 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.52 -12.68 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 119.236 0.925 . . . . 0.0 110.845 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.75 -158.17 18.28 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.65 -157.47 31.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 126.767 2.127 . . . . 0.0 111.108 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -38.44 83.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.923 -0.751 . . . . 0.0 110.335 -169.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -68.85 -44.82 72.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.634 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -65.17 -45.56 84.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.6 tp -53.98 -45.42 71.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.5 0.72 . . . . 0.0 112.057 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.89 -39.16 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 117.112 -1.423 . . . . 0.0 109.536 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -54.54 24.92 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -58.52 -33.54 69.96 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.29 -63.67 1.03 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.935 1.698 . . . . 0.0 110.705 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.26 78.3 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.864 1.266 . . . . 0.0 112.163 -166.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -86.39 -2.24 58.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.457 1.503 . . . . 0.0 110.972 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 -0.37 88.86 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 117.107 -1.941 . . . . 0.0 114.671 168.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.38 -31.54 72.73 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 121.285 2.542 . . . . 0.0 111.168 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.27 -35.65 70.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.987 1.315 . . . . 0.0 110.763 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.19 -44.09 76.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -61.25 -54.14 47.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -40.34 63.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.519 1.128 . . . . 0.0 111.07 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.1 mt -70.11 -57.56 4.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.78 1.632 . . . . 0.0 112.448 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HZ3' ' C ' ' A' ' 106' ' ' GLN . 4.5 tttm -65.88 -26.81 67.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.709 1.595 . . . . 0.0 111.913 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -44.95 -36.69 3.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.674 1.59 . . . . 0.0 111.528 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.57 14.3 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.44 1.018 . . . . 0.0 112.552 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.5 40.89 21.85 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.725 0.693 . . . . 0.0 112.286 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.21 -78.21 0.53 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.076 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.1 135.0 57.58 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.435 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 12.3 tt0 . . . . . 0 C--O 1.245 0.831 0 O-C-N 125.499 1.75 . . . . 0.0 108.006 -163.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.9 t80 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.7 -53.12 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.939 0.791 . . . . 0.0 109.937 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.36 -55.71 31.28 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.233 0.924 . . . . 0.0 111.467 -163.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.9 m -82.58 -6.69 59.49 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -65.52 -22.83 66.75 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.915 1.234 . . . . 0.0 110.639 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.8 154.87 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 120.637 1.562 . . . . 0.0 108.561 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -135.65 152.33 75.98 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.79 63.93 8.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.128 3.219 . . . . 0.0 110.976 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.4 31.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.933 1.254 . . . . 0.0 111.781 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -134.44 172.92 12.23 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.142 1.777 . . . . 0.0 107.756 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.76 111.51 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.7 t -132.38 115.91 27.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -158.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.69 130.16 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 123.003 0.521 . . . . 0.0 110.305 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.42 125.15 40.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.77 168.5 16.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.854 1.661 . . . . 0.0 110.512 -167.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -125.54 148.42 61.54 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 169.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.28 -39.08 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.701 2.267 . . . . 0.0 110.134 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 p -81.89 48.48 1.23 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.05 2.14 . . . . 0.0 109.966 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -140.67 127.06 11.77 Favored Pre-proline 0 C--O 1.242 0.679 0 C-N-CA 126.516 1.927 . . . . 0.0 109.387 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.56 -19.56 11.39 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.333 2.022 . . . . 0.0 112.038 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -73.59 -35.28 65.39 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 120.428 1.467 . . . . 0.0 108.305 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.27 -40.07 89.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -53.13 -53.95 42.93 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.156 0.434 . . . . 0.0 110.84 171.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -53.19 -59.18 4.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.552 0.741 . . . . 0.0 109.021 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -41.88 72.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 117.515 -1.231 . . . . 0.0 111.481 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -49.64 71.05 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 119.718 1.145 . . . . 0.0 112.162 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.43 -50.05 55.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.205 1.002 . . . . 0.0 110.124 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -46.69 -56.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 127.272 2.229 . . . . 0.0 109.586 170.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.66 -46.76 74.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -65.61 -18.65 65.48 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -73.52 -27.31 61.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.084 1.311 . . . . 0.0 110.397 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.66 135.43 81.13 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -82.25 63.32 8.2 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.089 2.526 . . . . 0.0 112.072 -167.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.57 147.74 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.244 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -46.45 124.54 5.94 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.856 1.662 . . . . 0.0 109.243 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.56 129.51 42.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -3.08 82.71 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 118.083 -1.398 . . . . 0.0 113.279 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.72 -30.99 46.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.813 2.306 . . . . 0.0 112.44 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 116.09 26.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -123.3 133.6 54.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.676 1.19 . . . . 0.0 108.219 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -110.56 139.03 46.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.7 t -135.39 108.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.288 1.035 . . . . 0.0 108.547 -164.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.29 122.76 17.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 111.942 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.63 ' CD1' ' HG1' ' A' ' 54' ' ' THR . 45.2 pt -75.11 -20.47 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.955 1.302 . . . . 0.0 112.449 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 124.472 1.109 . . . . 0.0 110.893 -179.126 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.63 ' HG1' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -52.29 -62.62 1.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.443 ' H ' HG21 ' A' ' 54' ' ' THR . 1.8 t30 -63.94 -7.41 8.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.096 1.758 . . . . 0.0 113.531 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -36.0 16.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.84 1.655 . . . . 0.0 109.637 161.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.36 -50.06 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -167.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.55 76.09 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.009 0.524 . . . . 0.0 110.015 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -55.48 -56.85 15.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.547 1.539 . . . . 0.0 110.946 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -56.84 -29.91 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.84 2.056 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.9 mt -60.48 -30.42 69.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.015 1.28 . . . . 0.0 111.73 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -60.28 -37.04 79.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.945 0.793 . . . . 0.0 109.731 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.16 -49.44 17.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.41 -30.42 57.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.54 -166.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.528 HG23 HH11 ' A' ' 72' ' ' ARG . 34.7 p -120.79 -62.56 1.44 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.904 1.229 . . . . 0.0 110.459 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.19 -34.69 0.2 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.154 -1.359 . . . . 0.0 114.341 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.35 144.88 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.123 1.461 . . . . 0.0 109.739 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -83.54 14.88 3.42 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.618 0.767 . . . . 0.0 112.368 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -105.84 163.76 12.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.578 1.656 . . . . 0.0 110.626 -158.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.99 144.38 46.18 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 127.632 2.373 . . . . 0.0 106.16 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.62 155.33 89.91 Favored 'Cis proline' 0 N--CA 1.454 -0.808 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 -4.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.528 HH11 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.46 130.24 17.1 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 176.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.17 128.15 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 124.185 0.994 . . . . 0.0 109.559 -163.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -94.23 124.98 38.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.29 113.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 160.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.69 15.27 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.28 -0.887 . . . . 0.0 112.483 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt 46.52 3.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.852 2.461 . . . . 0.0 116.917 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.33 142.02 28.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.171 1.805 . . . . 0.0 107.637 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -101.25 123.5 45.47 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.893 -1.13 . . . . 0.0 112.271 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.62 -23.1 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.359 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.93 -165.22 21.02 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.292 0.949 . . . . 0.0 111.201 -171.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 -163.58 32.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.486 1.517 . . . . 0.0 110.885 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.1 p -65.61 -34.37 78.07 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.409 1.104 . . . . 0.0 110.49 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -62.01 -42.55 99.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.872 0.76 . . . . 0.0 111.113 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.66 -54.52 22.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.2 tp -51.91 -39.24 58.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.92 1.288 . . . . 0.0 111.9 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.6 t -58.56 -59.35 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 117.012 -1.471 . . . . 0.0 108.797 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.2 p -48.65 -54.74 13.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.556 1.98 . . . . 0.0 115.003 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.75 -32.81 70.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.447 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -72.01 -51.89 19.66 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.893 1.679 . . . . 0.0 110.245 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -58.58 3.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.07 1.748 . . . . 0.0 110.097 -168.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -16.99 64.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.852 1.261 . . . . 0.0 110.895 173.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.64 78.94 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.185 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.49 -22.72 67.05 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.816 2.308 . . . . 0.0 111.68 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.8 -24.67 67.62 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.576 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.34 -52.32 59.0 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 120.354 1.434 . . . . 0.0 108.632 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.1 m -57.07 -50.88 71.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.727 0.811 . . . . 0.0 109.956 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -47.6 -51.6 20.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.001 0.92 . . . . 0.0 110.712 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.29 -52.06 37.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.175 1.39 . . . . 0.0 111.3 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -62.18 -26.05 68.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.562 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -57.25 -33.1 67.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.072 0.851 . . . . 0.0 112.305 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.1 -14.92 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.905 1.229 . . . . 0.0 112.133 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.04 83.9 0.74 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -166.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.85 -76.41 0.46 Allowed 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.721 -1.609 . . . . 0.0 110.92 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.47 135.29 54.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 121.968 2.167 . . . . 0.0 108.503 -172.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.844 1.34 . . . . 0.0 109.132 -158.364 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.79 -48.92 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.491 ' ND2' ' HH ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -68.47 -16.32 63.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.37 1.068 . . . . 0.0 112.421 -165.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -103.81 -26.24 12.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.862 1.665 . . . . 0.0 111.751 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -64.05 -43.8 94.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.491 1.042 . . . . 0.0 110.959 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.16 140.9 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -122.86 157.2 60.75 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.46 16.86 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.023 3.149 . . . . 0.0 114.828 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 11' ' ' GLN . . . -170.57 45.32 0.2 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.8 2.143 . . . . 0.0 110.795 -172.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -141.23 164.08 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.61 100.61 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.96 125.56 61.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 t -126.15 109.08 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -76.47 132.08 39.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -138.65 164.29 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.012 2.125 . . . . 0.0 108.874 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 145.87 34.02 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 158.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.53 16.11 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.923 3.082 . . . . 0.0 114.085 -161.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -129.4 -22.02 3.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.397 1.479 . . . . 0.0 112.665 -160.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -94.74 148.69 35.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -157.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.17 -25.19 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.874 2.382 . . . . 0.0 111.787 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -73.81 -43.39 58.96 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.12 1.768 . . . . 0.0 107.514 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -54.27 -47.12 72.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.476 1.111 . . . . 0.0 111.872 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -59.62 4.55 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.88 -36.69 65.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.356 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -54.91 -57.83 10.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.631 1.173 . . . . 0.0 112.554 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -70.68 -35.65 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.371 0.605 . . . . 0.0 110.815 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.63 -49.83 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.476 1.51 . . . . 0.0 109.796 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.31 -49.17 15.57 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.9 p -67.51 -25.96 66.1 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -162.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -80.83 -9.14 59.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 111.994 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.04 134.84 77.35 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 168.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.09 104.18 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.581 2.187 . . . . 0.0 108.784 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -122.71 151.7 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -57.87 124.27 18.64 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.71 136.51 56.37 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.95 84.6 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.18 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.51 -39.59 31.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.53 2.165 . . . . 0.0 111.675 166.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.7 93.48 8.04 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.035 0.834 . . . . 0.0 110.28 -159.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -110.63 116.05 30.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -84.73 119.18 24.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -113.63 131.42 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 127.591 2.356 . . . . 0.0 107.784 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.66 137.8 34.35 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.955 0.502 . . . . 0.0 110.279 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.8 pt -99.41 5.11 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 123.39 0.676 . . . . 0.0 112.248 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.33 -0.264 0 O-C-N 120.155 -1.59 . . . . 0.0 111.517 -174.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -33.93 -63.82 0.25 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 130.149 3.38 . . . . 0.0 110.059 166.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -49.36 -46.4 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.914 0.759 . . . . 0.0 111.606 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -49.97 59.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 110.973 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 mt -54.63 -43.41 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.706 1.602 . . . . 0.0 110.471 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -71.98 -45.85 59.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -170.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -48.55 76.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 109.888 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' HH ' ' ND2' ' A' ' 7' ' ' ASN . 34.6 t80 -65.33 -44.99 86.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.672 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.0 -42.61 76.67 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.261 1.024 . . . . 0.0 109.89 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -56.4 21.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.491 174.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.07 -51.23 68.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 123.556 0.535 . . . . 0.0 109.993 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.89 -45.26 95.3 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.306 1.442 . . . . 0.0 109.457 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 p -101.1 -65.19 0.99 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.552 0.614 . . . . 0.0 110.781 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.38 -4.48 2.55 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.638 2.066 . . . . 0.0 111.635 -172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.73 157.92 43.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.269 1.535 . . . . 0.0 109.141 169.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -118.77 -29.12 5.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.123 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 p -61.61 133.22 55.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -161.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.08 58.19 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.46 170.45 42.38 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 CA-C-N 118.649 0.553 . . . . 0.0 111.149 -7.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -130.12 100.33 5.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.15 129.26 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.11 104.87 12.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.768 2.027 . . . . 0.0 106.915 168.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 103.06 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 169.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.97 64.77 3.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.882 1.23 . . . . 0.0 113.014 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.72 13.09 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 127.7 2.4 . . . . 0.0 117.219 -168.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -100.69 103.55 14.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 120.454 1.479 . . . . 0.0 107.341 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.6 t -68.85 117.22 10.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.63 -25.8 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.563 0.745 . . . . 0.0 110.631 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.25 -171.29 23.75 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 123.462 0.553 . . . . 0.0 112.023 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.61 -169.01 41.41 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 125.409 1.481 . . . . 0.0 111.463 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 p -63.43 -38.01 89.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.871 0.835 . . . . 0.0 110.507 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.235 0.47 . . . . 0.0 111.804 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.64 -49.51 21.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -52.68 -34.66 53.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.059 1.744 . . . . 0.0 112.605 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.64 -50.84 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.164 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -44.99 92.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.606 1.548 . . . . 0.0 107.691 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.79 -31.65 71.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.04 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -69.18 -61.34 1.83 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.25 1.386 . . . . 0.0 109.085 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -50.7 66.47 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.872 2.069 . . . . 0.0 111.658 -166.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -3.71 32.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.27 1.828 . . . . 0.0 111.778 172.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.97 -0.72 82.19 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.038 -1.424 . . . . 0.0 115.113 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.24 -33.87 72.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.153 1.976 . . . . 0.0 111.442 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.3 tp -60.3 -33.22 72.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.689 0.796 . . . . 0.0 111.125 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.63 -40.03 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -72.48 -48.05 43.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -40.24 58.57 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.945 0.793 . . . . 0.0 111.815 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.76 -56.59 9.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 110.567 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -59.38 -24.31 63.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.829 1.195 . . . . 0.0 112.873 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -48.66 -41.69 32.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.681 1.193 . . . . 0.0 110.705 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.98 -1.63 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.26 59.97 1.79 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.28 -73.04 0.66 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.416 1.486 . . . . 0.0 112.412 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.454 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 2.8 mt -62.57 135.4 57.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.28 -153.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.5 t80 . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.59 -60.25 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 109.017 169.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -70.0 -11.86 61.18 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -159.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -106.55 -15.48 14.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.148 0.979 . . . . 0.0 112.931 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -63.93 -57.56 9.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.22 1.373 . . . . 0.0 107.517 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.6 150.48 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -144.34 172.4 5.52 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.189 1.795 . . . . 0.0 106.28 161.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.05 17.18 0.87 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.178 2.585 . . . . 0.0 114.912 -163.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.3 12.07 1.2 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.655 2.55 . . . . 0.0 112.16 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.06 148.67 29.46 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.849 1.824 . . . . 0.0 108.585 170.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 t -102.54 86.62 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.84 147.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 O-C-N 120.829 -1.169 . . . . 0.0 108.539 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.9 116.21 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.12 128.89 34.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.18 175.24 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.276 1.43 . . . . 0.0 110.879 -167.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -137.97 144.72 45.01 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 158.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.84 -31.66 47.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.305 2.67 . . . . 0.0 112.268 -168.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -65.78 -35.96 82.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.508 0.723 . . . . 0.0 111.829 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.7 t -61.01 118.67 37.97 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 124.557 1.143 . . . . 0.0 109.717 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.93 -20.25 34.26 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.772 1.648 . . . . 0.0 111.073 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -73.49 -39.35 64.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -60.61 -49.42 77.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -57.24 -46.07 83.34 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.425 0.557 . . . . 0.0 111.636 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -56.52 -54.24 48.14 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 118.833 0.742 . . . . 0.0 109.947 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.2 -39.23 59.87 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.223 0.952 . . . . 0.0 111.43 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.02 66.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.673 171.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -55.03 31.64 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.226 1.01 . . . . 0.0 109.741 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.63 -47.17 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.077 2.151 . . . . 0.0 110.237 176.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.11 -42.73 31.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 m -61.42 -21.87 64.5 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.85 -11.55 60.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.91 . . . . 0.0 111.851 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.3 133.51 21.97 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.85 81.77 2.49 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.633 2.889 . . . . 0.0 110.284 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -102.57 155.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -167.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -50.75 123.31 8.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.659 0.783 . . . . 0.0 109.266 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -66.58 157.05 33.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.099 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.86 -20.66 2.84 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.205 -1.331 . . . . 0.0 112.68 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -73.86 -37.14 64.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.538 2.169 . . . . 0.0 109.795 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 104.1 13.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -171.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -123.35 113.62 19.09 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -84.07 107.2 16.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.92 106.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 126.427 1.891 . . . . 0.0 107.288 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.78 133.08 52.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 122.649 -0.032 . . . . 0.0 110.953 166.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 pt -106.25 -13.75 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.33 1.452 . . . . 0.0 110.758 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.632 1.173 . . . . 0.0 111.083 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m170 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.77 -63.42 0.91 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.316 -1.325 . . . . 0.0 111.777 168.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -47.36 -51.45 19.57 Favored 'General case' 0 C--O 1.217 -0.629 0 O-C-N 124.452 1.095 . . . . 0.0 109.911 -171.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.11 -50.1 75.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.515 0.598 . . . . 0.0 110.352 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -62.34 -35.66 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.964 0.906 . . . . 0.0 108.816 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.21 -37.2 33.64 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 -168.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.43 -46.18 84.31 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 127.502 2.321 . . . . 0.0 110.475 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -61.51 -44.92 96.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.326 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -57.4 -39.21 75.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.973 1.261 . . . . 0.0 110.524 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -41.78 93.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.502 0.721 . . . . 0.0 110.385 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -63.62 -58.53 6.64 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.508 -0.745 . . . . 0.0 110.053 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 tp -65.32 -30.22 71.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.676 2.39 . . . . 0.0 111.775 -166.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.69 -26.47 2.96 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.192 1.36 . . . . 0.0 112.993 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.96 27.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.934 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.77 144.83 27.28 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.365 2.083 . . . . 0.0 110.414 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -85.84 -18.63 32.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.968 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -70.83 134.08 47.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -163.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.28 166.12 14.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.556 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -58.82 159.01 35.48 Favored 'Cis proline' 0 C--N 1.345 0.36 0 CA-C-N 119.657 0.913 . . . . 0.0 110.305 -15.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 mtp85 -126.39 105.7 8.97 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.58 125.25 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -110.79 99.57 8.47 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 107.065 168.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 109.79 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.28 64.67 2.17 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.016 1.769 . . . . 0.0 111.761 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 tttt 46.14 17.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.458 2.703 . . . . 0.0 117.394 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -98.53 115.56 28.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.26 1.391 . . . . 0.0 107.568 159.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -67.01 108.79 2.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.55 -11.01 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.656 0.662 . . . . 0.0 110.555 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -165.64 24.44 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.154 1.359 . . . . 0.0 110.008 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.65 -165.36 39.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -39.76 93.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.716 -0.873 . . . . 0.0 110.775 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -66.6 -26.01 66.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.316 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.74 -51.9 6.13 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.6 tp -46.55 -39.68 11.4 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.334 1.853 . . . . 0.0 111.269 172.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.29 -48.39 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 116.434 -1.746 . . . . 0.0 110.802 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -44.7 76.65 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.989 1.722 . . . . 0.0 106.857 -176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.36 -34.28 72.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.044 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.09 -56.37 9.09 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.627 1.558 . . . . 0.0 110.408 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -50.22 55.8 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.499 -1.375 . . . . 0.0 110.261 -167.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 t -70.74 -12.15 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.138 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.49 16.28 71.47 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 117.695 -1.614 . . . . 0.0 112.992 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.42 -30.91 70.86 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.542 2.171 . . . . 0.0 110.597 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -49.91 -37.39 31.38 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.985 2.114 . . . . 0.0 111.453 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -55.82 28.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.238 1.015 . . . . 0.0 110.534 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.0 m -62.49 -43.8 97.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.015 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -38.88 77.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.13 0.877 . . . . 0.0 110.302 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.67 -51.62 39.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.99 -1.069 . . . . 0.0 111.056 173.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -55.57 -25.84 40.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.054 1.297 . . . . 0.0 114.3 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -47.4 -36.03 9.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.985 1.314 . . . . 0.0 111.582 168.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -6.22 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.735 0.814 . . . . 0.0 111.973 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.92 85.02 0.23 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -169.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.41 -70.11 0.43 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.602 2.361 . . . . 0.0 109.008 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.58 148.68 51.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 121.081 1.764 . . . . 0.0 107.407 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.247 0.962 0 O-C-N 126.057 2.098 . . . . 0.0 107.37 158.725 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.626 0.25 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.92 -49.46 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.32 -46.86 81.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 t -79.69 10.27 4.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.144 2.178 . . . . 0.0 112.34 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -106.49 -34.61 7.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.712 -1.243 . . . . 0.0 109.862 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.07 148.2 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.53 1.059 . . . . 0.0 108.998 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -135.8 139.13 29.79 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 159.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -63.1 158.47 43.75 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.082 1.855 . . . . 0.0 109.098 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.75 17.36 41.95 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.547 -0.721 . . . . 0.0 113.528 -171.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 156.74 46.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.666 1.987 . . . . 0.0 107.981 172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -107.85 104.53 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.91 125.7 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.87 112.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -167.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.61 126.79 34.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.78 -178.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 0.0 111.429 -166.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.2 160.55 61.82 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 127.037 2.135 . . . . 0.0 107.086 172.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.67 -17.17 10.0 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.511 2.141 . . . . 0.0 111.638 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -129.16 24.57 5.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.732 2.013 . . . . 0.0 111.041 -163.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -107.17 115.29 60.16 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.16 -18.41 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.915 1.743 . . . . 0.0 111.07 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -74.17 -37.83 63.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.64 -50.35 65.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -49.03 -47.34 44.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.698 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -63.31 1.18 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 119.137 0.88 . . . . 0.0 109.348 173.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.0 58.87 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.143 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.48 -45.78 85.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.019 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.06 -30.95 55.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 121.724 2.056 . . . . 0.0 111.841 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mt -57.3 -55.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.282 1.433 . . . . 0.0 107.456 170.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.92 -56.13 4.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t -65.07 -20.91 66.71 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -160.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -73.62 -21.31 60.34 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.21 0.914 . . . . 0.0 111.914 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.93 149.53 90.01 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.181 0.9 . . . . 0.0 110.498 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.92 109.24 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.108 2.539 . . . . 0.0 108.57 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -130.72 147.55 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.39 155.21 5.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.028 1.331 . . . . 0.0 109.882 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.96 100.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.377 1.871 . . . . 0.0 111.043 -172.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.18 19.55 75.82 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.587 167.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.44 -25.88 60.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.31 2.055 . . . . 0.0 110.891 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 103.65 13.5 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 120.309 1.413 . . . . 0.0 107.305 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -115.14 102.29 9.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.039 1.336 . . . . 0.0 107.841 -170.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.13 131.08 34.81 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.0 t -128.14 100.85 6.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 125.542 1.537 . . . . 0.0 108.029 -166.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.61 119.6 22.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.075 0.55 . . . . 0.0 110.957 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.94 -9.15 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 124.58 1.152 . . . . 0.0 109.755 179.82 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.74 -63.77 0.29 Allowed 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 127.73 2.412 . . . . 0.0 109.961 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.29 -32.76 39.05 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -45.24 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.766 -1.209 . . . . 0.0 111.008 174.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 mt -57.34 -38.05 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.462 1.105 . . . . 0.0 110.208 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -63.33 -47.18 83.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.739 2.416 . . . . 0.0 106.934 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.67 -45.93 88.32 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.076 0.95 . . . . 0.0 110.006 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -61.06 -37.19 81.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.265 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.5 mt -55.77 -47.49 76.93 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 121.197 1.817 . . . . 0.0 109.206 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -54.12 -47.53 71.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.963 0.789 . . . . 0.0 111.08 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.91 77.48 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.054 0.542 . . . . 0.0 110.66 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.71 -24.5 56.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.891 0.876 . . . . 0.0 110.022 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.2 p -121.34 -65.92 1.09 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.513 1.051 . . . . 0.0 110.099 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.66 -4.76 0.68 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.564 2.03 . . . . 0.0 112.038 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.31 142.57 32.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.976 1.888 . . . . 0.0 109.518 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -95.63 -15.55 22.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 141.83 55.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.866 0.757 . . . . 0.0 110.755 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 158.22 33.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.994 1.718 . . . . 0.0 108.265 171.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.03 141.17 50.62 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 N-CA-C 110.034 -0.795 . . . . 0.0 110.034 -5.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -109.56 96.57 6.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.36 126.74 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -122.82 94.01 4.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.49 117.1 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.95 66.33 2.54 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 124.832 1.206 . . . . 0.0 114.016 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt 46.08 31.95 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -143.87 148.41 35.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.684 1.129 . . . . 0.0 110.09 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.3 139.32 30.61 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 119.334 0.97 . . . . 0.0 110.149 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.28 -7.89 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.47 0.577 . . . . 0.0 112.249 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.28 -88.23 0.25 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.76 -80.41 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -39.29 1.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.625 0.77 . . . . 0.0 112.255 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -76.89 -25.85 53.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.648 1.567 . . . . 0.0 111.15 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.74 -43.76 83.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.286 1.035 . . . . 0.0 108.318 165.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.34 -36.61 76.0 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.008 0.523 . . . . 0.0 111.086 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -60.41 -46.22 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 117.435 -1.269 . . . . 0.0 109.65 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -48.43 79.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.431 1.469 . . . . 0.0 107.217 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mt -56.21 -39.69 72.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.999 0.92 . . . . 0.0 109.006 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -58.65 6.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.394 1.452 . . . . 0.0 110.032 172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -50.55 66.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.095 1.358 . . . . 0.0 110.767 -164.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.9 t -75.97 -2.33 29.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.134 1.774 . . . . 0.0 111.562 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.44 5.74 44.92 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.624 -1.654 . . . . 0.0 113.866 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -65.2 -21.45 66.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.905 2.353 . . . . 0.0 110.504 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -49.85 -40.0 40.89 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.471 1.508 . . . . 0.0 111.88 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.87 -50.82 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -56.76 -54.15 49.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.9 1.28 . . . . 0.0 109.721 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -38.63 63.9 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.772 2.029 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.59 -49.68 20.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.073 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HZ3' ' C ' ' A' ' 106' ' ' GLN . 4.5 mttm -62.51 -23.47 66.97 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.642 1.565 . . . . 0.0 112.765 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -52.35 -20.38 2.72 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.883 1.673 . . . . 0.0 112.955 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.2 8.89 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.015 1.279 . . . . 0.0 113.671 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.38 41.13 31.39 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.383 -0.823 . . . . 0.0 111.6 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.14 -74.52 0.47 Allowed 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.285 1.434 . . . . 0.0 111.181 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.33 55.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 22.0 tt0 . . . . . 0 C--O 1.249 1.027 0 O-C-N 124.463 1.102 . . . . 0.0 108.933 -163.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.29 -49.69 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.021 0.828 . . . . 0.0 109.479 171.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.26 -48.19 81.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -164.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -74.16 -21.95 59.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.754 0.822 . . . . 0.0 111.733 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -64.79 -48.12 75.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.025 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.01 149.8 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -145.27 152.64 50.99 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.29 160.97 28.75 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.225 1.283 . . . . 0.0 109.78 159.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.86 24.33 33.47 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.869 -0.962 . . . . 0.0 113.917 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -141.43 160.11 40.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.531 1.666 . . . . 0.0 107.877 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.74 87.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.51 129.42 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.86 112.45 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -166.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.92 124.91 29.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.7 178.42 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.929 2.092 . . . . 0.0 110.395 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.89 160.31 69.05 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 159.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.5 -30.52 3.13 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.994 1.796 . . . . 0.0 110.848 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -91.21 3.18 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.048 1.339 . . . . 0.0 111.96 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.24 110.55 41.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.226 1.011 . . . . 0.0 112.042 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -28.51 38.34 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 112.12 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -73.78 -24.08 59.79 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.607 1.094 . . . . 0.0 110.977 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.73 -52.09 48.43 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 166.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -55.04 -37.6 66.9 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.413 1.085 . . . . 0.0 113.544 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HE ' HD13 ' A' ' 32' ' ' ILE . 29.2 ttt180 -59.32 -61.16 2.84 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 118.428 0.558 . . . . 0.0 110.263 169.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.4 -34.07 46.56 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 124.575 1.172 . . . . 0.0 110.969 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -53.18 60.2 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 126.256 1.822 . . . . 0.0 112.967 171.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -53.62 35.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.442 HD13 ' HE ' ' A' ' 28' ' ' ARG . 4.4 mt -46.96 -50.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.843 1.657 . . . . 0.0 110.905 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.89 -45.26 59.2 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -63.02 -16.37 59.59 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.39 -31.2 63.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.937 1.699 . . . . 0.0 109.939 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.6 136.89 55.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.26 61.45 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.203 3.268 . . . . 0.0 112.719 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.63 150.16 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -53.07 124.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.826 0.85 . . . . 0.0 110.119 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -53.2 128.26 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.48 -23.58 34.63 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.005 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.89 -37.89 64.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 119.823 1.811 . . . . 0.0 110.612 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 106.73 16.05 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -129.14 115.12 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.859 0.838 . . . . 0.0 111.426 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -83.9 105.46 14.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.84 125.67 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.907 2.083 . . . . 0.0 106.731 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -82.27 128.63 34.38 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.415 -0.803 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -63.09 -23.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.15 -0.969 . . . . 0.0 111.12 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.444 -0.733 0 C-N-CA 126.424 1.89 . . . . 0.0 106.822 -175.068 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -62.71 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 122.225 2.284 . . . . 0.0 111.473 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -48.55 -48.32 38.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.708 0.803 . . . . 0.0 112.101 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -28.81 69.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.526 1.53 . . . . 0.0 113.377 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 mt -81.65 -34.56 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.602 1.961 . . . . 0.0 107.922 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.61 -50.98 25.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.535 2.334 . . . . 0.0 107.851 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -45.51 -53.1 9.41 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.577 1.551 . . . . 0.0 111.013 167.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.09 -42.33 99.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.999 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.26 -40.29 85.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.839 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.63 -50.84 70.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.301 1.04 . . . . 0.0 109.386 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.06 -46.33 89.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 111.864 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.26 -38.4 56.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 109.287 -170.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -112.27 -28.99 7.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.06 -5.02 35.97 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.948 1.261 . . . . 0.0 112.738 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.47 147.06 28.7 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.512 1.656 . . . . 0.0 109.674 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -84.92 -18.44 34.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.085 -0.483 . . . . 0.0 111.914 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -64.72 133.55 52.32 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.345 0.52 . . . . 0.0 110.113 -162.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 165.41 31.94 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.542 0.737 . . . . 0.0 109.475 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -65.47 165.7 56.04 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -15.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.98 96.72 4.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.06 105.21 13.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.006 1.722 . . . . 0.0 106.791 166.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.06 107.22 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 167.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.07 69.38 0.77 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.428 1.49 . . . . 0.0 113.066 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tttm 46.05 31.0 1.03 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.421 1.888 . . . . 0.0 115.985 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -128.96 127.25 41.33 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.626 1.103 . . . . 0.0 108.885 159.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.54 138.48 43.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -114.86 12.92 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.148 0.979 . . . . 0.0 111.223 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -149.06 21.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 -10.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.25 150.83 29.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 t 61.46 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -48.96 69.19 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.005 1.322 . . . . 0.0 109.566 -175.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.3 -46.84 36.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.979 2.112 . . . . 0.0 111.475 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.53 -48.24 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.25 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -47.77 77.07 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.663 1.574 . . . . 0.0 109.128 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.58 -35.46 74.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.45 -56.91 6.79 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.58 1.536 . . . . 0.0 109.639 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -53.84 41.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.32 1.848 . . . . 0.0 111.303 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.5 t -70.6 -15.84 62.79 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.875 2.47 . . . . 0.0 111.019 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.09 1.33 84.63 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 118.393 -1.226 . . . . 0.0 113.617 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.23 -33.27 73.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 120.066 1.933 . . . . 0.0 111.394 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.19 -38.65 73.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.232 1.413 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -55.04 25.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.79 1.236 . . . . 0.0 108.677 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -61.47 -42.51 98.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.643 0.777 . . . . 0.0 110.246 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.91 83.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.692 0.797 . . . . 0.0 111.317 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.09 -48.69 61.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.283 1.033 . . . . 0.0 110.337 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -57.42 -31.12 65.55 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.788 -1.195 . . . . 0.0 112.979 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -24.54 40.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.737 0.815 . . . . 0.0 111.591 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.01 23.97 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.818 0.847 . . . . 0.0 111.514 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.0 16.34 57.99 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 164.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.96 -70.46 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.402 1.101 . . . . 0.0 111.167 -166.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.39 146.16 47.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.102 -165.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 112.67 -2.059 . . . . 0.0 109.968 -173.493 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.9 t80 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.97 -59.75 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 0.0 109.171 170.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.1 -33.73 76.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.091 2.556 . . . . 0.0 110.827 -166.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.23 -51.18 65.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.263 3.425 . . . . 0.0 110.443 172.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 40.7 mmtm -69.8 -17.27 63.39 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.842 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 ' CG2' ' HA ' ' A' ' 77' ' ' LYS . 6.9 mm -73.9 129.92 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 119.156 0.889 . . . . 0.0 108.694 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -131.11 159.22 72.57 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 159.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.07 70.05 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.884 3.056 . . . . 0.0 109.789 169.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.7 64.87 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 126.719 2.104 . . . . 0.0 108.464 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -151.11 159.05 44.71 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.622 2.369 . . . . 0.0 105.597 165.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.04 87.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.46 151.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.904 -1.123 . . . . 0.0 108.247 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.36 116.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 160.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -77.3 125.58 29.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.11 176.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.681 1.993 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 160.46 43.65 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.378 1.871 . . . . 0.0 108.956 171.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -82.19 26.43 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.191 3.261 . . . . 0.0 110.56 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.409 HG21 ' H ' ' A' ' 23' ' ' CYS 0.364 2.9 t -138.2 -106.63 0.18 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.75 172.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' H ' HG21 ' A' ' 22' ' ' THR . 7.2 m 32.65 104.21 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 129.916 3.286 . . . . 0.0 113.989 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.23 -16.88 36.37 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.202 1.268 . . . . 0.0 112.211 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -74.36 -47.91 31.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.062 1.345 . . . . 0.0 108.852 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.1 m -63.93 -44.35 93.16 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -53.19 -45.28 68.5 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.353 1.061 . . . . 0.0 110.343 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.66 -60.1 4.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 118.816 -0.612 . . . . 0.0 109.578 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.04 64.57 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.187 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -52.59 64.98 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.167 0.894 . . . . 0.0 112.451 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.18 -40.5 67.87 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.491 0.587 . . . . 0.0 109.753 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.0 mt -53.88 -53.13 29.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.821 1.248 . . . . 0.0 109.584 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.62 -44.47 56.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.132 -0.937 . . . . 0.0 108.564 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.1 m -55.81 -27.92 53.7 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -73.45 -19.71 60.89 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.018 0.826 . . . . 0.0 110.952 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -87.57 133.7 37.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.707 1.139 . . . . 0.0 107.936 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.77 114.55 4.05 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.206 1.938 . . . . 0.0 108.829 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.25 152.13 36.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -54.16 123.6 13.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.94 150.64 48.31 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 -30.03 6.34 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.931 -168.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.51 -47.05 24.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 120.42 2.11 . . . . 0.0 111.533 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 107.5 16.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.822 1.192 . . . . 0.0 108.433 -164.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.03 111.47 12.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.738 0.78 . . . . 0.0 110.431 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -84.01 102.55 12.56 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.41 121.3 49.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.78 1.632 . . . . 0.0 107.637 -172.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.7 133.68 34.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.593 -170.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -88.18 -12.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.846 1.658 . . . . 0.0 113.843 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 123.923 0.889 . . . . 0.0 110.987 -166.561 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m80 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -63.37 1.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 121.362 1.892 . . . . 0.0 110.236 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.25 -41.47 75.8 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 119.694 -0.194 . . . . 0.0 111.394 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -49.04 77.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.444 1.498 . . . . 0.0 111.65 173.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.43 -39.58 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.296 1.838 . . . . 0.0 108.512 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -80.33 -40.09 27.38 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -164.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -58.01 -53.94 52.57 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.449 1.9 . . . . 0.0 108.903 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -53.23 -49.4 66.9 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.896 1.278 . . . . 0.0 109.946 172.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.25 -29.29 63.68 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.436 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.93 -59.88 4.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.132 1.333 . . . . 0.0 109.13 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.13 -36.61 82.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.091 0.557 . . . . 0.0 111.23 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.61 -20.05 58.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.889 1.276 . . . . 0.0 110.404 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.4 p -125.84 -76.23 0.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.744 1.611 . . . . 0.0 112.744 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.1 -6.87 0.07 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.66 2.076 . . . . 0.0 113.797 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.09 152.78 35.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.559 1.68 . . . . 0.0 109.078 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -97.46 -3.2 40.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.112 0.965 . . . . 0.0 111.882 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -69.59 141.75 53.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.13 157.81 32.97 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 125.62 1.568 . . . . 0.0 108.931 166.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.7 161.85 52.49 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 CA-C-N 120.256 1.127 . . . . 0.0 111.829 -4.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -132.16 97.61 4.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.5 1.12 . . . . 0.0 108.313 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.9 t -75.03 120.93 25.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.94 96.58 6.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.827 1.651 . . . . 0.0 107.335 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -83.85 116.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 161.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 78' ' ' ASP . . . 46.29 87.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.514 2.007 . . . . 0.0 115.374 162.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HA ' ' CG2' ' A' ' 10' ' ' ILE . 15.4 mtpp 46.83 -12.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 131.512 3.925 . . . . 0.0 117.434 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 76' ' ' GLY . 31.7 t0 -99.06 167.74 10.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 119.529 1.058 . . . . 0.0 109.209 175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -120.16 125.49 48.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.401 1.48 . . . . 0.0 107.611 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.62 -23.58 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.567 0.222 . . . . 0.0 111.315 -164.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.85 177.11 15.43 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -159.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.45 -84.12 1.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -167.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.23 -64.15 1.06 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.234 1.014 . . . . 0.0 110.255 -173.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -49.8 64.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.74 1.155 . . . . 0.0 111.166 176.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.0 -36.66 78.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.138 1.775 . . . . 0.0 107.783 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.65 -40.51 84.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.083 0.953 . . . . 0.0 110.074 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.88 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 116.273 -1.822 . . . . 0.0 109.384 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.294 5.1 p -54.1 -47.27 71.96 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 121.987 2.176 . . . . 0.0 114.783 168.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.02 -43.87 70.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.333 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -60.69 -54.95 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.259 2.299 . . . . 0.0 110.693 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -42.99 58.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.486 1.914 . . . . 0.0 114.157 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -14.6 61.29 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 168.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.9 2.69 88.38 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.338 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.49 -17.49 64.83 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.916 1.858 . . . . 0.0 112.236 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -43.6 97.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.436 1.494 . . . . 0.0 109.495 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.22 -44.58 97.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 109.399 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -59.36 -54.08 50.85 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.079 0.552 . . . . 0.0 109.797 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -44.55 65.42 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.257 1.023 . . . . 0.0 111.55 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.5 mt -65.44 -50.59 64.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.56 1.144 . . . . 0.0 110.269 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -23.51 61.22 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.181 -0.949 . . . . 0.0 113.329 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.54 -29.09 9.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.173 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.16 26.6 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.394 1.078 . . . . 0.0 111.936 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.29 19.06 73.87 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.385 1.469 . . . . 0.0 114.725 168.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.34 -57.08 4.18 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 112.108 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.6 133.27 50.81 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -153.084 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -112.45 -47.52 3.08 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -57.31 -31.19 65.43 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.38 -60.6 3.6 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.542 1.065 . . . . 0.0 109.165 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.61 -45.77 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -55.79 -50.18 71.18 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.361 0.664 . . . . 0.0 111.34 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.22 -25.72 36.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.941 0.896 . . . . 0.0 111.781 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -65.58 -38.45 89.55 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.811 1.187 . . . . 0.0 110.621 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.91 154.84 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 120.63 1.559 . . . . 0.0 107.9 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.9 166.93 14.89 Favored Pre-proline 0 C--O 1.241 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 107.175 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.56 158.59 52.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 159.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.77 84.24 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 113.968 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.62 151.56 38.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.174 2.19 . . . . 0.0 108.961 163.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.68 79.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.203 1.401 . . . . 0.0 107.476 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.09 140.7 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.02 115.82 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -81.54 131.94 35.29 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 171.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 126.294 1.838 . . . . 0.0 111.235 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' NZ ' ' SG ' ' A' ' 23' ' ' CYS . 3.1 ptmm? -140.15 143.94 35.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 162.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.14 -10.99 24.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.602 1.535 . . . . 0.0 110.985 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 p -89.46 -9.31 50.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.472 1.509 . . . . 0.0 111.882 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.569 ' CB ' ' HG ' ' A' ' 26' ' ' CYS . 1.8 m -78.33 123.62 85.78 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.527 1.058 . . . . 0.0 109.092 161.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.67 -23.67 48.79 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.672 1.581 . . . . 0.0 110.291 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.37 -28.92 62.3 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.673 0.789 . . . . 0.0 110.369 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.569 ' HG ' ' CB ' ' A' ' 23' ' ' CYS . 63.0 m -68.02 -32.08 72.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -65.89 -38.28 88.33 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.932 0.787 . . . . 0.0 111.833 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -59.56 4.97 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.91 -35.88 58.86 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 124.051 0.845 . . . . 0.0 111.343 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -45.96 92.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.117 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.93 -50.9 25.12 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -46.05 -50.39 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.738 1.215 . . . . 0.0 110.563 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mt -79.59 -48.39 13.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -70.63 -6.18 34.93 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.8 -21.25 60.22 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.456 1.025 . . . . 0.0 110.725 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.91 142.09 24.58 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.797 . . . . 0.0 109.964 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.11 109.75 2.78 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.64 2.894 . . . . 0.0 110.075 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.2 mt -133.68 149.84 31.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -53.0 127.69 24.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 118.195 0.452 . . . . 0.0 110.995 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.12 131.08 49.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.757 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.86 52.73 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.287 1.422 . . . . 0.0 111.841 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.95 -34.44 64.3 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.951 1.375 . . . . 0.0 110.665 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.36 111.32 18.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -129.08 108.75 10.63 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -83.93 102.49 12.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.77 137.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.506 1.923 . . . . 0.0 106.965 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.12 149.5 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.728 -0.608 . . . . 0.0 110.816 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.65 10.19 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.102 1.761 . . . . 0.0 112.27 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -133.8 -20.43 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 120.581 1.537 . . . . 0.0 111.882 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.98 74.84 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.405 -1.435 . . . . 0.0 113.99 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.29 20.74 0.95 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -161.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.466 HD21 HD13 ' A' ' 57' ' ' ILE . 11.5 p-10 -156.6 -148.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.229 -0.919 . . . . 0.0 110.396 -162.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -137.06 100.76 4.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.15 2.98 . . . . 0.0 103.016 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -42.14 -63.31 0.77 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -43.85 -33.1 1.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.921 2.488 . . . . 0.0 113.758 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.36 -60.68 1.93 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.466 HD13 HD21 ' A' ' 52' ' ' ASN . 1.3 mt -54.76 -33.85 28.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 124.972 1.309 . . . . 0.0 111.173 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -73.63 -40.68 63.6 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.31 -44.63 87.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.077 1.751 . . . . 0.0 110.496 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.53 -48.15 81.81 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.035 -0.416 . . . . 0.0 110.469 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.78 -36.41 69.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.096 0.959 . . . . 0.0 110.288 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -50.47 68.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.509 0.724 . . . . 0.0 110.418 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -68.73 -45.28 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.084 0.553 . . . . 0.0 110.279 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.79 -30.79 59.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 p -123.72 -12.78 7.58 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.65 59.66 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.292 1.405 . . . . 0.0 113.178 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.46 149.47 18.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.357 1.079 . . . . 0.0 109.935 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -102.9 -25.29 13.53 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.811 0.844 . . . . 0.0 112.649 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -71.29 144.31 50.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.95 165.99 11.81 Favored Pre-proline 0 C--O 1.244 0.777 0 C-N-CA 126.372 1.869 . . . . 0.0 109.21 -170.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.58 161.91 51.53 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 119.287 0.781 . . . . 0.0 111.424 -3.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -137.81 97.11 3.35 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.14 127.49 39.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.23 96.03 5.59 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.836 2.454 . . . . 0.0 107.879 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.61 107.84 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 38.37 81.48 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 127.432 2.444 . . . . 0.0 113.135 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 16.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.37 2.268 . . . . 0.0 116.996 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.96 110.81 18.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 119.024 0.829 . . . . 0.0 108.836 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.28 117.12 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.54 -21.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.53 -155.76 21.3 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.64 -168.75 31.2 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.982 1.753 . . . . 0.0 110.253 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.75 -24.66 64.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.578 -1.201 . . . . 0.0 112.126 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m -60.63 -49.22 78.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 120.231 1.378 . . . . 0.0 109.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -41.29 84.86 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.692 0.797 . . . . 0.0 109.57 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.7 tp -56.59 -39.25 73.22 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.367 0.667 . . . . 0.0 112.004 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -61.92 -46.08 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.044 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.58 -56.47 21.73 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.73 -27.15 68.71 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.912 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -68.05 -54.07 21.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.586 1.539 . . . . 0.0 109.454 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -40.8 77.37 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.702 1.201 . . . . 0.0 111.775 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -70.61 -20.52 62.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.529 2.732 . . . . 0.0 110.262 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.9 6.63 82.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.722 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.61 -31.98 72.91 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 120.273 2.036 . . . . 0.0 109.514 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.43 -40.9 75.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.191 1.796 . . . . 0.0 110.445 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.11 -47.72 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.592 0.633 . . . . 0.0 109.339 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m -60.82 -49.52 77.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.279 0.632 . . . . 0.0 109.351 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -48.77 61.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.598 1.159 . . . . 0.0 110.688 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -49.3 70.88 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.334 1.054 . . . . 0.0 112.734 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -67.43 -25.11 65.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 117.088 -1.845 . . . . 0.0 112.717 -166.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -48.16 -46.22 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.764 0.665 . . . . 0.0 110.448 168.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.71 8.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.903 0.774 . . . . 0.0 112.078 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.67 34.21 44.64 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.602 1.096 . . . . 0.0 111.701 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.31 -74.52 0.38 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.39 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.59 133.75 55.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.773 1.169 . . . . 0.0 110.578 -159.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 131.144 3.778 . . . . 0.0 104.858 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 116.47 -1.728 . . . . 0.0 115.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -66.67 34.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 122.099 2.227 . . . . 0.0 113.559 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -163.42 -57.41 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.262 2.225 . . . . 0.0 105.502 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -55.81 -51.69 66.59 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.763 1.165 . . . . 0.0 110.923 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.43 -49.29 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.322 0.51 . . . . 0.0 109.895 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.86 -53.12 55.6 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.547 0.612 . . . . 0.0 111.262 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.9 m -68.76 -5.4 20.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.214 1.406 . . . . 0.0 112.659 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.6 -26.4 45.4 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.508 167.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.26 167.45 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 165.08 18.98 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 128.194 2.598 . . . . 0.0 105.735 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.6 61.47 7.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.709 2.273 . . . . 0.0 111.951 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.74 16.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.745 -1.031 . . . . 0.0 115.513 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -119.05 160.11 22.66 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.486 1.643 . . . . 0.0 108.002 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.96 98.78 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.59 151.68 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.56 115.22 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -74.81 120.42 20.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.07 176.04 7.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 127.462 2.305 . . . . 0.0 110.268 -171.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -122.89 158.69 56.49 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 164.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.95 9.75 2.26 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.759 2.972 . . . . 0.0 112.971 -168.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.306 0.1 OUTLIER -133.35 -106.17 0.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -173.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t 33.83 115.06 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 130.975 3.71 . . . . 0.0 113.702 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -61.75 -20.32 68.62 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.96 1.107 . . . . 0.0 112.602 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -81.8 -42.6 19.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.76 -43.13 99.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -54.35 -53.42 54.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.31 1.044 . . . . 0.0 110.204 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -55.81 27.8 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.1 69.89 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.677 0.611 . . . . 0.0 110.868 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -54.6 -51.98 63.61 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.81 1.244 . . . . 0.0 112.557 172.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.8 -47.61 45.12 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 126.342 1.857 . . . . 0.0 110.178 -171.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -50.21 -56.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.207 1.803 . . . . 0.0 108.079 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.83 -43.25 62.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.268 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.3 m -70.39 -4.43 22.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.8 -26.75 60.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.431 1.469 . . . . 0.0 111.874 172.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.83 150.51 65.88 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 119.137 0.881 . . . . 0.0 110.787 -171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.47 72.95 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.613 2.876 . . . . 0.0 108.731 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.61 147.57 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -50.21 124.21 9.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.941 0.496 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -65.14 140.87 58.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.1 -3.5 85.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.109 -1.384 . . . . 0.0 112.418 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -92.23 -28.88 16.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.201 2.001 . . . . 0.0 112.674 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.63 109.64 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.858 2.117 . . . . 0.0 108.193 -171.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -121.43 112.6 18.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.46 1.027 . . . . 0.0 109.885 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 74.5 m-85 -96.03 91.76 6.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.832 1.253 . . . . 0.0 108.963 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.67 104.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.299 1.84 . . . . 0.0 108.708 -168.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.73 104.79 2.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.69 1.596 . . . . 0.0 112.235 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.23 -8.98 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.639 1.175 . . . . 0.0 113.087 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -128.25 15.52 6.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.427 1.012 . . . . 0.0 110.79 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.44 -18.33 27.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.465 1.029 . . . . 0.0 113.19 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.251 0.4 OUTLIER -150.97 -43.67 0.12 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.076 158.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -160.3 0.2 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.004 1.274 . . . . 0.0 109.27 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.0 m170 66.3 2.43 2.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.384 2.274 . . . . 0.0 115.041 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.87 -63.4 0.98 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 120.397 1.453 . . . . 0.0 109.864 170.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -47.02 -49.7 20.63 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.373 -0.822 . . . . 0.0 113.01 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -60.9 -44.61 96.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.708 1.203 . . . . 0.0 110.06 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -68.31 -42.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.801 1.64 . . . . 0.0 107.32 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -48.92 70.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.567 2.347 . . . . 0.0 105.421 -172.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -52.91 -59.01 5.05 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 126.022 1.729 . . . . 0.0 109.942 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.97 -38.7 79.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.644 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.37 -32.1 72.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.462 1.028 . . . . 0.0 111.213 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -61.72 -38.69 88.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.277 0.944 . . . . 0.0 110.372 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -51.54 12.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.728 0.695 . . . . 0.0 111.395 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.59 -22.76 63.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.611 1.164 . . . . 0.0 110.533 -171.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.9 p -116.09 -71.67 0.73 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.608 1.095 . . . . 0.0 108.083 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.66 0.23 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.108 1.337 . . . . 0.0 110.811 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -134.89 144.95 47.8 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 108.871 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -21.66 51.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.117 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.5 p -63.05 133.37 54.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.493 0.496 . . . . 0.0 110.007 -158.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.76 155.57 61.69 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.39 166.28 64.93 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 CA-C-N 119.927 1.01 . . . . 0.0 111.419 -5.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -133.84 96.11 3.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 169.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.4 126.31 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -113.99 101.83 9.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.877 1.671 . . . . 0.0 107.477 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.04 115.26 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.554 -2.388 . . . . 0.0 104.554 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.35 72.38 0.48 Allowed Glycine 0 C--N 1.337 0.611 0 C-N-CA 124.621 1.105 . . . . 0.0 111.873 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 46.67 22.1 0.16 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.58 130.52 38.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.397 1.453 . . . . 0.0 110.854 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 t -71.58 115.96 11.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.776 0.83 . . . . 0.0 110.068 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.2 -6.65 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 118.442 0.565 . . . . 0.0 111.256 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.54 -175.93 19.68 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.561 1.553 . . . . 0.0 109.519 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.66 -91.82 1.2 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.43 -55.7 0.96 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.611 0.705 . . . . 0.0 112.457 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -61.18 -33.56 73.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.171 0.896 . . . . 0.0 111.107 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.12 -63.21 1.21 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.098 1.759 . . . . 0.0 107.766 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -37.25 23.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.683 2.393 . . . . 0.0 113.126 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.33 -36.03 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.341 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -49.39 66.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 121.3 1.864 . . . . 0.0 107.383 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.54 -37.48 75.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.36 -63.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.465 1.03 . . . . 0.0 109.692 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -51.64 58.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.155 1.782 . . . . 0.0 112.25 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -75.01 -36.73 61.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.594 1.157 . . . . 0.0 109.889 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.21 35.34 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.799 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -63.06 -26.97 69.09 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.621 2.21 . . . . 0.0 110.872 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -39.66 84.94 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 125.206 1.402 . . . . 0.0 109.172 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -39.71 84.93 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.526 0.73 . . . . 0.0 109.234 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 m -59.7 -57.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -34.51 78.3 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.888 -0.508 . . . . 0.0 112.174 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 mt -57.04 -53.73 54.71 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.946 1.298 . . . . 0.0 109.793 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -25.34 68.03 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.368 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -56.55 -30.31 62.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.42 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.74 8.78 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 112.53 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.59 30.95 59.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.305 -0.872 . . . . 0.0 112.858 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.74 -70.47 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 110.195 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.93 134.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -166.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--O 1.247 0.944 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 -174.041 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 4' ' ' GLU . 7.0 pt20 34.22 -91.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.086 2.554 . . . . 0.0 113.02 -174.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -34.85 -43.96 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 130.347 3.459 . . . . 0.0 113.458 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -53.14 -41.1 64.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.491 1.117 . . . . 0.0 111.729 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 18' ' ' PHE . 24.8 t -80.6 -56.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -60.47 -28.42 68.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -158.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -109.34 -16.66 13.98 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.398 1.079 . . . . 0.0 112.662 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -65.6 -39.07 91.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 0.0 110.149 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -69.9 144.86 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.26 160.27 37.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 163.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 71.5 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.499 3.466 . . . . 0.0 111.931 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.31 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.922 2.201 . . . . 0.0 110.555 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -151.24 162.92 40.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.76 2.424 . . . . 0.0 106.361 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.44 87.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 165.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -88.16 135.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.58 114.27 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' HG11 ' A' ' 6' ' ' VAL . 69.3 m-85 -84.11 130.04 34.87 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 167.77 18.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.005 1.322 . . . . 0.0 110.659 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.7 149.33 58.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 161.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.49 -19.68 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.617 2.878 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -75.58 31.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.758 2.423 . . . . 0.0 110.802 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.9 t -144.19 121.5 6.6 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.87 1.668 . . . . 0.0 111.289 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.98 -19.97 19.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.018 1.812 . . . . 0.0 111.238 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.409 ' HB3' ' HG ' ' A' ' 83' ' ' CYS . 26.4 m-85 -76.8 -41.18 45.46 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.38 -46.65 88.07 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.3 ttm-85 -57.17 -42.66 81.52 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.467 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -58.62 -56.91 16.14 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 120.321 1.418 . . . . 0.0 108.529 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.45 -32.7 51.09 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 123.722 0.639 . . . . 0.0 111.141 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -60.52 3.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.46 1.504 . . . . 0.0 112.474 169.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -66.11 -45.94 79.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.692 1.133 . . . . 0.0 109.243 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.12 -48.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.424 1.49 . . . . 0.0 110.494 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.96 -52.29 11.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -64.42 -14.43 56.75 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.47 1.508 . . . . 0.0 113.531 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.64 -24.25 59.98 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.073 1.306 . . . . 0.0 111.28 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.77 150.83 84.3 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.178 0.899 . . . . 0.0 110.714 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.88 67.69 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.565 2.843 . . . . 0.0 110.47 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -90.33 154.25 3.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -55.38 128.75 35.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.57 1.148 . . . . 0.0 109.469 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.93 136.22 57.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.26 -3.66 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.481 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mt -73.66 -41.15 63.08 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.888 1.844 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.79 110.04 18.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -121.52 120.25 34.33 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.79 94.76 9.95 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.585 1.554 . . . . 0.0 107.324 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -85.29 107.96 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.895 2.078 . . . . 0.0 107.988 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -70.92 107.86 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.97 1.308 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 pt -68.47 -15.19 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.605 0.762 . . . . 0.0 112.644 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -94.57 -9.33 35.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.274 1.03 . . . . 0.0 110.952 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.07 72.9 6.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.302 1.441 . . . . 0.0 109.085 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.25 35.1 p 60.95 8.29 1.82 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.596 3.159 . . . . 0.0 116.04 161.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -78.63 -106.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 163.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -163.6 93.12 0.73 Allowed 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -63.44 1.11 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.988 0.915 . . . . 0.0 109.53 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -27.24 32.71 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.58 -29.67 15.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.831 1.196 . . . . 0.0 111.448 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.77 -37.16 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -62.89 -51.67 66.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.38 1.872 . . . . 0.0 106.472 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -52.65 -53.84 41.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 111.054 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -41.44 80.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.92 -35.83 81.94 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.749 -1.22 . . . . 0.0 110.321 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.23 -39.02 92.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.373 0.533 . . . . 0.0 111.201 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -63.22 -52.45 62.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.805 . . . . 0.0 110.25 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -75.7 -52.95 9.35 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 p -97.57 -15.95 20.27 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.73 1.67 57.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.079 -0.845 . . . . 0.0 111.748 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.44 151.94 10.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.186 1.493 . . . . 0.0 110.756 169.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -87.9 -26.38 22.76 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 p -58.61 133.35 55.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -158.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.88 22.46 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.896 0.879 . . . . 0.0 110.007 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -60.53 155.33 51.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 CA-C-N 119.833 0.976 . . . . 0.0 110.111 -10.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.83 113.6 20.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.21 123.92 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 119.712 1.142 . . . . 0.0 109.08 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.87 104.09 13.72 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 121.93 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 160.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.4 80.58 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 127.736 2.589 . . . . 0.0 114.934 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.26 21.14 0.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.27 125.39 34.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 121.206 1.821 . . . . 0.0 111.722 158.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.6 t -65.56 113.46 4.21 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.592 1.957 . . . . 0.0 109.761 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.68 -21.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 O-C-N 122.935 0.147 . . . . 0.0 110.611 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.39 -165.44 24.72 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.65 -167.11 36.43 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.985 0.802 . . . . 0.0 111.312 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' HG ' ' HB3' ' A' ' 25' ' ' TYR . 5.2 p -60.87 -34.89 75.32 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.303 1.051 . . . . 0.0 111.707 -171.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -74.45 -42.98 58.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.543 0.611 . . . . 0.0 109.524 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.77 -46.97 82.85 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.95 -41.07 67.37 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.318 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.93 -48.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 116.827 -1.559 . . . . 0.0 109.9 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -47.02 87.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.206 1.821 . . . . 0.0 108.037 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.7 -40.56 83.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.933 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.36 -67.01 0.47 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.842 1.655 . . . . 0.0 110.211 172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -43.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.981 2.113 . . . . 0.0 113.294 -170.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.9 -4.17 50.41 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.73 1.212 . . . . 0.0 111.482 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.9 5.53 87.76 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 117.271 -1.849 . . . . 0.0 115.146 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.2 -29.08 69.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 121.495 2.648 . . . . 0.0 110.937 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -53.54 -38.1 63.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.88 1.672 . . . . 0.0 111.619 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.76 -50.67 48.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.5 m -60.5 -47.36 86.48 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.721 0.808 . . . . 0.0 110.132 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -52.05 41.1 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 110.213 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.3 -46.17 84.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -66.3 -26.84 67.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 117.995 -1.003 . . . . 0.0 113.031 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -54.84 -33.1 61.33 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.504 0.593 . . . . 0.0 110.558 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.45 9.38 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.438 1.017 . . . . 0.0 112.199 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.16 17.8 79.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.311 0.96 . . . . 0.0 114.181 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.32 -61.83 1.63 Allowed 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.123 1.769 . . . . 0.0 111.468 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.35 133.29 46.79 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.249 1.077 0 O-C-N 126.227 2.204 . . . . 0.0 112.195 -152.431 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 34.74 58.7 0.7 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 128.305 2.642 . . . . 0.0 112.437 163.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 61.79 -34.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.877 2.471 . . . . 0.0 115.674 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.12 -61.99 2.15 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 120.987 1.721 . . . . 0.0 110.522 -171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HB ' ' H2 ' ' A' ' 2' ' ' ALA . 2.4 t -63.75 -33.29 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' ND2' ' H1 ' ' A' ' 2' ' ' ALA . 74.1 m-20 -79.96 -30.86 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.861 -0.525 . . . . 0.0 111.541 -162.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -89.18 -19.22 25.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.091 1.757 . . . . 0.0 110.61 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -47.09 82.46 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.493 -1.38 . . . . 0.0 109.012 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -71.28 148.03 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -136.25 145.97 54.24 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.133 0.973 . . . . 0.0 108.878 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 61.21 7.62 Favored 'Trans proline' 0 CA--C 1.537 0.661 1 C-N-CA 125.324 4.016 . . . . 0.0 112.924 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.06 23.09 0.03 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 125.809 1.671 . . . . 0.0 111.723 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -137.94 154.04 49.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 127.003 2.121 . . . . 0.0 107.006 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.04 93.13 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.58 129.94 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.18 155.98 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.75 125.59 50.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.54 175.63 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.048 2.139 . . . . 0.0 110.005 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -129.73 152.96 80.68 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.11 1.764 . . . . 0.0 106.688 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.79 -13.62 26.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.235 2.623 . . . . 0.0 113.145 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -102.3 -10.68 19.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.816 2.047 . . . . 0.0 112.209 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -90.95 127.57 51.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.653 0.781 . . . . 0.0 109.381 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.89 -23.05 16.78 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.86 1.707 . . . . 0.0 111.293 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.38 -35.04 47.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -58.19 -54.08 51.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.581 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -51.11 -45.15 61.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.306 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -61.59 2.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.96 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.895 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -55.11 -58.74 6.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.38 1.472 . . . . 0.0 112.683 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.87 -41.49 82.75 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 118.549 0.613 . . . . 0.0 109.802 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -53.75 -52.82 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.443 1.497 . . . . 0.0 109.101 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.31 -44.77 64.51 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -55.73 -15.67 3.4 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.5 -23.02 59.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.802 2.092 . . . . 0.0 111.745 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.29 137.12 39.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 119.071 0.851 . . . . 0.0 109.682 -169.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.72 85.17 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.847 3.031 . . . . 0.0 111.032 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.34 151.63 7.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.474 1.51 . . . . 0.0 107.196 -165.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -49.24 126.65 13.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.026 0.93 . . . . 0.0 109.988 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.46 130.02 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.67 84.35 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 117.623 -1.654 . . . . 0.0 113.16 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.12 -37.72 64.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.594 2.197 . . . . 0.0 111.022 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 110.37 18.26 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.403 1.456 . . . . 0.0 107.589 -175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -124.53 98.61 5.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.221 1.408 . . . . 0.0 108.549 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -83.97 105.99 15.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.59 127.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.963 1.305 . . . . 0.0 107.568 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.842 1.257 . . . . 0.0 111.119 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.0 pt -68.6 -16.76 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.722 -1.237 . . . . 0.0 112.243 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 p -84.46 -7.35 59.31 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.315 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.17 -38.13 24.65 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.98 1.312 . . . . 0.0 112.447 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 p -121.61 9.13 10.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.215 1.006 . . . . 0.0 111.081 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.7 t30 40.92 63.95 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.164 2.585 . . . . 0.0 112.204 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -109.03 19.04 19.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.134 1.373 . . . . 0.0 109.307 160.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.89 -63.28 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.764 2.026 . . . . 0.0 109.96 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -45.19 -48.49 12.47 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.952 1.701 . . . . 0.0 113.719 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -40.19 73.51 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.58 0.627 . . . . 0.0 110.498 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 mt -63.31 -42.27 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -58.01 -51.32 70.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.17 2.988 . . . . 0.0 109.27 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.23 -62.16 1.9 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.041 1.737 . . . . 0.0 110.442 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 2' ' ' ALA . 13.7 t80 -53.17 -41.02 64.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.07 -27.57 69.19 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.753 1.221 . . . . 0.0 112.423 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -44.3 96.66 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.026 0.83 . . . . 0.0 110.049 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.45 -46.76 37.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.211 0.605 . . . . 0.0 110.359 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.69 -23.82 66.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 111.464 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 1.5 p -127.22 -72.22 0.65 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.741 1.609 . . . . 0.0 109.45 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.16 -21.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.492 -1.171 . . . . 0.0 114.864 -172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.71 156.94 45.09 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.861 1.831 . . . . 0.0 110.24 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -71.63 -30.49 65.82 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.692 -0.63 . . . . 0.0 110.01 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 p -61.16 133.54 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -165.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 165.64 22.28 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.354 1.462 . . . . 0.0 107.487 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.4 171.1 18.13 Favored 'Cis proline' 0 C--N 1.345 0.352 0 CA-C-N 120.883 1.351 . . . . 0.0 111.815 -6.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -142.37 108.01 5.1 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.85 133.27 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -114.75 140.4 48.92 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 113.08 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.59 58.53 13.94 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.353 -0.842 . . . . 0.0 112.008 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.256 1.0 OUTLIER 46.21 27.73 0.59 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -174.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -129.85 135.23 48.15 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.65 1.114 . . . . 0.0 109.187 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -71.11 150.03 45.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -105.51 -12.46 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 122.924 0.49 . . . . 0.0 111.39 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.18 -165.44 18.34 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -166.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.65 -95.57 2.41 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 119.006 -0.886 . . . . 0.0 110.921 -174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.89 -56.78 2.19 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.133 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -59.35 -39.04 81.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.861 1.664 . . . . 0.0 112.126 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -42.86 81.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.827 0.451 . . . . 0.0 109.871 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.16 -37.0 85.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.558 0.743 . . . . 0.0 110.479 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.39 -49.56 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 115.494 -2.193 . . . . 0.0 109.738 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -61.93 -39.95 93.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 122.939 2.608 . . . . 0.0 112.051 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -54.47 -46.18 73.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.41 -51.95 25.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 121.375 1.898 . . . . 0.0 110.959 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.2 -53.15 53.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.897 1.679 . . . . 0.0 112.01 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.4 t -71.59 -5.19 31.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.845 1.258 . . . . 0.0 110.775 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.93 9.29 59.44 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.016 -1.435 . . . . 0.0 112.968 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.38 -21.6 66.24 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.264 2.032 . . . . 0.0 111.842 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.49 -37.9 65.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 111.047 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.41 -48.69 74.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.667 0.667 . . . . 0.0 109.65 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -46.57 85.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.199 1.0 . . . . 0.0 110.236 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -47.7 -53.51 14.84 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.512 1.525 . . . . 0.0 110.392 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 mp -72.27 -34.85 68.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -58.95 -30.75 68.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.435 1.471 . . . . 0.0 111.419 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -54.62 -19.01 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 112.979 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.01 11.08 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.716 1.143 . . . . 0.0 112.384 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.23 46.9 7.27 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 118.703 0.683 . . . . 0.0 112.431 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.34 -72.49 0.58 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.842 1.257 . . . . 0.0 111.875 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.58 137.19 55.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 120.182 1.355 . . . . 0.0 109.528 -159.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 163.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -66.95 46.78 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.195 2.598 . . . . 0.0 114.536 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -163.53 -56.41 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.051 -1.031 . . . . 0.0 108.393 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.91 -39.05 87.87 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.061 0.392 . . . . 0.0 111.008 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.79 -62.85 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.86 -43.65 98.41 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -159.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.37 -15.13 60.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.273 -0.87 . . . . 0.0 113.296 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -71.99 -38.76 69.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.426 1.466 . . . . 0.0 111.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.05 126.36 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -106.88 162.32 20.07 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 123.42 0.688 . . . . 0.0 109.357 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.5 79.18 0.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.636 2.89 . . . . 0.0 109.658 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.79 19.7 0.49 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 127.313 2.387 . . . . 0.0 113.54 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -111.96 159.02 18.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.782 1.791 . . . . 0.0 108.467 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -113.07 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.8 t -84.06 147.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.98 113.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -76.52 126.28 30.71 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.11 168.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.791 1.236 . . . . 0.0 110.399 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -117.5 149.57 45.07 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 158.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.28 4.83 5.54 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.188 1.926 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -124.21 -17.25 6.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 132.33 89.12 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 168.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -64.85 -21.26 64.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.766 1.644 . . . . 0.0 109.78 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -74.34 -42.9 58.65 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.953 0.901 . . . . 0.0 109.609 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.64 -45.13 94.25 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -54.55 -44.93 73.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.103 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -57.74 10.27 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 118.793 0.724 . . . . 0.0 109.654 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.96 55.84 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -69.58 -37.62 77.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 117.558 -1.21 . . . . 0.0 114.113 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.51 -49.25 27.56 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 120.111 1.323 . . . . 0.0 108.464 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -49.28 -53.33 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.531 1.532 . . . . 0.0 109.982 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.46 -46.43 17.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -74.79 6.25 4.16 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.156 1.343 . . . . 0.0 114.196 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.1 -12.73 60.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.47 1.508 . . . . 0.0 112.572 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.4 148.66 56.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.55 1.068 . . . . 0.0 111.199 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.64 96.62 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.181 2.588 . . . . 0.0 109.911 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.82 145.98 30.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -47.32 134.34 11.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.272 0.629 . . . . 0.0 111.998 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -49.42 115.39 1.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.381 1.473 . . . . 0.0 109.137 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.92 86.75 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.404 -1.22 . . . . 0.0 114.126 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.73 -33.07 64.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 121.215 2.507 . . . . 0.0 109.962 165.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.46 109.59 17.47 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -171.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -129.25 102.72 6.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.51 90.4 8.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.128 1.371 . . . . 0.0 107.938 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.5 111.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.475 1.51 . . . . 0.0 109.212 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -71.31 115.01 9.97 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.314 1.046 . . . . 0.0 112.929 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 pt -70.82 -35.0 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.688 1.595 . . . . 0.0 112.494 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -101.9 4.16 39.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.297 1.039 . . . . 0.0 111.63 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.04 53.14 0.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.337 1.455 . . . . 0.0 110.702 162.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.321 0.3 OUTLIER 60.9 14.24 5.09 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.886 2.474 . . . . 0.0 112.101 178.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.08 11.06 10.4 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 119.448 -2.032 . . . . 0.0 114.162 -167.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m170 67.62 79.82 0.22 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 128.505 2.722 . . . . 0.0 108.48 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -63.68 1.2 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -67.7 -23.69 65.32 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.95 -48.62 73.43 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.061 1.744 . . . . 0.0 111.009 165.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.3 mt -60.86 -38.28 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.102 0.961 . . . . 0.0 109.066 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -59.96 -49.86 76.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.02 -44.09 85.74 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.5 1.143 . . . . 0.0 112.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -58.11 -43.64 87.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.624 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 mt -61.89 -33.24 73.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.116 0.966 . . . . 0.0 111.081 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.27 -51.0 69.75 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 119.15 0.886 . . . . 0.0 110.39 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.29 -49.54 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.209 0.528 . . . . 0.0 109.609 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tp -73.53 -17.9 61.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.792 0.837 . . . . 0.0 111.114 -167.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -129.25 -25.91 2.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 114.451 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.51 23.1 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.071 -1.405 . . . . 0.0 112.183 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.86 147.52 22.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 121.069 2.435 . . . . 0.0 110.698 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -21.09 61.05 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 p -70.24 133.75 47.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.806 0.73 . . . . 0.0 110.457 -159.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 161.74 22.54 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.483 1.913 . . . . 0.0 107.813 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.85 125.01 6.2 Favored 'Cis proline' 0 C--N 1.345 0.394 0 CA-C-N 120.344 1.158 . . . . 0.0 111.571 -1.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -95.61 91.25 6.04 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.64 125.07 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 94.03 4.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.142 2.577 . . . . 0.0 107.38 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.27 112.37 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.47 63.39 5.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.291 0.948 . . . . 0.0 113.41 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 46.48 15.28 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.838 2.455 . . . . 0.0 115.703 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -126.96 144.5 50.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 120.074 1.306 . . . . 0.0 109.887 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -86.57 134.96 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.974 0.91 . . . . 0.0 110.896 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pp -83.86 -18.41 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 119.104 0.866 . . . . 0.0 110.556 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.06 -141.3 12.48 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.8 -158.05 14.37 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.898 1.713 . . . . 0.0 108.838 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -22.03 59.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.756 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -65.32 -45.09 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.847 1.203 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.32 -57.62 12.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.162 1.785 . . . . 0.0 107.112 170.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.9 tp -52.0 -40.09 60.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.14 -50.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 117.266 -1.349 . . . . 0.0 108.382 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -43.24 99.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 120.82 1.645 . . . . 0.0 110.28 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -51.82 -47.48 64.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.097 0.862 . . . . 0.0 109.537 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.79 -52.58 42.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.515 1.052 . . . . 0.0 110.785 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -58.73 3.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.947 1.699 . . . . 0.0 111.244 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -11.46 59.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.463 1.505 . . . . 0.0 109.889 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.51 -2.53 49.76 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.569 161.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -59.27 -28.87 67.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.797 1.799 . . . . 0.0 111.435 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 tt -44.17 -57.89 3.17 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.359 1.863 . . . . 0.0 110.514 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.73 -42.09 98.5 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.864 0.756 . . . . 0.0 109.532 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -61.29 -54.23 46.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.791 0.836 . . . . 0.0 110.358 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.52 76.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.436 1.094 . . . . 0.0 111.021 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.66 -47.4 60.19 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.31 -26.34 67.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.174 1.352 . . . . 0.0 112.468 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -52.3 -33.04 40.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.346 1.458 . . . . 0.0 110.738 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.04 11.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.126 0.876 . . . . 0.0 112.674 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 37.9 26.68 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.2 -0.938 . . . . 0.0 112.328 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.99 -69.83 0.56 Allowed 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 112.131 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.84 136.58 52.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.991 0.814 . . . . 0.0 110.839 -158.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.664 3.185 . . . . 0.0 105.219 -175.245 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.711 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.513 -0.459 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -48.64 158.06 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.188 1.395 . . . . 0.0 111.972 -169.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -49.41 -31.64 10.05 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -158.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -55.4 -37.59 67.81 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.24 1.382 . . . . 0.0 112.766 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.96 -55.12 23.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.32 1.448 . . . . 0.0 109.448 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.66 -39.87 95.28 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 t -81.4 38.6 0.49 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.803 2.041 . . . . 0.0 111.772 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -130.91 -47.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.626 0.771 . . . . 0.0 109.647 159.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.17 133.76 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.21 165.07 34.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.58 156.77 40.22 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.008 -1.574 . . . . 0.0 108.008 159.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.69 17.1 77.94 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.191 -0.943 . . . . 0.0 115.08 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -135.78 162.04 33.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.684 1.593 . . . . 0.0 108.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.88 79.58 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.19 132.95 33.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.06 110.79 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.3 130.07 38.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.08 179.73 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 C-N-CA 126.362 1.865 . . . . 0.0 109.843 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -140.37 151.27 63.73 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 158.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.22 -15.01 20.49 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.588 2.192 . . . . 0.0 111.527 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -50.57 43.57 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.703 1.201 . . . . 0.0 110.131 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.41 ' H ' ' HG3' ' A' ' 20' ' ' LYS . 16.0 m -61.1 109.59 2.25 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.401 1.481 . . . . 0.0 111.398 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.75 -20.84 58.98 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.992 1.795 . . . . 0.0 110.898 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -73.2 -22.32 60.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.926 -1.109 . . . . 0.0 111.294 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.96 -33.12 74.05 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.47 -0.769 . . . . 0.0 109.755 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -63.17 -30.04 71.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.764 0.826 . . . . 0.0 111.774 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.76 4.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.22 51.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 124.365 1.041 . . . . 0.0 111.785 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.6 -56.53 16.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.549 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.46 -41.33 63.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 123.741 0.651 . . . . 0.0 110.263 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -50.21 -57.42 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.732 1.213 . . . . 0.0 108.737 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.96 -43.25 45.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.303 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.2 p -65.65 -20.83 66.45 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 120.03 1.286 . . . . 0.0 113.915 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -73.51 -21.77 60.31 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.626 1.103 . . . . 0.0 110.697 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.78 142.24 56.53 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -64.56 127.56 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -146.36 157.61 11.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 128.02 34.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.173 0.989 . . . . 0.0 109.646 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -64.43 126.24 27.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.985 -168.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.92 71.29 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.962 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.68 -37.58 65.19 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 119.847 1.824 . . . . 0.0 109.002 164.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 100.03 10.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -170.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -122.1 101.49 7.57 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 108.92 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -84.55 93.82 8.44 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.774 1.23 . . . . 0.0 108.638 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.56 112.22 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.809 1.244 . . . . 0.0 109.363 -171.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.83 121.29 13.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.506 1.523 . . . . 0.0 112.793 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.5 pt -85.18 -21.35 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.17 1.388 . . . . 0.0 113.382 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -90.09 -3.71 57.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.071 0.85 . . . . 0.0 110.134 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -40.11 -54.85 2.22 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.475 2.31 . . . . 0.0 113.691 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.03 -27.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.05 0.94 . . . . 0.0 109.41 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.35 -46.83 69.69 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.39 1.876 . . . . 0.0 115.073 -164.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 124.63 82.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 1 C-N-CA 131.941 4.096 . . . . 0.0 109.606 -169.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -37.13 -63.02 0.46 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.417 2.287 . . . . 0.0 109.792 164.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -43.74 -49.34 7.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.031 1.333 . . . . 0.0 113.372 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.68 -43.39 80.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.935 0.894 . . . . 0.0 111.458 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.2 mt -62.87 -31.75 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -69.35 -54.24 15.51 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.9 -55.8 17.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 123.679 1.704 . . . . 0.0 111.004 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.711 ' CG ' ' HA ' ' A' ' 2' ' ' ALA . 1.1 t80 -79.0 4.67 13.71 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.764 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -91.41 -37.7 13.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 118.122 -2.861 . . . . 0.0 109.907 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.83 -49.79 47.72 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.336 1.455 . . . . 0.0 108.142 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -57.49 5.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.412 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.86 -23.86 67.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 111.01 -163.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.1 p -126.45 -17.31 5.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.75 50.0 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.645 1.111 . . . . 0.0 112.155 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.28 158.16 31.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.336 1.854 . . . . 0.0 107.869 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -22.08 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -55.41 133.54 49.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.41 0.684 . . . . 0.0 111.139 -161.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.82 153.8 39.96 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -60.3 147.17 43.24 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.122 1.079 . . . . 0.0 110.043 -10.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -130.46 103.1 6.46 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.09 124.45 40.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 123.022 0.529 . . . . 0.0 109.92 -171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -103.37 105.5 15.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.605 1.562 . . . . 0.0 107.772 160.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.97 116.57 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 161.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 41.46 69.67 0.51 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 126.193 1.854 . . . . 0.0 114.019 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 47.31 21.37 0.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -116.82 120.67 39.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.908 1.283 . . . . 0.0 108.632 165.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -83.99 104.26 13.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.201 0.6 . . . . 0.0 110.088 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -83.85 -8.74 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.462 0.574 . . . . 0.0 112.008 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.97 -167.19 24.15 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.843 0.735 . . . . 0.0 112.606 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.7 -162.15 34.81 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.032 1.301 . . . . 0.0 110.373 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -37.93 71.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.652 1.226 . . . . 0.0 110.104 -165.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 m -68.43 -36.09 78.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.557 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.33 -49.76 58.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.607 1.163 . . . . 0.0 108.618 173.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -44.32 62.74 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.016 1.726 . . . . 0.0 111.821 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.17 -44.84 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-O 117.113 -1.422 . . . . 0.0 109.694 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.99 -48.79 75.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -173.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.12 -42.34 85.56 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.222 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -64.1 -56.84 12.04 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.371 0.987 . . . . 0.0 110.305 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -51.52 55.07 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.739 1.616 . . . . 0.0 111.364 -172.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.0 t -71.49 -7.23 46.19 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.325 1.45 . . . . 0.0 110.934 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.09 77.93 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.662 -1.632 . . . . 0.0 114.062 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.04 -33.66 73.64 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.742 2.271 . . . . 0.0 110.707 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -38.18 86.61 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.904 1.282 . . . . 0.0 109.545 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.25 -37.72 86.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.364 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -48.57 72.51 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.589 1.086 . . . . 0.0 109.736 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -50.73 62.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 110.593 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -60.11 -48.21 82.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.49 1.516 . . . . 0.0 110.715 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.59 -35.22 77.23 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.903 -1.123 . . . . 0.0 111.811 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -54.0 -32.42 54.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.007 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.96 5.5 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 119.484 1.038 . . . . 0.0 113.377 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.89 39.44 13.5 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.747 1.158 . . . . 0.0 112.87 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 106' ' ' GLN . . . -84.93 -74.86 0.38 Allowed 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 125.876 1.67 . . . . 0.0 112.602 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -53.13 -23.38 8.0 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.24 1.816 . . . . 0.0 114.872 -159.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 130.377 3.471 . . . . 0.0 110.523 -173.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.101 0.477 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -73.33 -67.43 0.58 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 0.0 110.977 -167.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -72.54 -22.87 60.95 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.54 -0.725 . . . . 0.0 111.261 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -32.66 63.15 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.51 -60.26 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.524 -0.735 . . . . 0.0 110.263 166.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.617 ' ND2' ' HH ' ' A' ' 60' ' ' TYR . 22.3 m-20 -63.38 -27.29 69.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -163.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.2 t -87.35 -24.15 24.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.087 0.955 . . . . 0.0 111.349 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -73.95 -37.84 64.43 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 121.074 -1.016 . . . . 0.0 111.406 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.61 149.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 160.05 34.92 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 72.0 Cg_endo -75.94 111.36 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.412 2.741 . . . . 0.0 108.733 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 9.12 21.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.42 1.486 . . . . 0.0 113.646 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -123.47 166.04 16.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.09 1.756 . . . . 0.0 109.241 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.0 110.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.01 139.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.43 112.91 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -78.4 119.91 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.42 161.28 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.629 1.172 . . . . 0.0 111.602 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -120.33 141.96 32.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.58 -20.12 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.903 1.736 . . . . 0.0 110.996 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 26.52 0.97 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.798 2.039 . . . . 0.0 111.44 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -130.92 134.97 26.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.622 2.369 . . . . 0.0 108.706 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.98 -25.87 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.179 2.586 . . . . 0.0 112.265 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -74.34 -29.98 61.83 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.37 -48.0 83.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.562 -0.711 . . . . 0.0 109.836 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -59.5 -41.51 90.06 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.518 -0.739 . . . . 0.0 110.164 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -58.67 6.53 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -39.85 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.154 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.449 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -56.46 -54.3 47.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.503 172.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -69.47 -41.93 75.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.288 0.949 . . . . 0.0 109.752 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.73 -52.28 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 125.727 1.611 . . . . 0.0 110.159 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.22 -48.97 16.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -69.83 -13.58 62.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.923 0.489 . . . . 0.0 112.269 -169.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.08 -23.33 60.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.035 0.834 . . . . 0.0 110.951 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.08 149.65 85.14 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.12 113.99 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 106.631 -2.103 . . . . 0.0 106.631 164.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.66 138.44 54.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 124.34 7.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.968 1.307 . . . . 0.0 108.687 -169.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.61 122.33 13.81 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -162.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.19 -12.96 58.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.082 1.325 . . . . 0.0 113.875 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.67 -28.29 61.68 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 120.697 2.249 . . . . 0.0 110.458 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 120.67 26.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 120.229 1.377 . . . . 0.0 107.482 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -131.61 104.71 7.09 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.473 1.109 . . . . 0.0 109.338 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 20.3 m-85 -84.6 100.76 11.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.07 107.39 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -67.06 104.45 1.41 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.1 pt -69.44 -18.25 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.64 0.776 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -84.18 8.61 15.16 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.386 -0.821 . . . . 0.0 111.382 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 -21.89 49.75 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.638 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -132.78 -106.41 0.25 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 161.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -134.03 1.85 3.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.68 1.992 . . . . 0.0 110.556 165.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -62.7 -3.1 1.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.921 -1.112 . . . . 0.0 112.091 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -43.41 -63.68 0.78 Allowed 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.558 1.943 . . . . 0.0 109.053 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -52.34 -43.27 64.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.196 1.398 . . . . 0.0 109.801 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.87 -36.1 69.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 112.246 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.7 -51.74 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -57.25 10.04 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.291 0.567 . . . . 0.0 110.822 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.67 -42.33 62.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.242 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' HH ' ' ND2' ' A' ' 7' ' ' ASN . 33.6 t80 -61.13 -43.43 98.9 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.682 0.673 . . . . 0.0 110.709 175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.78 -27.51 68.05 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.333 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -56.69 14.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 120.739 1.609 . . . . 0.0 109.67 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.79 -49.13 71.7 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.839 0.712 . . . . 0.0 109.972 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.3 -29.74 57.48 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.116 1.366 . . . . 0.0 111.606 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 p -125.63 -29.08 3.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.55 13.96 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.179 -1.345 . . . . 0.0 113.982 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.99 150.97 9.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.649 2.224 . . . . 0.0 110.68 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.8 ptt-85 -96.61 -7.87 33.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.738 0.815 . . . . 0.0 112.571 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -65.05 133.98 52.84 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 108.649 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.88 147.0 34.61 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 126.618 1.967 . . . . 0.0 105.794 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -66.35 155.1 81.97 Favored 'Cis proline' 0 N--CA 1.461 -0.436 0 CA-C-N 120.353 1.162 . . . . 0.0 111.666 3.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -140.29 106.48 5.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.89 127.46 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.73 93.98 4.3 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.598 2.359 . . . . 0.0 106.85 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -86.5 121.6 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.75 63.44 3.84 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.231 0.919 . . . . 0.0 113.425 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.406 ' HE3' ' HD3' ' A' ' 12' ' ' PRO . 3.5 ttmt 46.13 19.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.369 2.267 . . . . 0.0 117.056 -173.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.74 133.38 50.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.069 1.304 . . . . 0.0 110.571 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -81.11 121.99 26.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.106 -0.996 . . . . 0.0 109.899 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.31 -11.81 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 119.616 1.098 . . . . 0.0 111.502 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.83 -163.69 19.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.322 0.963 . . . . 0.0 111.137 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.19 -155.26 29.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.303 0.954 . . . . 0.0 111.076 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -41.96 95.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.465 0.633 . . . . 0.0 111.269 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -65.94 -44.63 84.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.444 0.566 . . . . 0.0 110.897 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.47 -58.13 9.34 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.0 tp -50.51 -42.13 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.436 1.094 . . . . 0.0 112.051 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.28 -51.02 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 116.347 -1.787 . . . . 0.0 109.229 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.47 54.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.448 1.931 . . . . 0.0 107.14 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.33 -40.98 83.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.111 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -74.67 -47.58 30.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.197 1.362 . . . . 0.0 107.806 -172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -35.85 60.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.373 1.069 . . . . 0.0 111.073 -169.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 t -94.13 -2.8 52.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.838 1.255 . . . . 0.0 111.15 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.76 0.32 87.74 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.082 -1.954 . . . . 0.0 115.075 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.54 -33.63 74.17 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 121.295 2.548 . . . . 0.0 110.37 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 tp -54.69 -37.64 66.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.48 -48.15 57.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -56.58 -49.87 73.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.981 0.913 . . . . 0.0 109.283 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.4 91.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.101 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -50.34 62.79 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.183 173.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.37 1.441 . . . . 0.0 111.801 -164.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.35 -39.08 14.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.304 1.441 . . . . 0.0 113.02 168.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.18 0.58 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 119.304 0.956 . . . . 0.0 111.936 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.34 55.2 2.94 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.7 1.143 . . . . 0.0 110.925 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.46 -75.65 0.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.79 1.636 . . . . 0.0 111.892 -167.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.89 133.73 52.49 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.235 -0.888 . . . . 0.0 108.826 -172.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.45 48.3 1.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.367 -1.458 . . . . 0.0 110.908 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -163.45 -43.13 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.019 1.328 . . . . 0.0 108.752 -172.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -50.72 -55.0 18.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.483 1.038 . . . . 0.0 109.961 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.94 -47.05 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.949 0.9 . . . . 0.0 109.976 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.84 -44.19 86.22 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.006 -0.434 . . . . 0.0 111.355 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.22 -23.52 65.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.703 1.601 . . . . 0.0 112.168 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.05 -44.33 69.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.913 1.233 . . . . 0.0 110.268 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.02 136.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.23 153.02 55.51 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.08 80.54 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.178 2.586 . . . . 0.0 109.361 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.51 18.54 0.27 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.074 1.797 . . . . 0.0 115.323 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -132.17 171.82 13.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.568 1.684 . . . . 0.0 108.074 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.87 110.39 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.0 t -126.73 126.16 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.81 112.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -81.83 120.16 24.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.22 164.52 34.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.391 1.477 . . . . 0.0 111.402 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -123.55 139.54 32.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 165.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.58 -9.55 21.42 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.373 2.049 . . . . 0.0 112.104 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 p -79.23 -18.81 52.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.581 2.352 . . . . 0.0 113.592 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -122.4 134.54 24.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -158.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.86 -14.25 26.67 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.805 2.337 . . . . 0.0 112.304 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -73.27 -35.17 66.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.566 1.075 . . . . 0.0 108.739 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.27 -47.07 74.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -52.05 -49.96 62.42 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.157 0.983 . . . . 0.0 113.049 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -57.03 14.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.582 1.083 . . . . 0.0 109.02 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -35.94 64.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.412 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -53.65 54.34 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.561 1.144 . . . . 0.0 112.435 174.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.69 -52.26 46.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.1 mt -46.73 -53.64 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.763 2.025 . . . . 0.0 109.413 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.94 -47.16 63.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.9 p -63.45 -19.14 64.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.538 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -73.28 -33.22 65.12 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 120.254 1.388 . . . . 0.0 109.966 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.12 136.05 95.28 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.81 76.98 3.87 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.493 2.795 . . . . 0.0 110.046 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.7 mt -87.76 145.51 7.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -53.25 123.39 11.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -66.3 122.87 18.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 -8.04 40.89 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.192 1.377 . . . . 0.0 111.801 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -78.04 -33.7 50.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.812 1.806 . . . . 0.0 111.489 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 120.73 29.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.433 1.015 . . . . 0.0 109.782 -171.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.67 130.68 47.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.481 0.712 . . . . 0.0 109.605 168.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.0 101.42 11.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.7 113.97 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.005 2.122 . . . . 0.0 108.485 -167.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -69.9 109.97 4.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.529 0.732 . . . . 0.0 110.532 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.43 13.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.316 1.046 . . . . 0.0 112.857 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -114.69 -44.17 3.09 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.449 -1.407 . . . . 0.0 111.45 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.33 -51.35 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.822 0.849 . . . . 0.0 113.042 -158.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -125.03 4.52 7.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 112.577 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.46 -162.4 1.29 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 0.0 110.384 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -129.46 87.17 2.51 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.388 1.075 . . . . 0.0 108.238 -158.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -63.53 0.99 Allowed 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 125.465 1.506 . . . . 0.0 107.495 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -44.14 -48.89 9.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.525 1.13 . . . . 0.0 113.013 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -52.64 64.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.552 1.141 . . . . 0.0 111.411 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.96 -31.82 54.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.75 1.22 . . . . 0.0 111.675 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.536 ' HA ' HH22 ' A' ' 72' ' ' ARG . 7.1 mt-30 -68.31 -45.31 73.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -64.64 -52.27 58.27 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.703 2.801 . . . . 0.0 110.405 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -55.05 -47.82 74.28 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.148 0.979 . . . . 0.0 111.205 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.66 -36.95 85.16 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.73 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.71 -44.31 96.76 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.53 1.059 . . . . 0.0 110.725 172.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -42.39 98.83 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.829 0.452 . . . . 0.0 110.597 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.05 -29.69 58.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.421 1.089 . . . . 0.0 109.399 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -125.06 -76.03 0.59 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.202 0.91 . . . . 0.0 109.072 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.31 -8.31 0.05 OUTLIER Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.728 -1.596 . . . . 0.0 116.715 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.43 146.26 48.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.572 2.686 . . . . 0.0 111.19 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.12 -28.29 15.15 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.302 1.441 . . . . 0.0 112.238 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 p -61.14 133.82 56.4 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 159.02 56.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.43 170.28 32.85 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 CA-C-N 118.763 0.594 . . . . 0.0 111.88 -11.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.536 HH22 ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -121.11 113.14 19.59 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 159.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.7 t -83.22 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.96 121.93 43.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 164.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.88 118.57 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 166.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.65 58.96 11.46 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.387 0.994 . . . . 0.0 112.689 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.285 3.6 tmtt? 45.49 30.73 0.78 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.58 1.952 . . . . 0.0 116.192 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.02 149.95 49.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.71 130.39 34.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.88 -26.08 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.14 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.17 -174.2 21.83 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.636 1.589 . . . . 0.0 112.057 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 -167.67 42.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.31 1.433 . . . . 0.0 112.042 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.42 -38.11 89.89 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.811 1.306 . . . . 0.0 111.598 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -64.99 -40.18 94.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.399 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.84 -51.65 45.97 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.421 1.088 . . . . 0.0 109.316 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.1 tp -51.89 -38.91 57.98 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 125.515 1.526 . . . . 0.0 111.652 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.42 -47.87 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 116.53 -1.7 . . . . 0.0 109.8 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -46.79 88.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.636 2.017 . . . . 0.0 108.615 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.155 -174.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.07 -52.54 23.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.385 1.448 . . . . 0.0 110.234 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.79 49.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.928 1.691 . . . . 0.0 111.399 -170.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -63.66 -33.55 75.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.76 2.024 . . . . 0.0 109.951 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.32 64.81 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.951 -1.472 . . . . 0.0 112.034 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.75 -32.04 65.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.089 1.945 . . . . 0.0 110.835 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.29 -36.23 70.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.846 1.659 . . . . 0.0 110.648 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.77 -50.67 61.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.916 0.487 . . . . 0.0 109.829 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 m -60.41 -49.29 78.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.883 0.873 . . . . 0.0 109.551 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -49.35 60.0 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.433 1.093 . . . . 0.0 110.348 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.4 mt -66.99 -45.09 78.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.32 -24.44 64.84 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.34 -1.475 . . . . 0.0 112.832 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.08 -39.34 59.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.861 0.755 . . . . 0.0 110.323 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.11 10.93 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.919 0.888 . . . . 0.0 111.914 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.45 76.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.411 -0.806 . . . . 0.0 113.571 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.0 -67.7 0.45 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 118.467 1.133 . . . . 0.0 110.142 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.92 134.01 45.75 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 118.163 -1.415 . . . . 0.0 107.669 -162.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 125.11 1.506 . . . . 0.0 108.668 -157.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.83 55.41 2.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.802 1.641 . . . . 0.0 110.507 -173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -163.1 -55.88 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.877 -1.14 . . . . 0.0 109.776 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -51.91 -47.38 64.65 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.974 0.806 . . . . 0.0 111.305 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.85 -54.19 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.851 0.861 . . . . 0.0 109.954 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.81 -38.22 75.16 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.051 0.94 . . . . 0.0 110.971 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.22 -29.76 64.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.736 0.815 . . . . 0.0 111.702 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -76.65 -45.6 29.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.797 1.635 . . . . 0.0 111.484 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.65 148.29 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -144.5 145.96 30.71 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.19 129.44 28.5 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.701 1.601 . . . . 0.0 108.617 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.54 77.88 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.372 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.6 169.91 8.99 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.237 2.019 . . . . 0.0 110.041 172.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.86 109.49 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.63 111.35 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.82 121.14 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.79 130.14 34.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.48 173.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 110.399 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.41 144.53 43.08 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 161.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.83 -15.04 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.749 1.633 . . . . 0.0 111.433 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -66.65 -49.03 67.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.106 2.162 . . . . 0.0 110.943 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 122.35 87.28 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.806 1.242 . . . . 0.0 110.257 -172.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.29 -11.5 31.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.272 2.648 . . . . 0.0 112.31 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.8 -31.46 63.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.241 -0.912 . . . . 0.0 109.588 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -72.82 -38.77 67.04 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -46.55 67.06 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.138 0.575 . . . . 0.0 110.068 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.92 -56.05 23.84 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.287 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.91 -38.85 65.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.238 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -48.64 79.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.37 0.986 . . . . 0.0 113.644 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.09 -44.57 53.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -49.3 -54.83 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.969 1.307 . . . . 0.0 110.323 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.9 mt -81.97 -41.56 20.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.813 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.7 t -70.65 -18.71 62.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.543 1.519 . . . . 0.0 112.498 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.83 -11.01 60.24 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.729 1.149 . . . . 0.0 111.827 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.12 133.06 39.77 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 163.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.44 62.52 8.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.011 2.474 . . . . 0.0 111.791 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.16 147.84 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -55.77 124.31 17.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -62.61 113.38 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.09 -12.9 9.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.744 1.164 . . . . 0.0 111.741 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.15 -39.81 15.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.691 1.745 . . . . 0.0 111.63 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 115.91 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.482 1.113 . . . . 0.0 109.465 -167.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -137.74 107.54 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.52 1.055 . . . . 0.0 109.078 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -85.93 105.12 16.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.842 1.257 . . . . 0.0 108.175 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.08 111.01 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -63.45 127.93 33.52 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 162.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 pt -93.04 -2.23 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 112.195 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -92.98 -40.48 10.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.847 1.203 . . . . 0.0 111.372 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.72 66.58 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.084 1.754 . . . . 0.0 113.487 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.77 161.56 40.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.79 1.636 . . . . 0.0 107.501 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 57.76 -163.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.606 1.162 . . . . 0.0 110.856 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -118.15 80.77 1.57 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -158.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.21 -63.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.468 1.507 . . . . 0.0 110.384 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -40.63 59.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.78 0.832 . . . . 0.0 110.969 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.5 -11.91 56.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.615 1.966 . . . . 0.0 114.425 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 mt -85.03 -47.49 16.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 125.379 1.472 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -40.98 70.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.521 0.677 . . . . 0.0 110.78 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.89 -36.86 72.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.918 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -66.36 -33.87 76.71 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.311 -1.493 . . . . 0.0 112.703 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.92 -29.62 70.78 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 120.186 1.357 . . . . 0.0 110.135 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.79 -38.5 78.67 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 120.354 1.434 . . . . 0.0 110.681 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -55.54 6.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.405 0.682 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.13 -25.79 55.71 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.1 p -122.9 -36.74 2.83 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.813 -1.18 . . . . 0.0 111.977 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.95 -17.69 5.15 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.378 -1.234 . . . . 0.0 114.211 168.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.91 148.33 38.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.899 1.85 . . . . 0.0 110.216 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -11.95 59.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.59 143.11 25.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.805 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 151.55 43.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.9 1.68 . . . . 0.0 106.573 164.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.28 165.45 43.8 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 CA-C-N 120.139 1.086 . . . . 0.0 111.33 -4.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -142.57 109.11 5.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.9 t -88.31 126.78 41.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.935 0.494 . . . . 0.0 110.145 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -105.06 130.47 53.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.82 111.78 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.43 73.39 0.42 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 125.145 1.355 . . . . 0.0 113.213 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.55 -9.18 0.0 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 130.658 3.583 . . . . 0.0 118.107 -173.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -91.73 163.82 13.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.923 1.238 . . . . 0.0 108.877 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 t -125.02 129.13 49.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.828 1.651 . . . . 0.0 109.006 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -106.48 -16.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -162.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.68 178.66 23.96 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.73 -89.54 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 125.206 1.384 . . . . 0.0 110.391 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.45 -62.15 1.05 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 111.642 -169.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.2 t -65.53 -36.79 84.85 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.108 0.867 . . . . 0.0 110.183 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.47 -55.61 29.25 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.5 tp -49.07 -45.49 43.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.995 1.318 . . . . 0.0 111.689 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -46.74 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 116.628 -1.653 . . . . 0.0 109.789 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -49.08 75.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.64 -33.11 69.7 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.489 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -71.4 -51.57 23.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 121.148 1.794 . . . . 0.0 109.784 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -47.73 60.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.015 1.326 . . . . 0.0 110.045 -166.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.98 -34.08 74.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.424 1.89 . . . . 0.0 110.436 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 19.65 57.78 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-O 118.156 -1.358 . . . . 0.0 112.043 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.54 -42.51 83.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.732 2.266 . . . . 0.0 110.381 170.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -35.27 63.55 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.23 1.812 . . . . 0.0 110.473 -174.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.31 -52.58 64.1 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.681 0.793 . . . . 0.0 111.945 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.1 m -65.71 -41.53 92.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.449 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -44.72 73.14 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.771 0.828 . . . . 0.0 110.167 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.93 -44.44 89.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.974 1.31 . . . . 0.0 112.752 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 105' ' ' LEU . 68.0 mttt -63.18 -27.08 69.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.696 1.135 . . . . 0.0 112.434 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -56.03 -15.89 4.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 112.878 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.59 12.3 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.141 1.337 . . . . 0.0 112.351 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.74 36.14 58.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.174 -0.954 . . . . 0.0 113.005 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.72 -66.05 0.96 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.253 1.421 . . . . 0.0 112.757 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . 17.1 mt -75.27 133.57 41.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 121.352 1.887 . . . . 0.0 107.572 -167.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.771 1.229 . . . . 0.0 109.315 -167.269 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -53.67 32.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 1 C-N-CA 133.77 4.828 . . . . 0.0 116.831 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -163.44 -58.04 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.512 1.925 . . . . 0.0 106.712 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -62.5 -46.12 89.89 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.903 0.774 . . . . 0.0 110.594 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -68.99 -59.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.51 -49.41 74.83 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -161.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 t -76.76 -26.44 54.54 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.79 0.836 . . . . 0.0 112.367 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -66.47 -39.18 88.64 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.322 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.81 132.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.18 155.49 71.07 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.83 26.08 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 125.302 4.001 . . . . 0.0 115.054 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.23 21.16 0.11 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.603 1.573 . . . . 0.0 113.169 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -120.79 168.24 11.65 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.84 120.55 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.07 135.1 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.73 118.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -82.19 124.53 29.99 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.51 177.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.384 1.474 . . . . 0.0 111.257 -166.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 158.98 64.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.009 1.724 . . . . 0.0 107.289 169.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.88 2.09 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.264 2.643 . . . . 0.0 114.592 -163.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -133.04 -25.3 1.82 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -158.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 156.41 77.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.32 1.448 . . . . 0.0 114.12 -158.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.27 -29.5 21.34 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.431 2.087 . . . . 0.0 110.666 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -73.92 -46.74 42.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.7 m -70.09 -44.23 69.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -48.56 -46.71 39.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.217 -0.927 . . . . 0.0 111.969 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -60.4 -60.54 3.64 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.891 0.769 . . . . 0.0 109.572 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.69 69.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 124.244 0.965 . . . . 0.0 111.968 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -47.54 85.93 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 117.827 -1.082 . . . . 0.0 111.503 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.77 -53.55 31.9 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 119.08 0.855 . . . . 0.0 109.9 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.04 -49.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.442 1.497 . . . . 0.0 109.763 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.27 -51.96 13.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -66.33 -23.44 66.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -73.84 -23.61 59.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.248 0.931 . . . . 0.0 110.044 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.98 138.15 69.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.1 65.79 8.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.303 2.668 . . . . 0.0 111.663 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.02 150.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -55.82 123.97 16.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.502 1.121 . . . . 0.0 109.516 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -65.29 151.31 46.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.322 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.61 -18.83 10.28 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.671 -1.627 . . . . 0.0 112.255 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -46.14 47.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 120.649 2.224 . . . . 0.0 109.803 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 116.08 22.69 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.044 0.84 . . . . 0.0 109.866 -169.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -124.48 150.67 45.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.987 1.315 . . . . 0.0 108.949 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -124.24 130.31 52.31 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.54 101.39 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.801 1.64 . . . . 0.0 107.82 -160.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -64.16 119.67 10.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 pt -89.77 -8.22 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.072 0.949 . . . . 0.0 113.196 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 t -124.74 16.8 8.73 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.556 1.142 . . . . 0.0 110.964 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.67 -56.99 7.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 159.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -148.8 -39.94 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -164.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.06 19.32 2.21 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -158.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.33 80.92 0.16 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.762 1.225 . . . . 0.0 110.69 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -62.46 1.56 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 125.377 1.471 . . . . 0.0 107.376 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -47.8 -45.42 29.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.494 1.118 . . . . 0.0 112.537 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.261 9.9 tm-20 -63.87 -44.47 93.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.751 2.02 . . . . 0.0 112.668 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 mt -62.99 -37.75 80.18 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 125.243 1.417 . . . . 0.0 110.335 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.63 -38.56 70.75 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.33 -50.47 72.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.267 1.427 . . . . 0.0 111.057 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.09 -43.31 82.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.9 mt -64.15 -34.85 79.01 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 111.543 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -57.89 -46.0 85.56 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -53.73 30.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.63 -29.77 69.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.708 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -121.8 -27.31 4.69 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.34 -33.99 3.97 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.405 1.479 . . . . 0.0 110.867 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.74 43.59 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.729 1.264 . . . . 0.0 112.077 -172.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.49 -5.89 28.52 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.299 1.039 . . . . 0.0 113.175 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.6 p -68.1 133.78 49.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.99 154.56 37.27 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 132.23 14.57 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.169 1.096 . . . . 0.0 111.716 -9.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -93.03 111.1 22.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.37 126.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -111.23 136.76 49.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 159.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.62 115.51 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 102.501 -3.148 . . . . 0.0 102.501 171.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.46 72.35 0.43 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.661 1.601 . . . . 0.0 114.183 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp 46.58 9.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.002 2.521 . . . . 0.0 116.12 -171.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -114.58 113.21 24.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.994 1.27 . . . . 0.0 108.848 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.94 123.93 21.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.71 -26.04 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 118.714 0.688 . . . . 0.0 109.707 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.38 -161.35 24.67 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.328 0.966 . . . . 0.0 111.133 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.42 -161.47 31.42 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.455 1.026 . . . . 0.0 111.444 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -33.59 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.326 1.063 . . . . 0.0 110.119 -165.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 t -71.42 -36.59 71.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.63 -53.8 30.22 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.3 tp -51.72 -46.42 63.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.313 1.445 . . . . 0.0 112.132 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.39 -44.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 117.357 -1.306 . . . . 0.0 108.892 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -50.02 63.9 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.45 -38.88 72.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.13 -57.32 6.99 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.381 1.446 . . . . 0.0 110.505 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -29.7 65.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.49 1.516 . . . . 0.0 112.486 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 t -87.17 -14.5 41.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.434 2.294 . . . . 0.0 110.638 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.3 89.39 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -25.31 67.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.246 2.523 . . . . 0.0 110.77 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.41 -34.32 76.51 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.605 1.962 . . . . 0.0 111.449 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.16 -50.24 66.74 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 m -61.55 -46.49 89.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.188 0.449 . . . . 0.0 109.808 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -47.0 72.26 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.234 0.47 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.44 -53.48 23.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 111.24 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -58.27 -29.19 65.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.655 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -51.34 -42.58 61.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.715 0.689 . . . . 0.0 110.093 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.31 6.05 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.027 0.831 . . . . 0.0 112.354 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.31 38.01 19.41 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.289 0.95 . . . . 0.0 112.821 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.87 -69.47 0.69 Allowed 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.801 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.46 133.84 49.24 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -172.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.253 1.276 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.934 -160.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 38.59 -62.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 1 C-N-CA 132.612 4.365 . . . . 0.0 117.49 159.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -163.31 -50.69 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.285 -0.884 . . . . 0.0 109.091 -167.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.34 -25.39 65.79 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.964 0.347 . . . . 0.0 111.432 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.07 -58.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.219 1.007 . . . . 0.0 109.549 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -68.41 -17.74 64.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -159.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.3 t -101.97 -26.42 13.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.983 1.313 . . . . 0.0 110.31 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -64.14 -45.75 87.11 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.659 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.2 143.75 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.682 1.128 . . . . 0.0 108.076 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.7 140.36 35.15 Favored Pre-proline 0 C--O 1.238 0.454 0 CA-C-N 119.296 0.953 . . . . 0.0 109.716 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.86 89.94 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.24 2.627 . . . . 0.0 108.714 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.53 17.04 2.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.896 1.712 . . . . 0.0 113.882 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -128.6 162.23 27.77 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.875 2.07 . . . . 0.0 109.636 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.29 81.45 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.43 134.93 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 t -134.3 111.71 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -78.46 128.36 33.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 pt -138.53 179.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.3 1.84 . . . . 0.0 109.24 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -144.79 147.6 36.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 158.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.34 -14.97 38.33 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.579 2.186 . . . . 0.0 113.042 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p -77.16 -28.82 54.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.333 0.97 . . . . 0.0 111.672 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -74.8 121.52 85.44 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.583 0.629 . . . . 0.0 110.382 -164.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.74 -15.62 33.43 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.012 1.808 . . . . 0.0 111.823 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.98 -33.55 24.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.772 1.169 . . . . 0.0 109.341 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.2 m -62.63 -41.52 99.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -53.49 -42.76 67.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.474 0.579 . . . . 0.0 112.29 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -55.82 23.19 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.02 -36.08 62.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.307 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.92 83.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.777 169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.81 -46.58 65.38 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 120.543 1.519 . . . . 0.0 109.414 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -52.09 -58.34 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 126.504 1.921 . . . . 0.0 107.7 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.47 -33.34 58.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.598 -170.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 m -67.33 -35.13 78.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 0.0 112.138 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.98 -9.43 58.63 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.904 1.229 . . . . 0.0 112.079 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.57 135.52 43.41 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.058 1.299 . . . . 0.0 109.392 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.12 75.96 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.515 3.477 . . . . 0.0 110.481 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.1 mt -102.93 151.3 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -169.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -48.25 130.53 16.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.383 1.073 . . . . 0.0 110.485 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.1 140.27 56.01 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.66 -7.81 57.18 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.814 -1.548 . . . . 0.0 113.733 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.57 -37.19 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 121.066 2.433 . . . . 0.0 110.966 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 103.29 13.26 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.26 103.68 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.377 1.071 . . . . 0.0 108.58 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -84.09 117.49 23.48 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.67 109.2 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.995 2.118 . . . . 0.0 108.834 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -64.02 104.95 0.78 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.494 2.318 . . . . 0.0 114.015 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.67 -22.38 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.757 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.262 3.0 t -99.38 2.83 45.59 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.877 -1.058 . . . . 0.0 111.135 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -40.19 -67.76 0.21 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.529 1.932 . . . . 0.0 112.0 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -160.08 -15.57 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.11 1.364 . . . . 0.0 111.508 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -50.3 -57.49 7.76 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.628 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 127.73 105.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 C-N-CA 131.276 3.83 . . . . 0.0 105.997 -158.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -63.51 1.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.462 1.105 . . . . 0.0 108.914 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.46 -29.96 70.29 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -167.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.24 -46.57 83.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.484 1.114 . . . . 0.0 110.985 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -59.26 -38.57 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -169.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -49.21 -55.31 12.94 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.211 1.404 . . . . 0.0 110.548 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -56.84 -45.12 82.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.169 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.06 -44.83 96.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.889 1.222 . . . . 0.0 111.032 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.8 -34.75 69.97 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 123.151 0.282 . . . . 0.0 111.034 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -76.29 -48.23 20.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.935 0.494 . . . . 0.0 111.567 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.28 -47.01 63.17 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.941 1.296 . . . . 0.0 108.5 -158.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 p -102.63 -44.9 5.19 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.34 -13.35 4.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.667 1.127 . . . . 0.0 113.001 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.78 160.28 41.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.486 1.643 . . . . 0.0 108.875 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -118.65 -24.16 6.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 117.394 -1.289 . . . . 0.0 114.221 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 p -64.16 133.24 52.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 160.73 56.16 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.783 1.233 . . . . 0.0 108.497 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.16 159.99 61.4 Favored 'Cis proline' 0 C--N 1.344 0.323 0 CA-C-N 120.314 1.148 . . . . 0.0 110.591 -4.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -123.27 101.2 7.24 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.07 126.56 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -114.25 97.86 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 123.12 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 168.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 42.6 68.79 0.69 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.924 1.25 . . . . 0.0 113.23 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.22 -2.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.813 2.845 . . . . 0.0 118.645 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.4 115.74 28.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.094 1.316 . . . . 0.0 107.87 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -63.74 117.26 6.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.32 -16.89 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.19 -146.79 17.88 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.26 -153.43 18.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.934 0.741 . . . . 0.0 111.783 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.2 p -65.64 -38.47 89.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.044 0.938 . . . . 0.0 110.653 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -75.92 -31.39 59.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.662 0.601 . . . . 0.0 111.62 -176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.05 -52.5 41.54 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 23.0 tp -57.01 -34.36 68.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.451 0.7 . . . . 0.0 111.351 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.65 -48.44 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 115.419 -2.229 . . . . 0.0 109.723 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -55.1 37.64 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.441 1.928 . . . . 0.0 107.256 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.54 -35.86 72.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.689 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -68.47 -47.77 66.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.335 1.425 . . . . 0.0 110.51 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -63.8 1.15 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.999 2.52 . . . . 0.0 109.818 -168.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -79.22 -12.54 59.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 119.253 -0.404 . . . . 0.0 110.523 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.7 18.81 53.92 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-O 117.228 -1.873 . . . . 0.0 113.282 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.52 -23.02 67.13 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 121.099 2.449 . . . . 0.0 111.049 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.44 -38.86 63.94 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.294 1.438 . . . . 0.0 111.09 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.57 -48.38 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.161 0.984 . . . . 0.0 109.182 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.2 m -66.69 -44.66 81.15 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.976 1.31 . . . . 0.0 110.658 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -47.76 64.33 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.6 0.76 . . . . 0.0 109.392 174.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.83 -50.67 40.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.126 0.57 . . . . 0.0 111.438 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -57.95 -29.94 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.362 -0.836 . . . . 0.0 112.627 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -47.96 -40.52 22.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.361 1.064 . . . . 0.0 111.601 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.4 8.17 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.646 0.657 . . . . 0.0 112.764 -168.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.4 50.81 5.54 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.694 0.679 . . . . 0.0 111.671 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.86 -74.17 0.65 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 126.508 1.923 . . . . 0.0 112.507 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.74 150.95 43.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.599 1.999 . . . . 0.0 106.93 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.964 -172.294 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.378 0 CA-C-O 115.807 -2.044 . . . . 0.0 106.672 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 56.42 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.284 3.033 . . . . 0.0 118.045 160.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -163.94 -38.9 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.96 2.104 . . . . 0.0 108.036 -164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -49.49 -48.41 47.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.224 1.374 . . . . 0.0 111.519 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.26 -48.67 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.726 -0.609 . . . . 0.0 110.033 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -70.95 -32.03 68.8 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.161 -0.962 . . . . 0.0 113.199 -167.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -18.12 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.973 -1.08 . . . . 0.0 110.818 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HE3' ' OE2' ' A' ' 44' ' ' GLU . 32.1 mmtm -76.46 -59.87 2.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.479 172.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.05 144.81 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.623 1.101 . . . . 0.0 108.928 -172.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -138.27 157.04 73.35 Favored Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 126.982 2.113 . . . . 0.0 106.559 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.26 66.76 7.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.518 2.812 . . . . 0.0 110.7 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.86 40.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.109 1.814 . . . . 0.0 111.21 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -143.49 168.99 18.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.22 1.808 . . . . 0.0 107.128 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.7 95.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.68 144.66 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 t -132.22 117.59 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -77.16 120.79 22.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.29 -178.15 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.745 2.418 . . . . 0.0 109.664 -172.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -136.27 164.48 42.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 126.496 1.918 . . . . 0.0 107.673 170.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.74 -1.97 12.14 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.452 2.101 . . . . 0.0 112.773 -165.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -118.67 -99.99 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.794 1.637 . . . . 0.0 107.426 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 t 32.48 100.94 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.599 2.76 . . . . 0.0 114.995 169.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.56 -10.0 26.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.247 1.298 . . . . 0.0 111.637 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.85 -35.1 15.85 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.727 -1.233 . . . . 0.0 108.169 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.7 -55.18 33.08 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -57.58 -41.4 81.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.845 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -56.89 -61.41 2.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 118.865 0.757 . . . . 0.0 109.69 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.13 -33.54 27.03 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.049 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.418 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.18 -55.52 33.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.56 1.544 . . . . 0.0 111.968 171.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.43 -38.58 77.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.078 1.763 . . . . 0.0 110.243 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.41 -50.33 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.291 1.436 . . . . 0.0 108.971 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.86 -53.0 9.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -63.21 -24.55 67.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.397 0.679 . . . . 0.0 112.098 -166.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -74.01 0.85 12.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.055 0.843 . . . . 0.0 112.392 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 120.796 -1.19 . . . . 0.0 109.207 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.35 57.24 6.16 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.159 3.24 . . . . 0.0 111.383 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.2 mt -74.52 151.2 7.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -53.92 123.93 13.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.06 133.33 50.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -171.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -14.33 63.9 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.571 -1.127 . . . . 0.0 113.005 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.16 -39.5 63.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.706 1.753 . . . . 0.0 110.754 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 104.18 14.14 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -168.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' OE2' ' HE3' ' A' ' 9' ' ' LYS . 42.5 tt0 -122.35 113.9 20.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 22.1 m-85 -83.84 133.28 34.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -125.03 100.2 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.369 1.468 . . . . 0.0 107.052 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -64.65 112.86 3.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.708 1.203 . . . . 0.0 111.131 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.7 pt -68.04 -9.39 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.113 -0.992 . . . . 0.0 112.689 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 p -89.02 -7.33 56.16 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.623 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.47 62.32 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.786 1.176 . . . . 0.0 113.184 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.4 p -121.02 2.79 10.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.813 1.645 . . . . 0.0 110.843 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.0 t30 54.57 -6.46 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.419 2.688 . . . . 0.0 115.855 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -68.02 17.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.657 1.583 . . . . 0.0 113.341 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.86 -63.0 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.674 1.99 . . . . 0.0 110.237 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.62 -22.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.629 1.572 . . . . 0.0 114.81 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.74 -30.71 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.155 1.343 . . . . 0.0 111.522 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mt -69.76 -33.68 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.896 1.279 . . . . 0.0 108.299 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -52.27 54.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -52.48 -54.96 25.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.199 1.8 . . . . 0.0 110.424 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -51.55 -46.0 63.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.608 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.97 -35.46 81.25 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.617 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.53 -54.91 28.79 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.973 1.26 . . . . 0.0 109.412 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -36.76 76.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.137 0.975 . . . . 0.0 110.393 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -76.34 -52.48 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 0.0 109.161 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -97.49 -75.89 0.53 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -168.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.06 -13.93 0.06 OUTLIER Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.022 1.296 . . . . 0.0 114.005 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.68 146.47 41.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.091 1.945 . . . . 0.0 108.97 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -29.43 45.8 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.861 171.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -62.41 133.29 54.83 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -159.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.03 153.91 52.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.32 156.85 80.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.24 0.764 . . . . 0.0 111.684 -7.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.48 106.69 10.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.2 129.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -118.53 93.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.912 2.485 . . . . 0.0 107.479 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.91 118.15 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 168.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 40.13 67.97 0.61 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.492 1.996 . . . . 0.0 114.489 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.61 24.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.89 97.75 5.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -67.84 118.1 10.62 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.806 -1.184 . . . . 0.0 108.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -83.76 -21.58 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -167.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -168.77 24.34 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -170.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.14 -85.62 1.79 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 -64.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.813 1.245 . . . . 0.0 108.157 -170.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m -58.77 -39.41 80.94 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.533 0.733 . . . . 0.0 111.721 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.83 -56.73 18.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.0 -39.35 74.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.099 1.36 . . . . 0.0 110.856 -168.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.8 t -64.85 -40.87 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 117.256 -1.354 . . . . 0.0 111.119 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -50.91 69.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -56.06 -37.65 69.58 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 117.743 -1.122 . . . . 0.0 109.613 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -63.64 -57.58 9.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.453 1.479 . . . . 0.0 109.613 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -42.9 83.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.299 1.44 . . . . 0.0 111.57 -166.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.1 t -65.06 -51.99 58.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.593 1.957 . . . . 0.0 107.845 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.73 1.77 27.3 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.259 -1.301 . . . . 0.0 111.475 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.7 -22.66 66.67 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.936 1.868 . . . . 0.0 110.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -54.51 -46.45 73.5 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 110.348 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.68 -51.14 68.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.478 0.711 . . . . 0.0 109.234 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -53.73 -45.62 70.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.009 0.924 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -56.23 21.36 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 110.678 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.22 -30.72 60.65 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.944 -1.097 . . . . 0.0 112.15 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.19 -30.15 66.21 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.396 -1.44 . . . . 0.0 112.474 169.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -60.17 -8.8 2.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.157 1.383 . . . . 0.0 113.773 171.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.16 8.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.437 1.895 . . . . 0.0 110.866 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.51 36.86 89.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.968 1.27 . . . . 0.0 112.951 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.45 -62.32 1.48 Allowed 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.71 1.204 . . . . 0.0 110.742 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -72.28 142.62 48.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.464 -161.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.319 -0.741 0 C-N-CA 127.994 2.518 . . . . 0.0 107.5 -178.199 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.469 ' H ' ' NE2' ' A' ' 3' ' ' GLN . 1.4 pm0 -67.4 -99.4 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 125.505 1.753 . . . . 0.0 106.755 159.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.06 -31.22 65.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -159.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.25 -26.91 63.48 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.476 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.79 -69.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.458 1.503 . . . . 0.0 110.687 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -65.79 -43.56 88.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.1 0.863 . . . . 0.0 111.834 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.1 t -72.83 -18.19 61.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.814 0.445 . . . . 0.0 111.009 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -71.2 -46.86 60.35 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.615 -1.184 . . . . 0.0 112.109 171.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.5 144.21 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 120.245 1.384 . . . . 0.0 108.526 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.74 168.18 14.62 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 125.372 1.469 . . . . 0.0 107.416 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.3 157.55 30.19 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.295 1.141 . . . . 0.0 109.399 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.63 79.55 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.575 -1.125 . . . . 0.0 115.372 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -132.39 158.58 41.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.656 1.728 . . . . 0.0 107.905 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.05 123.3 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.06 136.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.12 114.58 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -77.68 122.66 25.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -133.71 166.91 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.056 1.342 . . . . 0.0 109.758 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -132.33 125.18 19.66 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 158.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.4 -15.32 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.66 1.573 . . . . 0.0 111.414 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -83.0 -0.17 47.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.914 2.086 . . . . 0.0 113.356 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.13 132.49 21.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.159 1.345 . . . . 0.0 108.23 161.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.91 -17.72 56.2 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.479 2.786 . . . . 0.0 110.952 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -74.04 -38.21 64.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.457 ' HG ' ' HB3' ' A' ' 71' ' ' PRO . 64.0 m -61.95 -44.51 96.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 117.72 -1.134 . . . . 0.0 109.027 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -53.43 -50.35 65.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.606 1.094 . . . . 0.0 111.783 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -54.45 -59.21 4.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 119.202 -0.427 . . . . 0.0 110.187 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.06 60.84 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.604 1.19 . . . . 0.0 111.231 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.67 80.62 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 117.855 -1.069 . . . . 0.0 111.206 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -41.33 69.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 120.557 1.526 . . . . 0.0 109.336 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.17 -54.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.429 1.892 . . . . 0.0 109.263 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.43 -42.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -171.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 t -65.91 -25.11 67.0 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.247 0.476 . . . . 0.0 111.131 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.69 -22.72 59.84 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.355 0.98 . . . . 0.0 112.407 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.95 154.47 92.58 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 119.329 0.968 . . . . 0.0 109.496 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.57 77.93 3.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.853 2.369 . . . . 0.0 109.876 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mt -102.43 153.46 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' A' ' 39' ' ' LYS . 6.2 mmmt -51.97 124.27 12.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.033 0.933 . . . . 0.0 109.083 174.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.61 137.83 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.77 -14.07 64.13 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.841 -1.533 . . . . 0.0 112.247 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mt -73.81 -36.8 65.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.802 2.301 . . . . 0.0 111.78 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.04 118.02 23.79 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -170.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -122.04 123.6 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.627 1.171 . . . . 0.0 109.193 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.53 127.26 45.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.96 105.09 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.935 1.294 . . . . 0.0 108.735 -165.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.35 100.76 3.26 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.576 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -63.94 -14.46 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 113.18 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -114.69 10.5 16.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.871 1.268 . . . . 0.0 111.666 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.53 68.3 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.528 1.058 . . . . 0.0 109.5 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -157.61 -40.13 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.216 171.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -41.8 -63.43 0.72 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.739 1.215 . . . . 0.0 113.106 -158.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 144.24 103.57 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 130.409 3.484 . . . . 0.0 106.316 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -63.47 1.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.275 1.43 . . . . 0.0 108.323 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.47 -30.64 60.95 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.61 -52.31 61.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.839 1.199 . . . . 0.0 110.747 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.03 -39.24 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -57.2 -50.07 74.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.406 2.282 . . . . 0.0 107.459 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.27 -42.32 93.34 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 110.518 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -58.41 -47.42 83.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.9 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.19 -36.78 84.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.792 0.724 . . . . 0.0 110.581 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.83 -51.04 70.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.538 0.735 . . . . 0.0 109.945 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.91 -49.93 72.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.003 0.521 . . . . 0.0 109.851 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.49 -40.58 66.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.116 0.966 . . . . 0.0 109.373 -166.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 p -108.38 -15.37 14.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.255 0.934 . . . . 0.0 113.356 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.19 6.78 64.5 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.625 -1.097 . . . . 0.0 112.158 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.52 22.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.236 1.518 . . . . 0.0 109.265 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -94.67 -8.89 36.56 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.92 133.82 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.685 1.129 . . . . 0.0 110.66 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.11 161.11 29.27 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 160.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' A' ' 26' ' ' CYS . 43.6 Cg_endo -62.24 141.79 37.46 Favored 'Cis proline' 0 N--CA 1.463 -0.275 0 N-CA-C 110.158 -0.747 . . . . 0.0 110.158 -13.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.94 93.1 4.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.85 130.79 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.86 109.02 18.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.378 1.871 . . . . 0.0 106.927 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.5 108.66 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 163.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 67.48 1.91 Allowed Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.264 1.411 . . . . 0.0 112.849 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.0 mttt 46.06 20.39 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.166 1.787 . . . . 0.0 115.393 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.29 110.91 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 164.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -67.26 107.99 2.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.48 -14.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.485 0.584 . . . . 0.0 111.456 -170.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.47 -171.35 22.94 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 124.478 1.037 . . . . 0.0 111.355 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.81 -160.23 31.82 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.896 1.713 . . . . 0.0 110.251 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -37.78 86.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.026 0.913 . . . . 0.0 110.334 -170.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.6 m -67.36 -48.32 67.79 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.987 -172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 -51.94 67.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.7 tp -54.28 -37.33 64.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.074 -0.965 . . . . 0.0 112.231 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -60.85 -53.41 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 116.777 -1.582 . . . . 0.0 108.982 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.22 87.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 121.848 2.113 . . . . 0.0 108.692 -174.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.3 -32.03 71.88 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.745 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.34 -55.11 8.66 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 121.055 1.752 . . . . 0.0 111.087 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -51.91 34.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.635 2.374 . . . . 0.0 110.631 -168.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 t -70.34 -24.59 63.01 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.945 1.298 . . . . 0.0 109.977 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 11.06 65.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.166 173.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.55 -25.93 68.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.36 2.08 . . . . 0.0 111.726 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.73 -32.23 69.02 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.536 1.134 . . . . 0.0 111.513 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.09 -46.52 61.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.65 0.659 . . . . 0.0 109.656 -168.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.9 m -64.45 -40.49 95.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -40.97 85.37 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.54 -0.725 . . . . 0.0 111.687 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.75 -46.09 84.96 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.713 1.205 . . . . 0.0 110.503 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -62.12 -31.02 71.44 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.958 -1.089 . . . . 0.0 112.331 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -63.64 -10.99 21.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.92 11.75 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 119.474 1.034 . . . . 0.0 111.854 170.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.12 26.09 62.69 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.341 0.972 . . . . 0.0 112.887 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.616 1.166 . . . . 0.0 111.487 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.7 mt -77.55 134.32 38.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.802 -1.559 . . . . 0.0 110.944 -158.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 . . . . . 0 N--CA 1.428 -1.526 0 C-N-CA 130.134 3.374 . . . . 0.0 106.161 -179.273 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.45 ' H2 ' ' CD ' ' A' ' 56' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 75.22 -173.31 0.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 128.122 2.569 . . . . 0.0 113.487 170.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -10.04 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.807 2.443 . . . . 0.0 114.62 163.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -45.11 -57.03 4.17 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.371 1.441 . . . . 0.0 110.507 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.09 -58.93 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -55.32 -37.39 67.36 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.19 0.996 . . . . 0.0 113.573 -161.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.0 m -101.91 -8.87 21.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.971 0.908 . . . . 0.0 112.815 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.87 -45.26 90.24 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.966 1.257 . . . . 0.0 107.7 159.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.75 155.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 152.52 47.48 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.61 125.22 14.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 N-CA-C 104.763 -2.822 . . . . 0.0 104.763 158.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.49 35.58 25.63 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.737 0.684 . . . . 0.0 113.302 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -142.31 161.31 38.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.099 2.159 . . . . 0.0 109.341 166.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.33 109.25 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.56 132.25 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 120.555 -1.341 . . . . 0.0 108.289 -166.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.23 111.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -166.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -79.29 119.26 22.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.86 169.5 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.989 1.716 . . . . 0.0 109.921 -174.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 22' ' ' THR . 4.2 ptmm? -127.29 141.28 40.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 162.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.06 28.77 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.6 3.533 . . . . 0.0 111.315 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 20' ' ' LYS 0.323 9.6 t -147.23 29.48 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.813 2.045 . . . . 0.0 108.929 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.63 123.84 26.87 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.035 1.734 . . . . 0.0 108.595 167.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.98 -24.92 52.4 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.486 1.457 . . . . 0.0 111.984 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -78.98 -28.72 43.54 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.953 0.797 . . . . 0.0 109.353 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.2 m -66.11 -46.9 75.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -51.92 -48.15 64.33 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.166 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -55.5 -57.87 10.13 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 119.014 0.825 . . . . 0.0 109.938 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.42 62.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.328 1.018 . . . . 0.0 111.472 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -45.69 78.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.388 0.994 . . . . 0.0 113.295 172.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.66 -53.21 16.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt -44.34 -53.22 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.39 1.876 . . . . 0.0 110.442 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.64 -46.47 19.13 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.186 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -6.51 59.26 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.367 0.985 . . . . 0.0 112.608 -167.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -73.83 -16.16 61.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.66 1.118 . . . . 0.0 110.992 167.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -78.0 151.29 78.89 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 120.885 -1.134 . . . . 0.0 108.748 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 42.23 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.303 2.669 . . . . 0.0 111.295 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.1 145.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -58.38 123.06 14.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.27 146.66 54.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.78 10.22 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.589 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.49 -30.5 63.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.883 1.842 . . . . 0.0 109.68 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 119.72 25.18 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 120.515 1.507 . . . . 0.0 107.684 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -128.72 110.41 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.688 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -84.19 103.74 13.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -90.82 114.96 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 126.519 1.927 . . . . 0.0 107.231 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.57 110.58 3.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.591 1.156 . . . . 0.0 110.942 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.6 pt -70.45 -2.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.369 1.068 . . . . 0.0 113.006 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.261 3.3 t -137.12 35.64 2.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 118.775 0.716 . . . . 0.0 110.41 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.06 55.73 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.333 0.653 . . . . 0.0 109.363 159.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.6 p 53.54 65.65 1.46 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.965 2.506 . . . . 0.0 111.15 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -143.48 -93.64 0.11 Allowed 'General case' 0 C--O 1.23 0.07 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.008 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -160.22 57.28 0.35 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.422 1.464 . . . . 0.0 113.678 -163.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -63.66 0.86 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.581 1.152 . . . . 0.0 111.817 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -46.63 -54.68 9.02 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.901 0.75 . . . . 0.0 111.15 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' CD ' ' H2 ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -65.35 -41.66 93.63 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.554 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.4 -39.99 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.03 -41.45 74.25 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -42.05 35.9 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.49 1.916 . . . . 0.0 111.423 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.5 -50.99 66.49 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.753 1.221 . . . . 0.0 110.338 171.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.42 -30.71 65.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.789 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.485 ' NE2' HH21 ' A' ' 68' ' ' ARG . 22.7 tt0 -66.56 -37.79 85.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.627 1.558 . . . . 0.0 111.695 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -67.66 -47.54 69.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.53 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.27 -24.33 57.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.211 -168.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 p -133.51 -2.85 3.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.283 1.401 . . . . 0.0 114.101 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.13 -10.23 61.42 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 120.061 1.301 . . . . 0.0 112.857 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.62 137.33 54.48 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.126 -1.22 . . . . 0.0 110.587 -172.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' A' ' 62' ' ' GLN . 5.1 ptp85 -102.02 -31.31 10.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.475 174.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 133.33 41.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.285 0.564 . . . . 0.0 109.716 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.27 159.49 39.27 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.369 1.467 . . . . 0.0 108.458 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.54 167.77 22.72 Favored 'Cis proline' 0 C--N 1.347 0.457 0 CA-C-N 120.379 1.171 . . . . 0.0 111.881 -8.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 110.15 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.062 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.9 t -91.98 125.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 119.426 1.012 . . . . 0.0 108.761 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -102.21 114.68 29.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 158.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -93.18 123.68 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 160.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 43.78 72.43 0.33 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.301 1.429 . . . . 0.0 113.811 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 46.65 14.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.17 120.22 36.44 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.471 1.487 . . . . 0.0 110.658 170.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.71 114.66 4.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.706 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.52 -12.68 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 119.236 0.925 . . . . 0.0 110.845 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.75 -158.17 18.28 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.65 -157.47 31.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 126.767 2.127 . . . . 0.0 111.108 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -38.44 83.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.923 -0.751 . . . . 0.0 110.335 -169.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -68.85 -44.82 72.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.634 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -65.17 -45.56 84.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.6 tp -53.98 -45.42 71.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.5 0.72 . . . . 0.0 112.057 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.89 -39.16 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 117.112 -1.423 . . . . 0.0 109.536 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -54.54 24.92 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -58.52 -33.54 69.96 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.29 -63.67 1.03 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.935 1.698 . . . . 0.0 110.705 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.26 78.3 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.864 1.266 . . . . 0.0 112.163 -166.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -86.39 -2.24 58.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.457 1.503 . . . . 0.0 110.972 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 -0.37 88.86 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 117.107 -1.941 . . . . 0.0 114.671 168.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.38 -31.54 72.73 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 121.285 2.542 . . . . 0.0 111.168 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.27 -35.65 70.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.987 1.315 . . . . 0.0 110.763 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.19 -44.09 76.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -61.25 -54.14 47.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -40.34 63.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.519 1.128 . . . . 0.0 111.07 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.1 mt -70.11 -57.56 4.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.78 1.632 . . . . 0.0 112.448 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HZ3' ' C ' ' A' ' 106' ' ' GLN . 4.5 tttm -65.88 -26.81 67.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.709 1.595 . . . . 0.0 111.913 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -44.95 -36.69 3.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.674 1.59 . . . . 0.0 111.528 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.57 14.3 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.44 1.018 . . . . 0.0 112.552 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.5 40.89 21.85 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.725 0.693 . . . . 0.0 112.286 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.21 -78.21 0.53 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.076 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.1 135.0 57.58 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.435 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 12.3 tt0 . . . . . 0 C--O 1.245 0.831 0 O-C-N 125.499 1.75 . . . . 0.0 108.006 -163.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 57' ' ' ILE . . . . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 57.4 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 126.09 2.119 . . . . 0.0 113.747 -165.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.34 -19.2 65.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.658 -0.651 . . . . 0.0 111.073 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -47.08 -49.94 20.72 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.718 1.207 . . . . 0.0 110.111 168.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.7 -53.12 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.939 0.791 . . . . 0.0 109.937 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.36 -55.71 31.28 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.233 0.924 . . . . 0.0 111.467 -163.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.9 m -82.58 -6.69 59.49 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -65.52 -22.83 66.75 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.915 1.234 . . . . 0.0 110.639 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.8 154.87 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 120.637 1.562 . . . . 0.0 108.561 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -135.65 152.33 75.98 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.79 63.93 8.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.128 3.219 . . . . 0.0 110.976 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.4 31.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.933 1.254 . . . . 0.0 111.781 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -134.44 172.92 12.23 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.142 1.777 . . . . 0.0 107.756 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.76 111.51 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.7 t -132.38 115.91 27.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -158.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.69 130.16 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 123.003 0.521 . . . . 0.0 110.305 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.42 125.15 40.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.77 168.5 16.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.854 1.661 . . . . 0.0 110.512 -167.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -125.54 148.42 61.54 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 169.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.28 -39.08 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.701 2.267 . . . . 0.0 110.134 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 p -81.89 48.48 1.23 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.05 2.14 . . . . 0.0 109.966 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -140.67 127.06 11.77 Favored Pre-proline 0 C--O 1.242 0.679 0 C-N-CA 126.516 1.927 . . . . 0.0 109.387 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.56 -19.56 11.39 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.333 2.022 . . . . 0.0 112.038 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -73.59 -35.28 65.39 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 120.428 1.467 . . . . 0.0 108.305 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.27 -40.07 89.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -53.13 -53.95 42.93 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.156 0.434 . . . . 0.0 110.84 171.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -53.19 -59.18 4.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.552 0.741 . . . . 0.0 109.021 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -41.88 72.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 117.515 -1.231 . . . . 0.0 111.481 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -49.64 71.05 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 119.718 1.145 . . . . 0.0 112.162 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.43 -50.05 55.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.205 1.002 . . . . 0.0 110.124 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -46.69 -56.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 127.272 2.229 . . . . 0.0 109.586 170.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.66 -46.76 74.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -65.61 -18.65 65.48 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -73.52 -27.31 61.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.084 1.311 . . . . 0.0 110.397 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.66 135.43 81.13 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -82.25 63.32 8.2 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.089 2.526 . . . . 0.0 112.072 -167.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.57 147.74 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.244 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -46.45 124.54 5.94 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.856 1.662 . . . . 0.0 109.243 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.56 129.51 42.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -3.08 82.71 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 118.083 -1.398 . . . . 0.0 113.279 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.72 -30.99 46.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.813 2.306 . . . . 0.0 112.44 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 116.09 26.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -123.3 133.6 54.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.676 1.19 . . . . 0.0 108.219 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -110.56 139.03 46.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.7 t -135.39 108.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.288 1.035 . . . . 0.0 108.547 -164.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.29 122.76 17.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 111.942 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.63 ' CD1' ' HG1' ' A' ' 54' ' ' THR . 45.2 pt -75.11 -20.47 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.955 1.302 . . . . 0.0 112.449 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 p -88.28 -2.9 58.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.472 1.109 . . . . 0.0 110.893 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -58.43 6.01 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 124.992 1.317 . . . . 0.0 111.201 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.4 OUTLIER -149.47 -70.12 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.428 169.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -34.1 -86.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.834 2.054 . . . . 0.0 114.285 -158.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -164.18 99.91 0.85 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.213 1.805 . . . . 0.0 106.844 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.63 ' HG1' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -52.29 -62.62 1.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.443 ' H ' HG21 ' A' ' 54' ' ' THR . 1.8 t30 -63.94 -7.41 8.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.096 1.758 . . . . 0.0 113.531 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -36.0 16.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.84 1.655 . . . . 0.0 109.637 161.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.411 ' HA ' ' CB ' ' A' ' 2' ' ' ALA . 11.3 mt -71.36 -50.06 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -167.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.55 76.09 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.009 0.524 . . . . 0.0 110.015 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -55.48 -56.85 15.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.547 1.539 . . . . 0.0 110.946 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -56.84 -29.91 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.84 2.056 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.9 mt -60.48 -30.42 69.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.015 1.28 . . . . 0.0 111.73 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -60.28 -37.04 79.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.945 0.793 . . . . 0.0 109.731 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.16 -49.44 17.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.41 -30.42 57.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.54 -166.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.528 HG23 HH11 ' A' ' 72' ' ' ARG . 34.7 p -120.79 -62.56 1.44 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.904 1.229 . . . . 0.0 110.459 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.19 -34.69 0.2 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.154 -1.359 . . . . 0.0 114.341 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.35 144.88 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.123 1.461 . . . . 0.0 109.739 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -83.54 14.88 3.42 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.618 0.767 . . . . 0.0 112.368 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -105.84 163.76 12.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.578 1.656 . . . . 0.0 110.626 -158.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.99 144.38 46.18 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 127.632 2.373 . . . . 0.0 106.16 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.62 155.33 89.91 Favored 'Cis proline' 0 N--CA 1.454 -0.808 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 -4.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.528 HH11 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.46 130.24 17.1 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 176.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.17 128.15 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 124.185 0.994 . . . . 0.0 109.559 -163.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -94.23 124.98 38.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.29 113.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 160.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.69 15.27 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.28 -0.887 . . . . 0.0 112.483 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt 46.52 3.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.852 2.461 . . . . 0.0 116.917 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.33 142.02 28.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.171 1.805 . . . . 0.0 107.637 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -101.25 123.5 45.47 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.893 -1.13 . . . . 0.0 112.271 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.62 -23.1 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.359 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.93 -165.22 21.02 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.292 0.949 . . . . 0.0 111.201 -171.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 -163.58 32.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.486 1.517 . . . . 0.0 110.885 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.1 p -65.61 -34.37 78.07 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.409 1.104 . . . . 0.0 110.49 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -62.01 -42.55 99.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.872 0.76 . . . . 0.0 111.113 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.66 -54.52 22.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.2 tp -51.91 -39.24 58.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.92 1.288 . . . . 0.0 111.9 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.6 t -58.56 -59.35 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 117.012 -1.471 . . . . 0.0 108.797 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.2 p -48.65 -54.74 13.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.556 1.98 . . . . 0.0 115.003 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.75 -32.81 70.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.447 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -72.01 -51.89 19.66 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.893 1.679 . . . . 0.0 110.245 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -58.58 3.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.07 1.748 . . . . 0.0 110.097 -168.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -16.99 64.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.852 1.261 . . . . 0.0 110.895 173.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.64 78.94 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.185 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.49 -22.72 67.05 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.816 2.308 . . . . 0.0 111.68 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.8 -24.67 67.62 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.576 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.34 -52.32 59.0 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 120.354 1.434 . . . . 0.0 108.632 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.1 m -57.07 -50.88 71.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.727 0.811 . . . . 0.0 109.956 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -47.6 -51.6 20.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.001 0.92 . . . . 0.0 110.712 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.29 -52.06 37.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.175 1.39 . . . . 0.0 111.3 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -62.18 -26.05 68.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.562 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -57.25 -33.1 67.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.072 0.851 . . . . 0.0 112.305 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.1 -14.92 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.905 1.229 . . . . 0.0 112.133 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.04 83.9 0.74 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -166.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.85 -76.41 0.46 Allowed 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.721 -1.609 . . . . 0.0 110.92 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.47 135.29 54.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 121.968 2.167 . . . . 0.0 108.503 -172.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.844 1.34 . . . . 0.0 109.132 -158.364 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.206 0.527 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -81.49 63.08 5.64 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.618 -1.301 . . . . 0.0 110.194 172.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -163.04 -58.63 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.65 -57.89 10.99 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.628 1.558 . . . . 0.0 109.639 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.79 -48.92 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.491 ' ND2' ' HH ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -68.47 -16.32 63.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.37 1.068 . . . . 0.0 112.421 -165.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -103.81 -26.24 12.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.862 1.665 . . . . 0.0 111.751 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -64.05 -43.8 94.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.491 1.042 . . . . 0.0 110.959 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.16 140.9 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -122.86 157.2 60.75 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.46 16.86 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.023 3.149 . . . . 0.0 114.828 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 11' ' ' GLN . . . -170.57 45.32 0.2 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.8 2.143 . . . . 0.0 110.795 -172.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -141.23 164.08 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.61 100.61 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.96 125.56 61.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 t -126.15 109.08 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -76.47 132.08 39.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -138.65 164.29 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.012 2.125 . . . . 0.0 108.874 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 145.87 34.02 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 158.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.53 16.11 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.923 3.082 . . . . 0.0 114.085 -161.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -129.4 -22.02 3.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.397 1.479 . . . . 0.0 112.665 -160.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -94.74 148.69 35.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -157.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.17 -25.19 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.874 2.382 . . . . 0.0 111.787 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -73.81 -43.39 58.96 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.12 1.768 . . . . 0.0 107.514 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -54.27 -47.12 72.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.476 1.111 . . . . 0.0 111.872 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -59.62 4.55 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.88 -36.69 65.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.356 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -54.91 -57.83 10.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.631 1.173 . . . . 0.0 112.554 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -70.68 -35.65 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.371 0.605 . . . . 0.0 110.815 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.63 -49.83 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.476 1.51 . . . . 0.0 109.796 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.31 -49.17 15.57 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.9 p -67.51 -25.96 66.1 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -162.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -80.83 -9.14 59.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 111.994 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.04 134.84 77.35 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 168.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.09 104.18 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.581 2.187 . . . . 0.0 108.784 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -122.71 151.7 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -57.87 124.27 18.64 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.71 136.51 56.37 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.95 84.6 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.18 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.51 -39.59 31.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.53 2.165 . . . . 0.0 111.675 166.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.7 93.48 8.04 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.035 0.834 . . . . 0.0 110.28 -159.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -110.63 116.05 30.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -84.73 119.18 24.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -113.63 131.42 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 127.591 2.356 . . . . 0.0 107.784 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.66 137.8 34.35 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.955 0.502 . . . . 0.0 110.279 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.8 pt -99.41 5.11 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 123.39 0.676 . . . . 0.0 112.248 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 p -117.51 -26.92 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.155 -1.59 . . . . 0.0 111.517 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.01 -55.5 32.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.783 -164.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 p -147.11 5.18 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.648 0.779 . . . . 0.0 112.375 -158.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -146.62 -0.54 0.74 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -157.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 69.9 88.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.719 1.608 . . . . 0.0 114.91 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -33.93 -63.82 0.25 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 130.149 3.38 . . . . 0.0 110.059 166.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -49.36 -46.4 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.914 0.759 . . . . 0.0 111.606 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -49.97 59.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 110.973 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 mt -54.63 -43.41 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.706 1.602 . . . . 0.0 110.471 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -71.98 -45.85 59.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -170.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -48.55 76.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 109.888 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' HH ' ' ND2' ' A' ' 7' ' ' ASN . 34.6 t80 -65.33 -44.99 86.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.672 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.0 -42.61 76.67 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.261 1.024 . . . . 0.0 109.89 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -56.4 21.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.491 174.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.07 -51.23 68.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 123.556 0.535 . . . . 0.0 109.993 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.89 -45.26 95.3 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.306 1.442 . . . . 0.0 109.457 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 p -101.1 -65.19 0.99 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.552 0.614 . . . . 0.0 110.781 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.38 -4.48 2.55 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.638 2.066 . . . . 0.0 111.635 -172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.73 157.92 43.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.269 1.535 . . . . 0.0 109.141 169.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -118.77 -29.12 5.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.123 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 p -61.61 133.22 55.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -161.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.08 58.19 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.46 170.45 42.38 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 CA-C-N 118.649 0.553 . . . . 0.0 111.149 -7.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -130.12 100.33 5.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.15 129.26 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.11 104.87 12.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.768 2.027 . . . . 0.0 106.915 168.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 103.06 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 169.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.97 64.77 3.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.882 1.23 . . . . 0.0 113.014 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.72 13.09 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 127.7 2.4 . . . . 0.0 117.219 -168.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -100.69 103.55 14.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 120.454 1.479 . . . . 0.0 107.341 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.6 t -68.85 117.22 10.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.63 -25.8 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.563 0.745 . . . . 0.0 110.631 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.25 -171.29 23.75 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 123.462 0.553 . . . . 0.0 112.023 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.61 -169.01 41.41 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 125.409 1.481 . . . . 0.0 111.463 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 p -63.43 -38.01 89.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.871 0.835 . . . . 0.0 110.507 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.235 0.47 . . . . 0.0 111.804 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.64 -49.51 21.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -52.68 -34.66 53.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.059 1.744 . . . . 0.0 112.605 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.64 -50.84 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.164 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -44.99 92.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.606 1.548 . . . . 0.0 107.691 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.79 -31.65 71.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.04 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -69.18 -61.34 1.83 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.25 1.386 . . . . 0.0 109.085 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -50.7 66.47 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.872 2.069 . . . . 0.0 111.658 -166.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -3.71 32.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.27 1.828 . . . . 0.0 111.778 172.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.97 -0.72 82.19 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.038 -1.424 . . . . 0.0 115.113 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.24 -33.87 72.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.153 1.976 . . . . 0.0 111.442 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.3 tp -60.3 -33.22 72.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.689 0.796 . . . . 0.0 111.125 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.63 -40.03 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -72.48 -48.05 43.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -40.24 58.57 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.945 0.793 . . . . 0.0 111.815 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.76 -56.59 9.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 110.567 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -59.38 -24.31 63.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.829 1.195 . . . . 0.0 112.873 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -48.66 -41.69 32.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.681 1.193 . . . . 0.0 110.705 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.98 -1.63 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.26 59.97 1.79 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.28 -73.04 0.66 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.416 1.486 . . . . 0.0 112.412 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.454 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 2.8 mt -62.57 135.4 57.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.28 -153.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -136.98 -56.6 0.72 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.094 0.957 . . . . 0.0 108.816 163.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.11 -17.69 62.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.583 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -52.51 -45.02 66.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.298 1.408 . . . . 0.0 109.339 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.59 -60.25 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 109.017 169.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -70.0 -11.86 61.18 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -159.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -106.55 -15.48 14.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.148 0.979 . . . . 0.0 112.931 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -63.93 -57.56 9.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.22 1.373 . . . . 0.0 107.517 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.6 150.48 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -144.34 172.4 5.52 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.189 1.795 . . . . 0.0 106.28 161.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.05 17.18 0.87 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.178 2.585 . . . . 0.0 114.912 -163.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.3 12.07 1.2 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.655 2.55 . . . . 0.0 112.16 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.06 148.67 29.46 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.849 1.824 . . . . 0.0 108.585 170.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 t -102.54 86.62 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.84 147.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 O-C-N 120.829 -1.169 . . . . 0.0 108.539 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.9 116.21 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.12 128.89 34.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.18 175.24 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.276 1.43 . . . . 0.0 110.879 -167.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -137.97 144.72 45.01 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 158.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.84 -31.66 47.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.305 2.67 . . . . 0.0 112.268 -168.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -65.78 -35.96 82.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.508 0.723 . . . . 0.0 111.829 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.7 t -61.01 118.67 37.97 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 124.557 1.143 . . . . 0.0 109.717 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.93 -20.25 34.26 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.772 1.648 . . . . 0.0 111.073 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -73.49 -39.35 64.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -60.61 -49.42 77.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -57.24 -46.07 83.34 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.425 0.557 . . . . 0.0 111.636 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -56.52 -54.24 48.14 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 118.833 0.742 . . . . 0.0 109.947 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.2 -39.23 59.87 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.223 0.952 . . . . 0.0 111.43 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.02 66.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.673 171.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -55.03 31.64 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.226 1.01 . . . . 0.0 109.741 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.63 -47.17 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.077 2.151 . . . . 0.0 110.237 176.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.11 -42.73 31.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 m -61.42 -21.87 64.5 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.85 -11.55 60.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.91 . . . . 0.0 111.851 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.3 133.51 21.97 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.85 81.77 2.49 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.633 2.889 . . . . 0.0 110.284 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -102.57 155.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -167.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -50.75 123.31 8.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.659 0.783 . . . . 0.0 109.266 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -66.58 157.05 33.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.099 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.86 -20.66 2.84 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.205 -1.331 . . . . 0.0 112.68 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -73.86 -37.14 64.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.538 2.169 . . . . 0.0 109.795 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 104.1 13.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -171.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -123.35 113.62 19.09 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -84.07 107.2 16.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.92 106.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 126.427 1.891 . . . . 0.0 107.288 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.78 133.08 52.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 122.649 -0.032 . . . . 0.0 110.953 166.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 pt -106.25 -13.75 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.33 1.452 . . . . 0.0 110.758 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.92 -6.45 58.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.632 1.173 . . . . 0.0 111.083 174.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.62 68.79 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 129.338 3.055 . . . . 0.0 108.966 163.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p 55.99 -4.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 131.442 3.897 . . . . 0.0 116.51 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 14.95 29.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 113.182 -159.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m170 78.25 87.58 0.07 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.709 3.204 . . . . 0.0 110.121 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.77 -63.42 0.91 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.316 -1.325 . . . . 0.0 111.777 168.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -47.36 -51.45 19.57 Favored 'General case' 0 C--O 1.217 -0.629 0 O-C-N 124.452 1.095 . . . . 0.0 109.911 -171.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.11 -50.1 75.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.515 0.598 . . . . 0.0 110.352 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -62.34 -35.66 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.964 0.906 . . . . 0.0 108.816 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.21 -37.2 33.64 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 -168.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.43 -46.18 84.31 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 127.502 2.321 . . . . 0.0 110.475 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -61.51 -44.92 96.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.326 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -57.4 -39.21 75.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.973 1.261 . . . . 0.0 110.524 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -41.78 93.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.502 0.721 . . . . 0.0 110.385 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -63.62 -58.53 6.64 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.508 -0.745 . . . . 0.0 110.053 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 tp -65.32 -30.22 71.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.676 2.39 . . . . 0.0 111.775 -166.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.69 -26.47 2.96 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.192 1.36 . . . . 0.0 112.993 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.96 27.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.934 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.77 144.83 27.28 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.365 2.083 . . . . 0.0 110.414 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -85.84 -18.63 32.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.968 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -70.83 134.08 47.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -163.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.28 166.12 14.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.556 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -58.82 159.01 35.48 Favored 'Cis proline' 0 C--N 1.345 0.36 0 CA-C-N 119.657 0.913 . . . . 0.0 110.305 -15.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 mtp85 -126.39 105.7 8.97 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.58 125.25 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -110.79 99.57 8.47 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 107.065 168.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 109.79 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.28 64.67 2.17 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.016 1.769 . . . . 0.0 111.761 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 tttt 46.14 17.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.458 2.703 . . . . 0.0 117.394 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -98.53 115.56 28.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.26 1.391 . . . . 0.0 107.568 159.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -67.01 108.79 2.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.55 -11.01 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.656 0.662 . . . . 0.0 110.555 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -165.64 24.44 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.154 1.359 . . . . 0.0 110.008 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.65 -165.36 39.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -39.76 93.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.716 -0.873 . . . . 0.0 110.775 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -66.6 -26.01 66.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.316 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.74 -51.9 6.13 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.6 tp -46.55 -39.68 11.4 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.334 1.853 . . . . 0.0 111.269 172.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.29 -48.39 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 116.434 -1.746 . . . . 0.0 110.802 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -44.7 76.65 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.989 1.722 . . . . 0.0 106.857 -176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.36 -34.28 72.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.044 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.09 -56.37 9.09 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.627 1.558 . . . . 0.0 110.408 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -50.22 55.8 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.499 -1.375 . . . . 0.0 110.261 -167.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 t -70.74 -12.15 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.138 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.49 16.28 71.47 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 117.695 -1.614 . . . . 0.0 112.992 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.42 -30.91 70.86 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.542 2.171 . . . . 0.0 110.597 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -49.91 -37.39 31.38 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.985 2.114 . . . . 0.0 111.453 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -55.82 28.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.238 1.015 . . . . 0.0 110.534 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.0 m -62.49 -43.8 97.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.015 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -38.88 77.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.13 0.877 . . . . 0.0 110.302 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.67 -51.62 39.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.99 -1.069 . . . . 0.0 111.056 173.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -55.57 -25.84 40.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.054 1.297 . . . . 0.0 114.3 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -47.4 -36.03 9.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.985 1.314 . . . . 0.0 111.582 168.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -6.22 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.735 0.814 . . . . 0.0 111.973 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.92 85.02 0.23 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -169.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.41 -70.11 0.43 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.602 2.361 . . . . 0.0 109.008 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.58 148.68 51.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 121.081 1.764 . . . . 0.0 107.407 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.247 0.962 0 O-C-N 126.057 2.098 . . . . 0.0 107.37 158.725 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -111.72 81.6 1.48 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -163.07 -60.76 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 116.668 -1.634 . . . . 0.0 110.385 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -50.21 -49.48 52.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.226 1.375 . . . . 0.0 111.217 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.92 -49.46 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.32 -46.86 81.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 t -79.69 10.27 4.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.144 2.178 . . . . 0.0 112.34 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -106.49 -34.61 7.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.712 -1.243 . . . . 0.0 109.862 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.07 148.2 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.53 1.059 . . . . 0.0 108.998 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -135.8 139.13 29.79 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 159.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -63.1 158.47 43.75 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.082 1.855 . . . . 0.0 109.098 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.75 17.36 41.95 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.547 -0.721 . . . . 0.0 113.528 -171.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 156.74 46.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.666 1.987 . . . . 0.0 107.981 172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -107.85 104.53 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.91 125.7 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.87 112.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -167.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.61 126.79 34.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.78 -178.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 0.0 111.429 -166.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.2 160.55 61.82 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 127.037 2.135 . . . . 0.0 107.086 172.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.67 -17.17 10.0 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.511 2.141 . . . . 0.0 111.638 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -129.16 24.57 5.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.732 2.013 . . . . 0.0 111.041 -163.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -107.17 115.29 60.16 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.16 -18.41 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.915 1.743 . . . . 0.0 111.07 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -74.17 -37.83 63.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.64 -50.35 65.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -49.03 -47.34 44.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.698 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -63.31 1.18 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 119.137 0.88 . . . . 0.0 109.348 173.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.0 58.87 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.143 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.48 -45.78 85.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.019 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.06 -30.95 55.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 121.724 2.056 . . . . 0.0 111.841 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mt -57.3 -55.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.282 1.433 . . . . 0.0 107.456 170.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.92 -56.13 4.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t -65.07 -20.91 66.71 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -160.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -73.62 -21.31 60.34 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.21 0.914 . . . . 0.0 111.914 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.93 149.53 90.01 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.181 0.9 . . . . 0.0 110.498 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.92 109.24 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.108 2.539 . . . . 0.0 108.57 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -130.72 147.55 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.39 155.21 5.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.028 1.331 . . . . 0.0 109.882 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.96 100.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.377 1.871 . . . . 0.0 111.043 -172.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.18 19.55 75.82 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.587 167.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.44 -25.88 60.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.31 2.055 . . . . 0.0 110.891 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 103.65 13.5 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 120.309 1.413 . . . . 0.0 107.305 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -115.14 102.29 9.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.039 1.336 . . . . 0.0 107.841 -170.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.13 131.08 34.81 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.0 t -128.14 100.85 6.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 125.542 1.537 . . . . 0.0 108.029 -166.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.61 119.6 22.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.075 0.55 . . . . 0.0 110.957 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.94 -9.15 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 t -117.6 13.71 14.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.58 1.152 . . . . 0.0 109.755 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.16 67.59 0.31 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.087 1.755 . . . . 0.0 108.335 159.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.264 0.3 OUTLIER 68.36 -16.07 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 128.272 2.629 . . . . 0.0 113.286 175.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.23 168.17 16.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 109.981 174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -92.28 72.85 5.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.599 1.16 . . . . 0.0 109.145 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.74 -63.77 0.29 Allowed 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 127.73 2.412 . . . . 0.0 109.961 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.29 -32.76 39.05 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -45.24 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.766 -1.209 . . . . 0.0 111.008 174.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 mt -57.34 -38.05 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.462 1.105 . . . . 0.0 110.208 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -63.33 -47.18 83.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.739 2.416 . . . . 0.0 106.934 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.67 -45.93 88.32 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.076 0.95 . . . . 0.0 110.006 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -61.06 -37.19 81.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.265 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.5 mt -55.77 -47.49 76.93 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 121.197 1.817 . . . . 0.0 109.206 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -54.12 -47.53 71.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.963 0.789 . . . . 0.0 111.08 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.91 77.48 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.054 0.542 . . . . 0.0 110.66 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.71 -24.5 56.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.891 0.876 . . . . 0.0 110.022 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.2 p -121.34 -65.92 1.09 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.513 1.051 . . . . 0.0 110.099 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.66 -4.76 0.68 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.564 2.03 . . . . 0.0 112.038 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.31 142.57 32.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.976 1.888 . . . . 0.0 109.518 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -95.63 -15.55 22.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 141.83 55.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.866 0.757 . . . . 0.0 110.755 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 158.22 33.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.994 1.718 . . . . 0.0 108.265 171.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.03 141.17 50.62 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 N-CA-C 110.034 -0.795 . . . . 0.0 110.034 -5.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -109.56 96.57 6.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.36 126.74 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -122.82 94.01 4.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.49 117.1 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.95 66.33 2.54 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 124.832 1.206 . . . . 0.0 114.016 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt 46.08 31.95 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -143.87 148.41 35.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.684 1.129 . . . . 0.0 110.09 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.3 139.32 30.61 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 119.334 0.97 . . . . 0.0 110.149 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.28 -7.89 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.47 0.577 . . . . 0.0 112.249 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.28 -88.23 0.25 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.76 -80.41 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -39.29 1.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.625 0.77 . . . . 0.0 112.255 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -76.89 -25.85 53.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.648 1.567 . . . . 0.0 111.15 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.74 -43.76 83.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.286 1.035 . . . . 0.0 108.318 165.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.34 -36.61 76.0 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.008 0.523 . . . . 0.0 111.086 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -60.41 -46.22 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 117.435 -1.269 . . . . 0.0 109.65 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -48.43 79.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.431 1.469 . . . . 0.0 107.217 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mt -56.21 -39.69 72.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.999 0.92 . . . . 0.0 109.006 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -58.65 6.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.394 1.452 . . . . 0.0 110.032 172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -50.55 66.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.095 1.358 . . . . 0.0 110.767 -164.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.9 t -75.97 -2.33 29.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.134 1.774 . . . . 0.0 111.562 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.44 5.74 44.92 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.624 -1.654 . . . . 0.0 113.866 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -65.2 -21.45 66.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.905 2.353 . . . . 0.0 110.504 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -49.85 -40.0 40.89 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.471 1.508 . . . . 0.0 111.88 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.87 -50.82 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -56.76 -54.15 49.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.9 1.28 . . . . 0.0 109.721 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -38.63 63.9 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.772 2.029 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.59 -49.68 20.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.073 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HZ3' ' C ' ' A' ' 106' ' ' GLN . 4.5 mttm -62.51 -23.47 66.97 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.642 1.565 . . . . 0.0 112.765 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -52.35 -20.38 2.72 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.883 1.673 . . . . 0.0 112.955 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.2 8.89 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.015 1.279 . . . . 0.0 113.671 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.38 41.13 31.39 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.383 -0.823 . . . . 0.0 111.6 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.14 -74.52 0.47 Allowed 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.285 1.434 . . . . 0.0 111.181 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.33 55.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 22.0 tt0 . . . . . 0 C--O 1.249 1.027 0 O-C-N 124.463 1.102 . . . . 0.0 108.933 -163.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' H2 ' ' HB2' ' A' ' 60' ' ' TYR . . . . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 121.58 0.705 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 10.4 pt20 -75.92 28.56 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.577 1.951 . . . . 0.0 114.113 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -163.03 -56.93 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -58.6 -45.62 88.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.171 0.896 . . . . 0.0 110.94 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.29 -49.69 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.021 0.828 . . . . 0.0 109.479 171.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.26 -48.19 81.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -164.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -74.16 -21.95 59.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.754 0.822 . . . . 0.0 111.733 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -64.79 -48.12 75.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.025 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.01 149.8 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -145.27 152.64 50.99 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.29 160.97 28.75 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.225 1.283 . . . . 0.0 109.78 159.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.86 24.33 33.47 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.869 -0.962 . . . . 0.0 113.917 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -141.43 160.11 40.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.531 1.666 . . . . 0.0 107.877 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.74 87.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.51 129.42 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.86 112.45 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -166.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.92 124.91 29.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.7 178.42 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.929 2.092 . . . . 0.0 110.395 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.89 160.31 69.05 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 159.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.5 -30.52 3.13 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.994 1.796 . . . . 0.0 110.848 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -91.21 3.18 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.048 1.339 . . . . 0.0 111.96 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.24 110.55 41.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.226 1.011 . . . . 0.0 112.042 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -28.51 38.34 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 112.12 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -73.78 -24.08 59.79 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.607 1.094 . . . . 0.0 110.977 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.73 -52.09 48.43 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 166.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -55.04 -37.6 66.9 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.413 1.085 . . . . 0.0 113.544 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HE ' HD13 ' A' ' 32' ' ' ILE . 29.2 ttt180 -59.32 -61.16 2.84 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 118.428 0.558 . . . . 0.0 110.263 169.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.4 -34.07 46.56 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 124.575 1.172 . . . . 0.0 110.969 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -53.18 60.2 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 126.256 1.822 . . . . 0.0 112.967 171.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -53.62 35.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.442 HD13 ' HE ' ' A' ' 28' ' ' ARG . 4.4 mt -46.96 -50.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.843 1.657 . . . . 0.0 110.905 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.89 -45.26 59.2 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -63.02 -16.37 59.59 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.39 -31.2 63.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.937 1.699 . . . . 0.0 109.939 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.6 136.89 55.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.26 61.45 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.203 3.268 . . . . 0.0 112.719 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.63 150.16 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -53.07 124.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.826 0.85 . . . . 0.0 110.119 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -53.2 128.26 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.48 -23.58 34.63 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.005 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.89 -37.89 64.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 119.823 1.811 . . . . 0.0 110.612 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 106.73 16.05 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -129.14 115.12 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.859 0.838 . . . . 0.0 111.426 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -83.9 105.46 14.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.84 125.67 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.907 2.083 . . . . 0.0 106.731 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -82.27 128.63 34.38 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.415 -0.803 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -63.09 -23.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.15 -0.969 . . . . 0.0 111.12 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -133.61 47.11 2.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.424 1.89 . . . . 0.0 106.822 -175.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.94 -48.6 67.22 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.2 p -137.14 -55.11 0.71 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.807 1.643 . . . . 0.0 109.466 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -165.76 -161.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.038 1.735 . . . . 0.0 109.264 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 62.33 -3.39 0.28 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -62.71 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 122.225 2.284 . . . . 0.0 111.473 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -48.55 -48.32 38.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.708 0.803 . . . . 0.0 112.101 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -28.81 69.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.526 1.53 . . . . 0.0 113.377 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 mt -81.65 -34.56 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.602 1.961 . . . . 0.0 107.922 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.61 -50.98 25.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.535 2.334 . . . . 0.0 107.851 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -45.51 -53.1 9.41 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.577 1.551 . . . . 0.0 111.013 167.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.538 ' HB2' ' H2 ' ' A' ' 2' ' ' ALA . 26.7 t80 -62.09 -42.33 99.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.999 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.26 -40.29 85.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.839 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.63 -50.84 70.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.301 1.04 . . . . 0.0 109.386 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.06 -46.33 89.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 111.864 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.26 -38.4 56.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 109.287 -170.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -112.27 -28.99 7.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.06 -5.02 35.97 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.948 1.261 . . . . 0.0 112.738 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.47 147.06 28.7 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.512 1.656 . . . . 0.0 109.674 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -84.92 -18.44 34.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.085 -0.483 . . . . 0.0 111.914 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -64.72 133.55 52.32 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.345 0.52 . . . . 0.0 110.113 -162.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 165.41 31.94 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.542 0.737 . . . . 0.0 109.475 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -65.47 165.7 56.04 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -15.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.98 96.72 4.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.06 105.21 13.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.006 1.722 . . . . 0.0 106.791 166.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.06 107.22 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 167.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.07 69.38 0.77 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.428 1.49 . . . . 0.0 113.066 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tttm 46.05 31.0 1.03 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.421 1.888 . . . . 0.0 115.985 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -128.96 127.25 41.33 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.626 1.103 . . . . 0.0 108.885 159.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.54 138.48 43.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -114.86 12.92 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.148 0.979 . . . . 0.0 111.223 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -149.06 21.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 -10.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.25 150.83 29.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 t 61.46 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -48.96 69.19 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.005 1.322 . . . . 0.0 109.566 -175.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.3 -46.84 36.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.979 2.112 . . . . 0.0 111.475 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.53 -48.24 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.25 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -47.77 77.07 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.663 1.574 . . . . 0.0 109.128 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.58 -35.46 74.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.45 -56.91 6.79 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.58 1.536 . . . . 0.0 109.639 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -53.84 41.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.32 1.848 . . . . 0.0 111.303 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.5 t -70.6 -15.84 62.79 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.875 2.47 . . . . 0.0 111.019 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.09 1.33 84.63 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 118.393 -1.226 . . . . 0.0 113.617 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.23 -33.27 73.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 120.066 1.933 . . . . 0.0 111.394 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.19 -38.65 73.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.232 1.413 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -55.04 25.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.79 1.236 . . . . 0.0 108.677 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -61.47 -42.51 98.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.643 0.777 . . . . 0.0 110.246 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.91 83.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.692 0.797 . . . . 0.0 111.317 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.09 -48.69 61.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.283 1.033 . . . . 0.0 110.337 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -57.42 -31.12 65.55 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.788 -1.195 . . . . 0.0 112.979 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -24.54 40.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.737 0.815 . . . . 0.0 111.591 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.01 23.97 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.818 0.847 . . . . 0.0 111.514 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.0 16.34 57.99 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 164.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.96 -70.46 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.402 1.101 . . . . 0.0 111.167 -166.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.39 146.16 47.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.102 -165.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 112.67 -2.059 . . . . 0.0 109.968 -173.493 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' HA ' ' CD2' ' A' ' 60' ' ' TYR . . . . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -40.37 -61.9 0.84 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.238 1.015 . . . . 0.0 112.596 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -163.78 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.774 -1.107 . . . . 0.0 108.339 -165.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -55.02 -35.69 64.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.151 1.342 . . . . 0.0 113.59 -166.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.97 -59.75 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 0.0 109.171 170.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.1 -33.73 76.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.091 2.556 . . . . 0.0 110.827 -166.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.23 -51.18 65.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.263 3.425 . . . . 0.0 110.443 172.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 40.7 mmtm -69.8 -17.27 63.39 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.842 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 ' CG2' ' HA ' ' A' ' 77' ' ' LYS . 6.9 mm -73.9 129.92 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 119.156 0.889 . . . . 0.0 108.694 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -131.11 159.22 72.57 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 159.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.07 70.05 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.884 3.056 . . . . 0.0 109.789 169.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.7 64.87 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 126.719 2.104 . . . . 0.0 108.464 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -151.11 159.05 44.71 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.622 2.369 . . . . 0.0 105.597 165.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.04 87.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.46 151.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.904 -1.123 . . . . 0.0 108.247 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.36 116.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 160.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -77.3 125.58 29.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.11 176.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.681 1.993 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 160.46 43.65 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.378 1.871 . . . . 0.0 108.956 171.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -82.19 26.43 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.191 3.261 . . . . 0.0 110.56 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.409 HG21 ' H ' ' A' ' 23' ' ' CYS 0.364 2.9 t -138.2 -106.63 0.18 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.75 172.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' H ' HG21 ' A' ' 22' ' ' THR . 7.2 m 32.65 104.21 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 129.916 3.286 . . . . 0.0 113.989 173.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.23 -16.88 36.37 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.202 1.268 . . . . 0.0 112.211 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -74.36 -47.91 31.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.062 1.345 . . . . 0.0 108.852 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.1 m -63.93 -44.35 93.16 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -53.19 -45.28 68.5 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.353 1.061 . . . . 0.0 110.343 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.66 -60.1 4.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 118.816 -0.612 . . . . 0.0 109.578 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.04 64.57 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.187 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -52.59 64.98 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.167 0.894 . . . . 0.0 112.451 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.18 -40.5 67.87 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.491 0.587 . . . . 0.0 109.753 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.0 mt -53.88 -53.13 29.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.821 1.248 . . . . 0.0 109.584 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.62 -44.47 56.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.132 -0.937 . . . . 0.0 108.564 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.1 m -55.81 -27.92 53.7 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -73.45 -19.71 60.89 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.018 0.826 . . . . 0.0 110.952 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -87.57 133.7 37.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.707 1.139 . . . . 0.0 107.936 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.77 114.55 4.05 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.206 1.938 . . . . 0.0 108.829 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.25 152.13 36.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -54.16 123.6 13.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.94 150.64 48.31 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 -30.03 6.34 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.931 -168.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.51 -47.05 24.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 120.42 2.11 . . . . 0.0 111.533 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 107.5 16.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.822 1.192 . . . . 0.0 108.433 -164.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.03 111.47 12.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.738 0.78 . . . . 0.0 110.431 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -84.01 102.55 12.56 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.41 121.3 49.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.78 1.632 . . . . 0.0 107.637 -172.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.7 133.68 34.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.593 -170.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -88.18 -12.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.846 1.658 . . . . 0.0 113.843 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 t -141.48 2.93 1.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.923 0.889 . . . . 0.0 110.987 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.16 15.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.737 1.215 . . . . 0.0 112.13 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.9 p -122.7 -77.83 0.59 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 160.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -162.77 -163.12 0.84 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.155 1.382 . . . . 0.0 109.099 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m80 65.26 8.65 5.04 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.145 2.178 . . . . 0.0 115.571 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -63.37 1.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 121.362 1.892 . . . . 0.0 110.236 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.25 -41.47 75.8 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 119.694 -0.194 . . . . 0.0 111.394 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -49.04 77.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.444 1.498 . . . . 0.0 111.65 173.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.43 -39.58 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.296 1.838 . . . . 0.0 108.512 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -80.33 -40.09 27.38 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -164.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -58.01 -53.94 52.57 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.449 1.9 . . . . 0.0 108.903 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CD2' ' HA ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -53.23 -49.4 66.9 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.896 1.278 . . . . 0.0 109.946 172.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.25 -29.29 63.68 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.436 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.93 -59.88 4.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.132 1.333 . . . . 0.0 109.13 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.13 -36.61 82.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.091 0.557 . . . . 0.0 111.23 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.61 -20.05 58.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.889 1.276 . . . . 0.0 110.404 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.4 p -125.84 -76.23 0.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.744 1.611 . . . . 0.0 112.744 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.1 -6.87 0.07 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.66 2.076 . . . . 0.0 113.797 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.09 152.78 35.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.559 1.68 . . . . 0.0 109.078 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -97.46 -3.2 40.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.112 0.965 . . . . 0.0 111.882 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -69.59 141.75 53.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.13 157.81 32.97 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 125.62 1.568 . . . . 0.0 108.931 166.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.7 161.85 52.49 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 CA-C-N 120.256 1.127 . . . . 0.0 111.829 -4.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -132.16 97.61 4.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.5 1.12 . . . . 0.0 108.313 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.9 t -75.03 120.93 25.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.94 96.58 6.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.827 1.651 . . . . 0.0 107.335 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -83.85 116.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 161.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 78' ' ' ASP . . . 46.29 87.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.514 2.007 . . . . 0.0 115.374 162.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HA ' ' CG2' ' A' ' 10' ' ' ILE . 15.4 mtpp 46.83 -12.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 131.512 3.925 . . . . 0.0 117.434 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 76' ' ' GLY . 31.7 t0 -99.06 167.74 10.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 119.529 1.058 . . . . 0.0 109.209 175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -120.16 125.49 48.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.401 1.48 . . . . 0.0 107.611 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.62 -23.58 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.567 0.222 . . . . 0.0 111.315 -164.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.85 177.11 15.43 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -159.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.45 -84.12 1.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -167.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.23 -64.15 1.06 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.234 1.014 . . . . 0.0 110.255 -173.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -49.8 64.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.74 1.155 . . . . 0.0 111.166 176.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.0 -36.66 78.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.138 1.775 . . . . 0.0 107.783 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.65 -40.51 84.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.083 0.953 . . . . 0.0 110.074 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.88 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 116.273 -1.822 . . . . 0.0 109.384 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.294 5.1 p -54.1 -47.27 71.96 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 121.987 2.176 . . . . 0.0 114.783 168.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.02 -43.87 70.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.333 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -60.69 -54.95 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.259 2.299 . . . . 0.0 110.693 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -42.99 58.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.486 1.914 . . . . 0.0 114.157 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -14.6 61.29 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 168.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.9 2.69 88.38 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.338 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.49 -17.49 64.83 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.916 1.858 . . . . 0.0 112.236 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -43.6 97.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.436 1.494 . . . . 0.0 109.495 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.22 -44.58 97.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 109.399 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -59.36 -54.08 50.85 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.079 0.552 . . . . 0.0 109.797 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -44.55 65.42 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.257 1.023 . . . . 0.0 111.55 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.5 mt -65.44 -50.59 64.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.56 1.144 . . . . 0.0 110.269 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -23.51 61.22 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.181 -0.949 . . . . 0.0 113.329 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.54 -29.09 9.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.173 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.16 26.6 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.394 1.078 . . . . 0.0 111.936 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.29 19.06 73.87 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.385 1.469 . . . . 0.0 114.725 168.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.34 -57.08 4.18 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 112.108 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.6 133.27 50.81 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -153.084 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.61 -45.77 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -55.79 -50.18 71.18 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.361 0.664 . . . . 0.0 111.34 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.22 -25.72 36.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.941 0.896 . . . . 0.0 111.781 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -65.58 -38.45 89.55 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.811 1.187 . . . . 0.0 110.621 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.91 154.84 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 120.63 1.559 . . . . 0.0 107.9 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.9 166.93 14.89 Favored Pre-proline 0 C--O 1.241 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 107.175 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.56 158.59 52.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 159.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.77 84.24 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 113.968 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.62 151.56 38.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.174 2.19 . . . . 0.0 108.961 163.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.3 t -103.68 79.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.203 1.401 . . . . 0.0 107.476 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.09 140.7 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.02 115.82 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -81.54 131.94 35.29 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 171.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 126.294 1.838 . . . . 0.0 111.235 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -140.15 143.94 35.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 162.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.14 -10.99 24.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.602 1.535 . . . . 0.0 110.985 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 p -89.46 -9.31 50.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.472 1.509 . . . . 0.0 111.882 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.33 123.62 85.78 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.527 1.058 . . . . 0.0 109.092 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.67 -23.67 48.79 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.672 1.581 . . . . 0.0 110.291 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.37 -28.92 62.3 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.673 0.789 . . . . 0.0 110.369 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.0 m -68.02 -32.08 72.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -65.89 -38.28 88.33 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.932 0.787 . . . . 0.0 111.833 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -59.56 4.97 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.91 -35.88 58.86 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 124.051 0.845 . . . . 0.0 111.343 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -45.96 92.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.117 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.93 -50.9 25.12 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -46.05 -50.39 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.738 1.215 . . . . 0.0 110.563 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mt -79.59 -48.39 13.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -70.63 -6.18 34.93 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.8 -21.25 60.22 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.456 1.025 . . . . 0.0 110.725 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.91 142.09 24.58 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.797 . . . . 0.0 109.964 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.11 109.75 2.78 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.64 2.894 . . . . 0.0 110.075 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HD23 ' A' ' 43' ' ' LEU . 12.2 mt -133.68 149.84 31.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -169.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -53.0 127.69 24.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 118.195 0.452 . . . . 0.0 110.995 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.12 131.08 49.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.757 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.86 52.73 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.287 1.422 . . . . 0.0 111.841 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.95 -34.44 64.3 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.951 1.375 . . . . 0.0 110.665 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.36 111.32 18.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -175.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -129.08 108.75 10.63 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -83.93 102.49 12.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.77 137.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.506 1.923 . . . . 0.0 106.965 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.12 149.5 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.728 -0.608 . . . . 0.0 110.816 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.65 10.19 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.102 1.761 . . . . 0.0 112.27 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 CA--C 1.541 0.618 0 CA-C-N 120.581 1.537 . . . . 0.0 111.882 171.56 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.5 m170 . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -42.14 -63.31 0.77 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -43.85 -33.1 1.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.921 2.488 . . . . 0.0 113.758 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.36 -60.68 1.93 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.76 -33.85 28.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 124.972 1.309 . . . . 0.0 111.173 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -73.63 -40.68 63.6 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.31 -44.63 87.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.077 1.751 . . . . 0.0 110.496 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.53 -48.15 81.81 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.035 -0.416 . . . . 0.0 110.469 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.78 -36.41 69.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.096 0.959 . . . . 0.0 110.288 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -50.47 68.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.509 0.724 . . . . 0.0 110.418 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -68.73 -45.28 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.084 0.553 . . . . 0.0 110.279 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.79 -30.79 59.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 p -123.72 -12.78 7.58 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.65 59.66 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.292 1.405 . . . . 0.0 113.178 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.46 149.47 18.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.357 1.079 . . . . 0.0 109.935 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -102.9 -25.29 13.53 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.811 0.844 . . . . 0.0 112.649 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -71.29 144.31 50.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.95 165.99 11.81 Favored Pre-proline 0 C--O 1.244 0.777 0 C-N-CA 126.372 1.869 . . . . 0.0 109.21 -170.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.58 161.91 51.53 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 119.287 0.781 . . . . 0.0 111.424 -3.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -137.81 97.11 3.35 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.14 127.49 39.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.23 96.03 5.59 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.836 2.454 . . . . 0.0 107.879 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.428 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.61 107.84 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 38.37 81.48 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 127.432 2.444 . . . . 0.0 113.135 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 16.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.37 2.268 . . . . 0.0 116.996 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.96 110.81 18.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 119.024 0.829 . . . . 0.0 108.836 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.28 117.12 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.54 -21.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.53 -155.76 21.3 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.64 -168.75 31.2 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.982 1.753 . . . . 0.0 110.253 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.75 -24.66 64.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.578 -1.201 . . . . 0.0 112.126 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m -60.63 -49.22 78.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 120.231 1.378 . . . . 0.0 109.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -41.29 84.86 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.692 0.797 . . . . 0.0 109.57 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.7 tp -56.59 -39.25 73.22 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.367 0.667 . . . . 0.0 112.004 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -61.92 -46.08 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.044 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.58 -56.47 21.73 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.73 -27.15 68.71 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.912 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -68.05 -54.07 21.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.586 1.539 . . . . 0.0 109.454 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -40.8 77.37 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.702 1.201 . . . . 0.0 111.775 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -70.61 -20.52 62.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.529 2.732 . . . . 0.0 110.262 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.9 6.63 82.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.722 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.61 -31.98 72.91 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 120.273 2.036 . . . . 0.0 109.514 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.43 -40.9 75.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.191 1.796 . . . . 0.0 110.445 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.11 -47.72 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.592 0.633 . . . . 0.0 109.339 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m -60.82 -49.52 77.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.279 0.632 . . . . 0.0 109.351 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -48.77 61.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.598 1.159 . . . . 0.0 110.688 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -49.3 70.88 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.334 1.054 . . . . 0.0 112.734 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -67.43 -25.11 65.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 117.088 -1.845 . . . . 0.0 112.717 -166.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -48.16 -46.22 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.764 0.665 . . . . 0.0 110.448 168.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.71 8.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.903 0.774 . . . . 0.0 112.078 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.67 34.21 44.64 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.602 1.096 . . . . 0.0 111.701 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.31 -74.52 0.38 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.39 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.59 133.75 55.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.773 1.169 . . . . 0.0 110.578 -159.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 131.144 3.778 . . . . 0.0 104.858 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.9 t80 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 118.896 -0.574 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.43 -49.29 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.322 0.51 . . . . 0.0 109.895 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.86 -53.12 55.6 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.547 0.612 . . . . 0.0 111.262 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.9 m -68.76 -5.4 20.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.214 1.406 . . . . 0.0 112.659 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.6 -26.4 45.4 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.508 167.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.26 167.45 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 165.08 18.98 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 128.194 2.598 . . . . 0.0 105.735 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.6 61.47 7.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.709 2.273 . . . . 0.0 111.951 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.74 16.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.745 -1.031 . . . . 0.0 115.513 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -119.05 160.11 22.66 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.486 1.643 . . . . 0.0 108.002 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.1 t -108.96 98.78 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.59 151.68 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.56 115.22 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -74.81 120.42 20.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.07 176.04 7.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 127.462 2.305 . . . . 0.0 110.268 -171.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -122.89 158.69 56.49 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 164.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.95 9.75 2.26 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.759 2.972 . . . . 0.0 112.971 -168.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.306 0.1 OUTLIER -133.35 -106.17 0.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -173.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t 33.83 115.06 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 130.975 3.71 . . . . 0.0 113.702 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -61.75 -20.32 68.62 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.96 1.107 . . . . 0.0 112.602 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -81.8 -42.6 19.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.76 -43.13 99.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -54.35 -53.42 54.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.31 1.044 . . . . 0.0 110.204 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -55.81 27.8 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.1 69.89 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.677 0.611 . . . . 0.0 110.868 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -54.6 -51.98 63.61 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.81 1.244 . . . . 0.0 112.557 172.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.8 -47.61 45.12 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 126.342 1.857 . . . . 0.0 110.178 -171.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -50.21 -56.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.207 1.803 . . . . 0.0 108.079 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.83 -43.25 62.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.268 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.3 m -70.39 -4.43 22.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.8 -26.75 60.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.431 1.469 . . . . 0.0 111.874 172.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.83 150.51 65.88 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 119.137 0.881 . . . . 0.0 110.787 -171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.47 72.95 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.613 2.876 . . . . 0.0 108.731 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.61 147.57 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -50.21 124.21 9.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.941 0.496 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -65.14 140.87 58.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.1 -3.5 85.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.109 -1.384 . . . . 0.0 112.418 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -92.23 -28.88 16.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.201 2.001 . . . . 0.0 112.674 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.63 109.64 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.858 2.117 . . . . 0.0 108.193 -171.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -121.43 112.6 18.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.46 1.027 . . . . 0.0 109.885 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 74.5 m-85 -96.03 91.76 6.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.832 1.253 . . . . 0.0 108.963 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.67 104.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.299 1.84 . . . . 0.0 108.708 -168.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.73 104.79 2.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.69 1.596 . . . . 0.0 112.235 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.23 -8.98 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.639 1.175 . . . . 0.0 113.087 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.453 -0.289 0 CA-C-N 119.427 1.012 . . . . 0.0 110.79 -173.928 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.0 m170 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.87 -63.4 0.98 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 120.397 1.453 . . . . 0.0 109.864 170.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -47.02 -49.7 20.63 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.373 -0.822 . . . . 0.0 113.01 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -60.9 -44.61 96.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.708 1.203 . . . . 0.0 110.06 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -68.31 -42.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.801 1.64 . . . . 0.0 107.32 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -48.92 70.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.567 2.347 . . . . 0.0 105.421 -172.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -52.91 -59.01 5.05 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 126.022 1.729 . . . . 0.0 109.942 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.97 -38.7 79.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.644 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.37 -32.1 72.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.462 1.028 . . . . 0.0 111.213 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -61.72 -38.69 88.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.277 0.944 . . . . 0.0 110.372 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -51.54 12.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.728 0.695 . . . . 0.0 111.395 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.59 -22.76 63.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.611 1.164 . . . . 0.0 110.533 -171.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.9 p -116.09 -71.67 0.73 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.608 1.095 . . . . 0.0 108.083 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.66 0.23 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.108 1.337 . . . . 0.0 110.811 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -134.89 144.95 47.8 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 108.871 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -21.66 51.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.117 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.5 p -63.05 133.37 54.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.493 0.496 . . . . 0.0 110.007 -158.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.76 155.57 61.69 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.39 166.28 64.93 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 CA-C-N 119.927 1.01 . . . . 0.0 111.419 -5.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -133.84 96.11 3.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 169.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 86' ' ' LEU . 54.3 t -74.4 126.31 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -113.99 101.83 9.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.877 1.671 . . . . 0.0 107.477 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.471 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.04 115.26 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.554 -2.388 . . . . 0.0 104.554 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.35 72.38 0.48 Allowed Glycine 0 C--N 1.337 0.611 0 C-N-CA 124.621 1.105 . . . . 0.0 111.873 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 46.67 22.1 0.16 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.58 130.52 38.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.397 1.453 . . . . 0.0 110.854 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 t -71.58 115.96 11.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.776 0.83 . . . . 0.0 110.068 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -84.2 -6.65 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 118.442 0.565 . . . . 0.0 111.256 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.54 -175.93 19.68 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.561 1.553 . . . . 0.0 109.519 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.66 -91.82 1.2 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.43 -55.7 0.96 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.611 0.705 . . . . 0.0 112.457 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -61.18 -33.56 73.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.171 0.896 . . . . 0.0 111.107 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.12 -63.21 1.21 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.098 1.759 . . . . 0.0 107.766 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -49.31 -37.25 23.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.683 2.393 . . . . 0.0 113.126 -176.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.33 -36.03 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.341 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -49.39 66.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 121.3 1.864 . . . . 0.0 107.383 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.54 -37.48 75.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.36 -63.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.465 1.03 . . . . 0.0 109.692 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -51.64 58.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.155 1.782 . . . . 0.0 112.25 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -75.01 -36.73 61.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.594 1.157 . . . . 0.0 109.889 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.21 35.34 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.799 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -63.06 -26.97 69.09 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.621 2.21 . . . . 0.0 110.872 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -39.66 84.94 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 125.206 1.402 . . . . 0.0 109.172 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -39.71 84.93 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.526 0.73 . . . . 0.0 109.234 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 m -59.7 -57.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -34.51 78.3 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.888 -0.508 . . . . 0.0 112.174 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 mt -57.04 -53.73 54.71 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.946 1.298 . . . . 0.0 109.793 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -25.34 68.03 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.368 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -56.55 -30.31 62.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.42 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.74 8.78 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 112.53 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.59 30.95 59.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.305 -0.872 . . . . 0.0 112.858 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.74 -70.47 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 110.195 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.93 134.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -166.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--O 1.247 0.944 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 -174.041 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.0 t80 . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 18' ' ' PHE . 24.8 t -80.6 -56.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -60.47 -28.42 68.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -158.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -109.34 -16.66 13.98 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.398 1.079 . . . . 0.0 112.662 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -65.6 -39.07 91.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 0.0 110.149 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -69.9 144.86 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -148.26 160.27 37.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 163.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 71.5 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.499 3.466 . . . . 0.0 111.931 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.31 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.922 2.201 . . . . 0.0 110.555 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -151.24 162.92 40.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.76 2.424 . . . . 0.0 106.361 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.44 87.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 165.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -88.16 135.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.58 114.27 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 6' ' ' VAL . 69.3 m-85 -84.11 130.04 34.87 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 167.77 18.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.005 1.322 . . . . 0.0 110.659 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.7 149.33 58.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 161.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.49 -19.68 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.617 2.878 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -75.58 31.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.758 2.423 . . . . 0.0 110.802 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 12.9 t -144.19 121.5 6.6 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.87 1.668 . . . . 0.0 111.289 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.98 -19.97 19.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.018 1.812 . . . . 0.0 111.238 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 26.4 m-85 -76.8 -41.18 45.46 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.38 -46.65 88.07 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.3 ttm-85 -57.17 -42.66 81.52 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.467 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -58.62 -56.91 16.14 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 120.321 1.418 . . . . 0.0 108.529 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.45 -32.7 51.09 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 123.722 0.639 . . . . 0.0 111.141 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -56.7 -60.52 3.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.46 1.504 . . . . 0.0 112.474 169.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -66.11 -45.94 79.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.692 1.133 . . . . 0.0 109.243 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.12 -48.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.424 1.49 . . . . 0.0 110.494 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -74.96 -52.29 11.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -64.42 -14.43 56.75 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.47 1.508 . . . . 0.0 113.531 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.64 -24.25 59.98 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.073 1.306 . . . . 0.0 111.28 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.77 150.83 84.3 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.178 0.899 . . . . 0.0 110.714 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.88 67.69 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.565 2.843 . . . . 0.0 110.47 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -90.33 154.25 3.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -55.38 128.75 35.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.57 1.148 . . . . 0.0 109.469 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.93 136.22 57.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.26 -3.66 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.481 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mt -73.66 -41.15 63.08 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.888 1.844 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.79 110.04 18.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -121.52 120.25 34.33 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 54.0 m-85 -89.79 94.76 9.95 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.585 1.554 . . . . 0.0 107.324 172.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -85.29 107.96 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.895 2.078 . . . . 0.0 107.988 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -70.92 107.86 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.97 1.308 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 pt -68.47 -15.19 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.605 0.762 . . . . 0.0 112.644 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 124.274 1.03 . . . . 0.0 110.952 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.7 m170 . . . . . 0 N--CA 1.456 -0.125 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -63.44 1.11 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.988 0.915 . . . . 0.0 109.53 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -27.24 32.71 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.58 -29.67 15.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.831 1.196 . . . . 0.0 111.448 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.77 -37.16 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -62.89 -51.67 66.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.38 1.872 . . . . 0.0 106.472 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -52.65 -53.84 41.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 111.054 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -41.44 80.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.92 -35.83 81.94 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.749 -1.22 . . . . 0.0 110.321 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.23 -39.02 92.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.373 0.533 . . . . 0.0 111.201 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -63.22 -52.45 62.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.805 . . . . 0.0 110.25 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -75.7 -52.95 9.35 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 p -97.57 -15.95 20.27 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.73 1.67 57.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.079 -0.845 . . . . 0.0 111.748 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.44 151.94 10.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.186 1.493 . . . . 0.0 110.756 169.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -87.9 -26.38 22.76 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 p -58.61 133.35 55.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -158.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.88 22.46 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.896 0.879 . . . . 0.0 110.007 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -60.53 155.33 51.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 CA-C-N 119.833 0.976 . . . . 0.0 110.111 -10.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.83 113.6 20.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.21 123.92 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 119.712 1.142 . . . . 0.0 109.08 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.87 104.09 13.72 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 121.93 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 160.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.4 80.58 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 127.736 2.589 . . . . 0.0 114.934 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 47.26 21.14 0.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.27 125.39 34.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 121.206 1.821 . . . . 0.0 111.722 158.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.6 t -65.56 113.46 4.21 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.592 1.957 . . . . 0.0 109.761 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.68 -21.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 O-C-N 122.935 0.147 . . . . 0.0 110.611 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.39 -165.44 24.72 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.65 -167.11 36.43 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.985 0.802 . . . . 0.0 111.312 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.2 p -60.87 -34.89 75.32 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.303 1.051 . . . . 0.0 111.707 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -74.45 -42.98 58.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.543 0.611 . . . . 0.0 109.524 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.77 -46.97 82.85 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.95 -41.07 67.37 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.318 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.93 -48.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 116.827 -1.559 . . . . 0.0 109.9 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -47.02 87.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.206 1.821 . . . . 0.0 108.037 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.7 -40.56 83.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.933 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.36 -67.01 0.47 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.842 1.655 . . . . 0.0 110.211 172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -43.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.981 2.113 . . . . 0.0 113.294 -170.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.9 -4.17 50.41 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.73 1.212 . . . . 0.0 111.482 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.9 5.53 87.76 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 117.271 -1.849 . . . . 0.0 115.146 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.2 -29.08 69.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 121.495 2.648 . . . . 0.0 110.937 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 33' ' ' LEU . 54.1 tp -53.54 -38.1 63.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.88 1.672 . . . . 0.0 111.619 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.76 -50.67 48.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -172.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.5 m -60.5 -47.36 86.48 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.721 0.808 . . . . 0.0 110.132 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -52.05 41.1 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 110.213 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.3 -46.17 84.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -66.3 -26.84 67.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 117.995 -1.003 . . . . 0.0 113.031 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -54.84 -33.1 61.33 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.504 0.593 . . . . 0.0 110.558 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.45 9.38 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.438 1.017 . . . . 0.0 112.199 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.16 17.8 79.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.311 0.96 . . . . 0.0 114.181 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.32 -61.83 1.63 Allowed 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.123 1.769 . . . . 0.0 111.468 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.35 133.29 46.79 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.249 1.077 0 O-C-N 126.227 2.204 . . . . 0.0 112.195 -152.431 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 CA--C 1.53 0.212 0 CA-C-O 120.579 0.228 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.411 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.4 t -63.75 -33.29 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -79.96 -30.86 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.861 -0.525 . . . . 0.0 111.541 -162.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -89.18 -19.22 25.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.091 1.757 . . . . 0.0 110.61 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -47.09 82.46 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.493 -1.38 . . . . 0.0 109.012 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -71.28 148.03 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -136.25 145.97 54.24 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.133 0.973 . . . . 0.0 108.878 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 61.21 7.62 Favored 'Trans proline' 0 CA--C 1.537 0.661 1 C-N-CA 125.324 4.016 . . . . 0.0 112.924 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.06 23.09 0.03 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 125.809 1.671 . . . . 0.0 111.723 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -137.94 154.04 49.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 127.003 2.121 . . . . 0.0 107.006 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 75' ' ' ILE . 29.4 t -102.04 93.13 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.58 129.94 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.18 155.98 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE1' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -117.75 125.59 50.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.54 175.63 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.048 2.139 . . . . 0.0 110.005 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -129.73 152.96 80.68 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.11 1.764 . . . . 0.0 106.688 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.79 -13.62 26.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.235 2.623 . . . . 0.0 113.145 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -102.3 -10.68 19.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.816 2.047 . . . . 0.0 112.209 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -90.95 127.57 51.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.653 0.781 . . . . 0.0 109.381 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.89 -23.05 16.78 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.86 1.707 . . . . 0.0 111.293 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.38 -35.04 47.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -58.19 -54.08 51.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.581 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -51.11 -45.15 61.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.306 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -61.59 2.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.96 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.895 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -55.11 -58.74 6.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.38 1.472 . . . . 0.0 112.683 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.87 -41.49 82.75 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 118.549 0.613 . . . . 0.0 109.802 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -53.75 -52.82 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.443 1.497 . . . . 0.0 109.101 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.31 -44.77 64.51 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -55.73 -15.67 3.4 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.5 -23.02 59.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.802 2.092 . . . . 0.0 111.745 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.29 137.12 39.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 119.071 0.851 . . . . 0.0 109.682 -169.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.72 85.17 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.847 3.031 . . . . 0.0 111.032 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 43' ' ' LEU . 14.9 mt -105.34 151.63 7.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.474 1.51 . . . . 0.0 107.196 -165.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -49.24 126.65 13.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.026 0.93 . . . . 0.0 109.988 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.46 130.02 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.67 84.35 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 117.623 -1.654 . . . . 0.0 113.16 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.12 -37.72 64.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.594 2.197 . . . . 0.0 111.022 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.73 110.37 18.26 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.403 1.456 . . . . 0.0 107.589 -175.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -124.53 98.61 5.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.221 1.408 . . . . 0.0 108.549 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -83.97 105.99 15.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.59 127.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.963 1.305 . . . . 0.0 107.568 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.842 1.257 . . . . 0.0 111.119 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 57' ' ' ILE . 47.0 pt -68.6 -16.76 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.722 -1.237 . . . . 0.0 112.243 174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.315 174.514 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.89 -63.28 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.764 2.026 . . . . 0.0 109.96 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -45.19 -48.49 12.47 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.952 1.701 . . . . 0.0 113.719 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -40.19 73.51 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.58 0.627 . . . . 0.0 110.498 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CG2' ' A' ' 48' ' ' ILE . 13.4 mt -63.31 -42.27 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -58.01 -51.32 70.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.17 2.988 . . . . 0.0 109.27 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.23 -62.16 1.9 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.041 1.737 . . . . 0.0 110.442 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -53.17 -41.02 64.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.07 -27.57 69.19 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.753 1.221 . . . . 0.0 112.423 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -44.3 96.66 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.026 0.83 . . . . 0.0 110.049 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.45 -46.76 37.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.211 0.605 . . . . 0.0 110.359 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.69 -23.82 66.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 111.464 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 1.5 p -127.22 -72.22 0.65 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.741 1.609 . . . . 0.0 109.45 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.16 -21.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.492 -1.171 . . . . 0.0 114.864 -172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.71 156.94 45.09 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.861 1.831 . . . . 0.0 110.24 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -71.63 -30.49 65.82 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.692 -0.63 . . . . 0.0 110.01 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 p -61.16 133.54 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -165.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 165.64 22.28 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.354 1.462 . . . . 0.0 107.487 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.4 171.1 18.13 Favored 'Cis proline' 0 C--N 1.345 0.352 0 CA-C-N 120.883 1.351 . . . . 0.0 111.815 -6.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -142.37 108.01 5.1 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.85 133.27 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -114.75 140.4 48.92 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -123.51 113.08 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 177.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.59 58.53 13.94 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.353 -0.842 . . . . 0.0 112.008 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.256 1.0 OUTLIER 46.21 27.73 0.59 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -174.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -129.85 135.23 48.15 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.65 1.114 . . . . 0.0 109.187 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -71.11 150.03 45.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -105.51 -12.46 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 122.924 0.49 . . . . 0.0 111.39 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.18 -165.44 18.34 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -166.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.65 -95.57 2.41 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 119.006 -0.886 . . . . 0.0 110.921 -174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.89 -56.78 2.19 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.133 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -59.35 -39.04 81.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.861 1.664 . . . . 0.0 112.126 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -42.86 81.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.827 0.451 . . . . 0.0 109.871 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.16 -37.0 85.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.558 0.743 . . . . 0.0 110.479 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.39 -49.56 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 115.494 -2.193 . . . . 0.0 109.738 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -61.93 -39.95 93.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 122.939 2.608 . . . . 0.0 112.051 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 80' ' ' ILE . 10.3 mt -54.47 -46.18 73.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.41 -51.95 25.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 121.375 1.898 . . . . 0.0 110.959 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.2 -53.15 53.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.897 1.679 . . . . 0.0 112.01 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.4 t -71.59 -5.19 31.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.845 1.258 . . . . 0.0 110.775 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.93 9.29 59.44 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.016 -1.435 . . . . 0.0 112.968 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.38 -21.6 66.24 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.264 2.032 . . . . 0.0 111.842 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.49 -37.9 65.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 111.047 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.41 -48.69 74.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.667 0.667 . . . . 0.0 109.65 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -46.57 85.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.199 1.0 . . . . 0.0 110.236 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -47.7 -53.51 14.84 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.512 1.525 . . . . 0.0 110.392 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 mp -72.27 -34.85 68.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -58.95 -30.75 68.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.435 1.471 . . . . 0.0 111.419 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -54.62 -19.01 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 112.979 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.01 11.08 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.716 1.143 . . . . 0.0 112.384 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.23 46.9 7.27 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 118.703 0.683 . . . . 0.0 112.431 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.34 -72.49 0.58 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.842 1.257 . . . . 0.0 111.875 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.58 137.19 55.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 120.182 1.355 . . . . 0.0 109.528 -159.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 163.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.226 -0.177 0 CA-C-O 120.02 -0.038 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 40.6 t -68.79 -62.85 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.86 -43.65 98.41 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -159.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.37 -15.13 60.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.273 -0.87 . . . . 0.0 113.296 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -71.99 -38.76 69.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.426 1.466 . . . . 0.0 111.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.05 126.36 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -106.88 162.32 20.07 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 123.42 0.688 . . . . 0.0 109.357 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.5 79.18 0.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.636 2.89 . . . . 0.0 109.658 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.79 19.7 0.49 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 127.313 2.387 . . . . 0.0 113.54 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -111.96 159.02 18.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.782 1.791 . . . . 0.0 108.467 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG13 ' CD1' ' A' ' 75' ' ' ILE . 36.1 t -113.07 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.8 t -84.06 147.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.98 113.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 6' ' ' VAL . 86.1 m-85 -76.52 126.28 30.71 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.11 168.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.791 1.236 . . . . 0.0 110.399 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -117.5 149.57 45.07 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 158.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.28 4.83 5.54 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.188 1.926 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -124.21 -17.25 6.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 132.33 89.12 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 168.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -64.85 -21.26 64.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.766 1.644 . . . . 0.0 109.78 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -74.34 -42.9 58.65 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.953 0.901 . . . . 0.0 109.609 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.64 -45.13 94.25 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -54.55 -44.93 73.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.103 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -57.74 10.27 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 118.793 0.724 . . . . 0.0 109.654 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.96 55.84 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -69.58 -37.62 77.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 117.558 -1.21 . . . . 0.0 114.113 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.51 -49.25 27.56 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 120.111 1.323 . . . . 0.0 108.464 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -49.28 -53.33 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.531 1.532 . . . . 0.0 109.982 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.46 -46.43 17.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -74.79 6.25 4.16 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.156 1.343 . . . . 0.0 114.196 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.1 -12.73 60.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.47 1.508 . . . . 0.0 112.572 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.4 148.66 56.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.55 1.068 . . . . 0.0 111.199 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.64 96.62 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.181 2.588 . . . . 0.0 109.911 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.82 145.98 30.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -47.32 134.34 11.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.272 0.629 . . . . 0.0 111.998 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -49.42 115.39 1.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.381 1.473 . . . . 0.0 109.137 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.92 86.75 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.404 -1.22 . . . . 0.0 114.126 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.73 -33.07 64.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 121.215 2.507 . . . . 0.0 109.962 165.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.46 109.59 17.47 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -171.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -129.25 102.72 6.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.51 90.4 8.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.128 1.371 . . . . 0.0 107.938 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.5 111.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.475 1.51 . . . . 0.0 109.212 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -71.31 115.01 9.97 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.314 1.046 . . . . 0.0 112.929 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG22 HG21 ' A' ' 57' ' ' ILE . 20.2 pt -70.82 -35.0 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.688 1.595 . . . . 0.0 112.494 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.232 0.177 0 C-N-CA 124.297 1.039 . . . . 0.0 111.63 -166.732 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m170 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -63.68 1.2 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -67.7 -23.69 65.32 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.95 -48.62 73.43 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.061 1.744 . . . . 0.0 111.009 165.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.487 HG21 HG22 ' A' ' 48' ' ' ILE . 13.3 mt -60.86 -38.28 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.102 0.961 . . . . 0.0 109.066 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -59.96 -49.86 76.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.02 -44.09 85.74 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.5 1.143 . . . . 0.0 112.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -58.11 -43.64 87.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.624 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 mt -61.89 -33.24 73.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.116 0.966 . . . . 0.0 111.081 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.27 -51.0 69.75 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 119.15 0.886 . . . . 0.0 110.39 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.29 -49.54 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.209 0.528 . . . . 0.0 109.609 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tp -73.53 -17.9 61.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.792 0.837 . . . . 0.0 111.114 -167.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -129.25 -25.91 2.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 114.451 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.51 23.1 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.071 -1.405 . . . . 0.0 112.183 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.86 147.52 22.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 121.069 2.435 . . . . 0.0 110.698 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -21.09 61.05 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 p -70.24 133.75 47.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.806 0.73 . . . . 0.0 110.457 -159.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 161.74 22.54 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.483 1.913 . . . . 0.0 107.813 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.85 125.01 6.2 Favored 'Cis proline' 0 C--N 1.345 0.394 0 CA-C-N 120.344 1.158 . . . . 0.0 111.571 -1.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -95.61 91.25 6.04 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.64 125.07 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 94.03 4.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.142 2.577 . . . . 0.0 107.38 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.477 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -93.27 112.37 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.47 63.39 5.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.291 0.948 . . . . 0.0 113.41 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 46.48 15.28 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.838 2.455 . . . . 0.0 115.703 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -126.96 144.5 50.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 120.074 1.306 . . . . 0.0 109.887 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -86.57 134.96 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.974 0.91 . . . . 0.0 110.896 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pp -83.86 -18.41 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 119.104 0.866 . . . . 0.0 110.556 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.06 -141.3 12.48 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.8 -158.05 14.37 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.898 1.713 . . . . 0.0 108.838 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -22.03 59.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.756 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -65.32 -45.09 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.847 1.203 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.32 -57.62 12.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.162 1.785 . . . . 0.0 107.112 170.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.9 tp -52.0 -40.09 60.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.14 -50.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 117.266 -1.349 . . . . 0.0 108.382 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -43.24 99.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 120.82 1.645 . . . . 0.0 110.28 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -51.82 -47.48 64.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.097 0.862 . . . . 0.0 109.537 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.79 -52.58 42.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.515 1.052 . . . . 0.0 110.785 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -58.73 3.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.947 1.699 . . . . 0.0 111.244 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -11.46 59.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.463 1.505 . . . . 0.0 109.889 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.51 -2.53 49.76 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.569 161.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -59.27 -28.87 67.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.797 1.799 . . . . 0.0 111.435 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 tt -44.17 -57.89 3.17 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.359 1.863 . . . . 0.0 110.514 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.73 -42.09 98.5 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.864 0.756 . . . . 0.0 109.532 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -61.29 -54.23 46.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.791 0.836 . . . . 0.0 110.358 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.52 76.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.436 1.094 . . . . 0.0 111.021 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.66 -47.4 60.19 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.31 -26.34 67.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.174 1.352 . . . . 0.0 112.468 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -52.3 -33.04 40.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.346 1.458 . . . . 0.0 110.738 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.04 11.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.126 0.876 . . . . 0.0 112.674 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 37.9 26.68 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.2 -0.938 . . . . 0.0 112.328 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.99 -69.83 0.56 Allowed 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 112.131 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.84 136.58 52.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.991 0.814 . . . . 0.0 110.839 -158.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.664 3.185 . . . . 0.0 105.219 -175.245 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.96 -55.12 23.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.32 1.448 . . . . 0.0 109.448 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.66 -39.87 95.28 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 t -81.4 38.6 0.49 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.803 2.041 . . . . 0.0 111.772 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -130.91 -47.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.626 0.771 . . . . 0.0 109.647 159.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.17 133.76 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.21 165.07 34.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.58 156.77 40.22 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.008 -1.574 . . . . 0.0 108.008 159.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.69 17.1 77.94 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.191 -0.943 . . . . 0.0 115.08 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -135.78 162.04 33.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.684 1.593 . . . . 0.0 108.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.88 79.58 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.19 132.95 33.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.06 110.79 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.3 130.07 38.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.08 179.73 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 C-N-CA 126.362 1.865 . . . . 0.0 109.843 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -140.37 151.27 63.73 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 158.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.22 -15.01 20.49 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.588 2.192 . . . . 0.0 111.527 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -50.57 43.57 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.703 1.201 . . . . 0.0 110.131 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 20' ' ' LYS . 16.0 m -61.1 109.59 2.25 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.401 1.481 . . . . 0.0 111.398 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.75 -20.84 58.98 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.992 1.795 . . . . 0.0 110.898 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -73.2 -22.32 60.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.926 -1.109 . . . . 0.0 111.294 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.96 -33.12 74.05 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.47 -0.769 . . . . 0.0 109.755 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -63.17 -30.04 71.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.764 0.826 . . . . 0.0 111.774 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.76 4.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.22 51.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 124.365 1.041 . . . . 0.0 111.785 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.6 -56.53 16.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.549 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.46 -41.33 63.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 123.741 0.651 . . . . 0.0 110.263 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -50.21 -57.42 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.732 1.213 . . . . 0.0 108.737 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 33' ' ' LEU . 12.9 mt -75.96 -43.25 45.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.303 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.2 p -65.65 -20.83 66.45 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 120.03 1.286 . . . . 0.0 113.915 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -73.51 -21.77 60.31 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.626 1.103 . . . . 0.0 110.697 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.78 142.24 56.53 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -64.56 127.56 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -146.36 157.61 11.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 128.02 34.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.173 0.989 . . . . 0.0 109.646 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -64.43 126.24 27.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.985 -168.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.92 71.29 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.962 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.68 -37.58 65.19 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 119.847 1.824 . . . . 0.0 109.002 164.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 100.03 10.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -170.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -122.1 101.49 7.57 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 108.92 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -84.55 93.82 8.44 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.774 1.23 . . . . 0.0 108.638 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.56 112.22 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.809 1.244 . . . . 0.0 109.363 -171.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.83 121.29 13.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.506 1.523 . . . . 0.0 112.793 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.5 pt -85.18 -21.35 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.17 1.388 . . . . 0.0 113.382 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 119.071 0.85 . . . . 0.0 110.134 -179.611 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -37.13 -63.02 0.46 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.417 2.287 . . . . 0.0 109.792 164.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -43.74 -49.34 7.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.031 1.333 . . . . 0.0 113.372 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.68 -43.39 80.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.935 0.894 . . . . 0.0 111.458 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.2 mt -62.87 -31.75 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -69.35 -54.24 15.51 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.9 -55.8 17.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 123.679 1.704 . . . . 0.0 111.004 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 4.67 13.71 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.764 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -91.41 -37.7 13.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 118.122 -2.861 . . . . 0.0 109.907 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.83 -49.79 47.72 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.336 1.455 . . . . 0.0 108.142 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -57.49 5.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.412 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.86 -23.86 67.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 111.01 -163.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.1 p -126.45 -17.31 5.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.75 50.0 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.645 1.111 . . . . 0.0 112.155 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.28 158.16 31.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.336 1.854 . . . . 0.0 107.869 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -22.08 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -55.41 133.54 49.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.41 0.684 . . . . 0.0 111.139 -161.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.82 153.8 39.96 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -60.3 147.17 43.24 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.122 1.079 . . . . 0.0 110.043 -10.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -130.46 103.1 6.46 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 86' ' ' LEU . 69.7 t -87.09 124.45 40.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 123.022 0.529 . . . . 0.0 109.92 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -103.37 105.5 15.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.605 1.562 . . . . 0.0 107.772 160.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.97 116.57 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 161.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 41.46 69.67 0.51 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 126.193 1.854 . . . . 0.0 114.019 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 47.31 21.37 0.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -116.82 120.67 39.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.908 1.283 . . . . 0.0 108.632 165.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -83.99 104.26 13.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.201 0.6 . . . . 0.0 110.088 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -83.85 -8.74 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.462 0.574 . . . . 0.0 112.008 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.97 -167.19 24.15 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.843 0.735 . . . . 0.0 112.606 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.7 -162.15 34.81 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.032 1.301 . . . . 0.0 110.373 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -37.93 71.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.652 1.226 . . . . 0.0 110.104 -165.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 m -68.43 -36.09 78.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.557 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.33 -49.76 58.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.607 1.163 . . . . 0.0 108.618 173.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 73' ' ' VAL . 58.2 tp -51.58 -44.32 62.74 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.016 1.726 . . . . 0.0 111.821 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.17 -44.84 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-O 117.113 -1.422 . . . . 0.0 109.694 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.99 -48.79 75.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -173.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.12 -42.34 85.56 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.222 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -64.1 -56.84 12.04 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.371 0.987 . . . . 0.0 110.305 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -51.52 55.07 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.739 1.616 . . . . 0.0 111.364 -172.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.0 t -71.49 -7.23 46.19 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.325 1.45 . . . . 0.0 110.934 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.09 77.93 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.662 -1.632 . . . . 0.0 114.062 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.04 -33.66 73.64 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.742 2.271 . . . . 0.0 110.707 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -38.18 86.61 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.904 1.282 . . . . 0.0 109.545 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.25 -37.72 86.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.364 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -48.57 72.51 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.589 1.086 . . . . 0.0 109.736 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -50.73 62.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 110.593 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -60.11 -48.21 82.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.49 1.516 . . . . 0.0 110.715 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.59 -35.22 77.23 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.903 -1.123 . . . . 0.0 111.811 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -54.0 -32.42 54.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.007 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.96 5.5 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 119.484 1.038 . . . . 0.0 113.377 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.89 39.44 13.5 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.747 1.158 . . . . 0.0 112.87 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.93 -74.86 0.38 Allowed 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 125.876 1.67 . . . . 0.0 112.602 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -53.13 -23.38 8.0 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.24 1.816 . . . . 0.0 114.872 -159.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 130.377 3.471 . . . . 0.0 110.523 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.51 -60.26 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.524 -0.735 . . . . 0.0 110.263 166.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -63.38 -27.29 69.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -163.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.2 t -87.35 -24.15 24.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.087 0.955 . . . . 0.0 111.349 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -73.95 -37.84 64.43 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 121.074 -1.016 . . . . 0.0 111.406 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -82.61 149.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 160.05 34.92 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 72.0 Cg_endo -75.94 111.36 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.412 2.741 . . . . 0.0 108.733 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 9.12 21.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.42 1.486 . . . . 0.0 113.646 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -123.47 166.04 16.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.09 1.756 . . . . 0.0 109.241 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 47.3 t -124.0 110.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 10' ' ' ILE . 42.4 t -120.01 139.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.43 112.91 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -78.4 119.91 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.42 161.28 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.629 1.172 . . . . 0.0 111.602 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -120.33 141.96 32.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.58 -20.12 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.903 1.736 . . . . 0.0 110.996 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 26.52 0.97 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.798 2.039 . . . . 0.0 111.44 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -130.92 134.97 26.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.622 2.369 . . . . 0.0 108.706 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.98 -25.87 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.179 2.586 . . . . 0.0 112.265 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -74.34 -29.98 61.83 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.37 -48.0 83.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.562 -0.711 . . . . 0.0 109.836 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -59.5 -41.51 90.06 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.518 -0.739 . . . . 0.0 110.164 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -58.67 6.53 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -39.85 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.154 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -56.46 -54.3 47.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.503 172.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -69.47 -41.93 75.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.288 0.949 . . . . 0.0 109.752 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.73 -52.28 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 125.727 1.611 . . . . 0.0 110.159 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.22 -48.97 16.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -69.83 -13.58 62.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.923 0.489 . . . . 0.0 112.269 -169.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.08 -23.33 60.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.035 0.834 . . . . 0.0 110.951 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.08 149.65 85.14 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.12 113.99 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 106.631 -2.103 . . . . 0.0 106.631 164.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.66 138.44 54.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 124.34 7.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.968 1.307 . . . . 0.0 108.687 -169.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.61 122.33 13.81 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -162.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.19 -12.96 58.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.082 1.325 . . . . 0.0 113.875 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.67 -28.29 61.68 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 120.697 2.249 . . . . 0.0 110.458 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.81 120.67 26.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 120.229 1.377 . . . . 0.0 107.482 -177.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -131.61 104.71 7.09 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.473 1.109 . . . . 0.0 109.338 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 20.3 m-85 -84.6 100.76 11.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.07 107.39 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -67.06 104.45 1.41 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 54' ' ' THR . 19.1 pt -69.44 -18.25 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.64 0.776 . . . . 0.0 111.463 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 CA--C 1.535 0.366 0 O-C-N 121.386 -0.821 . . . . 0.0 111.382 179.216 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m170 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -43.41 -63.68 0.78 Allowed 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.558 1.943 . . . . 0.0 109.053 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -52.34 -43.27 64.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.196 1.398 . . . . 0.0 109.801 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.87 -36.1 69.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 112.246 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.7 -51.74 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -57.25 10.04 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.291 0.567 . . . . 0.0 110.822 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.67 -42.33 62.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.242 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -61.13 -43.43 98.9 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.682 0.673 . . . . 0.0 110.709 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.78 -27.51 68.05 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.333 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -63.23 -56.69 14.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 120.739 1.609 . . . . 0.0 109.67 171.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.79 -49.13 71.7 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.839 0.712 . . . . 0.0 109.972 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.3 -29.74 57.48 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.116 1.366 . . . . 0.0 111.606 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 p -125.63 -29.08 3.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.55 13.96 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.179 -1.345 . . . . 0.0 113.982 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.99 150.97 9.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.649 2.224 . . . . 0.0 110.68 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' A' ' 62' ' ' GLN . 2.8 ptt-85 -96.61 -7.87 33.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.738 0.815 . . . . 0.0 112.571 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -65.05 133.98 52.84 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 108.649 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.88 147.0 34.61 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 126.618 1.967 . . . . 0.0 105.794 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -66.35 155.1 81.97 Favored 'Cis proline' 0 N--CA 1.461 -0.436 0 CA-C-N 120.353 1.162 . . . . 0.0 111.666 3.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -140.29 106.48 5.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 86' ' ' LEU . 55.2 t -87.89 127.46 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.73 93.98 4.3 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.598 2.359 . . . . 0.0 106.85 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -86.5 121.6 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.75 63.44 3.84 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.231 0.919 . . . . 0.0 113.425 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HE3' ' HD3' ' A' ' 12' ' ' PRO . 3.5 ttmt 46.13 19.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.369 2.267 . . . . 0.0 117.056 -173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.74 133.38 50.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.069 1.304 . . . . 0.0 110.571 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -81.11 121.99 26.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.106 -0.996 . . . . 0.0 109.899 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.4 pp -84.31 -11.81 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 119.616 1.098 . . . . 0.0 111.502 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.83 -163.69 19.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.322 0.963 . . . . 0.0 111.137 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.19 -155.26 29.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.303 0.954 . . . . 0.0 111.076 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -41.96 95.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.465 0.633 . . . . 0.0 111.269 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -65.94 -44.63 84.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.444 0.566 . . . . 0.0 110.897 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.47 -58.13 9.34 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 73' ' ' VAL . 65.0 tp -50.51 -42.13 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.436 1.094 . . . . 0.0 112.051 -174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.28 -51.02 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 116.347 -1.787 . . . . 0.0 109.229 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.47 54.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.448 1.931 . . . . 0.0 107.14 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.33 -40.98 83.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.111 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -74.67 -47.58 30.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.197 1.362 . . . . 0.0 107.806 -172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -35.85 60.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.373 1.069 . . . . 0.0 111.073 -169.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 t -94.13 -2.8 52.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.838 1.255 . . . . 0.0 111.15 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.76 0.32 87.74 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.082 -1.954 . . . . 0.0 115.075 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.54 -33.63 74.17 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 121.295 2.548 . . . . 0.0 110.37 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 tp -54.69 -37.64 66.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.48 -48.15 57.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -56.58 -49.87 73.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.981 0.913 . . . . 0.0 109.283 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.4 91.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.101 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -50.34 62.79 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.183 173.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.37 1.441 . . . . 0.0 111.801 -164.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.35 -39.08 14.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.304 1.441 . . . . 0.0 113.02 168.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.18 0.58 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 119.304 0.956 . . . . 0.0 111.936 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.34 55.2 2.94 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.7 1.143 . . . . 0.0 110.925 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.46 -75.65 0.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.79 1.636 . . . . 0.0 111.892 -167.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.89 133.73 52.49 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.235 -0.888 . . . . 0.0 108.826 -172.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.8 t80 . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.94 -47.05 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.949 0.9 . . . . 0.0 109.976 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.84 -44.19 86.22 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.006 -0.434 . . . . 0.0 111.355 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.22 -23.52 65.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.703 1.601 . . . . 0.0 112.168 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.05 -44.33 69.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.913 1.233 . . . . 0.0 110.268 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -80.02 136.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.23 153.02 55.51 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.08 80.54 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.178 2.586 . . . . 0.0 109.361 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.51 18.54 0.27 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.074 1.797 . . . . 0.0 115.323 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -132.17 171.82 13.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.568 1.684 . . . . 0.0 108.074 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.8 t -115.87 110.39 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 10' ' ' ILE . 75.0 t -126.73 126.16 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -169.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.81 112.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -81.83 120.16 24.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.22 164.52 34.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.391 1.477 . . . . 0.0 111.402 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -123.55 139.54 32.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 165.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.58 -9.55 21.42 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.373 2.049 . . . . 0.0 112.104 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 p -79.23 -18.81 52.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.581 2.352 . . . . 0.0 113.592 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -122.4 134.54 24.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -158.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.86 -14.25 26.67 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.805 2.337 . . . . 0.0 112.304 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -73.27 -35.17 66.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.566 1.075 . . . . 0.0 108.739 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.27 -47.07 74.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -52.05 -49.96 62.42 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.157 0.983 . . . . 0.0 113.049 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -57.03 14.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.582 1.083 . . . . 0.0 109.02 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -35.94 64.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.412 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -53.65 54.34 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.561 1.144 . . . . 0.0 112.435 174.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.69 -52.26 46.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.1 mt -46.73 -53.64 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.763 2.025 . . . . 0.0 109.413 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.94 -47.16 63.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.9 p -63.45 -19.14 64.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.538 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -73.28 -33.22 65.12 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 120.254 1.388 . . . . 0.0 109.966 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.12 136.05 95.28 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.81 76.98 3.87 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.493 2.795 . . . . 0.0 110.046 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.7 mt -87.76 145.51 7.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -53.25 123.39 11.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -66.3 122.87 18.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 -8.04 40.89 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.192 1.377 . . . . 0.0 111.801 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -78.04 -33.7 50.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.812 1.806 . . . . 0.0 111.489 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 120.73 29.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.433 1.015 . . . . 0.0 109.782 -171.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.67 130.68 47.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.481 0.712 . . . . 0.0 109.605 168.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.0 101.42 11.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.7 113.97 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.005 2.122 . . . . 0.0 108.485 -167.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -69.9 109.97 4.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.529 0.732 . . . . 0.0 110.532 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.43 13.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.316 1.046 . . . . 0.0 112.857 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.234 0.253 0 O-C-N 120.449 -1.407 . . . . 0.0 111.45 179.702 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 CA--C 1.515 -0.383 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -63.53 0.99 Allowed 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 125.465 1.506 . . . . 0.0 107.495 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -44.14 -48.89 9.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.525 1.13 . . . . 0.0 113.013 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -52.64 64.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.552 1.141 . . . . 0.0 111.411 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.96 -31.82 54.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.75 1.22 . . . . 0.0 111.675 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HA ' HH22 ' A' ' 72' ' ' ARG . 7.1 mt-30 -68.31 -45.31 73.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -64.64 -52.27 58.27 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.703 2.801 . . . . 0.0 110.405 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -55.05 -47.82 74.28 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.148 0.979 . . . . 0.0 111.205 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 64' ' ' LEU . 61.8 mt -65.66 -36.95 85.16 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.73 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.71 -44.31 96.76 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.53 1.059 . . . . 0.0 110.725 172.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -42.39 98.83 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.829 0.452 . . . . 0.0 110.597 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -76.05 -29.69 58.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.421 1.089 . . . . 0.0 109.399 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -125.06 -76.03 0.59 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.202 0.91 . . . . 0.0 109.072 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.31 -8.31 0.05 OUTLIER Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.728 -1.596 . . . . 0.0 116.715 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.43 146.26 48.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.572 2.686 . . . . 0.0 111.19 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.12 -28.29 15.15 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.302 1.441 . . . . 0.0 112.238 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 p -61.14 133.82 56.4 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 159.02 56.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.43 170.28 32.85 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 CA-C-N 118.763 0.594 . . . . 0.0 111.88 -11.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.584 HH22 ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -121.11 113.14 19.59 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 159.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.7 t -83.22 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.96 121.93 43.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 164.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -107.88 118.57 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 166.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.65 58.96 11.46 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.387 0.994 . . . . 0.0 112.689 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.285 3.6 tmtt? 45.49 30.73 0.78 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.58 1.952 . . . . 0.0 116.192 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.02 149.95 49.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.71 130.39 34.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.88 -26.08 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.14 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.17 -174.2 21.83 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.636 1.589 . . . . 0.0 112.057 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 -167.67 42.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.31 1.433 . . . . 0.0 112.042 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.42 -38.11 89.89 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.811 1.306 . . . . 0.0 111.598 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -64.99 -40.18 94.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.399 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.84 -51.65 45.97 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.421 1.088 . . . . 0.0 109.316 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.1 tp -51.89 -38.91 57.98 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 125.515 1.526 . . . . 0.0 111.652 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.42 -47.87 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 116.53 -1.7 . . . . 0.0 109.8 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -46.79 88.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.636 2.017 . . . . 0.0 108.615 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.155 -174.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.07 -52.54 23.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.385 1.448 . . . . 0.0 110.234 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.79 49.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.928 1.691 . . . . 0.0 111.399 -170.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -63.66 -33.55 75.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.76 2.024 . . . . 0.0 109.951 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.32 64.81 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.951 -1.472 . . . . 0.0 112.034 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.75 -32.04 65.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.089 1.945 . . . . 0.0 110.835 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.29 -36.23 70.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.846 1.659 . . . . 0.0 110.648 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.77 -50.67 61.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.916 0.487 . . . . 0.0 109.829 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 m -60.41 -49.29 78.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.883 0.873 . . . . 0.0 109.551 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -49.35 60.0 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.433 1.093 . . . . 0.0 110.348 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.4 mt -66.99 -45.09 78.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.32 -24.44 64.84 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.34 -1.475 . . . . 0.0 112.832 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.08 -39.34 59.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.861 0.755 . . . . 0.0 110.323 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.11 10.93 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.919 0.888 . . . . 0.0 111.914 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.45 76.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.411 -0.806 . . . . 0.0 113.571 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.0 -67.7 0.45 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 118.467 1.133 . . . . 0.0 110.142 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.92 134.01 45.75 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 118.163 -1.415 . . . . 0.0 107.669 -162.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 125.11 1.506 . . . . 0.0 108.668 -157.858 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.85 -54.19 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.851 0.861 . . . . 0.0 109.954 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.81 -38.22 75.16 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.051 0.94 . . . . 0.0 110.971 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.22 -29.76 64.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.736 0.815 . . . . 0.0 111.702 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -76.65 -45.6 29.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.797 1.635 . . . . 0.0 111.484 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.65 148.29 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -144.5 145.96 30.71 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.19 129.44 28.5 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.701 1.601 . . . . 0.0 108.617 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.54 77.88 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.372 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.6 169.91 8.99 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.237 2.019 . . . . 0.0 110.041 172.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.86 109.49 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.63 111.35 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 73' ' ' VAL . 14.3 t -100.82 121.14 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.79 130.14 34.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.48 173.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 110.399 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.41 144.53 43.08 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 161.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.83 -15.04 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.749 1.633 . . . . 0.0 111.433 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -66.65 -49.03 67.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.106 2.162 . . . . 0.0 110.943 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 122.35 87.28 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.806 1.242 . . . . 0.0 110.257 -172.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.29 -11.5 31.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.272 2.648 . . . . 0.0 112.31 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.8 -31.46 63.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.241 -0.912 . . . . 0.0 109.588 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -72.82 -38.77 67.04 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -46.55 67.06 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.138 0.575 . . . . 0.0 110.068 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.92 -56.05 23.84 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.287 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.91 -38.85 65.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.238 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -48.64 79.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.37 0.986 . . . . 0.0 113.644 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.09 -44.57 53.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -49.3 -54.83 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.969 1.307 . . . . 0.0 110.323 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD12 HG21 ' A' ' 17' ' ' VAL . 9.9 mt -81.97 -41.56 20.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.813 -172.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.7 t -70.65 -18.71 62.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.543 1.519 . . . . 0.0 112.498 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.83 -11.01 60.24 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.729 1.149 . . . . 0.0 111.827 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.12 133.06 39.77 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 163.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.44 62.52 8.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.011 2.474 . . . . 0.0 111.791 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.16 147.84 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -55.77 124.31 17.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -62.61 113.38 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.09 -12.9 9.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.744 1.164 . . . . 0.0 111.741 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.15 -39.81 15.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.691 1.745 . . . . 0.0 111.63 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 115.91 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.482 1.113 . . . . 0.0 109.465 -167.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -137.74 107.54 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.52 1.055 . . . . 0.0 109.078 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -85.93 105.12 16.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.842 1.257 . . . . 0.0 108.175 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.08 111.01 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -63.45 127.93 33.52 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 162.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 pt -93.04 -2.23 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 112.195 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 119.847 1.203 . . . . 0.0 111.372 179.323 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.21 -63.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.468 1.507 . . . . 0.0 110.384 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -40.63 59.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.78 0.832 . . . . 0.0 110.969 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.5 -11.91 56.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.615 1.966 . . . . 0.0 114.425 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 mt -85.03 -47.49 16.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 125.379 1.472 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -71.17 -40.98 70.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.521 0.677 . . . . 0.0 110.78 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.89 -36.86 72.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.918 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -66.36 -33.87 76.71 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.311 -1.493 . . . . 0.0 112.703 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.92 -29.62 70.78 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 120.186 1.357 . . . . 0.0 110.135 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.79 -38.5 78.67 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 120.354 1.434 . . . . 0.0 110.681 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -55.54 6.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.405 0.682 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.13 -25.79 55.71 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.1 p -122.9 -36.74 2.83 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.813 -1.18 . . . . 0.0 111.977 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.95 -17.69 5.15 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.378 -1.234 . . . . 0.0 114.211 168.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.91 148.33 38.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.899 1.85 . . . . 0.0 110.216 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -11.95 59.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.59 143.11 25.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.805 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 151.55 43.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.9 1.68 . . . . 0.0 106.573 164.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.28 165.45 43.8 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 CA-C-N 120.139 1.086 . . . . 0.0 111.33 -4.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -142.57 109.11 5.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 86' ' ' LEU . 97.9 t -88.31 126.78 41.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.935 0.494 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -105.06 130.47 53.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.82 111.78 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.43 73.39 0.42 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 125.145 1.355 . . . . 0.0 113.213 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.55 -9.18 0.0 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 130.658 3.583 . . . . 0.0 118.107 -173.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -91.73 163.82 13.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.923 1.238 . . . . 0.0 108.877 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 t -125.02 129.13 49.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.828 1.651 . . . . 0.0 109.006 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -106.48 -16.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.68 178.66 23.96 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.73 -89.54 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 125.206 1.384 . . . . 0.0 110.391 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.45 -62.15 1.05 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 111.642 -169.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.2 t -65.53 -36.79 84.85 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.108 0.867 . . . . 0.0 110.183 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.47 -55.61 29.25 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.53 HD13 HG21 ' A' ' 73' ' ' VAL . 48.5 tp -49.07 -45.49 43.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.995 1.318 . . . . 0.0 111.689 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -46.74 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 116.628 -1.653 . . . . 0.0 109.789 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -49.08 75.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.64 -33.11 69.7 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.489 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -71.4 -51.57 23.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 121.148 1.794 . . . . 0.0 109.784 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -47.73 60.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.015 1.326 . . . . 0.0 110.045 -166.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.98 -34.08 74.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.424 1.89 . . . . 0.0 110.436 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 19.65 57.78 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-O 118.156 -1.358 . . . . 0.0 112.043 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.54 -42.51 83.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.732 2.266 . . . . 0.0 110.381 170.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -35.27 63.55 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.23 1.812 . . . . 0.0 110.473 -174.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.31 -52.58 64.1 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.681 0.793 . . . . 0.0 111.945 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.1 m -65.71 -41.53 92.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.449 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -44.72 73.14 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.771 0.828 . . . . 0.0 110.167 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.93 -44.44 89.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.974 1.31 . . . . 0.0 112.752 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 105' ' ' LEU . 68.0 mttt -63.18 -27.08 69.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.696 1.135 . . . . 0.0 112.434 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -56.03 -15.89 4.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 112.878 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.59 12.3 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.141 1.337 . . . . 0.0 112.351 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.74 36.14 58.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.174 -0.954 . . . . 0.0 113.005 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.72 -66.05 0.96 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.253 1.421 . . . . 0.0 112.757 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . 17.1 mt -75.27 133.57 41.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 121.352 1.887 . . . . 0.0 107.572 -167.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.771 1.229 . . . . 0.0 109.315 -167.269 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.4 t80 . . . . . 0 C--O 1.225 -0.201 0 CA-C-O 119.643 -0.218 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 57' ' ' ILE . 8.9 t -68.99 -59.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.51 -49.41 74.83 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 t -76.76 -26.44 54.54 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.79 0.836 . . . . 0.0 112.367 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -66.47 -39.18 88.64 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.322 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -75.81 132.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.18 155.49 71.07 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.83 26.08 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 125.302 4.001 . . . . 0.0 115.054 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.23 21.16 0.11 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.603 1.573 . . . . 0.0 113.169 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -120.79 168.24 11.65 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.84 120.55 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.07 135.1 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.73 118.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -82.19 124.53 29.99 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.51 177.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.384 1.474 . . . . 0.0 111.257 -166.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 158.98 64.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.009 1.724 . . . . 0.0 107.289 169.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.88 2.09 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.264 2.643 . . . . 0.0 114.592 -163.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -133.04 -25.3 1.82 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -158.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 156.41 77.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.32 1.448 . . . . 0.0 114.12 -158.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.27 -29.5 21.34 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.431 2.087 . . . . 0.0 110.666 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -73.92 -46.74 42.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.7 m -70.09 -44.23 69.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -48.56 -46.71 39.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.217 -0.927 . . . . 0.0 111.969 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -60.4 -60.54 3.64 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.891 0.769 . . . . 0.0 109.572 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.69 69.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 124.244 0.965 . . . . 0.0 111.968 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -60.88 -47.54 85.93 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 117.827 -1.082 . . . . 0.0 111.503 177.168 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.77 -53.55 31.9 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 119.08 0.855 . . . . 0.0 109.9 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.04 -49.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.442 1.497 . . . . 0.0 109.763 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.27 -51.96 13.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -66.33 -23.44 66.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -73.84 -23.61 59.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.248 0.931 . . . . 0.0 110.044 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.98 138.15 69.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.1 65.79 8.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.303 2.668 . . . . 0.0 111.663 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.02 150.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -55.82 123.97 16.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.502 1.121 . . . . 0.0 109.516 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -65.29 151.31 46.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.322 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.61 -18.83 10.28 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.671 -1.627 . . . . 0.0 112.255 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -46.14 47.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 120.649 2.224 . . . . 0.0 109.803 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 116.08 22.69 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.044 0.84 . . . . 0.0 109.866 -169.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -124.48 150.67 45.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.987 1.315 . . . . 0.0 108.949 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 7.6 m-85 -124.24 130.31 52.31 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.54 101.39 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.801 1.64 . . . . 0.0 107.82 -160.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -64.16 119.67 10.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 pt -89.77 -8.22 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.072 0.949 . . . . 0.0 113.196 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 124.556 1.142 . . . . 0.0 110.964 -175.725 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.738 0.78 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -62.46 1.56 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 125.377 1.471 . . . . 0.0 107.376 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -47.8 -45.42 29.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.494 1.118 . . . . 0.0 112.537 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.261 9.9 tm-20 -63.87 -44.47 93.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.751 2.02 . . . . 0.0 112.668 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.475 HG23 HG21 ' A' ' 6' ' ' VAL . 11.7 mt -62.99 -37.75 80.18 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 125.243 1.417 . . . . 0.0 110.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.63 -38.56 70.75 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.33 -50.47 72.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.267 1.427 . . . . 0.0 111.057 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.09 -43.31 82.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.429 HD13 ' HG3' ' A' ' 72' ' ' ARG . 23.9 mt -64.15 -34.85 79.01 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -57.89 -46.0 85.56 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -53.73 30.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.63 -29.77 69.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.708 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -121.8 -27.31 4.69 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.34 -33.99 3.97 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.405 1.479 . . . . 0.0 110.867 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.74 43.59 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.729 1.264 . . . . 0.0 112.077 -172.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.49 -5.89 28.52 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.299 1.039 . . . . 0.0 113.175 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.6 p -68.1 133.78 49.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.99 154.56 37.27 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 132.23 14.57 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.169 1.096 . . . . 0.0 111.716 -9.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 61' ' ' LEU . 3.5 mmp_? -93.03 111.1 22.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.37 126.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -111.23 136.76 49.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 159.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.62 115.51 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 102.501 -3.148 . . . . 0.0 102.501 171.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.46 72.35 0.43 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.661 1.601 . . . . 0.0 114.183 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' A' ' 10' ' ' ILE . 2.6 mmtp 46.58 9.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.002 2.521 . . . . 0.0 116.12 -171.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -114.58 113.21 24.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.994 1.27 . . . . 0.0 108.848 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.94 123.93 21.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.71 -26.04 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 118.714 0.688 . . . . 0.0 109.707 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.38 -161.35 24.67 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.328 0.966 . . . . 0.0 111.133 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.42 -161.47 31.42 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.455 1.026 . . . . 0.0 111.444 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -33.59 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.326 1.063 . . . . 0.0 110.119 -165.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 t -71.42 -36.59 71.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.63 -53.8 30.22 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.3 tp -51.72 -46.42 63.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.313 1.445 . . . . 0.0 112.132 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.39 -44.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 117.357 -1.306 . . . . 0.0 108.892 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -50.02 63.9 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.45 -38.88 72.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.13 -57.32 6.99 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.381 1.446 . . . . 0.0 110.505 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -29.7 65.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.49 1.516 . . . . 0.0 112.486 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 t -87.17 -14.5 41.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.434 2.294 . . . . 0.0 110.638 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.3 89.39 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -25.31 67.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.246 2.523 . . . . 0.0 110.77 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.41 -34.32 76.51 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.605 1.962 . . . . 0.0 111.449 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.16 -50.24 66.74 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 m -61.55 -46.49 89.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.188 0.449 . . . . 0.0 109.808 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -47.0 72.26 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.234 0.47 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.44 -53.48 23.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 111.24 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -58.27 -29.19 65.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.655 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -51.34 -42.58 61.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.715 0.689 . . . . 0.0 110.093 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.31 6.05 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.027 0.831 . . . . 0.0 112.354 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.31 38.01 19.41 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.289 0.95 . . . . 0.0 112.821 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.87 -69.47 0.69 Allowed 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.801 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.46 133.84 49.24 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -172.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.253 1.276 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.934 -160.934 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.07 -58.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.219 1.007 . . . . 0.0 109.549 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -68.41 -17.74 64.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -159.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.3 t -101.97 -26.42 13.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.983 1.313 . . . . 0.0 110.31 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -64.14 -45.75 87.11 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.659 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.2 143.75 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.682 1.128 . . . . 0.0 108.076 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.7 140.36 35.15 Favored Pre-proline 0 C--O 1.238 0.454 0 CA-C-N 119.296 0.953 . . . . 0.0 109.716 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.86 89.94 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.24 2.627 . . . . 0.0 108.714 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.53 17.04 2.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.896 1.712 . . . . 0.0 113.882 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -128.6 162.23 27.77 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.875 2.07 . . . . 0.0 109.636 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.2 t -112.29 81.45 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.43 134.93 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 t -134.3 111.71 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -78.46 128.36 33.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 pt -138.53 179.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.3 1.84 . . . . 0.0 109.24 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -144.79 147.6 36.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 158.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.34 -14.97 38.33 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.579 2.186 . . . . 0.0 113.042 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p -77.16 -28.82 54.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.333 0.97 . . . . 0.0 111.672 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -74.8 121.52 85.44 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.583 0.629 . . . . 0.0 110.382 -164.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.74 -15.62 33.43 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.012 1.808 . . . . 0.0 111.823 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.98 -33.55 24.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.772 1.169 . . . . 0.0 109.341 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.2 m -62.63 -41.52 99.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -53.49 -42.76 67.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.474 0.579 . . . . 0.0 112.29 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -55.82 23.19 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.02 -36.08 62.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.307 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.92 83.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.777 169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.81 -46.58 65.38 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 120.543 1.519 . . . . 0.0 109.414 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -52.09 -58.34 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 126.504 1.921 . . . . 0.0 107.7 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.47 -33.34 58.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.598 -170.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 m -67.33 -35.13 78.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 0.0 112.138 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.98 -9.43 58.63 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.904 1.229 . . . . 0.0 112.079 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.57 135.52 43.41 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.058 1.299 . . . . 0.0 109.392 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.12 75.96 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.515 3.477 . . . . 0.0 110.481 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.494 HD11 HD13 ' A' ' 99' ' ' LEU . 8.1 mt -102.93 151.3 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -169.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -48.25 130.53 16.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.383 1.073 . . . . 0.0 110.485 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.1 140.27 56.01 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.66 -7.81 57.18 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.814 -1.548 . . . . 0.0 113.733 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.57 -37.19 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 121.066 2.433 . . . . 0.0 110.966 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 103.29 13.26 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.26 103.68 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.377 1.071 . . . . 0.0 108.58 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -84.09 117.49 23.48 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.67 109.2 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.995 2.118 . . . . 0.0 108.834 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -64.02 104.95 0.78 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.494 2.318 . . . . 0.0 114.015 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.67 -22.38 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.757 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.262 3.0 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 117.877 -1.058 . . . . 0.0 111.135 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 1.1 m-70 . . . . . 0 C--O 1.232 0.144 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -63.51 1.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.462 1.105 . . . . 0.0 108.914 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 58' ' ' GLN . 7.1 t30 -61.46 -29.96 70.29 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . 3.6 tm-20 -64.24 -46.57 83.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.484 1.114 . . . . 0.0 110.985 171.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -59.26 -38.57 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 55' ' ' ASN . 6.9 mm-40 -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -169.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -49.21 -55.31 12.94 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.211 1.404 . . . . 0.0 110.548 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -56.84 -45.12 82.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.169 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.06 -44.83 96.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.889 1.222 . . . . 0.0 111.032 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.8 -34.75 69.97 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 123.151 0.282 . . . . 0.0 111.034 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -76.29 -48.23 20.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.935 0.494 . . . . 0.0 111.567 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.28 -47.01 63.17 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.941 1.296 . . . . 0.0 108.5 -158.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 p -102.63 -44.9 5.19 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.34 -13.35 4.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.667 1.127 . . . . 0.0 113.001 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.78 160.28 41.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.486 1.643 . . . . 0.0 108.875 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -118.65 -24.16 6.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 117.394 -1.289 . . . . 0.0 114.221 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 p -64.16 133.24 52.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 160.73 56.16 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.783 1.233 . . . . 0.0 108.497 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.16 159.99 61.4 Favored 'Cis proline' 0 C--N 1.344 0.323 0 CA-C-N 120.314 1.148 . . . . 0.0 110.591 -4.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -123.27 101.2 7.24 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.07 126.56 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -114.25 97.86 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -83.79 123.12 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 168.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 42.6 68.79 0.69 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.924 1.25 . . . . 0.0 113.23 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.22 -2.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.813 2.845 . . . . 0.0 118.645 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.4 115.74 28.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.094 1.316 . . . . 0.0 107.87 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -63.74 117.26 6.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.32 -16.89 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.19 -146.79 17.88 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.26 -153.43 18.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.934 0.741 . . . . 0.0 111.783 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.2 p -65.64 -38.47 89.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.044 0.938 . . . . 0.0 110.653 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -75.92 -31.39 59.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.662 0.601 . . . . 0.0 111.62 -176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.05 -52.5 41.54 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 23.0 tp -57.01 -34.36 68.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.451 0.7 . . . . 0.0 111.351 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.65 -48.44 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 115.419 -2.229 . . . . 0.0 109.723 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -55.1 37.64 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.441 1.928 . . . . 0.0 107.256 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.54 -35.86 72.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.689 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -68.47 -47.77 66.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.335 1.425 . . . . 0.0 110.51 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -63.8 1.15 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.999 2.52 . . . . 0.0 109.818 -168.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -79.22 -12.54 59.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 119.253 -0.404 . . . . 0.0 110.523 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.7 18.81 53.92 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-O 117.228 -1.873 . . . . 0.0 113.282 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.52 -23.02 67.13 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 121.099 2.449 . . . . 0.0 111.049 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.44 -38.86 63.94 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.294 1.438 . . . . 0.0 111.09 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.57 -48.38 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.161 0.984 . . . . 0.0 109.182 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.2 m -66.69 -44.66 81.15 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.976 1.31 . . . . 0.0 110.658 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -47.76 64.33 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.6 0.76 . . . . 0.0 109.392 174.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 38' ' ' ILE . 23.4 mt -69.83 -50.67 40.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.126 0.57 . . . . 0.0 111.438 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -57.95 -29.94 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.362 -0.836 . . . . 0.0 112.627 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -47.96 -40.52 22.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.361 1.064 . . . . 0.0 111.601 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.4 8.17 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.646 0.657 . . . . 0.0 112.764 -168.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.4 50.81 5.54 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.694 0.679 . . . . 0.0 111.671 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.86 -74.17 0.65 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 126.508 1.923 . . . . 0.0 112.507 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.74 150.95 43.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.599 1.999 . . . . 0.0 106.93 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.964 -172.294 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.574 0.702 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.26 -48.67 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.726 -0.609 . . . . 0.0 110.033 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -70.95 -32.03 68.8 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.161 -0.962 . . . . 0.0 113.199 -167.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -18.12 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.973 -1.08 . . . . 0.0 110.818 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 44' ' ' GLU . 32.1 mmtm -76.46 -59.87 2.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.479 172.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.05 144.81 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.623 1.101 . . . . 0.0 108.928 -172.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -138.27 157.04 73.35 Favored Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 126.982 2.113 . . . . 0.0 106.559 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.26 66.76 7.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.518 2.812 . . . . 0.0 110.7 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.86 40.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.109 1.814 . . . . 0.0 111.21 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -143.49 168.99 18.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.22 1.808 . . . . 0.0 107.128 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 75' ' ' ILE . 25.3 t -114.7 95.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 165.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.68 144.66 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 t -132.22 117.59 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -77.16 120.79 22.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.29 -178.15 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.745 2.418 . . . . 0.0 109.664 -172.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 11.8 ptpt -136.27 164.48 42.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 126.496 1.918 . . . . 0.0 107.673 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 82.3 Cg_endo -76.74 -1.97 12.14 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.452 2.101 . . . . 0.0 112.773 -165.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -118.67 -99.99 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.794 1.637 . . . . 0.0 107.426 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 t 32.48 100.94 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.599 2.76 . . . . 0.0 114.995 169.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.56 -10.0 26.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.247 1.298 . . . . 0.0 111.637 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.85 -35.1 15.85 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.727 -1.233 . . . . 0.0 108.169 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.7 -55.18 33.08 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -57.58 -41.4 81.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.845 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -56.89 -61.41 2.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 118.865 0.757 . . . . 0.0 109.69 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.13 -33.54 27.03 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.049 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.18 -55.52 33.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.56 1.544 . . . . 0.0 111.968 171.034 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.43 -38.58 77.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.078 1.763 . . . . 0.0 110.243 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.41 -50.33 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.291 1.436 . . . . 0.0 108.971 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.86 -53.0 9.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -63.21 -24.55 67.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.397 0.679 . . . . 0.0 112.098 -166.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -74.01 0.85 12.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.055 0.843 . . . . 0.0 112.392 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 120.796 -1.19 . . . . 0.0 109.207 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.35 57.24 6.16 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.159 3.24 . . . . 0.0 111.383 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 99' ' ' LEU . 9.2 mt -74.52 151.2 7.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -175.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -53.92 123.93 13.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.06 133.33 50.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -171.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -14.33 63.9 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.571 -1.127 . . . . 0.0 113.005 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.16 -39.5 63.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.706 1.753 . . . . 0.0 110.754 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 104.18 14.14 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -168.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' OE2' ' HE3' ' A' ' 9' ' ' LYS . 42.5 tt0 -122.35 113.9 20.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 22.1 m-85 -83.84 133.28 34.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -125.03 100.2 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.369 1.468 . . . . 0.0 107.052 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -64.65 112.86 3.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.708 1.203 . . . . 0.0 111.131 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.7 pt -68.04 -9.39 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.113 -0.992 . . . . 0.0 112.689 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 CA--C 1.54 0.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.623 172.731 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.86 -63.0 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.674 1.99 . . . . 0.0 110.237 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.62 -22.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.629 1.572 . . . . 0.0 114.81 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.74 -30.71 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.155 1.343 . . . . 0.0 111.522 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mt -69.76 -33.68 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.896 1.279 . . . . 0.0 108.299 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -52.27 54.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -52.48 -54.96 25.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.199 1.8 . . . . 0.0 110.424 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -51.55 -46.0 63.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.608 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.97 -35.46 81.25 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.617 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.53 -54.91 28.79 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.973 1.26 . . . . 0.0 109.412 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -36.76 76.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.137 0.975 . . . . 0.0 110.393 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -76.34 -52.48 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 0.0 109.161 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -97.49 -75.89 0.53 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -168.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.06 -13.93 0.06 OUTLIER Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.022 1.296 . . . . 0.0 114.005 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.68 146.47 41.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.091 1.945 . . . . 0.0 108.97 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -29.43 45.8 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.861 171.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -62.41 133.29 54.83 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -159.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.03 153.91 52.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.32 156.85 80.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.24 0.764 . . . . 0.0 111.684 -7.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.48 106.69 10.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.2 129.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -118.53 93.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.912 2.485 . . . . 0.0 107.479 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.91 118.15 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 40.13 67.97 0.61 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.492 1.996 . . . . 0.0 114.489 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.61 24.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.89 97.75 5.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -67.84 118.1 10.62 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.806 -1.184 . . . . 0.0 108.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 89' ' ' LEU . 1.1 pp -83.76 -21.58 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -167.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -168.77 24.34 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -170.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.14 -85.62 1.79 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 -64.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.813 1.245 . . . . 0.0 108.157 -170.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m -58.77 -39.41 80.94 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.533 0.733 . . . . 0.0 111.721 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.83 -56.73 18.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.0 -39.35 74.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.099 1.36 . . . . 0.0 110.856 -168.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.8 t -64.85 -40.87 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 117.256 -1.354 . . . . 0.0 111.119 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -50.91 69.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 80' ' ' ILE . 4.0 mp -56.06 -37.65 69.58 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 117.743 -1.122 . . . . 0.0 109.613 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -63.64 -57.58 9.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.453 1.479 . . . . 0.0 109.613 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -42.9 83.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.299 1.44 . . . . 0.0 111.57 -166.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.1 t -65.06 -51.99 58.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.593 1.957 . . . . 0.0 107.845 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.73 1.77 27.3 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.259 -1.301 . . . . 0.0 111.475 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.7 -22.66 66.67 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.936 1.868 . . . . 0.0 110.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -54.51 -46.45 73.5 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 110.348 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.68 -51.14 68.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.478 0.711 . . . . 0.0 109.234 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -53.73 -45.62 70.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.009 0.924 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -56.23 21.36 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 110.678 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -75.22 -30.72 60.65 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.944 -1.097 . . . . 0.0 112.15 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.19 -30.15 66.21 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.396 -1.44 . . . . 0.0 112.474 169.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -60.17 -8.8 2.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.157 1.383 . . . . 0.0 113.773 171.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.16 8.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.437 1.895 . . . . 0.0 110.866 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.51 36.86 89.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.968 1.27 . . . . 0.0 112.951 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.45 -62.32 1.48 Allowed 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.71 1.204 . . . . 0.0 110.742 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -72.28 142.62 48.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.464 -161.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.319 -0.741 0 C-N-CA 127.994 2.518 . . . . 0.0 107.5 -178.199 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.7 t80 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.79 -69.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.458 1.503 . . . . 0.0 110.687 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -65.79 -43.56 88.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.1 0.863 . . . . 0.0 111.834 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.1 t -72.83 -18.19 61.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.814 0.445 . . . . 0.0 111.009 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -71.2 -46.86 60.35 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.615 -1.184 . . . . 0.0 112.109 171.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.5 144.21 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 120.245 1.384 . . . . 0.0 108.526 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.74 168.18 14.62 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 125.372 1.469 . . . . 0.0 107.416 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.3 157.55 30.19 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.295 1.141 . . . . 0.0 109.399 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.63 79.55 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.575 -1.125 . . . . 0.0 115.372 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -132.39 158.58 41.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.656 1.728 . . . . 0.0 107.905 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 43' ' ' LEU . 21.2 t -107.05 123.3 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.06 136.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.12 114.58 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -77.68 122.66 25.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -133.71 166.91 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.056 1.342 . . . . 0.0 109.758 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -132.33 125.18 19.66 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 158.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.4 -15.32 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.66 1.573 . . . . 0.0 111.414 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -83.0 -0.17 47.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.914 2.086 . . . . 0.0 113.356 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.13 132.49 21.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.159 1.345 . . . . 0.0 108.23 161.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.91 -17.72 56.2 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.479 2.786 . . . . 0.0 110.952 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -74.04 -38.21 64.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.95 -44.51 96.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 117.72 -1.134 . . . . 0.0 109.027 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -53.43 -50.35 65.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.606 1.094 . . . . 0.0 111.783 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -54.45 -59.21 4.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 119.202 -0.427 . . . . 0.0 110.187 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.06 60.84 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.604 1.19 . . . . 0.0 111.231 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.67 80.62 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 117.855 -1.069 . . . . 0.0 111.206 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -41.33 69.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 120.557 1.526 . . . . 0.0 109.336 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.17 -54.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.429 1.892 . . . . 0.0 109.263 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.43 -42.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -171.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 t -65.91 -25.11 67.0 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.247 0.476 . . . . 0.0 111.131 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.69 -22.72 59.84 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.355 0.98 . . . . 0.0 112.407 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.95 154.47 92.58 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 119.329 0.968 . . . . 0.0 109.496 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.57 77.93 3.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.853 2.369 . . . . 0.0 109.876 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mt -102.43 153.46 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -51.97 124.27 12.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.033 0.933 . . . . 0.0 109.083 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.61 137.83 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.77 -14.07 64.13 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.841 -1.533 . . . . 0.0 112.247 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mt -73.81 -36.8 65.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.802 2.301 . . . . 0.0 111.78 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.04 118.02 23.79 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -170.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -122.04 123.6 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.627 1.171 . . . . 0.0 109.193 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.53 127.26 45.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.96 105.09 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.935 1.294 . . . . 0.0 108.735 -165.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.35 100.76 3.26 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.576 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.488 HG22 HG21 ' A' ' 57' ' ' ILE . 8.9 pt -63.94 -14.46 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 113.18 175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.871 1.268 . . . . 0.0 111.666 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 CA--C 1.513 -0.452 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -63.47 1.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.275 1.43 . . . . 0.0 108.323 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.47 -30.64 60.95 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.61 -52.31 61.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.839 1.199 . . . . 0.0 110.747 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 48' ' ' ILE . 6.4 mt -64.03 -39.24 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -57.2 -50.07 74.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.406 2.282 . . . . 0.0 107.459 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.27 -42.32 93.34 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 110.518 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -58.41 -47.42 83.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.9 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.19 -36.78 84.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.792 0.724 . . . . 0.0 110.581 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.83 -51.04 70.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.538 0.735 . . . . 0.0 109.945 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.91 -49.93 72.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.003 0.521 . . . . 0.0 109.851 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.49 -40.58 66.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.116 0.966 . . . . 0.0 109.373 -166.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 p -108.38 -15.37 14.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.255 0.934 . . . . 0.0 113.356 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.19 6.78 64.5 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.625 -1.097 . . . . 0.0 112.158 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.52 22.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.236 1.518 . . . . 0.0 109.265 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -94.67 -8.89 36.56 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.92 133.82 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.685 1.129 . . . . 0.0 110.66 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.11 161.11 29.27 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 160.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.24 141.79 37.46 Favored 'Cis proline' 0 N--CA 1.463 -0.275 0 N-CA-C 110.158 -0.747 . . . . 0.0 110.158 -13.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.94 93.1 4.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.85 130.79 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.86 109.02 18.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.378 1.871 . . . . 0.0 106.927 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.5 108.66 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 163.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 67.48 1.91 Allowed Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.264 1.411 . . . . 0.0 112.849 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.0 mttt 46.06 20.39 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.166 1.787 . . . . 0.0 115.393 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.29 110.91 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 164.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -67.26 107.99 2.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.5 pp -83.48 -14.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.485 0.584 . . . . 0.0 111.456 -170.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.47 -171.35 22.94 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 124.478 1.037 . . . . 0.0 111.355 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.81 -160.23 31.82 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.896 1.713 . . . . 0.0 110.251 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -37.78 86.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.026 0.913 . . . . 0.0 110.334 -170.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.6 m -67.36 -48.32 67.79 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.987 -172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 -51.94 67.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.7 tp -54.28 -37.33 64.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.074 -0.965 . . . . 0.0 112.231 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -60.85 -53.41 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 116.777 -1.582 . . . . 0.0 108.982 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.22 87.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 121.848 2.113 . . . . 0.0 108.692 -174.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.3 -32.03 71.88 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.745 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.34 -55.11 8.66 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 121.055 1.752 . . . . 0.0 111.087 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -51.91 34.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.635 2.374 . . . . 0.0 110.631 -168.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 t -70.34 -24.59 63.01 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.945 1.298 . . . . 0.0 109.977 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 11.06 65.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.166 173.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.55 -25.93 68.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.36 2.08 . . . . 0.0 111.726 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.73 -32.23 69.02 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.536 1.134 . . . . 0.0 111.513 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.09 -46.52 61.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.65 0.659 . . . . 0.0 109.656 -168.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.9 m -64.45 -40.49 95.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -40.97 85.37 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.54 -0.725 . . . . 0.0 111.687 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.75 -46.09 84.96 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.713 1.205 . . . . 0.0 110.503 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -62.12 -31.02 71.44 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.958 -1.089 . . . . 0.0 112.331 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -63.64 -10.99 21.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.92 11.75 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 119.474 1.034 . . . . 0.0 111.854 170.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.12 26.09 62.69 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.341 0.972 . . . . 0.0 112.887 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.616 1.166 . . . . 0.0 111.487 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.7 mt -77.55 134.32 38.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.802 -1.559 . . . . 0.0 110.944 -158.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 . . . . . 0 N--CA 1.428 -1.526 0 C-N-CA 130.134 3.374 . . . . 0.0 106.161 -179.273 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 . . . . . 0 N--CA 1.461 0.104 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.09 -58.93 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -55.32 -37.39 67.36 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.19 0.996 . . . . 0.0 113.573 -161.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.0 m -101.91 -8.87 21.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.971 0.908 . . . . 0.0 112.815 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.87 -45.26 90.24 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.966 1.257 . . . . 0.0 107.7 159.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.44 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 mt -63.75 155.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 152.52 47.48 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.61 125.22 14.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 N-CA-C 104.763 -2.822 . . . . 0.0 104.763 158.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.49 35.58 25.63 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.737 0.684 . . . . 0.0 113.302 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -142.31 161.31 38.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.099 2.159 . . . . 0.0 109.341 166.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 75' ' ' ILE . 38.3 t -118.33 109.25 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 10' ' ' ILE . 61.6 t -127.56 132.25 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 120.555 -1.341 . . . . 0.0 108.289 -166.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.23 111.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -166.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -79.29 119.26 22.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.86 169.5 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.989 1.716 . . . . 0.0 109.921 -174.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -127.29 141.28 40.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 162.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.06 28.77 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.6 3.533 . . . . 0.0 111.315 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.323 9.6 t -147.23 29.48 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.813 2.045 . . . . 0.0 108.929 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.63 123.84 26.87 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.035 1.734 . . . . 0.0 108.595 167.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.98 -24.92 52.4 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.486 1.457 . . . . 0.0 111.984 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -78.98 -28.72 43.54 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.953 0.797 . . . . 0.0 109.353 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.2 m -66.11 -46.9 75.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -51.92 -48.15 64.33 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.166 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -55.5 -57.87 10.13 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 119.014 0.825 . . . . 0.0 109.938 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.42 62.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.328 1.018 . . . . 0.0 111.472 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -45.69 78.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.388 0.994 . . . . 0.0 113.295 172.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.66 -53.21 16.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt -44.34 -53.22 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.39 1.876 . . . . 0.0 110.442 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.64 -46.47 19.13 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.186 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -6.51 59.26 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.367 0.985 . . . . 0.0 112.608 -167.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -73.83 -16.16 61.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.66 1.118 . . . . 0.0 110.992 167.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -78.0 151.29 78.89 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 120.885 -1.134 . . . . 0.0 108.748 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 42.23 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.303 2.669 . . . . 0.0 111.295 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.1 145.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -58.38 123.06 14.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.27 146.66 54.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.78 10.22 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.589 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.49 -30.5 63.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.883 1.842 . . . . 0.0 109.68 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 119.72 25.18 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 120.515 1.507 . . . . 0.0 107.684 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -128.72 110.41 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.688 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -84.19 103.74 13.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -90.82 114.96 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 126.519 1.927 . . . . 0.0 107.231 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.57 110.58 3.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.591 1.156 . . . . 0.0 110.942 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.6 pt -70.45 -2.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.369 1.068 . . . . 0.0 113.006 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.261 3.3 t . . . . . 0 N--CA 1.443 -0.824 0 CA-C-N 118.775 0.716 . . . . 0.0 110.41 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -63.66 0.86 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.581 1.152 . . . . 0.0 111.817 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -46.63 -54.68 9.02 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.901 0.75 . . . . 0.0 111.15 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -41.66 93.63 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.554 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.4 -39.99 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.03 -41.45 74.25 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -42.05 35.9 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.49 1.916 . . . . 0.0 111.423 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.5 -50.99 66.49 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.753 1.221 . . . . 0.0 110.338 171.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.42 -30.71 65.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.789 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' NE2' HH21 ' A' ' 68' ' ' ARG . 22.7 tt0 -66.56 -37.79 85.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.627 1.558 . . . . 0.0 111.695 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -67.66 -47.54 69.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.53 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.27 -24.33 57.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.211 -168.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 p -133.51 -2.85 3.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.283 1.401 . . . . 0.0 114.101 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.13 -10.23 61.42 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 120.061 1.301 . . . . 0.0 112.857 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.62 137.33 54.48 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.126 -1.22 . . . . 0.0 110.587 -172.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.503 HH21 ' NE2' ' A' ' 62' ' ' GLN . 5.1 ptp85 -102.02 -31.31 10.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.475 174.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 133.33 41.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.285 0.564 . . . . 0.0 109.716 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.27 159.49 39.27 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.369 1.467 . . . . 0.0 108.458 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.54 167.77 22.72 Favored 'Cis proline' 0 C--N 1.347 0.457 0 CA-C-N 120.379 1.171 . . . . 0.0 111.881 -8.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 110.15 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.062 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.9 t -91.98 125.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 119.426 1.012 . . . . 0.0 108.761 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -102.21 114.68 29.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 158.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.41 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -93.18 123.68 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 160.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 43.78 72.43 0.33 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.301 1.429 . . . . 0.0 113.811 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 46.65 14.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.17 120.22 36.44 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.471 1.487 . . . . 0.0 110.658 170.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.71 114.66 4.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.706 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.8 pp -83.52 -12.68 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 119.236 0.925 . . . . 0.0 110.845 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.75 -158.17 18.28 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.65 -157.47 31.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 126.767 2.127 . . . . 0.0 111.108 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -38.44 83.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.923 -0.751 . . . . 0.0 110.335 -169.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -68.85 -44.82 72.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.634 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -65.17 -45.56 84.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.6 tp -53.98 -45.42 71.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.5 0.72 . . . . 0.0 112.057 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.89 -39.16 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 117.112 -1.423 . . . . 0.0 109.536 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -54.54 24.92 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -58.52 -33.54 69.96 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.29 -63.67 1.03 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.935 1.698 . . . . 0.0 110.705 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.26 78.3 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.864 1.266 . . . . 0.0 112.163 -166.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -86.39 -2.24 58.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.457 1.503 . . . . 0.0 110.972 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 -0.37 88.86 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 117.107 -1.941 . . . . 0.0 114.671 168.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.38 -31.54 72.73 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 121.285 2.542 . . . . 0.0 111.168 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.27 -35.65 70.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.987 1.315 . . . . 0.0 110.763 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.19 -44.09 76.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -61.25 -54.14 47.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -40.34 63.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.519 1.128 . . . . 0.0 111.07 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.1 mt -70.11 -57.56 4.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.78 1.632 . . . . 0.0 112.448 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 105' ' ' LEU . 4.5 tttm -65.88 -26.81 67.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.709 1.595 . . . . 0.0 111.913 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -44.95 -36.69 3.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.674 1.59 . . . . 0.0 111.528 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.57 14.3 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.44 1.018 . . . . 0.0 112.552 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.5 40.89 21.85 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.725 0.693 . . . . 0.0 112.286 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.21 -78.21 0.53 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.076 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -60.1 135.0 57.58 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 C--O 1.245 0.831 0 O-C-N 125.499 1.75 . . . . 0.0 108.006 -163.835 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.9 t80 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.7 -53.12 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.939 0.791 . . . . 0.0 109.937 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.36 -55.71 31.28 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.233 0.924 . . . . 0.0 111.467 -163.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.9 m -82.58 -6.69 59.49 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -65.52 -22.83 66.75 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.915 1.234 . . . . 0.0 110.639 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.8 154.87 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 120.637 1.562 . . . . 0.0 108.561 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -135.65 152.33 75.98 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.79 63.93 8.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.128 3.219 . . . . 0.0 110.976 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.4 31.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.933 1.254 . . . . 0.0 111.781 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -134.44 172.92 12.23 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.142 1.777 . . . . 0.0 107.756 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 21.1 t -116.76 111.51 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.7 t -132.38 115.91 27.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -158.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.69 130.16 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 123.003 0.521 . . . . 0.0 110.305 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.42 125.15 40.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.77 168.5 16.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.854 1.661 . . . . 0.0 110.512 -167.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -125.54 148.42 61.54 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 169.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.28 -39.08 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.701 2.267 . . . . 0.0 110.134 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 p -81.89 48.48 1.23 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.05 2.14 . . . . 0.0 109.966 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -140.67 127.06 11.77 Favored Pre-proline 0 C--O 1.242 0.679 0 C-N-CA 126.516 1.927 . . . . 0.0 109.387 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.56 -19.56 11.39 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.333 2.022 . . . . 0.0 112.038 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -73.59 -35.28 65.39 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 120.428 1.467 . . . . 0.0 108.305 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.27 -40.07 89.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -53.13 -53.95 42.93 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.156 0.434 . . . . 0.0 110.84 171.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -53.19 -59.18 4.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.552 0.741 . . . . 0.0 109.021 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -41.88 72.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 117.515 -1.231 . . . . 0.0 111.481 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -49.64 71.05 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 119.718 1.145 . . . . 0.0 112.162 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.43 -50.05 55.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.205 1.002 . . . . 0.0 110.124 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -46.69 -56.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 127.272 2.229 . . . . 0.0 109.586 170.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.66 -46.76 74.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -65.61 -18.65 65.48 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -73.52 -27.31 61.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.084 1.311 . . . . 0.0 110.397 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.66 135.43 81.13 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -82.25 63.32 8.2 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.089 2.526 . . . . 0.0 112.072 -167.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.57 147.74 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.244 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -46.45 124.54 5.94 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.856 1.662 . . . . 0.0 109.243 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.56 129.51 42.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -3.08 82.71 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 118.083 -1.398 . . . . 0.0 113.279 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.72 -30.99 46.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.813 2.306 . . . . 0.0 112.44 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 116.09 26.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -123.3 133.6 54.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.676 1.19 . . . . 0.0 108.219 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -110.56 139.03 46.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.7 t -135.39 108.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.288 1.035 . . . . 0.0 108.547 -164.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.29 122.76 17.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 111.942 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.427 HG22 HG21 ' A' ' 57' ' ' ILE . 45.2 pt -75.11 -20.47 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.955 1.302 . . . . 0.0 112.449 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 124.472 1.109 . . . . 0.0 110.893 -179.126 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.29 -62.62 1.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.94 -7.41 8.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.096 1.758 . . . . 0.0 113.531 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -36.0 16.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.84 1.655 . . . . 0.0 109.637 161.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 48' ' ' ILE . 11.3 mt -71.36 -50.06 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -167.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.55 76.09 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.009 0.524 . . . . 0.0 110.015 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -55.48 -56.85 15.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.547 1.539 . . . . 0.0 110.946 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -56.84 -29.91 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.84 2.056 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 72' ' ' ARG . 33.9 mt -60.48 -30.42 69.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.015 1.28 . . . . 0.0 111.73 174.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -60.28 -37.04 79.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.945 0.793 . . . . 0.0 109.731 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.16 -49.44 17.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.41 -30.42 57.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.54 -166.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.778 HG21 HH11 ' A' ' 72' ' ' ARG . 34.7 p -120.79 -62.56 1.44 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.904 1.229 . . . . 0.0 110.459 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.19 -34.69 0.2 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.154 -1.359 . . . . 0.0 114.341 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.35 144.88 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.123 1.461 . . . . 0.0 109.739 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -83.54 14.88 3.42 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.618 0.767 . . . . 0.0 112.368 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -105.84 163.76 12.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.578 1.656 . . . . 0.0 110.626 -158.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.99 144.38 46.18 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 127.632 2.373 . . . . 0.0 106.16 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.62 155.33 89.91 Favored 'Cis proline' 0 N--CA 1.454 -0.808 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 -4.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.778 HH11 HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.46 130.24 17.1 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 176.282 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.17 128.15 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 124.185 0.994 . . . . 0.0 109.559 -163.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -94.23 124.98 38.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.29 113.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 160.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.69 15.27 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.28 -0.887 . . . . 0.0 112.483 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt 46.52 3.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.852 2.461 . . . . 0.0 116.917 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.33 142.02 28.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.171 1.805 . . . . 0.0 107.637 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -101.25 123.5 45.47 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.893 -1.13 . . . . 0.0 112.271 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.62 -23.1 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.359 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.93 -165.22 21.02 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.292 0.949 . . . . 0.0 111.201 -171.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 -163.58 32.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.486 1.517 . . . . 0.0 110.885 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.1 p -65.61 -34.37 78.07 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.409 1.104 . . . . 0.0 110.49 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -62.01 -42.55 99.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.872 0.76 . . . . 0.0 111.113 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.66 -54.52 22.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.2 tp -51.91 -39.24 58.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.92 1.288 . . . . 0.0 111.9 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.6 t -58.56 -59.35 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 117.012 -1.471 . . . . 0.0 108.797 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.2 p -48.65 -54.74 13.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.556 1.98 . . . . 0.0 115.003 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . 6.6 mp -59.75 -32.81 70.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.447 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -72.01 -51.89 19.66 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.893 1.679 . . . . 0.0 110.245 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -58.58 3.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.07 1.748 . . . . 0.0 110.097 -168.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -16.99 64.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.852 1.261 . . . . 0.0 110.895 173.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.64 78.94 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.185 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.49 -22.72 67.05 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.816 2.308 . . . . 0.0 111.68 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 89' ' ' LEU . 5.9 tp -64.8 -24.67 67.62 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.576 174.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.34 -52.32 59.0 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 120.354 1.434 . . . . 0.0 108.632 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.1 m -57.07 -50.88 71.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.727 0.811 . . . . 0.0 109.956 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -47.6 -51.6 20.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.001 0.92 . . . . 0.0 110.712 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.29 -52.06 37.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.175 1.39 . . . . 0.0 111.3 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -62.18 -26.05 68.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.562 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -57.25 -33.1 67.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.072 0.851 . . . . 0.0 112.305 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.1 -14.92 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.905 1.229 . . . . 0.0 112.133 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.04 83.9 0.74 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -166.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.85 -76.41 0.46 Allowed 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.721 -1.609 . . . . 0.0 110.92 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.47 135.29 54.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 121.968 2.167 . . . . 0.0 108.503 -172.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.844 1.34 . . . . 0.0 109.132 -158.364 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.79 -48.92 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -68.47 -16.32 63.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.37 1.068 . . . . 0.0 112.421 -165.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -103.81 -26.24 12.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.862 1.665 . . . . 0.0 111.751 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -64.05 -43.8 94.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.491 1.042 . . . . 0.0 110.959 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.16 140.9 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.86 157.2 60.75 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.46 16.86 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.023 3.149 . . . . 0.0 114.828 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.57 45.32 0.2 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.8 2.143 . . . . 0.0 110.795 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -141.23 164.08 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.594 HG13 HD12 ' A' ' 75' ' ' ILE . 36.2 t -101.61 100.61 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.96 125.56 61.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 t -126.15 109.08 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -76.47 132.08 39.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -138.65 164.29 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.012 2.125 . . . . 0.0 108.874 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 145.87 34.02 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 158.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.53 16.11 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.923 3.082 . . . . 0.0 114.085 -161.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -129.4 -22.02 3.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.397 1.479 . . . . 0.0 112.665 -160.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -94.74 148.69 35.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -157.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.17 -25.19 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.874 2.382 . . . . 0.0 111.787 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -73.81 -43.39 58.96 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.12 1.768 . . . . 0.0 107.514 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -54.27 -47.12 72.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.476 1.111 . . . . 0.0 111.872 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -59.62 4.55 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.88 -36.69 65.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.356 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -54.91 -57.83 10.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.631 1.173 . . . . 0.0 112.554 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -70.68 -35.65 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.371 0.605 . . . . 0.0 110.815 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.63 -49.83 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.476 1.51 . . . . 0.0 109.796 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.31 -49.17 15.57 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.9 p -67.51 -25.96 66.1 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -162.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -80.83 -9.14 59.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 111.994 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.04 134.84 77.35 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 168.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.09 104.18 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.581 2.187 . . . . 0.0 108.784 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -122.71 151.7 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -57.87 124.27 18.64 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.71 136.51 56.37 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.95 84.6 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.18 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.51 -39.59 31.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.53 2.165 . . . . 0.0 111.675 166.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.7 93.48 8.04 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.035 0.834 . . . . 0.0 110.28 -159.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -110.63 116.05 30.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -84.73 119.18 24.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -113.63 131.42 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 127.591 2.356 . . . . 0.0 107.784 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.66 137.8 34.35 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.955 0.502 . . . . 0.0 110.279 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.8 pt -99.41 5.11 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 123.39 0.676 . . . . 0.0 112.248 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.33 -0.264 0 O-C-N 120.155 -1.59 . . . . 0.0 111.517 -174.851 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -33.93 -63.82 0.25 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 130.149 3.38 . . . . 0.0 110.059 166.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -49.36 -46.4 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.914 0.759 . . . . 0.0 111.606 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -49.97 59.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 110.973 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 mt -54.63 -43.41 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.706 1.602 . . . . 0.0 110.471 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -71.98 -45.85 59.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -170.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -48.55 76.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 109.888 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.33 -44.99 86.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.672 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.0 -42.61 76.67 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.261 1.024 . . . . 0.0 109.89 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -56.4 21.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.491 174.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.07 -51.23 68.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 123.556 0.535 . . . . 0.0 109.993 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.89 -45.26 95.3 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.306 1.442 . . . . 0.0 109.457 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 p -101.1 -65.19 0.99 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.552 0.614 . . . . 0.0 110.781 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.38 -4.48 2.55 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.638 2.066 . . . . 0.0 111.635 -172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.73 157.92 43.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.269 1.535 . . . . 0.0 109.141 169.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -118.77 -29.12 5.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.123 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 p -61.61 133.22 55.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -161.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.08 58.19 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.46 170.45 42.38 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 CA-C-N 118.649 0.553 . . . . 0.0 111.149 -7.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -130.12 100.33 5.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.15 129.26 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.11 104.87 12.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.768 2.027 . . . . 0.0 106.915 168.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.92 103.06 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 169.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.97 64.77 3.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.882 1.23 . . . . 0.0 113.014 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.72 13.09 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 127.7 2.4 . . . . 0.0 117.219 -168.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -100.69 103.55 14.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 120.454 1.479 . . . . 0.0 107.341 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.6 t -68.85 117.22 10.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.63 -25.8 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.563 0.745 . . . . 0.0 110.631 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.25 -171.29 23.75 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 123.462 0.553 . . . . 0.0 112.023 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.61 -169.01 41.41 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 125.409 1.481 . . . . 0.0 111.463 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 p -63.43 -38.01 89.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.871 0.835 . . . . 0.0 110.507 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.235 0.47 . . . . 0.0 111.804 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.64 -49.51 21.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -52.68 -34.66 53.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.059 1.744 . . . . 0.0 112.605 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.64 -50.84 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.164 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -44.99 92.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.606 1.548 . . . . 0.0 107.691 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.79 -31.65 71.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.04 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -69.18 -61.34 1.83 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.25 1.386 . . . . 0.0 109.085 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -50.7 66.47 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.872 2.069 . . . . 0.0 111.658 -166.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -3.71 32.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.27 1.828 . . . . 0.0 111.778 172.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.97 -0.72 82.19 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.038 -1.424 . . . . 0.0 115.113 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.24 -33.87 72.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.153 1.976 . . . . 0.0 111.442 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.3 tp -60.3 -33.22 72.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.689 0.796 . . . . 0.0 111.125 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.63 -40.03 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -72.48 -48.05 43.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -40.24 58.57 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.945 0.793 . . . . 0.0 111.815 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.76 -56.59 9.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 110.567 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -59.38 -24.31 63.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.829 1.195 . . . . 0.0 112.873 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -48.66 -41.69 32.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.681 1.193 . . . . 0.0 110.705 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.98 -1.63 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.26 59.97 1.79 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.28 -73.04 0.66 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.416 1.486 . . . . 0.0 112.412 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 2.8 mt -62.57 135.4 57.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.28 -153.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.5 t80 . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.59 -60.25 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 109.017 169.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -70.0 -11.86 61.18 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -159.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -106.55 -15.48 14.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.148 0.979 . . . . 0.0 112.931 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -63.93 -57.56 9.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.22 1.373 . . . . 0.0 107.517 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.6 150.48 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -144.34 172.4 5.52 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.189 1.795 . . . . 0.0 106.28 161.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.05 17.18 0.87 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.178 2.585 . . . . 0.0 114.912 -163.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.3 12.07 1.2 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.655 2.55 . . . . 0.0 112.16 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.06 148.67 29.46 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.849 1.824 . . . . 0.0 108.585 170.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 t -102.54 86.62 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.84 147.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 O-C-N 120.829 -1.169 . . . . 0.0 108.539 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.9 116.21 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.12 128.89 34.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.18 175.24 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.276 1.43 . . . . 0.0 110.879 -167.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 70' ' ' VAL . 15.3 ptpt -137.97 144.72 45.01 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 158.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.84 -31.66 47.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.305 2.67 . . . . 0.0 112.268 -168.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -65.78 -35.96 82.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.508 0.723 . . . . 0.0 111.829 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 48.7 t -61.01 118.67 37.97 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 124.557 1.143 . . . . 0.0 109.717 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.93 -20.25 34.26 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.772 1.648 . . . . 0.0 111.073 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.416 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 22.9 m-85 -73.49 -39.35 64.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -60.61 -49.42 77.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -57.24 -46.07 83.34 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.425 0.557 . . . . 0.0 111.636 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -56.52 -54.24 48.14 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 118.833 0.742 . . . . 0.0 109.947 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.2 -39.23 59.87 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.223 0.952 . . . . 0.0 111.43 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.02 66.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.673 171.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -55.03 31.64 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.226 1.01 . . . . 0.0 109.741 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.63 -47.17 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.077 2.151 . . . . 0.0 110.237 176.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.11 -42.73 31.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 m -61.42 -21.87 64.5 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.85 -11.55 60.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.91 . . . . 0.0 111.851 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.3 133.51 21.97 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.85 81.77 2.49 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.633 2.889 . . . . 0.0 110.284 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 99' ' ' LEU . 9.5 mt -102.57 155.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -167.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -50.75 123.31 8.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.659 0.783 . . . . 0.0 109.266 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -66.58 157.05 33.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.099 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.86 -20.66 2.84 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.205 -1.331 . . . . 0.0 112.68 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -73.86 -37.14 64.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.538 2.169 . . . . 0.0 109.795 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -83.92 104.1 13.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -171.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -123.35 113.62 19.09 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 43' ' ' LEU . 14.1 m-85 -84.07 107.2 16.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 171.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.92 106.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 126.427 1.891 . . . . 0.0 107.288 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.78 133.08 52.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 122.649 -0.032 . . . . 0.0 110.953 166.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 pt -106.25 -13.75 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.33 1.452 . . . . 0.0 110.758 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.632 1.173 . . . . 0.0 111.083 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m170 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.77 -63.42 0.91 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.316 -1.325 . . . . 0.0 111.777 168.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -47.36 -51.45 19.57 Favored 'General case' 0 C--O 1.217 -0.629 0 O-C-N 124.452 1.095 . . . . 0.0 109.911 -171.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.11 -50.1 75.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.515 0.598 . . . . 0.0 110.352 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -62.34 -35.66 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.964 0.906 . . . . 0.0 108.816 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.21 -37.2 33.64 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 -168.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.43 -46.18 84.31 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 127.502 2.321 . . . . 0.0 110.475 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -61.51 -44.92 96.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.326 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -57.4 -39.21 75.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.973 1.261 . . . . 0.0 110.524 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -41.78 93.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.502 0.721 . . . . 0.0 110.385 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -63.62 -58.53 6.64 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.508 -0.745 . . . . 0.0 110.053 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 tp -65.32 -30.22 71.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.676 2.39 . . . . 0.0 111.775 -166.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.69 -26.47 2.96 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.192 1.36 . . . . 0.0 112.993 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.96 27.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.934 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.77 144.83 27.28 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.365 2.083 . . . . 0.0 110.414 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -85.84 -18.63 32.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.968 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -70.83 134.08 47.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -163.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.4 m -96.28 166.12 14.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.556 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -58.82 159.01 35.48 Favored 'Cis proline' 0 C--N 1.345 0.36 0 CA-C-N 119.657 0.913 . . . . 0.0 110.305 -15.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 mtp85 -126.39 105.7 8.97 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.58 125.25 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -110.79 99.57 8.47 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 107.065 168.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 109.79 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.28 64.67 2.17 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.016 1.769 . . . . 0.0 111.761 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 tttt 46.14 17.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.458 2.703 . . . . 0.0 117.394 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -98.53 115.56 28.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.26 1.391 . . . . 0.0 107.568 159.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -67.01 108.79 2.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.2 pp -83.55 -11.01 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.656 0.662 . . . . 0.0 110.555 -174.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -165.64 24.44 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.154 1.359 . . . . 0.0 110.008 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.65 -165.36 39.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -39.76 93.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.716 -0.873 . . . . 0.0 110.775 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -66.6 -26.01 66.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.316 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.74 -51.9 6.13 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.6 tp -46.55 -39.68 11.4 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.334 1.853 . . . . 0.0 111.269 172.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.29 -48.39 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 116.434 -1.746 . . . . 0.0 110.802 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -44.7 76.65 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.989 1.722 . . . . 0.0 106.857 -176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.36 -34.28 72.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.044 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.09 -56.37 9.09 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.627 1.558 . . . . 0.0 110.408 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -50.22 55.8 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.499 -1.375 . . . . 0.0 110.261 -167.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 t -70.74 -12.15 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.138 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.49 16.28 71.47 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 117.695 -1.614 . . . . 0.0 112.992 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.42 -30.91 70.86 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.542 2.171 . . . . 0.0 110.597 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -49.91 -37.39 31.38 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.985 2.114 . . . . 0.0 111.453 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -55.82 28.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.238 1.015 . . . . 0.0 110.534 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.0 m -62.49 -43.8 97.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.015 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -38.88 77.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.13 0.877 . . . . 0.0 110.302 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' ILE . 14.6 mt -68.67 -51.62 39.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.99 -1.069 . . . . 0.0 111.056 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -55.57 -25.84 40.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.054 1.297 . . . . 0.0 114.3 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -47.4 -36.03 9.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.985 1.314 . . . . 0.0 111.582 168.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -6.22 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.735 0.814 . . . . 0.0 111.973 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.92 85.02 0.23 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -169.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.41 -70.11 0.43 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.602 2.361 . . . . 0.0 109.008 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.58 148.68 51.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 121.081 1.764 . . . . 0.0 107.407 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.247 0.962 0 O-C-N 126.057 2.098 . . . . 0.0 107.37 158.725 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.626 0.25 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.92 -49.46 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.32 -46.86 81.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 t -79.69 10.27 4.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.144 2.178 . . . . 0.0 112.34 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -106.49 -34.61 7.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.712 -1.243 . . . . 0.0 109.862 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.07 148.2 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.53 1.059 . . . . 0.0 108.998 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -135.8 139.13 29.79 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 159.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -63.1 158.47 43.75 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.082 1.855 . . . . 0.0 109.098 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.75 17.36 41.95 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.547 -0.721 . . . . 0.0 113.528 -171.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 156.74 46.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.666 1.987 . . . . 0.0 107.981 172.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -107.85 104.53 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.91 125.7 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.87 112.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -167.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.61 126.79 34.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.78 -178.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 0.0 111.429 -166.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.2 160.55 61.82 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 127.037 2.135 . . . . 0.0 107.086 172.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.67 -17.17 10.0 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.511 2.141 . . . . 0.0 111.638 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -129.16 24.57 5.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.732 2.013 . . . . 0.0 111.041 -163.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -107.17 115.29 60.16 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.16 -18.41 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.915 1.743 . . . . 0.0 111.07 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -74.17 -37.83 63.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.64 -50.35 65.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -49.03 -47.34 44.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.698 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -63.31 1.18 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 119.137 0.88 . . . . 0.0 109.348 173.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.0 58.87 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.143 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.48 -45.78 85.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.019 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.06 -30.95 55.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 121.724 2.056 . . . . 0.0 111.841 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mt -57.3 -55.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.282 1.433 . . . . 0.0 107.456 170.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.92 -56.13 4.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t -65.07 -20.91 66.71 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -160.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -73.62 -21.31 60.34 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.21 0.914 . . . . 0.0 111.914 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.93 149.53 90.01 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.181 0.9 . . . . 0.0 110.498 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.92 109.24 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.108 2.539 . . . . 0.0 108.57 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.416 HD13 HD23 ' A' ' 43' ' ' LEU . 6.2 mt -130.72 147.55 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -174.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.39 155.21 5.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.028 1.331 . . . . 0.0 109.882 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.96 100.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.377 1.871 . . . . 0.0 111.043 -172.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.18 19.55 75.82 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.587 167.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 mt -73.44 -25.88 60.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.31 2.055 . . . . 0.0 110.891 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.09 103.65 13.5 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 120.309 1.413 . . . . 0.0 107.305 178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -115.14 102.29 9.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.039 1.336 . . . . 0.0 107.841 -170.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.13 131.08 34.81 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.0 t -128.14 100.85 6.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 125.542 1.537 . . . . 0.0 108.029 -166.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.61 119.6 22.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.075 0.55 . . . . 0.0 110.957 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.94 -9.15 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 124.58 1.152 . . . . 0.0 109.755 179.82 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.74 -63.77 0.29 Allowed 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 127.73 2.412 . . . . 0.0 109.961 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.29 -32.76 39.05 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -45.24 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.766 -1.209 . . . . 0.0 111.008 174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 mt -57.34 -38.05 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.462 1.105 . . . . 0.0 110.208 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -63.33 -47.18 83.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.739 2.416 . . . . 0.0 106.934 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.67 -45.93 88.32 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.076 0.95 . . . . 0.0 110.006 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -61.06 -37.19 81.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.265 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.5 mt -55.77 -47.49 76.93 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 121.197 1.817 . . . . 0.0 109.206 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -54.12 -47.53 71.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.963 0.789 . . . . 0.0 111.08 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.91 77.48 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.054 0.542 . . . . 0.0 110.66 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD2' HH12 ' A' ' 72' ' ' ARG . 9.5 tp -75.71 -24.5 56.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.891 0.876 . . . . 0.0 110.022 -168.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.2 p -121.34 -65.92 1.09 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.513 1.051 . . . . 0.0 110.099 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.66 -4.76 0.68 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.564 2.03 . . . . 0.0 112.038 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.31 142.57 32.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.976 1.888 . . . . 0.0 109.518 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -95.63 -15.55 22.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 141.83 55.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.866 0.757 . . . . 0.0 110.755 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 158.22 33.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.994 1.718 . . . . 0.0 108.265 171.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.03 141.17 50.62 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 N-CA-C 110.034 -0.795 . . . . 0.0 110.034 -5.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.407 HH12 ' CD2' ' A' ' 64' ' ' LEU . 21.0 ttp180 -109.56 96.57 6.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.36 126.74 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -122.82 94.01 4.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.49 117.1 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.95 66.33 2.54 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 124.832 1.206 . . . . 0.0 114.016 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt 46.08 31.95 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -143.87 148.41 35.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.684 1.129 . . . . 0.0 110.09 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.3 139.32 30.61 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 119.334 0.97 . . . . 0.0 110.149 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.28 -7.89 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.47 0.577 . . . . 0.0 112.249 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.28 -88.23 0.25 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.76 -80.41 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -39.29 1.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.625 0.77 . . . . 0.0 112.255 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -76.89 -25.85 53.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.648 1.567 . . . . 0.0 111.15 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.74 -43.76 83.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.286 1.035 . . . . 0.0 108.318 165.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.34 -36.61 76.0 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.008 0.523 . . . . 0.0 111.086 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -60.41 -46.22 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 117.435 -1.269 . . . . 0.0 109.65 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -48.43 79.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.431 1.469 . . . . 0.0 107.217 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mt -56.21 -39.69 72.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.999 0.92 . . . . 0.0 109.006 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -58.65 6.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.394 1.452 . . . . 0.0 110.032 172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -50.55 66.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.095 1.358 . . . . 0.0 110.767 -164.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.9 t -75.97 -2.33 29.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.134 1.774 . . . . 0.0 111.562 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.44 5.74 44.92 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.624 -1.654 . . . . 0.0 113.866 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -65.2 -21.45 66.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.905 2.353 . . . . 0.0 110.504 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -49.85 -40.0 40.89 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.471 1.508 . . . . 0.0 111.88 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.87 -50.82 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -56.76 -54.15 49.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.9 1.28 . . . . 0.0 109.721 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -38.63 63.9 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.772 2.029 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.59 -49.68 20.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.073 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -62.51 -23.47 66.97 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.642 1.565 . . . . 0.0 112.765 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -52.35 -20.38 2.72 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.883 1.673 . . . . 0.0 112.955 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.2 8.89 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.015 1.279 . . . . 0.0 113.671 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.38 41.13 31.39 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.383 -0.823 . . . . 0.0 111.6 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -89.14 -74.52 0.47 Allowed 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.285 1.434 . . . . 0.0 111.181 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.33 55.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.249 1.027 0 O-C-N 124.463 1.102 . . . . 0.0 108.933 -163.069 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.29 -49.69 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.021 0.828 . . . . 0.0 109.479 171.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.26 -48.19 81.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -164.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -74.16 -21.95 59.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.754 0.822 . . . . 0.0 111.733 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HG2' HG11 ' A' ' 46' ' ' VAL . 2.8 mptp? -64.79 -48.12 75.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.025 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.01 149.8 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -145.27 152.64 50.99 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.29 160.97 28.75 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.225 1.283 . . . . 0.0 109.78 159.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.86 24.33 33.47 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.869 -0.962 . . . . 0.0 113.917 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -141.43 160.11 40.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.531 1.666 . . . . 0.0 107.877 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 75' ' ' ILE . 40.4 t -120.74 87.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.51 129.42 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.86 112.45 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -166.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.92 124.91 29.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.7 178.42 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.929 2.092 . . . . 0.0 110.395 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -133.89 160.31 69.05 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 159.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.5 -30.52 3.13 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.994 1.796 . . . . 0.0 110.848 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -91.21 3.18 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.048 1.339 . . . . 0.0 111.96 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 1.3 m -90.24 110.55 41.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.226 1.011 . . . . 0.0 112.042 173.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -28.51 38.34 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 112.12 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -73.78 -24.08 59.79 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.607 1.094 . . . . 0.0 110.977 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.73 -52.09 48.43 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 166.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -55.04 -37.6 66.9 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.413 1.085 . . . . 0.0 113.544 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -59.32 -61.16 2.84 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 118.428 0.558 . . . . 0.0 110.263 169.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.4 -34.07 46.56 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 124.575 1.172 . . . . 0.0 110.969 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -53.18 60.2 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 126.256 1.822 . . . . 0.0 112.967 171.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -53.62 35.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.96 -50.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.843 1.657 . . . . 0.0 110.905 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.89 -45.26 59.2 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -63.02 -16.37 59.59 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.39 -31.2 63.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.937 1.699 . . . . 0.0 109.939 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.6 136.89 55.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.26 61.45 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.203 3.268 . . . . 0.0 112.719 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.63 150.16 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -53.07 124.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.826 0.85 . . . . 0.0 110.119 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -53.2 128.26 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.48 -23.58 34.63 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.005 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.89 -37.89 64.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 119.823 1.811 . . . . 0.0 110.612 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.19 106.73 16.05 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -129.14 115.12 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.859 0.838 . . . . 0.0 111.426 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -83.9 105.46 14.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.416 HG11 ' HG2' ' A' ' 9' ' ' LYS . 47.6 t -91.84 125.67 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.907 2.083 . . . . 0.0 106.731 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -82.27 128.63 34.38 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.415 -0.803 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -63.09 -23.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.15 -0.969 . . . . 0.0 111.12 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.444 -0.733 0 C-N-CA 126.424 1.89 . . . . 0.0 106.822 -175.068 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -62.71 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 122.225 2.284 . . . . 0.0 111.473 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -48.55 -48.32 38.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.708 0.803 . . . . 0.0 112.101 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -28.81 69.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.526 1.53 . . . . 0.0 113.377 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 mt -81.65 -34.56 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.602 1.961 . . . . 0.0 107.922 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.61 -50.98 25.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.535 2.334 . . . . 0.0 107.851 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -45.51 -53.1 9.41 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.577 1.551 . . . . 0.0 111.013 167.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.09 -42.33 99.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.999 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.26 -40.29 85.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.839 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.63 -50.84 70.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.301 1.04 . . . . 0.0 109.386 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.06 -46.33 89.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 111.864 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.26 -38.4 56.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 109.287 -170.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -112.27 -28.99 7.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.06 -5.02 35.97 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.948 1.261 . . . . 0.0 112.738 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.47 147.06 28.7 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.512 1.656 . . . . 0.0 109.674 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -84.92 -18.44 34.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.085 -0.483 . . . . 0.0 111.914 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -64.72 133.55 52.32 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.345 0.52 . . . . 0.0 110.113 -162.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 165.41 31.94 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.542 0.737 . . . . 0.0 109.475 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -65.47 165.7 56.04 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -15.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.98 96.72 4.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.06 105.21 13.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.006 1.722 . . . . 0.0 106.791 166.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.06 107.22 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 167.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.07 69.38 0.77 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.428 1.49 . . . . 0.0 113.066 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tttm 46.05 31.0 1.03 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.421 1.888 . . . . 0.0 115.985 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -128.96 127.25 41.33 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.626 1.103 . . . . 0.0 108.885 159.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.54 138.48 43.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -114.86 12.92 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.148 0.979 . . . . 0.0 111.223 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -149.06 21.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 -10.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.25 150.83 29.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 t 61.46 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -48.96 69.19 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.005 1.322 . . . . 0.0 109.566 -175.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.3 -46.84 36.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.979 2.112 . . . . 0.0 111.475 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.53 -48.24 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.25 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -47.77 77.07 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.663 1.574 . . . . 0.0 109.128 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.58 -35.46 74.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.45 -56.91 6.79 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.58 1.536 . . . . 0.0 109.639 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -53.84 41.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.32 1.848 . . . . 0.0 111.303 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.5 t -70.6 -15.84 62.79 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.875 2.47 . . . . 0.0 111.019 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.09 1.33 84.63 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 118.393 -1.226 . . . . 0.0 113.617 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.23 -33.27 73.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 120.066 1.933 . . . . 0.0 111.394 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.19 -38.65 73.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.232 1.413 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -55.04 25.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.79 1.236 . . . . 0.0 108.677 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -61.47 -42.51 98.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.643 0.777 . . . . 0.0 110.246 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.91 83.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.692 0.797 . . . . 0.0 111.317 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.09 -48.69 61.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.283 1.033 . . . . 0.0 110.337 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' CG ' ' HB2' ' A' ' 105' ' ' LEU . 11.6 mtpt -57.42 -31.12 65.55 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.788 -1.195 . . . . 0.0 112.979 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -24.54 40.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.737 0.815 . . . . 0.0 111.591 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.01 23.97 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.818 0.847 . . . . 0.0 111.514 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.0 16.34 57.99 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 164.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.96 -70.46 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.402 1.101 . . . . 0.0 111.167 -166.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HB2' ' CG ' ' A' ' 100' ' ' LYS . 3.0 mm? -72.39 146.16 47.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.102 -165.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 112.67 -2.059 . . . . 0.0 109.968 -173.493 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.9 t80 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.97 -59.75 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 0.0 109.171 170.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.1 -33.73 76.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.091 2.556 . . . . 0.0 110.827 -166.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.23 -51.18 65.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.263 3.425 . . . . 0.0 110.443 172.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 40.7 mmtm -69.8 -17.27 63.39 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.842 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 77' ' ' LYS . 6.9 mm -73.9 129.92 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 119.156 0.889 . . . . 0.0 108.694 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -131.11 159.22 72.57 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 159.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.07 70.05 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.884 3.056 . . . . 0.0 109.789 169.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.7 64.87 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 126.719 2.104 . . . . 0.0 108.464 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -151.11 159.05 44.71 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.622 2.369 . . . . 0.0 105.597 165.174 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.704 HG13 HD12 ' A' ' 75' ' ' ILE . 60.3 t -117.04 87.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 172.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.421 HG11 ' CZ ' ' A' ' 18' ' ' PHE . 64.0 t -85.46 151.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.904 -1.123 . . . . 0.0 108.247 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.36 116.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 160.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' A' ' 16' ' ' VAL . 71.1 m-85 -77.3 125.58 29.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.11 176.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.681 1.993 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 160.46 43.65 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.378 1.871 . . . . 0.0 108.956 171.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -82.19 26.43 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.191 3.261 . . . . 0.0 110.56 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.364 2.9 t -138.2 -106.63 0.18 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.75 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m 32.65 104.21 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 129.916 3.286 . . . . 0.0 113.989 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.23 -16.88 36.37 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.202 1.268 . . . . 0.0 112.211 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -74.36 -47.91 31.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.062 1.345 . . . . 0.0 108.852 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.1 m -63.93 -44.35 93.16 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -53.19 -45.28 68.5 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.353 1.061 . . . . 0.0 110.343 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.66 -60.1 4.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 118.816 -0.612 . . . . 0.0 109.578 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.04 64.57 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.187 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -52.59 64.98 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.167 0.894 . . . . 0.0 112.451 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.18 -40.5 67.87 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.491 0.587 . . . . 0.0 109.753 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.0 mt -53.88 -53.13 29.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.821 1.248 . . . . 0.0 109.584 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.62 -44.47 56.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.132 -0.937 . . . . 0.0 108.564 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.1 m -55.81 -27.92 53.7 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -73.45 -19.71 60.89 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.018 0.826 . . . . 0.0 110.952 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -87.57 133.7 37.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.707 1.139 . . . . 0.0 107.936 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.77 114.55 4.05 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.206 1.938 . . . . 0.0 108.829 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.25 152.13 36.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -54.16 123.6 13.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.94 150.64 48.31 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 -30.03 6.34 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.931 -168.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.51 -47.05 24.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 120.42 2.11 . . . . 0.0 111.533 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -83.57 107.5 16.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.822 1.192 . . . . 0.0 108.433 -164.16 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.03 111.47 12.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.738 0.78 . . . . 0.0 110.431 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -84.01 102.55 12.56 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.41 121.3 49.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.78 1.632 . . . . 0.0 107.637 -172.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.7 133.68 34.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.593 -170.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -88.18 -12.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.846 1.658 . . . . 0.0 113.843 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 123.923 0.889 . . . . 0.0 110.987 -166.561 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m80 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -63.37 1.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 121.362 1.892 . . . . 0.0 110.236 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.25 -41.47 75.8 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 119.694 -0.194 . . . . 0.0 111.394 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -49.04 77.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.444 1.498 . . . . 0.0 111.65 173.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.43 -39.58 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.296 1.838 . . . . 0.0 108.512 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -80.33 -40.09 27.38 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -164.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -58.01 -53.94 52.57 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.449 1.9 . . . . 0.0 108.903 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -53.23 -49.4 66.9 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.896 1.278 . . . . 0.0 109.946 172.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.25 -29.29 63.68 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.436 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.93 -59.88 4.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.132 1.333 . . . . 0.0 109.13 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.13 -36.61 82.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.091 0.557 . . . . 0.0 111.23 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.61 -20.05 58.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.889 1.276 . . . . 0.0 110.404 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.4 p -125.84 -76.23 0.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.744 1.611 . . . . 0.0 112.744 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.1 -6.87 0.07 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.66 2.076 . . . . 0.0 113.797 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.09 152.78 35.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.559 1.68 . . . . 0.0 109.078 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -97.46 -3.2 40.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.112 0.965 . . . . 0.0 111.882 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -69.59 141.75 53.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.13 157.81 32.97 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 125.62 1.568 . . . . 0.0 108.931 166.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.7 161.85 52.49 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 CA-C-N 120.256 1.127 . . . . 0.0 111.829 -4.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -132.16 97.61 4.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.5 1.12 . . . . 0.0 108.313 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.9 t -75.03 120.93 25.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.94 96.58 6.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.827 1.651 . . . . 0.0 107.335 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.704 HD12 HG13 ' A' ' 15' ' ' VAL . 1.4 mp -83.85 116.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 161.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.29 87.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.514 2.007 . . . . 0.0 115.374 162.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 10' ' ' ILE . 15.4 mtpp 46.83 -12.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 131.512 3.925 . . . . 0.0 117.434 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -99.06 167.74 10.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 119.529 1.058 . . . . 0.0 109.209 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -120.16 125.49 48.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.401 1.48 . . . . 0.0 107.611 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.62 -23.58 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.567 0.222 . . . . 0.0 111.315 -164.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.85 177.11 15.43 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -159.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.45 -84.12 1.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -167.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.23 -64.15 1.06 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.234 1.014 . . . . 0.0 110.255 -173.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -49.8 64.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.74 1.155 . . . . 0.0 111.166 176.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.0 -36.66 78.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.138 1.775 . . . . 0.0 107.783 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.65 -40.51 84.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.083 0.953 . . . . 0.0 110.074 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.88 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 116.273 -1.822 . . . . 0.0 109.384 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.294 5.1 p -54.1 -47.27 71.96 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 121.987 2.176 . . . . 0.0 114.783 168.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.02 -43.87 70.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.333 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -60.69 -54.95 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.259 2.299 . . . . 0.0 110.693 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -42.99 58.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.486 1.914 . . . . 0.0 114.157 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -14.6 61.29 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 168.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.9 2.69 88.38 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.338 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.49 -17.49 64.83 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.916 1.858 . . . . 0.0 112.236 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -43.6 97.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.436 1.494 . . . . 0.0 109.495 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.22 -44.58 97.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 109.399 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -59.36 -54.08 50.85 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.079 0.552 . . . . 0.0 109.797 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -44.55 65.42 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.257 1.023 . . . . 0.0 111.55 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.5 mt -65.44 -50.59 64.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.56 1.144 . . . . 0.0 110.269 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -23.51 61.22 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.181 -0.949 . . . . 0.0 113.329 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.54 -29.09 9.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.173 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.16 26.6 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.394 1.078 . . . . 0.0 111.936 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.29 19.06 73.87 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.385 1.469 . . . . 0.0 114.725 168.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.34 -57.08 4.18 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 112.108 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.6 133.27 50.81 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -153.084 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -112.45 -47.52 3.08 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -57.31 -31.19 65.43 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.38 -60.6 3.6 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.542 1.065 . . . . 0.0 109.165 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.61 -45.77 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -55.79 -50.18 71.18 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.361 0.664 . . . . 0.0 111.34 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.22 -25.72 36.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.941 0.896 . . . . 0.0 111.781 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -65.58 -38.45 89.55 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.811 1.187 . . . . 0.0 110.621 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.91 154.84 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 120.63 1.559 . . . . 0.0 107.9 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.9 166.93 14.89 Favored Pre-proline 0 C--O 1.241 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 107.175 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.56 158.59 52.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 159.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.77 84.24 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 113.968 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.62 151.56 38.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.174 2.19 . . . . 0.0 108.961 163.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.3 t -103.68 79.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.203 1.401 . . . . 0.0 107.476 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.09 140.7 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.02 115.82 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -81.54 131.94 35.29 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 171.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 126.294 1.838 . . . . 0.0 111.235 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -140.15 143.94 35.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 162.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.14 -10.99 24.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.602 1.535 . . . . 0.0 110.985 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 p -89.46 -9.31 50.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.472 1.509 . . . . 0.0 111.882 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.33 123.62 85.78 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.527 1.058 . . . . 0.0 109.092 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.67 -23.67 48.79 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.672 1.581 . . . . 0.0 110.291 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.37 -28.92 62.3 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.673 0.789 . . . . 0.0 110.369 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.0 m -68.02 -32.08 72.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -65.89 -38.28 88.33 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.932 0.787 . . . . 0.0 111.833 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -59.56 4.97 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.91 -35.88 58.86 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 124.051 0.845 . . . . 0.0 111.343 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -45.96 92.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.117 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.93 -50.9 25.12 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -46.05 -50.39 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.738 1.215 . . . . 0.0 110.563 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mt -79.59 -48.39 13.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -70.63 -6.18 34.93 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.8 -21.25 60.22 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.456 1.025 . . . . 0.0 110.725 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.91 142.09 24.58 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.797 . . . . 0.0 109.964 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.11 109.75 2.78 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.64 2.894 . . . . 0.0 110.075 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HD23 ' A' ' 43' ' ' LEU . 12.2 mt -133.68 149.84 31.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -169.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -53.0 127.69 24.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 118.195 0.452 . . . . 0.0 110.995 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.12 131.08 49.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.757 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.86 52.73 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.287 1.422 . . . . 0.0 111.841 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.95 -34.44 64.3 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.951 1.375 . . . . 0.0 110.665 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.36 111.32 18.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -175.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -129.08 108.75 10.63 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -83.93 102.49 12.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.77 137.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.506 1.923 . . . . 0.0 106.965 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.12 149.5 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.728 -0.608 . . . . 0.0 110.816 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.65 10.19 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.102 1.761 . . . . 0.0 112.27 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -133.8 -20.43 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 120.581 1.537 . . . . 0.0 111.882 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.98 74.84 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.405 -1.435 . . . . 0.0 113.99 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.29 20.74 0.95 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -161.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.497 HD22 HD12 ' A' ' 57' ' ' ILE . 11.5 p-10 -156.6 -148.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.229 -0.919 . . . . 0.0 110.396 -162.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -137.06 100.76 4.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.15 2.98 . . . . 0.0 103.016 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -42.14 -63.31 0.77 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -43.85 -33.1 1.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.921 2.488 . . . . 0.0 113.758 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.36 -60.68 1.93 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 52' ' ' ASN . 1.3 mt -54.76 -33.85 28.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 124.972 1.309 . . . . 0.0 111.173 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -73.63 -40.68 63.6 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.31 -44.63 87.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.077 1.751 . . . . 0.0 110.496 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.53 -48.15 81.81 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.035 -0.416 . . . . 0.0 110.469 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.78 -36.41 69.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.096 0.959 . . . . 0.0 110.288 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -50.47 68.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.509 0.724 . . . . 0.0 110.418 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -68.73 -45.28 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.084 0.553 . . . . 0.0 110.279 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.79 -30.79 59.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 p -123.72 -12.78 7.58 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.65 59.66 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.292 1.405 . . . . 0.0 113.178 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.46 149.47 18.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.357 1.079 . . . . 0.0 109.935 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -102.9 -25.29 13.53 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.811 0.844 . . . . 0.0 112.649 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -71.29 144.31 50.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.95 165.99 11.81 Favored Pre-proline 0 C--O 1.244 0.777 0 C-N-CA 126.372 1.869 . . . . 0.0 109.21 -170.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.58 161.91 51.53 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 119.287 0.781 . . . . 0.0 111.424 -3.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -137.81 97.11 3.35 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.14 127.49 39.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.23 96.03 5.59 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.836 2.454 . . . . 0.0 107.879 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.428 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.61 107.84 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 38.37 81.48 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 127.432 2.444 . . . . 0.0 113.135 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 16.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.37 2.268 . . . . 0.0 116.996 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.96 110.81 18.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 119.024 0.829 . . . . 0.0 108.836 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.28 117.12 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.54 -21.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.53 -155.76 21.3 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.64 -168.75 31.2 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.982 1.753 . . . . 0.0 110.253 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.75 -24.66 64.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.578 -1.201 . . . . 0.0 112.126 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m -60.63 -49.22 78.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 120.231 1.378 . . . . 0.0 109.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -41.29 84.86 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.692 0.797 . . . . 0.0 109.57 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.7 tp -56.59 -39.25 73.22 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.367 0.667 . . . . 0.0 112.004 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -61.92 -46.08 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.044 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.58 -56.47 21.73 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.73 -27.15 68.71 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.912 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -68.05 -54.07 21.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.586 1.539 . . . . 0.0 109.454 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -40.8 77.37 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.702 1.201 . . . . 0.0 111.775 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -70.61 -20.52 62.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.529 2.732 . . . . 0.0 110.262 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.9 6.63 82.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.722 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.61 -31.98 72.91 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 120.273 2.036 . . . . 0.0 109.514 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.43 -40.9 75.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.191 1.796 . . . . 0.0 110.445 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.11 -47.72 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.592 0.633 . . . . 0.0 109.339 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m -60.82 -49.52 77.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.279 0.632 . . . . 0.0 109.351 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -48.77 61.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.598 1.159 . . . . 0.0 110.688 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -49.3 70.88 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.334 1.054 . . . . 0.0 112.734 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -67.43 -25.11 65.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 117.088 -1.845 . . . . 0.0 112.717 -166.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -48.16 -46.22 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.764 0.665 . . . . 0.0 110.448 168.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.71 8.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.903 0.774 . . . . 0.0 112.078 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.67 34.21 44.64 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.602 1.096 . . . . 0.0 111.701 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.31 -74.52 0.38 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.39 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.59 133.75 55.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.773 1.169 . . . . 0.0 110.578 -159.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 131.144 3.778 . . . . 0.0 104.858 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 116.47 -1.728 . . . . 0.0 115.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -66.67 34.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 122.099 2.227 . . . . 0.0 113.559 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -163.42 -57.41 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.262 2.225 . . . . 0.0 105.502 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -55.81 -51.69 66.59 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.763 1.165 . . . . 0.0 110.923 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.43 -49.29 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.322 0.51 . . . . 0.0 109.895 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.86 -53.12 55.6 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.547 0.612 . . . . 0.0 111.262 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.9 m -68.76 -5.4 20.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.214 1.406 . . . . 0.0 112.659 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.6 -26.4 45.4 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.508 167.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.26 167.45 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 165.08 18.98 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 128.194 2.598 . . . . 0.0 105.735 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.6 61.47 7.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.709 2.273 . . . . 0.0 111.951 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.74 16.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.745 -1.031 . . . . 0.0 115.513 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -119.05 160.11 22.66 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.486 1.643 . . . . 0.0 108.002 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.1 t -108.96 98.78 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.59 151.68 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.56 115.22 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -74.81 120.42 20.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.07 176.04 7.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 127.462 2.305 . . . . 0.0 110.268 -171.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -122.89 158.69 56.49 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 164.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.95 9.75 2.26 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.759 2.972 . . . . 0.0 112.971 -168.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.306 0.1 OUTLIER -133.35 -106.17 0.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -173.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t 33.83 115.06 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 130.975 3.71 . . . . 0.0 113.702 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -61.75 -20.32 68.62 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.96 1.107 . . . . 0.0 112.602 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -81.8 -42.6 19.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.76 -43.13 99.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -54.35 -53.42 54.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.31 1.044 . . . . 0.0 110.204 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -55.81 27.8 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.1 69.89 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.677 0.611 . . . . 0.0 110.868 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -54.6 -51.98 63.61 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.81 1.244 . . . . 0.0 112.557 172.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.8 -47.61 45.12 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 126.342 1.857 . . . . 0.0 110.178 -171.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -50.21 -56.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.207 1.803 . . . . 0.0 108.079 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.83 -43.25 62.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.268 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.3 m -70.39 -4.43 22.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.8 -26.75 60.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.431 1.469 . . . . 0.0 111.874 172.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.83 150.51 65.88 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 119.137 0.881 . . . . 0.0 110.787 -171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.47 72.95 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.613 2.876 . . . . 0.0 108.731 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.61 147.57 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -50.21 124.21 9.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.941 0.496 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -65.14 140.87 58.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.1 -3.5 85.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.109 -1.384 . . . . 0.0 112.418 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -92.23 -28.88 16.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.201 2.001 . . . . 0.0 112.674 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.63 109.64 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.858 2.117 . . . . 0.0 108.193 -171.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -121.43 112.6 18.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.46 1.027 . . . . 0.0 109.885 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 74.5 m-85 -96.03 91.76 6.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.832 1.253 . . . . 0.0 108.963 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.67 104.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.299 1.84 . . . . 0.0 108.708 -168.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.73 104.79 2.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.69 1.596 . . . . 0.0 112.235 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.23 -8.98 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.639 1.175 . . . . 0.0 113.087 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -128.25 15.52 6.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.427 1.012 . . . . 0.0 110.79 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.44 -18.33 27.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.465 1.029 . . . . 0.0 113.19 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.251 0.4 OUTLIER -150.97 -43.67 0.12 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.076 158.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -160.3 0.2 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.004 1.274 . . . . 0.0 109.27 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.0 m170 66.3 2.43 2.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.384 2.274 . . . . 0.0 115.041 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.87 -63.4 0.98 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 120.397 1.453 . . . . 0.0 109.864 170.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -47.02 -49.7 20.63 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.373 -0.822 . . . . 0.0 113.01 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -60.9 -44.61 96.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.708 1.203 . . . . 0.0 110.06 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -68.31 -42.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.801 1.64 . . . . 0.0 107.32 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -48.92 70.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.567 2.347 . . . . 0.0 105.421 -172.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -52.91 -59.01 5.05 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 126.022 1.729 . . . . 0.0 109.942 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.97 -38.7 79.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.644 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.37 -32.1 72.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.462 1.028 . . . . 0.0 111.213 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -61.72 -38.69 88.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.277 0.944 . . . . 0.0 110.372 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -51.54 12.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.728 0.695 . . . . 0.0 111.395 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.59 -22.76 63.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.611 1.164 . . . . 0.0 110.533 -171.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.9 p -116.09 -71.67 0.73 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.608 1.095 . . . . 0.0 108.083 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.66 0.23 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.108 1.337 . . . . 0.0 110.811 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -134.89 144.95 47.8 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 108.871 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -21.66 51.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.117 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.5 p -63.05 133.37 54.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.493 0.496 . . . . 0.0 110.007 -158.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.76 155.57 61.69 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.39 166.28 64.93 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 CA-C-N 119.927 1.01 . . . . 0.0 111.419 -5.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -133.84 96.11 3.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 169.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 86' ' ' LEU . 54.3 t -74.4 126.31 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -113.99 101.83 9.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.877 1.671 . . . . 0.0 107.477 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.471 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.04 115.26 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.554 -2.388 . . . . 0.0 104.554 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.35 72.38 0.48 Allowed Glycine 0 C--N 1.337 0.611 0 C-N-CA 124.621 1.105 . . . . 0.0 111.873 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 46.67 22.1 0.16 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.58 130.52 38.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.397 1.453 . . . . 0.0 110.854 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 t -71.58 115.96 11.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.776 0.83 . . . . 0.0 110.068 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -84.2 -6.65 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 118.442 0.565 . . . . 0.0 111.256 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.54 -175.93 19.68 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.561 1.553 . . . . 0.0 109.519 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.66 -91.82 1.2 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.43 -55.7 0.96 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.611 0.705 . . . . 0.0 112.457 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -61.18 -33.56 73.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.171 0.896 . . . . 0.0 111.107 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.12 -63.21 1.21 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.098 1.759 . . . . 0.0 107.766 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -49.31 -37.25 23.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.683 2.393 . . . . 0.0 113.126 -176.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.33 -36.03 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.341 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -49.39 66.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 121.3 1.864 . . . . 0.0 107.383 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.54 -37.48 75.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.36 -63.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.465 1.03 . . . . 0.0 109.692 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -51.64 58.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.155 1.782 . . . . 0.0 112.25 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -75.01 -36.73 61.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.594 1.157 . . . . 0.0 109.889 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.21 35.34 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.799 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -63.06 -26.97 69.09 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.621 2.21 . . . . 0.0 110.872 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -39.66 84.94 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 125.206 1.402 . . . . 0.0 109.172 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -39.71 84.93 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.526 0.73 . . . . 0.0 109.234 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 m -59.7 -57.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -34.51 78.3 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.888 -0.508 . . . . 0.0 112.174 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 mt -57.04 -53.73 54.71 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.946 1.298 . . . . 0.0 109.793 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -25.34 68.03 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.368 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -56.55 -30.31 62.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.42 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.74 8.78 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 112.53 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.59 30.95 59.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.305 -0.872 . . . . 0.0 112.858 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.74 -70.47 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 110.195 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.93 134.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -166.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--O 1.247 0.944 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 -174.041 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 4' ' ' GLU . 7.0 pt20 34.22 -91.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.086 2.554 . . . . 0.0 113.02 -174.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -34.85 -43.96 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 130.347 3.459 . . . . 0.0 113.458 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -53.14 -41.1 64.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.491 1.117 . . . . 0.0 111.729 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 18' ' ' PHE . 24.8 t -80.6 -56.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -60.47 -28.42 68.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -158.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -109.34 -16.66 13.98 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.398 1.079 . . . . 0.0 112.662 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -65.6 -39.07 91.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 0.0 110.149 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -69.9 144.86 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -148.26 160.27 37.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 163.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 71.5 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.499 3.466 . . . . 0.0 111.931 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.31 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.922 2.201 . . . . 0.0 110.555 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -151.24 162.92 40.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.76 2.424 . . . . 0.0 106.361 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.44 87.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 165.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -88.16 135.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.58 114.27 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 6' ' ' VAL . 69.3 m-85 -84.11 130.04 34.87 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 167.77 18.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.005 1.322 . . . . 0.0 110.659 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.7 149.33 58.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 161.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.49 -19.68 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.617 2.878 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -75.58 31.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.758 2.423 . . . . 0.0 110.802 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 12.9 t -144.19 121.5 6.6 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.87 1.668 . . . . 0.0 111.289 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.98 -19.97 19.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.018 1.812 . . . . 0.0 111.238 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 26.4 m-85 -76.8 -41.18 45.46 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.38 -46.65 88.07 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.3 ttm-85 -57.17 -42.66 81.52 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.467 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -58.62 -56.91 16.14 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 120.321 1.418 . . . . 0.0 108.529 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.45 -32.7 51.09 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 123.722 0.639 . . . . 0.0 111.141 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -56.7 -60.52 3.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.46 1.504 . . . . 0.0 112.474 169.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -66.11 -45.94 79.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.692 1.133 . . . . 0.0 109.243 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.12 -48.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.424 1.49 . . . . 0.0 110.494 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -74.96 -52.29 11.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -64.42 -14.43 56.75 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.47 1.508 . . . . 0.0 113.531 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.64 -24.25 59.98 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.073 1.306 . . . . 0.0 111.28 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.77 150.83 84.3 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.178 0.899 . . . . 0.0 110.714 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.88 67.69 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.565 2.843 . . . . 0.0 110.47 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -90.33 154.25 3.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -55.38 128.75 35.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.57 1.148 . . . . 0.0 109.469 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.93 136.22 57.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.26 -3.66 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.481 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mt -73.66 -41.15 63.08 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.888 1.844 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.79 110.04 18.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -121.52 120.25 34.33 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 54.0 m-85 -89.79 94.76 9.95 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.585 1.554 . . . . 0.0 107.324 172.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -85.29 107.96 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.895 2.078 . . . . 0.0 107.988 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -70.92 107.86 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.97 1.308 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 pt -68.47 -15.19 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.605 0.762 . . . . 0.0 112.644 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -94.57 -9.33 35.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.274 1.03 . . . . 0.0 110.952 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.07 72.9 6.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.302 1.441 . . . . 0.0 109.085 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.25 35.1 p 60.95 8.29 1.82 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.596 3.159 . . . . 0.0 116.04 161.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -78.63 -106.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 163.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -163.6 93.12 0.73 Allowed 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -63.44 1.11 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.988 0.915 . . . . 0.0 109.53 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -27.24 32.71 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.58 -29.67 15.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.831 1.196 . . . . 0.0 111.448 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.77 -37.16 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -62.89 -51.67 66.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.38 1.872 . . . . 0.0 106.472 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -52.65 -53.84 41.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 111.054 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -41.44 80.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.92 -35.83 81.94 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.749 -1.22 . . . . 0.0 110.321 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.23 -39.02 92.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.373 0.533 . . . . 0.0 111.201 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -63.22 -52.45 62.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.805 . . . . 0.0 110.25 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -75.7 -52.95 9.35 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 p -97.57 -15.95 20.27 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.73 1.67 57.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.079 -0.845 . . . . 0.0 111.748 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.44 151.94 10.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.186 1.493 . . . . 0.0 110.756 169.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -87.9 -26.38 22.76 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 p -58.61 133.35 55.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -158.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.88 22.46 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.896 0.879 . . . . 0.0 110.007 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -60.53 155.33 51.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 CA-C-N 119.833 0.976 . . . . 0.0 110.111 -10.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.83 113.6 20.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.21 123.92 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 119.712 1.142 . . . . 0.0 109.08 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.87 104.09 13.72 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 121.93 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 160.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.4 80.58 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 127.736 2.589 . . . . 0.0 114.934 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 47.26 21.14 0.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.27 125.39 34.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 121.206 1.821 . . . . 0.0 111.722 158.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.6 t -65.56 113.46 4.21 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.592 1.957 . . . . 0.0 109.761 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.68 -21.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 O-C-N 122.935 0.147 . . . . 0.0 110.611 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.39 -165.44 24.72 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.65 -167.11 36.43 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.985 0.802 . . . . 0.0 111.312 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.2 p -60.87 -34.89 75.32 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.303 1.051 . . . . 0.0 111.707 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -74.45 -42.98 58.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.543 0.611 . . . . 0.0 109.524 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.77 -46.97 82.85 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.95 -41.07 67.37 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.318 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.93 -48.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 116.827 -1.559 . . . . 0.0 109.9 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -47.02 87.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.206 1.821 . . . . 0.0 108.037 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.7 -40.56 83.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.933 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.36 -67.01 0.47 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.842 1.655 . . . . 0.0 110.211 172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -43.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.981 2.113 . . . . 0.0 113.294 -170.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.9 -4.17 50.41 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.73 1.212 . . . . 0.0 111.482 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.9 5.53 87.76 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 117.271 -1.849 . . . . 0.0 115.146 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.2 -29.08 69.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 121.495 2.648 . . . . 0.0 110.937 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 33' ' ' LEU . 54.1 tp -53.54 -38.1 63.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.88 1.672 . . . . 0.0 111.619 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.76 -50.67 48.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -172.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.5 m -60.5 -47.36 86.48 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.721 0.808 . . . . 0.0 110.132 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -52.05 41.1 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 110.213 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.3 -46.17 84.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -66.3 -26.84 67.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 117.995 -1.003 . . . . 0.0 113.031 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -54.84 -33.1 61.33 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.504 0.593 . . . . 0.0 110.558 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.45 9.38 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.438 1.017 . . . . 0.0 112.199 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.16 17.8 79.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.311 0.96 . . . . 0.0 114.181 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.32 -61.83 1.63 Allowed 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.123 1.769 . . . . 0.0 111.468 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.35 133.29 46.79 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.249 1.077 0 O-C-N 126.227 2.204 . . . . 0.0 112.195 -152.431 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 34.74 58.7 0.7 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 128.305 2.642 . . . . 0.0 112.437 163.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 61.79 -34.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.877 2.471 . . . . 0.0 115.674 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.12 -61.99 2.15 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 120.987 1.721 . . . . 0.0 110.522 -171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.411 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.4 t -63.75 -33.29 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 2' ' ' ALA . 13.8 m120 -79.96 -30.86 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.861 -0.525 . . . . 0.0 111.541 -162.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -89.18 -19.22 25.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.091 1.757 . . . . 0.0 110.61 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -47.09 82.46 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.493 -1.38 . . . . 0.0 109.012 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -71.28 148.03 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -136.25 145.97 54.24 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.133 0.973 . . . . 0.0 108.878 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 61.21 7.62 Favored 'Trans proline' 0 CA--C 1.537 0.661 1 C-N-CA 125.324 4.016 . . . . 0.0 112.924 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.06 23.09 0.03 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 125.809 1.671 . . . . 0.0 111.723 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -137.94 154.04 49.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 127.003 2.121 . . . . 0.0 107.006 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 75' ' ' ILE . 29.4 t -102.04 93.13 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.58 129.94 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.18 155.98 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE1' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -117.75 125.59 50.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.54 175.63 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.048 2.139 . . . . 0.0 110.005 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -129.73 152.96 80.68 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.11 1.764 . . . . 0.0 106.688 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.79 -13.62 26.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.235 2.623 . . . . 0.0 113.145 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -102.3 -10.68 19.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.816 2.047 . . . . 0.0 112.209 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -90.95 127.57 51.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.653 0.781 . . . . 0.0 109.381 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.89 -23.05 16.78 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.86 1.707 . . . . 0.0 111.293 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.38 -35.04 47.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -58.19 -54.08 51.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.581 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -51.11 -45.15 61.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.306 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -61.59 2.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.96 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.895 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -55.11 -58.74 6.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.38 1.472 . . . . 0.0 112.683 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.87 -41.49 82.75 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 118.549 0.613 . . . . 0.0 109.802 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -53.75 -52.82 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.443 1.497 . . . . 0.0 109.101 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.31 -44.77 64.51 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -55.73 -15.67 3.4 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.5 -23.02 59.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.802 2.092 . . . . 0.0 111.745 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.29 137.12 39.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 119.071 0.851 . . . . 0.0 109.682 -169.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.72 85.17 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.847 3.031 . . . . 0.0 111.032 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 43' ' ' LEU . 14.9 mt -105.34 151.63 7.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.474 1.51 . . . . 0.0 107.196 -165.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -49.24 126.65 13.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.026 0.93 . . . . 0.0 109.988 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.46 130.02 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.67 84.35 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 117.623 -1.654 . . . . 0.0 113.16 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.12 -37.72 64.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.594 2.197 . . . . 0.0 111.022 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.73 110.37 18.26 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.403 1.456 . . . . 0.0 107.589 -175.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -124.53 98.61 5.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.221 1.408 . . . . 0.0 108.549 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -83.97 105.99 15.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.59 127.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.963 1.305 . . . . 0.0 107.568 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.842 1.257 . . . . 0.0 111.119 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 57' ' ' ILE . 47.0 pt -68.6 -16.76 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.722 -1.237 . . . . 0.0 112.243 174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 p -84.46 -7.35 59.31 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.315 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.17 -38.13 24.65 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.98 1.312 . . . . 0.0 112.447 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 p -121.61 9.13 10.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.215 1.006 . . . . 0.0 111.081 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.7 t30 40.92 63.95 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.164 2.585 . . . . 0.0 112.204 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -109.03 19.04 19.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.134 1.373 . . . . 0.0 109.307 160.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.89 -63.28 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.764 2.026 . . . . 0.0 109.96 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -45.19 -48.49 12.47 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.952 1.701 . . . . 0.0 113.719 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -40.19 73.51 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.58 0.627 . . . . 0.0 110.498 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CG2' ' A' ' 48' ' ' ILE . 13.4 mt -63.31 -42.27 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -58.01 -51.32 70.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.17 2.988 . . . . 0.0 109.27 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.23 -62.16 1.9 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.041 1.737 . . . . 0.0 110.442 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 2' ' ' ALA . 13.7 t80 -53.17 -41.02 64.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.07 -27.57 69.19 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.753 1.221 . . . . 0.0 112.423 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -44.3 96.66 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.026 0.83 . . . . 0.0 110.049 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.45 -46.76 37.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.211 0.605 . . . . 0.0 110.359 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.69 -23.82 66.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 111.464 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 1.5 p -127.22 -72.22 0.65 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.741 1.609 . . . . 0.0 109.45 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.16 -21.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.492 -1.171 . . . . 0.0 114.864 -172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.71 156.94 45.09 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.861 1.831 . . . . 0.0 110.24 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -71.63 -30.49 65.82 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.692 -0.63 . . . . 0.0 110.01 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 p -61.16 133.54 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -165.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 165.64 22.28 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.354 1.462 . . . . 0.0 107.487 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.4 171.1 18.13 Favored 'Cis proline' 0 C--N 1.345 0.352 0 CA-C-N 120.883 1.351 . . . . 0.0 111.815 -6.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -142.37 108.01 5.1 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.85 133.27 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -114.75 140.4 48.92 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -123.51 113.08 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 177.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.59 58.53 13.94 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.353 -0.842 . . . . 0.0 112.008 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.256 1.0 OUTLIER 46.21 27.73 0.59 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -174.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -129.85 135.23 48.15 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.65 1.114 . . . . 0.0 109.187 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -71.11 150.03 45.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -105.51 -12.46 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 122.924 0.49 . . . . 0.0 111.39 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.18 -165.44 18.34 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -166.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.65 -95.57 2.41 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 119.006 -0.886 . . . . 0.0 110.921 -174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.89 -56.78 2.19 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.133 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -59.35 -39.04 81.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.861 1.664 . . . . 0.0 112.126 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -42.86 81.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.827 0.451 . . . . 0.0 109.871 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.16 -37.0 85.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.558 0.743 . . . . 0.0 110.479 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.39 -49.56 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 115.494 -2.193 . . . . 0.0 109.738 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -61.93 -39.95 93.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 122.939 2.608 . . . . 0.0 112.051 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 80' ' ' ILE . 10.3 mt -54.47 -46.18 73.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.41 -51.95 25.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 121.375 1.898 . . . . 0.0 110.959 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.2 -53.15 53.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.897 1.679 . . . . 0.0 112.01 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.4 t -71.59 -5.19 31.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.845 1.258 . . . . 0.0 110.775 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.93 9.29 59.44 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.016 -1.435 . . . . 0.0 112.968 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.38 -21.6 66.24 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.264 2.032 . . . . 0.0 111.842 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.49 -37.9 65.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 111.047 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.41 -48.69 74.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.667 0.667 . . . . 0.0 109.65 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -46.57 85.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.199 1.0 . . . . 0.0 110.236 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -47.7 -53.51 14.84 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.512 1.525 . . . . 0.0 110.392 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 mp -72.27 -34.85 68.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -58.95 -30.75 68.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.435 1.471 . . . . 0.0 111.419 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -54.62 -19.01 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 112.979 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.01 11.08 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.716 1.143 . . . . 0.0 112.384 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.23 46.9 7.27 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 118.703 0.683 . . . . 0.0 112.431 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.34 -72.49 0.58 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.842 1.257 . . . . 0.0 111.875 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.58 137.19 55.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 120.182 1.355 . . . . 0.0 109.528 -159.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 163.975 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -66.95 46.78 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.195 2.598 . . . . 0.0 114.536 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -163.53 -56.41 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.051 -1.031 . . . . 0.0 108.393 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.91 -39.05 87.87 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.061 0.392 . . . . 0.0 111.008 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 40.6 t -68.79 -62.85 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.86 -43.65 98.41 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -159.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.37 -15.13 60.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.273 -0.87 . . . . 0.0 113.296 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -71.99 -38.76 69.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.426 1.466 . . . . 0.0 111.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.05 126.36 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -106.88 162.32 20.07 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 123.42 0.688 . . . . 0.0 109.357 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.5 79.18 0.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.636 2.89 . . . . 0.0 109.658 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.79 19.7 0.49 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 127.313 2.387 . . . . 0.0 113.54 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -111.96 159.02 18.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.782 1.791 . . . . 0.0 108.467 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG13 ' CD1' ' A' ' 75' ' ' ILE . 36.1 t -113.07 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.8 t -84.06 147.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.98 113.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 6' ' ' VAL . 86.1 m-85 -76.52 126.28 30.71 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.11 168.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.791 1.236 . . . . 0.0 110.399 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -117.5 149.57 45.07 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 158.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.28 4.83 5.54 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.188 1.926 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -124.21 -17.25 6.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 132.33 89.12 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 168.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -64.85 -21.26 64.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.766 1.644 . . . . 0.0 109.78 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -74.34 -42.9 58.65 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.953 0.901 . . . . 0.0 109.609 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.64 -45.13 94.25 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -54.55 -44.93 73.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.103 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -57.74 10.27 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 118.793 0.724 . . . . 0.0 109.654 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.96 55.84 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -69.58 -37.62 77.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 117.558 -1.21 . . . . 0.0 114.113 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.51 -49.25 27.56 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 120.111 1.323 . . . . 0.0 108.464 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -49.28 -53.33 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.531 1.532 . . . . 0.0 109.982 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.46 -46.43 17.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -74.79 6.25 4.16 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.156 1.343 . . . . 0.0 114.196 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.1 -12.73 60.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.47 1.508 . . . . 0.0 112.572 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.4 148.66 56.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.55 1.068 . . . . 0.0 111.199 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.64 96.62 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.181 2.588 . . . . 0.0 109.911 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.82 145.98 30.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -47.32 134.34 11.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.272 0.629 . . . . 0.0 111.998 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -49.42 115.39 1.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.381 1.473 . . . . 0.0 109.137 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.92 86.75 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.404 -1.22 . . . . 0.0 114.126 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.73 -33.07 64.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 121.215 2.507 . . . . 0.0 109.962 165.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.46 109.59 17.47 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -171.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -129.25 102.72 6.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.51 90.4 8.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.128 1.371 . . . . 0.0 107.938 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.5 111.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.475 1.51 . . . . 0.0 109.212 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -71.31 115.01 9.97 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.314 1.046 . . . . 0.0 112.929 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG22 HG21 ' A' ' 57' ' ' ILE . 20.2 pt -70.82 -35.0 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.688 1.595 . . . . 0.0 112.494 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -101.9 4.16 39.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.297 1.039 . . . . 0.0 111.63 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.04 53.14 0.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.337 1.455 . . . . 0.0 110.702 162.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.321 0.3 OUTLIER 60.9 14.24 5.09 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.886 2.474 . . . . 0.0 112.101 178.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.08 11.06 10.4 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 119.448 -2.032 . . . . 0.0 114.162 -167.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m170 67.62 79.82 0.22 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 128.505 2.722 . . . . 0.0 108.48 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -63.68 1.2 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -67.7 -23.69 65.32 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.95 -48.62 73.43 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.061 1.744 . . . . 0.0 111.009 165.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.487 HG21 HG22 ' A' ' 48' ' ' ILE . 13.3 mt -60.86 -38.28 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.102 0.961 . . . . 0.0 109.066 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -59.96 -49.86 76.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.02 -44.09 85.74 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.5 1.143 . . . . 0.0 112.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -58.11 -43.64 87.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.624 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 mt -61.89 -33.24 73.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.116 0.966 . . . . 0.0 111.081 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.27 -51.0 69.75 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 119.15 0.886 . . . . 0.0 110.39 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.29 -49.54 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.209 0.528 . . . . 0.0 109.609 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tp -73.53 -17.9 61.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.792 0.837 . . . . 0.0 111.114 -167.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -129.25 -25.91 2.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 114.451 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.51 23.1 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.071 -1.405 . . . . 0.0 112.183 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.86 147.52 22.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 121.069 2.435 . . . . 0.0 110.698 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -21.09 61.05 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 p -70.24 133.75 47.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.806 0.73 . . . . 0.0 110.457 -159.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 161.74 22.54 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.483 1.913 . . . . 0.0 107.813 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.85 125.01 6.2 Favored 'Cis proline' 0 C--N 1.345 0.394 0 CA-C-N 120.344 1.158 . . . . 0.0 111.571 -1.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -95.61 91.25 6.04 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.64 125.07 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 94.03 4.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.142 2.577 . . . . 0.0 107.38 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.477 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -93.27 112.37 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.47 63.39 5.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.291 0.948 . . . . 0.0 113.41 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 46.48 15.28 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.838 2.455 . . . . 0.0 115.703 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -126.96 144.5 50.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 120.074 1.306 . . . . 0.0 109.887 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -86.57 134.96 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.974 0.91 . . . . 0.0 110.896 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pp -83.86 -18.41 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 119.104 0.866 . . . . 0.0 110.556 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.06 -141.3 12.48 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.8 -158.05 14.37 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.898 1.713 . . . . 0.0 108.838 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -22.03 59.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.756 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -65.32 -45.09 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.847 1.203 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.32 -57.62 12.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.162 1.785 . . . . 0.0 107.112 170.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.9 tp -52.0 -40.09 60.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.14 -50.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 117.266 -1.349 . . . . 0.0 108.382 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -43.24 99.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 120.82 1.645 . . . . 0.0 110.28 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -51.82 -47.48 64.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.097 0.862 . . . . 0.0 109.537 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.79 -52.58 42.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.515 1.052 . . . . 0.0 110.785 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -58.73 3.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.947 1.699 . . . . 0.0 111.244 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -11.46 59.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.463 1.505 . . . . 0.0 109.889 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.51 -2.53 49.76 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.569 161.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -59.27 -28.87 67.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.797 1.799 . . . . 0.0 111.435 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 tt -44.17 -57.89 3.17 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.359 1.863 . . . . 0.0 110.514 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.73 -42.09 98.5 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.864 0.756 . . . . 0.0 109.532 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -61.29 -54.23 46.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.791 0.836 . . . . 0.0 110.358 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.52 76.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.436 1.094 . . . . 0.0 111.021 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.66 -47.4 60.19 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.31 -26.34 67.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.174 1.352 . . . . 0.0 112.468 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -52.3 -33.04 40.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.346 1.458 . . . . 0.0 110.738 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.04 11.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.126 0.876 . . . . 0.0 112.674 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 37.9 26.68 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.2 -0.938 . . . . 0.0 112.328 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.99 -69.83 0.56 Allowed 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 112.131 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.84 136.58 52.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.991 0.814 . . . . 0.0 110.839 -158.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.664 3.185 . . . . 0.0 105.219 -175.245 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.693 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.513 -0.459 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -48.64 158.06 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.188 1.395 . . . . 0.0 111.972 -169.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -49.41 -31.64 10.05 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -158.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -55.4 -37.59 67.81 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.24 1.382 . . . . 0.0 112.766 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 2' ' ' ALA . 2.2 t -63.96 -55.12 23.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.32 1.448 . . . . 0.0 109.448 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.66 -39.87 95.28 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 t -81.4 38.6 0.49 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.803 2.041 . . . . 0.0 111.772 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -130.91 -47.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.626 0.771 . . . . 0.0 109.647 159.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.17 133.76 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.21 165.07 34.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.58 156.77 40.22 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.008 -1.574 . . . . 0.0 108.008 159.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.69 17.1 77.94 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.191 -0.943 . . . . 0.0 115.08 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -135.78 162.04 33.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.684 1.593 . . . . 0.0 108.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.88 79.58 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.19 132.95 33.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.06 110.79 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.3 130.07 38.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.08 179.73 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 C-N-CA 126.362 1.865 . . . . 0.0 109.843 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -140.37 151.27 63.73 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 158.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.22 -15.01 20.49 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.588 2.192 . . . . 0.0 111.527 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -50.57 43.57 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.703 1.201 . . . . 0.0 110.131 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 20' ' ' LYS . 16.0 m -61.1 109.59 2.25 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.401 1.481 . . . . 0.0 111.398 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.75 -20.84 58.98 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.992 1.795 . . . . 0.0 110.898 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -73.2 -22.32 60.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.926 -1.109 . . . . 0.0 111.294 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.96 -33.12 74.05 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.47 -0.769 . . . . 0.0 109.755 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -63.17 -30.04 71.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.764 0.826 . . . . 0.0 111.774 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.76 4.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.22 51.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 124.365 1.041 . . . . 0.0 111.785 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.6 -56.53 16.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.549 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.46 -41.33 63.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 123.741 0.651 . . . . 0.0 110.263 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -50.21 -57.42 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.732 1.213 . . . . 0.0 108.737 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 33' ' ' LEU . 12.9 mt -75.96 -43.25 45.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.303 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.2 p -65.65 -20.83 66.45 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 120.03 1.286 . . . . 0.0 113.915 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -73.51 -21.77 60.31 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.626 1.103 . . . . 0.0 110.697 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.78 142.24 56.53 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -64.56 127.56 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -146.36 157.61 11.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 128.02 34.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.173 0.989 . . . . 0.0 109.646 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -64.43 126.24 27.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.985 -168.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.92 71.29 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.962 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.68 -37.58 65.19 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 119.847 1.824 . . . . 0.0 109.002 164.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 100.03 10.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -170.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -122.1 101.49 7.57 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 108.92 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -84.55 93.82 8.44 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.774 1.23 . . . . 0.0 108.638 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.56 112.22 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.809 1.244 . . . . 0.0 109.363 -171.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.83 121.29 13.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.506 1.523 . . . . 0.0 112.793 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.5 pt -85.18 -21.35 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.17 1.388 . . . . 0.0 113.382 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -90.09 -3.71 57.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.071 0.85 . . . . 0.0 110.134 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -40.11 -54.85 2.22 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.475 2.31 . . . . 0.0 113.691 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.03 -27.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.05 0.94 . . . . 0.0 109.41 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.35 -46.83 69.69 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.39 1.876 . . . . 0.0 115.073 -164.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 124.63 82.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 1 C-N-CA 131.941 4.096 . . . . 0.0 109.606 -169.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -37.13 -63.02 0.46 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.417 2.287 . . . . 0.0 109.792 164.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -43.74 -49.34 7.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.031 1.333 . . . . 0.0 113.372 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.68 -43.39 80.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.935 0.894 . . . . 0.0 111.458 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HA ' ' HB1' ' A' ' 2' ' ' ALA . 13.2 mt -62.87 -31.75 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -69.35 -54.24 15.51 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.9 -55.8 17.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 123.679 1.704 . . . . 0.0 111.004 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.693 ' CG ' ' HA ' ' A' ' 2' ' ' ALA . 1.1 t80 -79.0 4.67 13.71 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.764 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -91.41 -37.7 13.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 118.122 -2.861 . . . . 0.0 109.907 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.83 -49.79 47.72 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.336 1.455 . . . . 0.0 108.142 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -57.49 5.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.412 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.86 -23.86 67.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 111.01 -163.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.1 p -126.45 -17.31 5.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.75 50.0 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.645 1.111 . . . . 0.0 112.155 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.28 158.16 31.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.336 1.854 . . . . 0.0 107.869 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -22.08 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -55.41 133.54 49.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.41 0.684 . . . . 0.0 111.139 -161.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.82 153.8 39.96 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -60.3 147.17 43.24 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.122 1.079 . . . . 0.0 110.043 -10.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -130.46 103.1 6.46 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 86' ' ' LEU . 69.7 t -87.09 124.45 40.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 123.022 0.529 . . . . 0.0 109.92 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -103.37 105.5 15.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.605 1.562 . . . . 0.0 107.772 160.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.97 116.57 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 161.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 41.46 69.67 0.51 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 126.193 1.854 . . . . 0.0 114.019 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 47.31 21.37 0.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -116.82 120.67 39.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.908 1.283 . . . . 0.0 108.632 165.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -83.99 104.26 13.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.201 0.6 . . . . 0.0 110.088 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -83.85 -8.74 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.462 0.574 . . . . 0.0 112.008 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.97 -167.19 24.15 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.843 0.735 . . . . 0.0 112.606 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.7 -162.15 34.81 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.032 1.301 . . . . 0.0 110.373 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -37.93 71.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.652 1.226 . . . . 0.0 110.104 -165.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 m -68.43 -36.09 78.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.557 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.33 -49.76 58.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.607 1.163 . . . . 0.0 108.618 173.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 73' ' ' VAL . 58.2 tp -51.58 -44.32 62.74 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.016 1.726 . . . . 0.0 111.821 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.17 -44.84 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-O 117.113 -1.422 . . . . 0.0 109.694 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.99 -48.79 75.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -173.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.12 -42.34 85.56 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.222 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -64.1 -56.84 12.04 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.371 0.987 . . . . 0.0 110.305 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -51.52 55.07 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.739 1.616 . . . . 0.0 111.364 -172.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.0 t -71.49 -7.23 46.19 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.325 1.45 . . . . 0.0 110.934 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.09 77.93 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.662 -1.632 . . . . 0.0 114.062 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.04 -33.66 73.64 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.742 2.271 . . . . 0.0 110.707 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -38.18 86.61 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.904 1.282 . . . . 0.0 109.545 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.25 -37.72 86.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.364 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -48.57 72.51 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.589 1.086 . . . . 0.0 109.736 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -50.73 62.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 110.593 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -60.11 -48.21 82.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.49 1.516 . . . . 0.0 110.715 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.59 -35.22 77.23 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.903 -1.123 . . . . 0.0 111.811 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -54.0 -32.42 54.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.007 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.96 5.5 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 119.484 1.038 . . . . 0.0 113.377 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.89 39.44 13.5 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.747 1.158 . . . . 0.0 112.87 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.93 -74.86 0.38 Allowed 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 125.876 1.67 . . . . 0.0 112.602 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -53.13 -23.38 8.0 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.24 1.816 . . . . 0.0 114.872 -159.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 130.377 3.471 . . . . 0.0 110.523 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.101 0.477 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -73.33 -67.43 0.58 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 0.0 110.977 -167.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -72.54 -22.87 60.95 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.54 -0.725 . . . . 0.0 111.261 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -32.66 63.15 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.51 -60.26 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.524 -0.735 . . . . 0.0 110.263 166.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -63.38 -27.29 69.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -163.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.2 t -87.35 -24.15 24.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.087 0.955 . . . . 0.0 111.349 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -73.95 -37.84 64.43 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 121.074 -1.016 . . . . 0.0 111.406 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -82.61 149.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 160.05 34.92 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 72.0 Cg_endo -75.94 111.36 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.412 2.741 . . . . 0.0 108.733 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 9.12 21.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.42 1.486 . . . . 0.0 113.646 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -123.47 166.04 16.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.09 1.756 . . . . 0.0 109.241 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 47.3 t -124.0 110.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 10' ' ' ILE . 42.4 t -120.01 139.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.43 112.91 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -78.4 119.91 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.42 161.28 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.629 1.172 . . . . 0.0 111.602 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -120.33 141.96 32.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.58 -20.12 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.903 1.736 . . . . 0.0 110.996 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 26.52 0.97 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.798 2.039 . . . . 0.0 111.44 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -130.92 134.97 26.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.622 2.369 . . . . 0.0 108.706 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.98 -25.87 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.179 2.586 . . . . 0.0 112.265 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -74.34 -29.98 61.83 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.37 -48.0 83.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.562 -0.711 . . . . 0.0 109.836 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -59.5 -41.51 90.06 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.518 -0.739 . . . . 0.0 110.164 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -58.67 6.53 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -39.85 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.154 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -56.46 -54.3 47.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.503 172.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -69.47 -41.93 75.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.288 0.949 . . . . 0.0 109.752 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.73 -52.28 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 125.727 1.611 . . . . 0.0 110.159 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.22 -48.97 16.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -69.83 -13.58 62.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.923 0.489 . . . . 0.0 112.269 -169.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.08 -23.33 60.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.035 0.834 . . . . 0.0 110.951 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.08 149.65 85.14 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.12 113.99 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 106.631 -2.103 . . . . 0.0 106.631 164.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.66 138.44 54.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 124.34 7.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.968 1.307 . . . . 0.0 108.687 -169.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.61 122.33 13.81 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -162.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.19 -12.96 58.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.082 1.325 . . . . 0.0 113.875 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.67 -28.29 61.68 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 120.697 2.249 . . . . 0.0 110.458 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.81 120.67 26.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 120.229 1.377 . . . . 0.0 107.482 -177.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -131.61 104.71 7.09 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.473 1.109 . . . . 0.0 109.338 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 20.3 m-85 -84.6 100.76 11.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.07 107.39 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -67.06 104.45 1.41 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 54' ' ' THR . 19.1 pt -69.44 -18.25 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.64 0.776 . . . . 0.0 111.463 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -84.18 8.61 15.16 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.386 -0.821 . . . . 0.0 111.382 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 -21.89 49.75 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.638 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -132.78 -106.41 0.25 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 161.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -134.03 1.85 3.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.68 1.992 . . . . 0.0 110.556 165.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -62.7 -3.1 1.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.921 -1.112 . . . . 0.0 112.091 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -43.41 -63.68 0.78 Allowed 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.558 1.943 . . . . 0.0 109.053 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -52.34 -43.27 64.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.196 1.398 . . . . 0.0 109.801 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.87 -36.1 69.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 112.246 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.7 -51.74 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -57.25 10.04 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.291 0.567 . . . . 0.0 110.822 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.67 -42.33 62.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.242 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -61.13 -43.43 98.9 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.682 0.673 . . . . 0.0 110.709 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.78 -27.51 68.05 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.333 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -63.23 -56.69 14.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 120.739 1.609 . . . . 0.0 109.67 171.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.79 -49.13 71.7 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.839 0.712 . . . . 0.0 109.972 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.3 -29.74 57.48 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.116 1.366 . . . . 0.0 111.606 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 p -125.63 -29.08 3.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.55 13.96 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.179 -1.345 . . . . 0.0 113.982 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.99 150.97 9.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.649 2.224 . . . . 0.0 110.68 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' A' ' 62' ' ' GLN . 2.8 ptt-85 -96.61 -7.87 33.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.738 0.815 . . . . 0.0 112.571 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -65.05 133.98 52.84 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 108.649 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.88 147.0 34.61 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 126.618 1.967 . . . . 0.0 105.794 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -66.35 155.1 81.97 Favored 'Cis proline' 0 N--CA 1.461 -0.436 0 CA-C-N 120.353 1.162 . . . . 0.0 111.666 3.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -140.29 106.48 5.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 86' ' ' LEU . 55.2 t -87.89 127.46 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.73 93.98 4.3 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.598 2.359 . . . . 0.0 106.85 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -86.5 121.6 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.75 63.44 3.84 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.231 0.919 . . . . 0.0 113.425 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HE3' ' HD3' ' A' ' 12' ' ' PRO . 3.5 ttmt 46.13 19.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.369 2.267 . . . . 0.0 117.056 -173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.74 133.38 50.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.069 1.304 . . . . 0.0 110.571 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -81.11 121.99 26.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.106 -0.996 . . . . 0.0 109.899 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.4 pp -84.31 -11.81 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 119.616 1.098 . . . . 0.0 111.502 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.83 -163.69 19.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.322 0.963 . . . . 0.0 111.137 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.19 -155.26 29.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.303 0.954 . . . . 0.0 111.076 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -41.96 95.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.465 0.633 . . . . 0.0 111.269 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -65.94 -44.63 84.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.444 0.566 . . . . 0.0 110.897 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.47 -58.13 9.34 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 73' ' ' VAL . 65.0 tp -50.51 -42.13 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.436 1.094 . . . . 0.0 112.051 -174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.28 -51.02 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 116.347 -1.787 . . . . 0.0 109.229 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.47 54.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.448 1.931 . . . . 0.0 107.14 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.33 -40.98 83.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.111 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -74.67 -47.58 30.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.197 1.362 . . . . 0.0 107.806 -172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -35.85 60.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.373 1.069 . . . . 0.0 111.073 -169.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 t -94.13 -2.8 52.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.838 1.255 . . . . 0.0 111.15 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.76 0.32 87.74 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.082 -1.954 . . . . 0.0 115.075 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.54 -33.63 74.17 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 121.295 2.548 . . . . 0.0 110.37 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 tp -54.69 -37.64 66.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.48 -48.15 57.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -56.58 -49.87 73.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.981 0.913 . . . . 0.0 109.283 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.4 91.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.101 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -50.34 62.79 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.183 173.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.37 1.441 . . . . 0.0 111.801 -164.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.35 -39.08 14.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.304 1.441 . . . . 0.0 113.02 168.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.18 0.58 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 119.304 0.956 . . . . 0.0 111.936 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.34 55.2 2.94 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.7 1.143 . . . . 0.0 110.925 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.46 -75.65 0.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.79 1.636 . . . . 0.0 111.892 -167.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.89 133.73 52.49 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.235 -0.888 . . . . 0.0 108.826 -172.914 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.45 48.3 1.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.367 -1.458 . . . . 0.0 110.908 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -163.45 -43.13 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.019 1.328 . . . . 0.0 108.752 -172.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -50.72 -55.0 18.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.483 1.038 . . . . 0.0 109.961 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.94 -47.05 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.949 0.9 . . . . 0.0 109.976 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.84 -44.19 86.22 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.006 -0.434 . . . . 0.0 111.355 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.22 -23.52 65.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.703 1.601 . . . . 0.0 112.168 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.05 -44.33 69.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.913 1.233 . . . . 0.0 110.268 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -80.02 136.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.23 153.02 55.51 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.08 80.54 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.178 2.586 . . . . 0.0 109.361 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.51 18.54 0.27 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.074 1.797 . . . . 0.0 115.323 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -132.17 171.82 13.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.568 1.684 . . . . 0.0 108.074 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.8 t -115.87 110.39 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 10' ' ' ILE . 75.0 t -126.73 126.16 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -169.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.81 112.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -81.83 120.16 24.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.22 164.52 34.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.391 1.477 . . . . 0.0 111.402 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -123.55 139.54 32.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 165.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.58 -9.55 21.42 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.373 2.049 . . . . 0.0 112.104 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 p -79.23 -18.81 52.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.581 2.352 . . . . 0.0 113.592 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -122.4 134.54 24.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -158.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.86 -14.25 26.67 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.805 2.337 . . . . 0.0 112.304 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -73.27 -35.17 66.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.566 1.075 . . . . 0.0 108.739 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.27 -47.07 74.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -52.05 -49.96 62.42 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.157 0.983 . . . . 0.0 113.049 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -57.03 14.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.582 1.083 . . . . 0.0 109.02 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -35.94 64.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.412 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -53.65 54.34 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.561 1.144 . . . . 0.0 112.435 174.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.69 -52.26 46.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.1 mt -46.73 -53.64 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.763 2.025 . . . . 0.0 109.413 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.94 -47.16 63.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.9 p -63.45 -19.14 64.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.538 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -73.28 -33.22 65.12 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 120.254 1.388 . . . . 0.0 109.966 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.12 136.05 95.28 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.81 76.98 3.87 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.493 2.795 . . . . 0.0 110.046 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.7 mt -87.76 145.51 7.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -53.25 123.39 11.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -66.3 122.87 18.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 -8.04 40.89 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.192 1.377 . . . . 0.0 111.801 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -78.04 -33.7 50.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.812 1.806 . . . . 0.0 111.489 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 120.73 29.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.433 1.015 . . . . 0.0 109.782 -171.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.67 130.68 47.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.481 0.712 . . . . 0.0 109.605 168.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.0 101.42 11.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.7 113.97 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.005 2.122 . . . . 0.0 108.485 -167.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -69.9 109.97 4.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.529 0.732 . . . . 0.0 110.532 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.43 13.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.316 1.046 . . . . 0.0 112.857 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -114.69 -44.17 3.09 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.449 -1.407 . . . . 0.0 111.45 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.33 -51.35 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.822 0.849 . . . . 0.0 113.042 -158.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -125.03 4.52 7.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 112.577 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.46 -162.4 1.29 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 0.0 110.384 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -129.46 87.17 2.51 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.388 1.075 . . . . 0.0 108.238 -158.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -63.53 0.99 Allowed 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 125.465 1.506 . . . . 0.0 107.495 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -44.14 -48.89 9.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.525 1.13 . . . . 0.0 113.013 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -52.64 64.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.552 1.141 . . . . 0.0 111.411 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.96 -31.82 54.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.75 1.22 . . . . 0.0 111.675 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HA ' HH22 ' A' ' 72' ' ' ARG . 7.1 mt-30 -68.31 -45.31 73.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -64.64 -52.27 58.27 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.703 2.801 . . . . 0.0 110.405 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -55.05 -47.82 74.28 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.148 0.979 . . . . 0.0 111.205 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 64' ' ' LEU . 61.8 mt -65.66 -36.95 85.16 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.73 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.71 -44.31 96.76 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.53 1.059 . . . . 0.0 110.725 172.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -42.39 98.83 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.829 0.452 . . . . 0.0 110.597 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -76.05 -29.69 58.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.421 1.089 . . . . 0.0 109.399 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -125.06 -76.03 0.59 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.202 0.91 . . . . 0.0 109.072 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.31 -8.31 0.05 OUTLIER Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.728 -1.596 . . . . 0.0 116.715 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.43 146.26 48.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.572 2.686 . . . . 0.0 111.19 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.12 -28.29 15.15 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.302 1.441 . . . . 0.0 112.238 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 p -61.14 133.82 56.4 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 159.02 56.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.43 170.28 32.85 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 CA-C-N 118.763 0.594 . . . . 0.0 111.88 -11.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.584 HH22 ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -121.11 113.14 19.59 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 159.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.7 t -83.22 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.96 121.93 43.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 164.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -107.88 118.57 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 166.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.65 58.96 11.46 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.387 0.994 . . . . 0.0 112.689 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.285 3.6 tmtt? 45.49 30.73 0.78 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.58 1.952 . . . . 0.0 116.192 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.02 149.95 49.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.71 130.39 34.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.88 -26.08 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.14 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.17 -174.2 21.83 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.636 1.589 . . . . 0.0 112.057 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 -167.67 42.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.31 1.433 . . . . 0.0 112.042 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.42 -38.11 89.89 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.811 1.306 . . . . 0.0 111.598 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -64.99 -40.18 94.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.399 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.84 -51.65 45.97 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.421 1.088 . . . . 0.0 109.316 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.1 tp -51.89 -38.91 57.98 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 125.515 1.526 . . . . 0.0 111.652 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.42 -47.87 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 116.53 -1.7 . . . . 0.0 109.8 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -46.79 88.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.636 2.017 . . . . 0.0 108.615 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.155 -174.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.07 -52.54 23.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.385 1.448 . . . . 0.0 110.234 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.79 49.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.928 1.691 . . . . 0.0 111.399 -170.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -63.66 -33.55 75.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.76 2.024 . . . . 0.0 109.951 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.32 64.81 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.951 -1.472 . . . . 0.0 112.034 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.75 -32.04 65.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.089 1.945 . . . . 0.0 110.835 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.29 -36.23 70.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.846 1.659 . . . . 0.0 110.648 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.77 -50.67 61.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.916 0.487 . . . . 0.0 109.829 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 m -60.41 -49.29 78.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.883 0.873 . . . . 0.0 109.551 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -49.35 60.0 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.433 1.093 . . . . 0.0 110.348 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.4 mt -66.99 -45.09 78.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.32 -24.44 64.84 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.34 -1.475 . . . . 0.0 112.832 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.08 -39.34 59.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.861 0.755 . . . . 0.0 110.323 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.11 10.93 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.919 0.888 . . . . 0.0 111.914 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.45 76.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.411 -0.806 . . . . 0.0 113.571 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.0 -67.7 0.45 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 118.467 1.133 . . . . 0.0 110.142 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.92 134.01 45.75 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 118.163 -1.415 . . . . 0.0 107.669 -162.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 125.11 1.506 . . . . 0.0 108.668 -157.858 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.83 55.41 2.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.802 1.641 . . . . 0.0 110.507 -173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -163.1 -55.88 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.877 -1.14 . . . . 0.0 109.776 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -51.91 -47.38 64.65 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.974 0.806 . . . . 0.0 111.305 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.85 -54.19 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.851 0.861 . . . . 0.0 109.954 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.81 -38.22 75.16 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.051 0.94 . . . . 0.0 110.971 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.22 -29.76 64.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.736 0.815 . . . . 0.0 111.702 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -76.65 -45.6 29.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.797 1.635 . . . . 0.0 111.484 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.65 148.29 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -144.5 145.96 30.71 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.19 129.44 28.5 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.701 1.601 . . . . 0.0 108.617 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.54 77.88 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.372 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.6 169.91 8.99 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.237 2.019 . . . . 0.0 110.041 172.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.86 109.49 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.63 111.35 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 73' ' ' VAL . 14.3 t -100.82 121.14 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.79 130.14 34.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.48 173.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 110.399 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.41 144.53 43.08 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 161.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.83 -15.04 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.749 1.633 . . . . 0.0 111.433 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -66.65 -49.03 67.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.106 2.162 . . . . 0.0 110.943 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 122.35 87.28 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.806 1.242 . . . . 0.0 110.257 -172.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.29 -11.5 31.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.272 2.648 . . . . 0.0 112.31 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.8 -31.46 63.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.241 -0.912 . . . . 0.0 109.588 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -72.82 -38.77 67.04 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -46.55 67.06 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.138 0.575 . . . . 0.0 110.068 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.92 -56.05 23.84 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.287 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.91 -38.85 65.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.238 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -48.64 79.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.37 0.986 . . . . 0.0 113.644 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.09 -44.57 53.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -49.3 -54.83 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.969 1.307 . . . . 0.0 110.323 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD12 HG21 ' A' ' 17' ' ' VAL . 9.9 mt -81.97 -41.56 20.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.813 -172.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.7 t -70.65 -18.71 62.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.543 1.519 . . . . 0.0 112.498 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.83 -11.01 60.24 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.729 1.149 . . . . 0.0 111.827 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.12 133.06 39.77 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 163.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.44 62.52 8.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.011 2.474 . . . . 0.0 111.791 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.16 147.84 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -55.77 124.31 17.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -62.61 113.38 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.09 -12.9 9.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.744 1.164 . . . . 0.0 111.741 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.15 -39.81 15.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.691 1.745 . . . . 0.0 111.63 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 115.91 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.482 1.113 . . . . 0.0 109.465 -167.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -137.74 107.54 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.52 1.055 . . . . 0.0 109.078 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -85.93 105.12 16.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.842 1.257 . . . . 0.0 108.175 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.08 111.01 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -63.45 127.93 33.52 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 162.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 pt -93.04 -2.23 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 112.195 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -92.98 -40.48 10.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.847 1.203 . . . . 0.0 111.372 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.72 66.58 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.084 1.754 . . . . 0.0 113.487 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.77 161.56 40.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.79 1.636 . . . . 0.0 107.501 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 57.76 -163.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.606 1.162 . . . . 0.0 110.856 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -118.15 80.77 1.57 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -158.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.21 -63.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.468 1.507 . . . . 0.0 110.384 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -40.63 59.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.78 0.832 . . . . 0.0 110.969 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.5 -11.91 56.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.615 1.966 . . . . 0.0 114.425 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 mt -85.03 -47.49 16.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 125.379 1.472 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -71.17 -40.98 70.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.521 0.677 . . . . 0.0 110.78 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.89 -36.86 72.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.918 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -66.36 -33.87 76.71 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.311 -1.493 . . . . 0.0 112.703 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.92 -29.62 70.78 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 120.186 1.357 . . . . 0.0 110.135 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.79 -38.5 78.67 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 120.354 1.434 . . . . 0.0 110.681 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -55.54 6.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.405 0.682 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.13 -25.79 55.71 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.1 p -122.9 -36.74 2.83 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.813 -1.18 . . . . 0.0 111.977 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.95 -17.69 5.15 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.378 -1.234 . . . . 0.0 114.211 168.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.91 148.33 38.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.899 1.85 . . . . 0.0 110.216 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -11.95 59.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.59 143.11 25.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.805 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 151.55 43.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.9 1.68 . . . . 0.0 106.573 164.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.28 165.45 43.8 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 CA-C-N 120.139 1.086 . . . . 0.0 111.33 -4.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -142.57 109.11 5.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 86' ' ' LEU . 97.9 t -88.31 126.78 41.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.935 0.494 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -105.06 130.47 53.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.82 111.78 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.43 73.39 0.42 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 125.145 1.355 . . . . 0.0 113.213 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.55 -9.18 0.0 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 130.658 3.583 . . . . 0.0 118.107 -173.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -91.73 163.82 13.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.923 1.238 . . . . 0.0 108.877 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 t -125.02 129.13 49.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.828 1.651 . . . . 0.0 109.006 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -106.48 -16.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.68 178.66 23.96 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.73 -89.54 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 125.206 1.384 . . . . 0.0 110.391 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.45 -62.15 1.05 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 111.642 -169.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.2 t -65.53 -36.79 84.85 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.108 0.867 . . . . 0.0 110.183 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.47 -55.61 29.25 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.53 HD13 HG21 ' A' ' 73' ' ' VAL . 48.5 tp -49.07 -45.49 43.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.995 1.318 . . . . 0.0 111.689 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -46.74 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 116.628 -1.653 . . . . 0.0 109.789 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -49.08 75.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.64 -33.11 69.7 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.489 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -71.4 -51.57 23.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 121.148 1.794 . . . . 0.0 109.784 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -47.73 60.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.015 1.326 . . . . 0.0 110.045 -166.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.98 -34.08 74.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.424 1.89 . . . . 0.0 110.436 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 19.65 57.78 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-O 118.156 -1.358 . . . . 0.0 112.043 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.54 -42.51 83.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.732 2.266 . . . . 0.0 110.381 170.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -35.27 63.55 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.23 1.812 . . . . 0.0 110.473 -174.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.31 -52.58 64.1 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.681 0.793 . . . . 0.0 111.945 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.1 m -65.71 -41.53 92.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.449 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -44.72 73.14 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.771 0.828 . . . . 0.0 110.167 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.93 -44.44 89.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.974 1.31 . . . . 0.0 112.752 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 105' ' ' LEU . 68.0 mttt -63.18 -27.08 69.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.696 1.135 . . . . 0.0 112.434 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -56.03 -15.89 4.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 112.878 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.59 12.3 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.141 1.337 . . . . 0.0 112.351 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.74 36.14 58.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.174 -0.954 . . . . 0.0 113.005 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.72 -66.05 0.96 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.253 1.421 . . . . 0.0 112.757 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . 17.1 mt -75.27 133.57 41.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 121.352 1.887 . . . . 0.0 107.572 -167.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.771 1.229 . . . . 0.0 109.315 -167.269 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.463 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 5.2 pm0 -53.67 32.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 1 C-N-CA 133.77 4.828 . . . . 0.0 116.831 178.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -163.44 -58.04 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.512 1.925 . . . . 0.0 106.712 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -62.5 -46.12 89.89 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.903 0.774 . . . . 0.0 110.594 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 57' ' ' ILE . 8.9 t -68.99 -59.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.51 -49.41 74.83 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 t -76.76 -26.44 54.54 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.79 0.836 . . . . 0.0 112.367 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -66.47 -39.18 88.64 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.322 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -75.81 132.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.18 155.49 71.07 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.83 26.08 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 125.302 4.001 . . . . 0.0 115.054 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.23 21.16 0.11 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.603 1.573 . . . . 0.0 113.169 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -120.79 168.24 11.65 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.84 120.55 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.07 135.1 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.73 118.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -82.19 124.53 29.99 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.51 177.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.384 1.474 . . . . 0.0 111.257 -166.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 158.98 64.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.009 1.724 . . . . 0.0 107.289 169.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.88 2.09 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.264 2.643 . . . . 0.0 114.592 -163.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -133.04 -25.3 1.82 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -158.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 156.41 77.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.32 1.448 . . . . 0.0 114.12 -158.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.27 -29.5 21.34 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.431 2.087 . . . . 0.0 110.666 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -73.92 -46.74 42.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.7 m -70.09 -44.23 69.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -48.56 -46.71 39.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.217 -0.927 . . . . 0.0 111.969 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -60.4 -60.54 3.64 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.891 0.769 . . . . 0.0 109.572 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.69 69.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 124.244 0.965 . . . . 0.0 111.968 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -60.88 -47.54 85.93 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 117.827 -1.082 . . . . 0.0 111.503 177.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.77 -53.55 31.9 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 119.08 0.855 . . . . 0.0 109.9 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.04 -49.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.442 1.497 . . . . 0.0 109.763 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.27 -51.96 13.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -66.33 -23.44 66.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -73.84 -23.61 59.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.248 0.931 . . . . 0.0 110.044 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.98 138.15 69.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.1 65.79 8.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.303 2.668 . . . . 0.0 111.663 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.02 150.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -55.82 123.97 16.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.502 1.121 . . . . 0.0 109.516 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -65.29 151.31 46.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.322 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.61 -18.83 10.28 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.671 -1.627 . . . . 0.0 112.255 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -46.14 47.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 120.649 2.224 . . . . 0.0 109.803 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 116.08 22.69 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.044 0.84 . . . . 0.0 109.866 -169.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -124.48 150.67 45.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.987 1.315 . . . . 0.0 108.949 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 7.6 m-85 -124.24 130.31 52.31 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.54 101.39 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.801 1.64 . . . . 0.0 107.82 -160.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -64.16 119.67 10.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 pt -89.77 -8.22 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.072 0.949 . . . . 0.0 113.196 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 t -124.74 16.8 8.73 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.556 1.142 . . . . 0.0 110.964 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.67 -56.99 7.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 159.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -148.8 -39.94 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -164.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.06 19.32 2.21 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -158.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.33 80.92 0.16 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.762 1.225 . . . . 0.0 110.69 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -62.46 1.56 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 125.377 1.471 . . . . 0.0 107.376 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -47.8 -45.42 29.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.494 1.118 . . . . 0.0 112.537 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.261 9.9 tm-20 -63.87 -44.47 93.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.751 2.02 . . . . 0.0 112.668 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.475 HG23 HG21 ' A' ' 6' ' ' VAL . 11.7 mt -62.99 -37.75 80.18 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 125.243 1.417 . . . . 0.0 110.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.63 -38.56 70.75 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.33 -50.47 72.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.267 1.427 . . . . 0.0 111.057 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.09 -43.31 82.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.429 HD13 ' HG3' ' A' ' 72' ' ' ARG . 23.9 mt -64.15 -34.85 79.01 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -57.89 -46.0 85.56 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -53.73 30.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.63 -29.77 69.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.708 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -121.8 -27.31 4.69 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.34 -33.99 3.97 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.405 1.479 . . . . 0.0 110.867 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.74 43.59 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.729 1.264 . . . . 0.0 112.077 -172.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.49 -5.89 28.52 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.299 1.039 . . . . 0.0 113.175 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.6 p -68.1 133.78 49.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.99 154.56 37.27 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 132.23 14.57 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.169 1.096 . . . . 0.0 111.716 -9.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 61' ' ' LEU . 3.5 mmp_? -93.03 111.1 22.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.37 126.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -111.23 136.76 49.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 159.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.62 115.51 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 102.501 -3.148 . . . . 0.0 102.501 171.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.46 72.35 0.43 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.661 1.601 . . . . 0.0 114.183 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' A' ' 10' ' ' ILE . 2.6 mmtp 46.58 9.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.002 2.521 . . . . 0.0 116.12 -171.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -114.58 113.21 24.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.994 1.27 . . . . 0.0 108.848 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.94 123.93 21.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.71 -26.04 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 118.714 0.688 . . . . 0.0 109.707 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.38 -161.35 24.67 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.328 0.966 . . . . 0.0 111.133 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.42 -161.47 31.42 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.455 1.026 . . . . 0.0 111.444 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -33.59 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.326 1.063 . . . . 0.0 110.119 -165.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 t -71.42 -36.59 71.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.63 -53.8 30.22 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.3 tp -51.72 -46.42 63.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.313 1.445 . . . . 0.0 112.132 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.39 -44.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 117.357 -1.306 . . . . 0.0 108.892 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -50.02 63.9 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.45 -38.88 72.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.13 -57.32 6.99 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.381 1.446 . . . . 0.0 110.505 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -29.7 65.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.49 1.516 . . . . 0.0 112.486 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 t -87.17 -14.5 41.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.434 2.294 . . . . 0.0 110.638 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.3 89.39 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -25.31 67.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.246 2.523 . . . . 0.0 110.77 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.41 -34.32 76.51 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.605 1.962 . . . . 0.0 111.449 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.16 -50.24 66.74 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 m -61.55 -46.49 89.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.188 0.449 . . . . 0.0 109.808 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -47.0 72.26 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.234 0.47 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.44 -53.48 23.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 111.24 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -58.27 -29.19 65.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.655 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -51.34 -42.58 61.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.715 0.689 . . . . 0.0 110.093 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.31 6.05 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.027 0.831 . . . . 0.0 112.354 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.31 38.01 19.41 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.289 0.95 . . . . 0.0 112.821 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.87 -69.47 0.69 Allowed 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.801 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.46 133.84 49.24 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -172.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.253 1.276 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.934 -160.934 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 38.59 -62.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 1 C-N-CA 132.612 4.365 . . . . 0.0 117.49 159.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -163.31 -50.69 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.285 -0.884 . . . . 0.0 109.091 -167.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.34 -25.39 65.79 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.964 0.347 . . . . 0.0 111.432 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.07 -58.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.219 1.007 . . . . 0.0 109.549 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -68.41 -17.74 64.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -159.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.3 t -101.97 -26.42 13.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.983 1.313 . . . . 0.0 110.31 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -64.14 -45.75 87.11 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.659 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.2 143.75 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.682 1.128 . . . . 0.0 108.076 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.7 140.36 35.15 Favored Pre-proline 0 C--O 1.238 0.454 0 CA-C-N 119.296 0.953 . . . . 0.0 109.716 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.86 89.94 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.24 2.627 . . . . 0.0 108.714 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.53 17.04 2.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.896 1.712 . . . . 0.0 113.882 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -128.6 162.23 27.77 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.875 2.07 . . . . 0.0 109.636 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.2 t -112.29 81.45 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.43 134.93 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 t -134.3 111.71 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -78.46 128.36 33.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 pt -138.53 179.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.3 1.84 . . . . 0.0 109.24 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -144.79 147.6 36.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 158.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.34 -14.97 38.33 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.579 2.186 . . . . 0.0 113.042 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p -77.16 -28.82 54.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.333 0.97 . . . . 0.0 111.672 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -74.8 121.52 85.44 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.583 0.629 . . . . 0.0 110.382 -164.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.74 -15.62 33.43 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.012 1.808 . . . . 0.0 111.823 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.98 -33.55 24.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.772 1.169 . . . . 0.0 109.341 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.2 m -62.63 -41.52 99.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -53.49 -42.76 67.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.474 0.579 . . . . 0.0 112.29 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -55.82 23.19 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.02 -36.08 62.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.307 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.92 83.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.777 169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.81 -46.58 65.38 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 120.543 1.519 . . . . 0.0 109.414 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -52.09 -58.34 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 126.504 1.921 . . . . 0.0 107.7 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.47 -33.34 58.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.598 -170.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 m -67.33 -35.13 78.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 0.0 112.138 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.98 -9.43 58.63 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.904 1.229 . . . . 0.0 112.079 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.57 135.52 43.41 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.058 1.299 . . . . 0.0 109.392 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.12 75.96 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.515 3.477 . . . . 0.0 110.481 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.494 HD11 HD13 ' A' ' 99' ' ' LEU . 8.1 mt -102.93 151.3 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -169.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -48.25 130.53 16.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.383 1.073 . . . . 0.0 110.485 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.1 140.27 56.01 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.66 -7.81 57.18 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.814 -1.548 . . . . 0.0 113.733 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.57 -37.19 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 121.066 2.433 . . . . 0.0 110.966 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 103.29 13.26 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.26 103.68 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.377 1.071 . . . . 0.0 108.58 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -84.09 117.49 23.48 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.67 109.2 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.995 2.118 . . . . 0.0 108.834 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -64.02 104.95 0.78 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.494 2.318 . . . . 0.0 114.015 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.67 -22.38 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.757 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.262 3.0 t -99.38 2.83 45.59 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.877 -1.058 . . . . 0.0 111.135 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -40.19 -67.76 0.21 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.529 1.932 . . . . 0.0 112.0 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -160.08 -15.57 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.11 1.364 . . . . 0.0 111.508 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -50.3 -57.49 7.76 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.628 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 1.1 m-70 127.73 105.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 C-N-CA 131.276 3.83 . . . . 0.0 105.997 -158.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -63.51 1.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.462 1.105 . . . . 0.0 108.914 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 58' ' ' GLN . 7.1 t30 -61.46 -29.96 70.29 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . 3.6 tm-20 -64.24 -46.57 83.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.484 1.114 . . . . 0.0 110.985 171.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -59.26 -38.57 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 55' ' ' ASN . 6.9 mm-40 -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -169.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -49.21 -55.31 12.94 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.211 1.404 . . . . 0.0 110.548 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 2' ' ' ALA . 24.9 t80 -56.84 -45.12 82.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.169 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.06 -44.83 96.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.889 1.222 . . . . 0.0 111.032 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.8 -34.75 69.97 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 123.151 0.282 . . . . 0.0 111.034 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -76.29 -48.23 20.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.935 0.494 . . . . 0.0 111.567 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.28 -47.01 63.17 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.941 1.296 . . . . 0.0 108.5 -158.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 p -102.63 -44.9 5.19 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.34 -13.35 4.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.667 1.127 . . . . 0.0 113.001 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.78 160.28 41.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.486 1.643 . . . . 0.0 108.875 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -118.65 -24.16 6.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 117.394 -1.289 . . . . 0.0 114.221 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 p -64.16 133.24 52.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 160.73 56.16 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.783 1.233 . . . . 0.0 108.497 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.16 159.99 61.4 Favored 'Cis proline' 0 C--N 1.344 0.323 0 CA-C-N 120.314 1.148 . . . . 0.0 110.591 -4.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -123.27 101.2 7.24 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.07 126.56 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -114.25 97.86 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -83.79 123.12 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 168.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 42.6 68.79 0.69 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.924 1.25 . . . . 0.0 113.23 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.22 -2.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.813 2.845 . . . . 0.0 118.645 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.4 115.74 28.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.094 1.316 . . . . 0.0 107.87 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -63.74 117.26 6.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.32 -16.89 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.19 -146.79 17.88 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.26 -153.43 18.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.934 0.741 . . . . 0.0 111.783 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.2 p -65.64 -38.47 89.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.044 0.938 . . . . 0.0 110.653 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -75.92 -31.39 59.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.662 0.601 . . . . 0.0 111.62 -176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.05 -52.5 41.54 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 23.0 tp -57.01 -34.36 68.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.451 0.7 . . . . 0.0 111.351 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.65 -48.44 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 115.419 -2.229 . . . . 0.0 109.723 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -55.1 37.64 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.441 1.928 . . . . 0.0 107.256 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.54 -35.86 72.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.689 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -68.47 -47.77 66.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.335 1.425 . . . . 0.0 110.51 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -63.8 1.15 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.999 2.52 . . . . 0.0 109.818 -168.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -79.22 -12.54 59.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 119.253 -0.404 . . . . 0.0 110.523 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.7 18.81 53.92 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-O 117.228 -1.873 . . . . 0.0 113.282 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.52 -23.02 67.13 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 121.099 2.449 . . . . 0.0 111.049 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.44 -38.86 63.94 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.294 1.438 . . . . 0.0 111.09 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.57 -48.38 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.161 0.984 . . . . 0.0 109.182 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.2 m -66.69 -44.66 81.15 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.976 1.31 . . . . 0.0 110.658 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -47.76 64.33 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.6 0.76 . . . . 0.0 109.392 174.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 38' ' ' ILE . 23.4 mt -69.83 -50.67 40.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.126 0.57 . . . . 0.0 111.438 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -57.95 -29.94 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.362 -0.836 . . . . 0.0 112.627 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -47.96 -40.52 22.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.361 1.064 . . . . 0.0 111.601 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.4 8.17 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.646 0.657 . . . . 0.0 112.764 -168.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.4 50.81 5.54 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.694 0.679 . . . . 0.0 111.671 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.86 -74.17 0.65 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 126.508 1.923 . . . . 0.0 112.507 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.74 150.95 43.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.599 1.999 . . . . 0.0 106.93 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.964 -172.294 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.378 0 CA-C-O 115.807 -2.044 . . . . 0.0 106.672 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 56.42 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.284 3.033 . . . . 0.0 118.045 160.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -163.94 -38.9 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.96 2.104 . . . . 0.0 108.036 -164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -49.49 -48.41 47.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.224 1.374 . . . . 0.0 111.519 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.26 -48.67 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.726 -0.609 . . . . 0.0 110.033 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -70.95 -32.03 68.8 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.161 -0.962 . . . . 0.0 113.199 -167.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -18.12 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.973 -1.08 . . . . 0.0 110.818 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 44' ' ' GLU . 32.1 mmtm -76.46 -59.87 2.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.479 172.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.05 144.81 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.623 1.101 . . . . 0.0 108.928 -172.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -138.27 157.04 73.35 Favored Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 126.982 2.113 . . . . 0.0 106.559 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.26 66.76 7.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.518 2.812 . . . . 0.0 110.7 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.86 40.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.109 1.814 . . . . 0.0 111.21 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -143.49 168.99 18.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.22 1.808 . . . . 0.0 107.128 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 75' ' ' ILE . 25.3 t -114.7 95.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 165.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.68 144.66 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 t -132.22 117.59 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -77.16 120.79 22.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.29 -178.15 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.745 2.418 . . . . 0.0 109.664 -172.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 11.8 ptpt -136.27 164.48 42.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 126.496 1.918 . . . . 0.0 107.673 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 82.3 Cg_endo -76.74 -1.97 12.14 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.452 2.101 . . . . 0.0 112.773 -165.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -118.67 -99.99 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.794 1.637 . . . . 0.0 107.426 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 t 32.48 100.94 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.599 2.76 . . . . 0.0 114.995 169.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.56 -10.0 26.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.247 1.298 . . . . 0.0 111.637 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.85 -35.1 15.85 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.727 -1.233 . . . . 0.0 108.169 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.7 -55.18 33.08 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -57.58 -41.4 81.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.845 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -56.89 -61.41 2.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 118.865 0.757 . . . . 0.0 109.69 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.13 -33.54 27.03 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.049 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.18 -55.52 33.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.56 1.544 . . . . 0.0 111.968 171.034 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.43 -38.58 77.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.078 1.763 . . . . 0.0 110.243 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.41 -50.33 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.291 1.436 . . . . 0.0 108.971 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.86 -53.0 9.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -63.21 -24.55 67.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.397 0.679 . . . . 0.0 112.098 -166.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -74.01 0.85 12.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.055 0.843 . . . . 0.0 112.392 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 120.796 -1.19 . . . . 0.0 109.207 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.35 57.24 6.16 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.159 3.24 . . . . 0.0 111.383 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 99' ' ' LEU . 9.2 mt -74.52 151.2 7.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -175.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -53.92 123.93 13.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.06 133.33 50.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -171.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -14.33 63.9 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.571 -1.127 . . . . 0.0 113.005 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.16 -39.5 63.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.706 1.753 . . . . 0.0 110.754 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 104.18 14.14 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -168.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' OE2' ' HE3' ' A' ' 9' ' ' LYS . 42.5 tt0 -122.35 113.9 20.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 22.1 m-85 -83.84 133.28 34.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -125.03 100.2 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.369 1.468 . . . . 0.0 107.052 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -64.65 112.86 3.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.708 1.203 . . . . 0.0 111.131 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.7 pt -68.04 -9.39 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.113 -0.992 . . . . 0.0 112.689 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 p -89.02 -7.33 56.16 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.623 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.47 62.32 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.786 1.176 . . . . 0.0 113.184 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.4 p -121.02 2.79 10.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.813 1.645 . . . . 0.0 110.843 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.0 t30 54.57 -6.46 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.419 2.688 . . . . 0.0 115.855 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -68.02 17.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.657 1.583 . . . . 0.0 113.341 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.86 -63.0 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.674 1.99 . . . . 0.0 110.237 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.62 -22.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.629 1.572 . . . . 0.0 114.81 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.74 -30.71 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.155 1.343 . . . . 0.0 111.522 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mt -69.76 -33.68 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.896 1.279 . . . . 0.0 108.299 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -52.27 54.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -52.48 -54.96 25.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.199 1.8 . . . . 0.0 110.424 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -51.55 -46.0 63.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.608 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.97 -35.46 81.25 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.617 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.53 -54.91 28.79 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.973 1.26 . . . . 0.0 109.412 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -36.76 76.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.137 0.975 . . . . 0.0 110.393 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -76.34 -52.48 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 0.0 109.161 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -97.49 -75.89 0.53 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -168.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.06 -13.93 0.06 OUTLIER Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.022 1.296 . . . . 0.0 114.005 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.68 146.47 41.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.091 1.945 . . . . 0.0 108.97 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -29.43 45.8 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.861 171.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -62.41 133.29 54.83 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -159.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.03 153.91 52.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.32 156.85 80.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.24 0.764 . . . . 0.0 111.684 -7.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.48 106.69 10.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.2 129.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -118.53 93.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.912 2.485 . . . . 0.0 107.479 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.91 118.15 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 40.13 67.97 0.61 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.492 1.996 . . . . 0.0 114.489 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.61 24.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.89 97.75 5.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -67.84 118.1 10.62 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.806 -1.184 . . . . 0.0 108.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 89' ' ' LEU . 1.1 pp -83.76 -21.58 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -167.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -168.77 24.34 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -170.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.14 -85.62 1.79 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 -64.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.813 1.245 . . . . 0.0 108.157 -170.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m -58.77 -39.41 80.94 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.533 0.733 . . . . 0.0 111.721 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.83 -56.73 18.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.0 -39.35 74.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.099 1.36 . . . . 0.0 110.856 -168.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.8 t -64.85 -40.87 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 117.256 -1.354 . . . . 0.0 111.119 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -50.91 69.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 80' ' ' ILE . 4.0 mp -56.06 -37.65 69.58 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 117.743 -1.122 . . . . 0.0 109.613 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -63.64 -57.58 9.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.453 1.479 . . . . 0.0 109.613 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -42.9 83.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.299 1.44 . . . . 0.0 111.57 -166.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.1 t -65.06 -51.99 58.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.593 1.957 . . . . 0.0 107.845 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.73 1.77 27.3 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.259 -1.301 . . . . 0.0 111.475 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.7 -22.66 66.67 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.936 1.868 . . . . 0.0 110.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -54.51 -46.45 73.5 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 110.348 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.68 -51.14 68.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.478 0.711 . . . . 0.0 109.234 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -53.73 -45.62 70.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.009 0.924 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -56.23 21.36 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 110.678 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -75.22 -30.72 60.65 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.944 -1.097 . . . . 0.0 112.15 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.19 -30.15 66.21 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.396 -1.44 . . . . 0.0 112.474 169.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -60.17 -8.8 2.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.157 1.383 . . . . 0.0 113.773 171.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.16 8.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.437 1.895 . . . . 0.0 110.866 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.51 36.86 89.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.968 1.27 . . . . 0.0 112.951 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.45 -62.32 1.48 Allowed 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.71 1.204 . . . . 0.0 110.742 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -72.28 142.62 48.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.464 -161.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.319 -0.741 0 C-N-CA 127.994 2.518 . . . . 0.0 107.5 -178.199 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.571 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER -67.4 -99.4 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 125.505 1.753 . . . . 0.0 106.755 159.148 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.06 -31.22 65.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -159.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.25 -26.91 63.48 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.476 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.79 -69.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.458 1.503 . . . . 0.0 110.687 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -65.79 -43.56 88.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.1 0.863 . . . . 0.0 111.834 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.1 t -72.83 -18.19 61.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.814 0.445 . . . . 0.0 111.009 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -71.2 -46.86 60.35 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.615 -1.184 . . . . 0.0 112.109 171.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.5 144.21 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 120.245 1.384 . . . . 0.0 108.526 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.74 168.18 14.62 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 125.372 1.469 . . . . 0.0 107.416 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.3 157.55 30.19 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.295 1.141 . . . . 0.0 109.399 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.63 79.55 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.575 -1.125 . . . . 0.0 115.372 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -132.39 158.58 41.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.656 1.728 . . . . 0.0 107.905 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 43' ' ' LEU . 21.2 t -107.05 123.3 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.06 136.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.12 114.58 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -77.68 122.66 25.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -133.71 166.91 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.056 1.342 . . . . 0.0 109.758 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -132.33 125.18 19.66 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 158.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.4 -15.32 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.66 1.573 . . . . 0.0 111.414 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -83.0 -0.17 47.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.914 2.086 . . . . 0.0 113.356 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.13 132.49 21.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.159 1.345 . . . . 0.0 108.23 161.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.91 -17.72 56.2 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.479 2.786 . . . . 0.0 110.952 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -74.04 -38.21 64.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.95 -44.51 96.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 117.72 -1.134 . . . . 0.0 109.027 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -53.43 -50.35 65.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.606 1.094 . . . . 0.0 111.783 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -54.45 -59.21 4.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 119.202 -0.427 . . . . 0.0 110.187 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.06 60.84 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.604 1.19 . . . . 0.0 111.231 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.67 80.62 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 117.855 -1.069 . . . . 0.0 111.206 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -41.33 69.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 120.557 1.526 . . . . 0.0 109.336 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.17 -54.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.429 1.892 . . . . 0.0 109.263 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.43 -42.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -171.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 t -65.91 -25.11 67.0 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.247 0.476 . . . . 0.0 111.131 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.69 -22.72 59.84 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.355 0.98 . . . . 0.0 112.407 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.95 154.47 92.58 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 119.329 0.968 . . . . 0.0 109.496 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.57 77.93 3.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.853 2.369 . . . . 0.0 109.876 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mt -102.43 153.46 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -51.97 124.27 12.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.033 0.933 . . . . 0.0 109.083 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.61 137.83 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.77 -14.07 64.13 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.841 -1.533 . . . . 0.0 112.247 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mt -73.81 -36.8 65.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.802 2.301 . . . . 0.0 111.78 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.04 118.02 23.79 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -170.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -122.04 123.6 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.627 1.171 . . . . 0.0 109.193 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.53 127.26 45.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.96 105.09 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.935 1.294 . . . . 0.0 108.735 -165.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.35 100.76 3.26 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.576 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.488 HG22 HG21 ' A' ' 57' ' ' ILE . 8.9 pt -63.94 -14.46 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 113.18 175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -114.69 10.5 16.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.871 1.268 . . . . 0.0 111.666 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.53 68.3 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.528 1.058 . . . . 0.0 109.5 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -157.61 -40.13 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.216 171.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -41.8 -63.43 0.72 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.739 1.215 . . . . 0.0 113.106 -158.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 144.24 103.57 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 130.409 3.484 . . . . 0.0 106.316 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -63.47 1.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.275 1.43 . . . . 0.0 108.323 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.47 -30.64 60.95 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.61 -52.31 61.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.839 1.199 . . . . 0.0 110.747 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 48' ' ' ILE . 6.4 mt -64.03 -39.24 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -57.2 -50.07 74.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.406 2.282 . . . . 0.0 107.459 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.27 -42.32 93.34 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 110.518 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -58.41 -47.42 83.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.9 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.19 -36.78 84.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.792 0.724 . . . . 0.0 110.581 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.83 -51.04 70.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.538 0.735 . . . . 0.0 109.945 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.91 -49.93 72.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.003 0.521 . . . . 0.0 109.851 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.49 -40.58 66.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.116 0.966 . . . . 0.0 109.373 -166.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 p -108.38 -15.37 14.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.255 0.934 . . . . 0.0 113.356 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.19 6.78 64.5 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.625 -1.097 . . . . 0.0 112.158 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.52 22.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.236 1.518 . . . . 0.0 109.265 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -94.67 -8.89 36.56 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.92 133.82 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.685 1.129 . . . . 0.0 110.66 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.11 161.11 29.27 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 160.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.24 141.79 37.46 Favored 'Cis proline' 0 N--CA 1.463 -0.275 0 N-CA-C 110.158 -0.747 . . . . 0.0 110.158 -13.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.94 93.1 4.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.85 130.79 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.86 109.02 18.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.378 1.871 . . . . 0.0 106.927 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.5 108.66 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 163.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 67.48 1.91 Allowed Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.264 1.411 . . . . 0.0 112.849 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.0 mttt 46.06 20.39 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.166 1.787 . . . . 0.0 115.393 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.29 110.91 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 164.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -67.26 107.99 2.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.5 pp -83.48 -14.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.485 0.584 . . . . 0.0 111.456 -170.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.47 -171.35 22.94 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 124.478 1.037 . . . . 0.0 111.355 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.81 -160.23 31.82 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.896 1.713 . . . . 0.0 110.251 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -37.78 86.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.026 0.913 . . . . 0.0 110.334 -170.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.6 m -67.36 -48.32 67.79 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.987 -172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 -51.94 67.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.7 tp -54.28 -37.33 64.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.074 -0.965 . . . . 0.0 112.231 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -60.85 -53.41 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 116.777 -1.582 . . . . 0.0 108.982 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.22 87.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 121.848 2.113 . . . . 0.0 108.692 -174.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.3 -32.03 71.88 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.745 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.34 -55.11 8.66 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 121.055 1.752 . . . . 0.0 111.087 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -51.91 34.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.635 2.374 . . . . 0.0 110.631 -168.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 t -70.34 -24.59 63.01 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.945 1.298 . . . . 0.0 109.977 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 11.06 65.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.166 173.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.55 -25.93 68.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.36 2.08 . . . . 0.0 111.726 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.73 -32.23 69.02 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.536 1.134 . . . . 0.0 111.513 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.09 -46.52 61.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.65 0.659 . . . . 0.0 109.656 -168.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.9 m -64.45 -40.49 95.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -40.97 85.37 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.54 -0.725 . . . . 0.0 111.687 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.75 -46.09 84.96 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.713 1.205 . . . . 0.0 110.503 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -62.12 -31.02 71.44 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.958 -1.089 . . . . 0.0 112.331 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -63.64 -10.99 21.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.92 11.75 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 119.474 1.034 . . . . 0.0 111.854 170.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.12 26.09 62.69 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.341 0.972 . . . . 0.0 112.887 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.616 1.166 . . . . 0.0 111.487 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.7 mt -77.55 134.32 38.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.802 -1.559 . . . . 0.0 110.944 -158.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 . . . . . 0 N--CA 1.428 -1.526 0 C-N-CA 130.134 3.374 . . . . 0.0 106.161 -179.273 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 75.22 -173.31 0.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 128.122 2.569 . . . . 0.0 113.487 170.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -10.04 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.807 2.443 . . . . 0.0 114.62 163.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -45.11 -57.03 4.17 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.371 1.441 . . . . 0.0 110.507 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.09 -58.93 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.32 -37.39 67.36 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.19 0.996 . . . . 0.0 113.573 -161.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.0 m -101.91 -8.87 21.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.971 0.908 . . . . 0.0 112.815 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.87 -45.26 90.24 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.966 1.257 . . . . 0.0 107.7 159.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.44 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 mt -63.75 155.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 152.52 47.48 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.61 125.22 14.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 N-CA-C 104.763 -2.822 . . . . 0.0 104.763 158.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.49 35.58 25.63 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.737 0.684 . . . . 0.0 113.302 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -142.31 161.31 38.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.099 2.159 . . . . 0.0 109.341 166.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 75' ' ' ILE . 38.3 t -118.33 109.25 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 10' ' ' ILE . 61.6 t -127.56 132.25 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 120.555 -1.341 . . . . 0.0 108.289 -166.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.23 111.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -166.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -79.29 119.26 22.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.86 169.5 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.989 1.716 . . . . 0.0 109.921 -174.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -127.29 141.28 40.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 162.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.06 28.77 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.6 3.533 . . . . 0.0 111.315 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.323 9.6 t -147.23 29.48 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.813 2.045 . . . . 0.0 108.929 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.63 123.84 26.87 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.035 1.734 . . . . 0.0 108.595 167.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.98 -24.92 52.4 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.486 1.457 . . . . 0.0 111.984 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -78.98 -28.72 43.54 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.953 0.797 . . . . 0.0 109.353 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.2 m -66.11 -46.9 75.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -51.92 -48.15 64.33 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.166 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -55.5 -57.87 10.13 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 119.014 0.825 . . . . 0.0 109.938 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.42 62.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.328 1.018 . . . . 0.0 111.472 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -45.69 78.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.388 0.994 . . . . 0.0 113.295 172.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.66 -53.21 16.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt -44.34 -53.22 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.39 1.876 . . . . 0.0 110.442 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.64 -46.47 19.13 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.186 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -6.51 59.26 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.367 0.985 . . . . 0.0 112.608 -167.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -73.83 -16.16 61.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.66 1.118 . . . . 0.0 110.992 167.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -78.0 151.29 78.89 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 120.885 -1.134 . . . . 0.0 108.748 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 42.23 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.303 2.669 . . . . 0.0 111.295 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.1 145.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -58.38 123.06 14.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.27 146.66 54.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.78 10.22 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.589 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.49 -30.5 63.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.883 1.842 . . . . 0.0 109.68 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 119.72 25.18 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 120.515 1.507 . . . . 0.0 107.684 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -128.72 110.41 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.688 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -84.19 103.74 13.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -90.82 114.96 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 126.519 1.927 . . . . 0.0 107.231 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.57 110.58 3.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.591 1.156 . . . . 0.0 110.942 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.6 pt -70.45 -2.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.369 1.068 . . . . 0.0 113.006 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.261 3.3 t -137.12 35.64 2.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 118.775 0.716 . . . . 0.0 110.41 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.06 55.73 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.333 0.653 . . . . 0.0 109.363 159.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.6 p 53.54 65.65 1.46 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.965 2.506 . . . . 0.0 111.15 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -143.48 -93.64 0.11 Allowed 'General case' 0 C--O 1.23 0.07 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.008 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.22 57.28 0.35 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.422 1.464 . . . . 0.0 113.678 -163.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -63.66 0.86 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.581 1.152 . . . . 0.0 111.817 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -46.63 -54.68 9.02 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.901 0.75 . . . . 0.0 111.15 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -41.66 93.63 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.554 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.4 -39.99 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.03 -41.45 74.25 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -42.05 35.9 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.49 1.916 . . . . 0.0 111.423 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.5 -50.99 66.49 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.753 1.221 . . . . 0.0 110.338 171.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.42 -30.71 65.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.789 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' NE2' HH21 ' A' ' 68' ' ' ARG . 22.7 tt0 -66.56 -37.79 85.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.627 1.558 . . . . 0.0 111.695 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -67.66 -47.54 69.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.53 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.27 -24.33 57.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.211 -168.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 p -133.51 -2.85 3.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.283 1.401 . . . . 0.0 114.101 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.13 -10.23 61.42 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 120.061 1.301 . . . . 0.0 112.857 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.62 137.33 54.48 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.126 -1.22 . . . . 0.0 110.587 -172.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.503 HH21 ' NE2' ' A' ' 62' ' ' GLN . 5.1 ptp85 -102.02 -31.31 10.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.475 174.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 133.33 41.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.285 0.564 . . . . 0.0 109.716 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.27 159.49 39.27 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.369 1.467 . . . . 0.0 108.458 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.54 167.77 22.72 Favored 'Cis proline' 0 C--N 1.347 0.457 0 CA-C-N 120.379 1.171 . . . . 0.0 111.881 -8.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 110.15 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.062 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.9 t -91.98 125.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 119.426 1.012 . . . . 0.0 108.761 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -102.21 114.68 29.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 158.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.41 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -93.18 123.68 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 160.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 43.78 72.43 0.33 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.301 1.429 . . . . 0.0 113.811 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 46.65 14.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.17 120.22 36.44 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.471 1.487 . . . . 0.0 110.658 170.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.71 114.66 4.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.706 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.8 pp -83.52 -12.68 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 119.236 0.925 . . . . 0.0 110.845 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.75 -158.17 18.28 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.65 -157.47 31.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 126.767 2.127 . . . . 0.0 111.108 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -38.44 83.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.923 -0.751 . . . . 0.0 110.335 -169.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -68.85 -44.82 72.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.634 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -65.17 -45.56 84.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.6 tp -53.98 -45.42 71.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.5 0.72 . . . . 0.0 112.057 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.89 -39.16 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 117.112 -1.423 . . . . 0.0 109.536 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -54.54 24.92 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -58.52 -33.54 69.96 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.29 -63.67 1.03 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.935 1.698 . . . . 0.0 110.705 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.26 78.3 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.864 1.266 . . . . 0.0 112.163 -166.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -86.39 -2.24 58.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.457 1.503 . . . . 0.0 110.972 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 -0.37 88.86 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 117.107 -1.941 . . . . 0.0 114.671 168.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.38 -31.54 72.73 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 121.285 2.542 . . . . 0.0 111.168 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.27 -35.65 70.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.987 1.315 . . . . 0.0 110.763 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.19 -44.09 76.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -61.25 -54.14 47.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -40.34 63.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.519 1.128 . . . . 0.0 111.07 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.1 mt -70.11 -57.56 4.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.78 1.632 . . . . 0.0 112.448 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 105' ' ' LEU . 4.5 tttm -65.88 -26.81 67.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.709 1.595 . . . . 0.0 111.913 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -44.95 -36.69 3.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.674 1.59 . . . . 0.0 111.528 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.57 14.3 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.44 1.018 . . . . 0.0 112.552 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.5 40.89 21.85 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.725 0.693 . . . . 0.0 112.286 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.21 -78.21 0.53 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.076 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -60.1 135.0 57.58 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 C--O 1.245 0.831 0 O-C-N 125.499 1.75 . . . . 0.0 108.006 -163.835 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 57.4 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 126.09 2.119 . . . . 0.0 113.747 -165.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.34 -19.2 65.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.658 -0.651 . . . . 0.0 111.073 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -47.08 -49.94 20.72 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.718 1.207 . . . . 0.0 110.111 168.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.7 -53.12 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.939 0.791 . . . . 0.0 109.937 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.36 -55.71 31.28 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.233 0.924 . . . . 0.0 111.467 -163.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.9 m -82.58 -6.69 59.49 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -65.52 -22.83 66.75 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.915 1.234 . . . . 0.0 110.639 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.8 154.87 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 120.637 1.562 . . . . 0.0 108.561 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -135.65 152.33 75.98 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.79 63.93 8.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.128 3.219 . . . . 0.0 110.976 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.4 31.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.933 1.254 . . . . 0.0 111.781 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -134.44 172.92 12.23 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.142 1.777 . . . . 0.0 107.756 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 21.1 t -116.76 111.51 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.7 t -132.38 115.91 27.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -158.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.69 130.16 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 123.003 0.521 . . . . 0.0 110.305 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.42 125.15 40.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.77 168.5 16.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.854 1.661 . . . . 0.0 110.512 -167.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -125.54 148.42 61.54 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 169.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.28 -39.08 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.701 2.267 . . . . 0.0 110.134 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 p -81.89 48.48 1.23 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.05 2.14 . . . . 0.0 109.966 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -140.67 127.06 11.77 Favored Pre-proline 0 C--O 1.242 0.679 0 C-N-CA 126.516 1.927 . . . . 0.0 109.387 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.56 -19.56 11.39 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.333 2.022 . . . . 0.0 112.038 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -73.59 -35.28 65.39 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 120.428 1.467 . . . . 0.0 108.305 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.27 -40.07 89.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -53.13 -53.95 42.93 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.156 0.434 . . . . 0.0 110.84 171.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -53.19 -59.18 4.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.552 0.741 . . . . 0.0 109.021 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -41.88 72.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 117.515 -1.231 . . . . 0.0 111.481 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -49.64 71.05 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 119.718 1.145 . . . . 0.0 112.162 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.43 -50.05 55.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.205 1.002 . . . . 0.0 110.124 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -46.69 -56.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 127.272 2.229 . . . . 0.0 109.586 170.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.66 -46.76 74.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -65.61 -18.65 65.48 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -73.52 -27.31 61.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.084 1.311 . . . . 0.0 110.397 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.66 135.43 81.13 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -82.25 63.32 8.2 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.089 2.526 . . . . 0.0 112.072 -167.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.57 147.74 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.244 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -46.45 124.54 5.94 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.856 1.662 . . . . 0.0 109.243 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.56 129.51 42.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -3.08 82.71 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 118.083 -1.398 . . . . 0.0 113.279 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.72 -30.99 46.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.813 2.306 . . . . 0.0 112.44 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 116.09 26.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -123.3 133.6 54.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.676 1.19 . . . . 0.0 108.219 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -110.56 139.03 46.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.7 t -135.39 108.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.288 1.035 . . . . 0.0 108.547 -164.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.29 122.76 17.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 111.942 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.427 HG22 HG21 ' A' ' 57' ' ' ILE . 45.2 pt -75.11 -20.47 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.955 1.302 . . . . 0.0 112.449 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 p -88.28 -2.9 58.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.472 1.109 . . . . 0.0 110.893 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -58.43 6.01 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 124.992 1.317 . . . . 0.0 111.201 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.4 OUTLIER -149.47 -70.12 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.428 169.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -34.1 -86.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.834 2.054 . . . . 0.0 114.285 -158.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -164.18 99.91 0.85 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.213 1.805 . . . . 0.0 106.844 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.29 -62.62 1.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.94 -7.41 8.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.096 1.758 . . . . 0.0 113.531 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -36.0 16.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.84 1.655 . . . . 0.0 109.637 161.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 2' ' ' ALA . 11.3 mt -71.36 -50.06 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -167.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.55 76.09 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.009 0.524 . . . . 0.0 110.015 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -55.48 -56.85 15.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.547 1.539 . . . . 0.0 110.946 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 12.4 t80 -56.84 -29.91 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.84 2.056 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 72' ' ' ARG . 33.9 mt -60.48 -30.42 69.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.015 1.28 . . . . 0.0 111.73 174.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -60.28 -37.04 79.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.945 0.793 . . . . 0.0 109.731 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.16 -49.44 17.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.41 -30.42 57.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.54 -166.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.778 HG21 HH11 ' A' ' 72' ' ' ARG . 34.7 p -120.79 -62.56 1.44 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.904 1.229 . . . . 0.0 110.459 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.19 -34.69 0.2 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.154 -1.359 . . . . 0.0 114.341 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.35 144.88 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.123 1.461 . . . . 0.0 109.739 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -83.54 14.88 3.42 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.618 0.767 . . . . 0.0 112.368 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -105.84 163.76 12.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.578 1.656 . . . . 0.0 110.626 -158.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.99 144.38 46.18 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 127.632 2.373 . . . . 0.0 106.16 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.62 155.33 89.91 Favored 'Cis proline' 0 N--CA 1.454 -0.808 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 -4.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.778 HH11 HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.46 130.24 17.1 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 176.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.17 128.15 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 124.185 0.994 . . . . 0.0 109.559 -163.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -94.23 124.98 38.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.29 113.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 160.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.69 15.27 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.28 -0.887 . . . . 0.0 112.483 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt 46.52 3.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.852 2.461 . . . . 0.0 116.917 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.33 142.02 28.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.171 1.805 . . . . 0.0 107.637 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -101.25 123.5 45.47 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.893 -1.13 . . . . 0.0 112.271 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.62 -23.1 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.359 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.93 -165.22 21.02 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.292 0.949 . . . . 0.0 111.201 -171.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 -163.58 32.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.486 1.517 . . . . 0.0 110.885 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.1 p -65.61 -34.37 78.07 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.409 1.104 . . . . 0.0 110.49 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -62.01 -42.55 99.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.872 0.76 . . . . 0.0 111.113 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.66 -54.52 22.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.2 tp -51.91 -39.24 58.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.92 1.288 . . . . 0.0 111.9 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.6 t -58.56 -59.35 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 117.012 -1.471 . . . . 0.0 108.797 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.2 p -48.65 -54.74 13.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.556 1.98 . . . . 0.0 115.003 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . 6.6 mp -59.75 -32.81 70.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.447 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -72.01 -51.89 19.66 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.893 1.679 . . . . 0.0 110.245 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -58.58 3.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.07 1.748 . . . . 0.0 110.097 -168.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -16.99 64.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.852 1.261 . . . . 0.0 110.895 173.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.64 78.94 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.185 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.49 -22.72 67.05 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.816 2.308 . . . . 0.0 111.68 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 89' ' ' LEU . 5.9 tp -64.8 -24.67 67.62 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.576 174.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.34 -52.32 59.0 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 120.354 1.434 . . . . 0.0 108.632 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.1 m -57.07 -50.88 71.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.727 0.811 . . . . 0.0 109.956 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -47.6 -51.6 20.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.001 0.92 . . . . 0.0 110.712 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.29 -52.06 37.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.175 1.39 . . . . 0.0 111.3 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -62.18 -26.05 68.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.562 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -57.25 -33.1 67.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.072 0.851 . . . . 0.0 112.305 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.1 -14.92 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.905 1.229 . . . . 0.0 112.133 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.04 83.9 0.74 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -166.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.85 -76.41 0.46 Allowed 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.721 -1.609 . . . . 0.0 110.92 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.47 135.29 54.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 121.968 2.167 . . . . 0.0 108.503 -172.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.844 1.34 . . . . 0.0 109.132 -158.364 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.206 0.527 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -81.49 63.08 5.64 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.618 -1.301 . . . . 0.0 110.194 172.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -163.04 -58.63 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.65 -57.89 10.99 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.628 1.558 . . . . 0.0 109.639 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.79 -48.92 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -68.47 -16.32 63.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.37 1.068 . . . . 0.0 112.421 -165.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -103.81 -26.24 12.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.862 1.665 . . . . 0.0 111.751 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -64.05 -43.8 94.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.491 1.042 . . . . 0.0 110.959 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.16 140.9 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.86 157.2 60.75 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.46 16.86 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.023 3.149 . . . . 0.0 114.828 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.57 45.32 0.2 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.8 2.143 . . . . 0.0 110.795 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -141.23 164.08 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.594 HG13 HD12 ' A' ' 75' ' ' ILE . 36.2 t -101.61 100.61 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.96 125.56 61.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 t -126.15 109.08 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -76.47 132.08 39.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -138.65 164.29 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.012 2.125 . . . . 0.0 108.874 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 145.87 34.02 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 158.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.53 16.11 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.923 3.082 . . . . 0.0 114.085 -161.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -129.4 -22.02 3.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.397 1.479 . . . . 0.0 112.665 -160.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -94.74 148.69 35.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -157.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.17 -25.19 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.874 2.382 . . . . 0.0 111.787 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -73.81 -43.39 58.96 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.12 1.768 . . . . 0.0 107.514 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -54.27 -47.12 72.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.476 1.111 . . . . 0.0 111.872 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -59.62 4.55 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.88 -36.69 65.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.356 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -54.91 -57.83 10.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.631 1.173 . . . . 0.0 112.554 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -70.68 -35.65 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.371 0.605 . . . . 0.0 110.815 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.63 -49.83 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.476 1.51 . . . . 0.0 109.796 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.31 -49.17 15.57 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.9 p -67.51 -25.96 66.1 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -162.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -80.83 -9.14 59.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 111.994 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.04 134.84 77.35 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 168.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.09 104.18 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.581 2.187 . . . . 0.0 108.784 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -122.71 151.7 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -57.87 124.27 18.64 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.71 136.51 56.37 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.95 84.6 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.18 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.51 -39.59 31.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.53 2.165 . . . . 0.0 111.675 166.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.7 93.48 8.04 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.035 0.834 . . . . 0.0 110.28 -159.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -110.63 116.05 30.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -84.73 119.18 24.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -113.63 131.42 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 127.591 2.356 . . . . 0.0 107.784 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.66 137.8 34.35 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.955 0.502 . . . . 0.0 110.279 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.8 pt -99.41 5.11 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 123.39 0.676 . . . . 0.0 112.248 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 p -117.51 -26.92 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.155 -1.59 . . . . 0.0 111.517 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.01 -55.5 32.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.783 -164.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 p -147.11 5.18 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.648 0.779 . . . . 0.0 112.375 -158.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -146.62 -0.54 0.74 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -157.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 69.9 88.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.719 1.608 . . . . 0.0 114.91 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -33.93 -63.82 0.25 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 130.149 3.38 . . . . 0.0 110.059 166.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -49.36 -46.4 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.914 0.759 . . . . 0.0 111.606 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -49.97 59.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 110.973 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 mt -54.63 -43.41 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.706 1.602 . . . . 0.0 110.471 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -71.98 -45.85 59.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -170.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -48.55 76.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 109.888 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.33 -44.99 86.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.672 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.0 -42.61 76.67 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.261 1.024 . . . . 0.0 109.89 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -56.4 21.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.491 174.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.07 -51.23 68.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 123.556 0.535 . . . . 0.0 109.993 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.89 -45.26 95.3 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.306 1.442 . . . . 0.0 109.457 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 p -101.1 -65.19 0.99 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.552 0.614 . . . . 0.0 110.781 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.38 -4.48 2.55 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.638 2.066 . . . . 0.0 111.635 -172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.73 157.92 43.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.269 1.535 . . . . 0.0 109.141 169.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -118.77 -29.12 5.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.123 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 p -61.61 133.22 55.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -161.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.08 58.19 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.46 170.45 42.38 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 CA-C-N 118.649 0.553 . . . . 0.0 111.149 -7.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -130.12 100.33 5.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.15 129.26 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.11 104.87 12.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.768 2.027 . . . . 0.0 106.915 168.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.92 103.06 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 169.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.97 64.77 3.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.882 1.23 . . . . 0.0 113.014 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.72 13.09 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 127.7 2.4 . . . . 0.0 117.219 -168.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -100.69 103.55 14.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 120.454 1.479 . . . . 0.0 107.341 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.6 t -68.85 117.22 10.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.63 -25.8 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.563 0.745 . . . . 0.0 110.631 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.25 -171.29 23.75 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 123.462 0.553 . . . . 0.0 112.023 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.61 -169.01 41.41 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 125.409 1.481 . . . . 0.0 111.463 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 p -63.43 -38.01 89.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.871 0.835 . . . . 0.0 110.507 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.235 0.47 . . . . 0.0 111.804 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.64 -49.51 21.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -52.68 -34.66 53.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.059 1.744 . . . . 0.0 112.605 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.64 -50.84 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.164 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -44.99 92.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.606 1.548 . . . . 0.0 107.691 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.79 -31.65 71.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.04 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -69.18 -61.34 1.83 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.25 1.386 . . . . 0.0 109.085 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -50.7 66.47 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.872 2.069 . . . . 0.0 111.658 -166.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -3.71 32.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.27 1.828 . . . . 0.0 111.778 172.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.97 -0.72 82.19 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.038 -1.424 . . . . 0.0 115.113 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.24 -33.87 72.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.153 1.976 . . . . 0.0 111.442 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.3 tp -60.3 -33.22 72.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.689 0.796 . . . . 0.0 111.125 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.63 -40.03 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -72.48 -48.05 43.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -40.24 58.57 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.945 0.793 . . . . 0.0 111.815 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.76 -56.59 9.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 110.567 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -59.38 -24.31 63.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.829 1.195 . . . . 0.0 112.873 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -48.66 -41.69 32.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.681 1.193 . . . . 0.0 110.705 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.98 -1.63 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.26 59.97 1.79 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.28 -73.04 0.66 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.416 1.486 . . . . 0.0 112.412 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 2.8 mt -62.57 135.4 57.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.28 -153.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -136.98 -56.6 0.72 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.094 0.957 . . . . 0.0 108.816 163.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.11 -17.69 62.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.583 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -52.51 -45.02 66.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.298 1.408 . . . . 0.0 109.339 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.59 -60.25 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 109.017 169.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -70.0 -11.86 61.18 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -159.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -106.55 -15.48 14.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.148 0.979 . . . . 0.0 112.931 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -63.93 -57.56 9.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.22 1.373 . . . . 0.0 107.517 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.6 150.48 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -144.34 172.4 5.52 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.189 1.795 . . . . 0.0 106.28 161.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.05 17.18 0.87 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.178 2.585 . . . . 0.0 114.912 -163.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.3 12.07 1.2 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.655 2.55 . . . . 0.0 112.16 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.06 148.67 29.46 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.849 1.824 . . . . 0.0 108.585 170.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 t -102.54 86.62 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.84 147.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 O-C-N 120.829 -1.169 . . . . 0.0 108.539 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.9 116.21 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.12 128.89 34.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.18 175.24 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.276 1.43 . . . . 0.0 110.879 -167.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 70' ' ' VAL . 15.3 ptpt -137.97 144.72 45.01 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 158.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.84 -31.66 47.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.305 2.67 . . . . 0.0 112.268 -168.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -65.78 -35.96 82.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.508 0.723 . . . . 0.0 111.829 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 48.7 t -61.01 118.67 37.97 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 124.557 1.143 . . . . 0.0 109.717 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.93 -20.25 34.26 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.772 1.648 . . . . 0.0 111.073 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 22.9 m-85 -73.49 -39.35 64.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -60.61 -49.42 77.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -57.24 -46.07 83.34 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.425 0.557 . . . . 0.0 111.636 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -56.52 -54.24 48.14 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 118.833 0.742 . . . . 0.0 109.947 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.2 -39.23 59.87 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.223 0.952 . . . . 0.0 111.43 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.02 66.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.673 171.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -55.03 31.64 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.226 1.01 . . . . 0.0 109.741 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.63 -47.17 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.077 2.151 . . . . 0.0 110.237 176.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.11 -42.73 31.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 m -61.42 -21.87 64.5 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.85 -11.55 60.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.91 . . . . 0.0 111.851 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.3 133.51 21.97 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.85 81.77 2.49 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.633 2.889 . . . . 0.0 110.284 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 99' ' ' LEU . 9.5 mt -102.57 155.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -167.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -50.75 123.31 8.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.659 0.783 . . . . 0.0 109.266 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -66.58 157.05 33.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.099 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.86 -20.66 2.84 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.205 -1.331 . . . . 0.0 112.68 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -73.86 -37.14 64.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.538 2.169 . . . . 0.0 109.795 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -83.92 104.1 13.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -171.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -123.35 113.62 19.09 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 43' ' ' LEU . 14.1 m-85 -84.07 107.2 16.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 171.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.92 106.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 126.427 1.891 . . . . 0.0 107.288 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.78 133.08 52.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 122.649 -0.032 . . . . 0.0 110.953 166.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 pt -106.25 -13.75 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.33 1.452 . . . . 0.0 110.758 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.92 -6.45 58.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.632 1.173 . . . . 0.0 111.083 174.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.62 68.79 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 129.338 3.055 . . . . 0.0 108.966 163.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p 55.99 -4.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 131.442 3.897 . . . . 0.0 116.51 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 14.95 29.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 113.182 -159.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m170 78.25 87.58 0.07 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.709 3.204 . . . . 0.0 110.121 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.77 -63.42 0.91 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.316 -1.325 . . . . 0.0 111.777 168.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -47.36 -51.45 19.57 Favored 'General case' 0 C--O 1.217 -0.629 0 O-C-N 124.452 1.095 . . . . 0.0 109.911 -171.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.11 -50.1 75.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.515 0.598 . . . . 0.0 110.352 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -62.34 -35.66 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.964 0.906 . . . . 0.0 108.816 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.21 -37.2 33.64 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 -168.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.43 -46.18 84.31 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 127.502 2.321 . . . . 0.0 110.475 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -61.51 -44.92 96.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.326 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -57.4 -39.21 75.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.973 1.261 . . . . 0.0 110.524 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -41.78 93.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.502 0.721 . . . . 0.0 110.385 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -63.62 -58.53 6.64 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.508 -0.745 . . . . 0.0 110.053 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 tp -65.32 -30.22 71.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.676 2.39 . . . . 0.0 111.775 -166.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.69 -26.47 2.96 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.192 1.36 . . . . 0.0 112.993 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.96 27.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.934 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.77 144.83 27.28 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.365 2.083 . . . . 0.0 110.414 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -85.84 -18.63 32.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.968 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -70.83 134.08 47.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -163.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.4 m -96.28 166.12 14.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.556 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -58.82 159.01 35.48 Favored 'Cis proline' 0 C--N 1.345 0.36 0 CA-C-N 119.657 0.913 . . . . 0.0 110.305 -15.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 mtp85 -126.39 105.7 8.97 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.58 125.25 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -110.79 99.57 8.47 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 107.065 168.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 109.79 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.28 64.67 2.17 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.016 1.769 . . . . 0.0 111.761 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 tttt 46.14 17.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.458 2.703 . . . . 0.0 117.394 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -98.53 115.56 28.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.26 1.391 . . . . 0.0 107.568 159.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -67.01 108.79 2.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.2 pp -83.55 -11.01 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.656 0.662 . . . . 0.0 110.555 -174.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -165.64 24.44 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.154 1.359 . . . . 0.0 110.008 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.65 -165.36 39.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -39.76 93.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.716 -0.873 . . . . 0.0 110.775 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -66.6 -26.01 66.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.316 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.74 -51.9 6.13 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.6 tp -46.55 -39.68 11.4 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.334 1.853 . . . . 0.0 111.269 172.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.29 -48.39 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 116.434 -1.746 . . . . 0.0 110.802 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -44.7 76.65 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.989 1.722 . . . . 0.0 106.857 -176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.36 -34.28 72.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.044 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.09 -56.37 9.09 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.627 1.558 . . . . 0.0 110.408 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -50.22 55.8 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.499 -1.375 . . . . 0.0 110.261 -167.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 t -70.74 -12.15 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.138 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.49 16.28 71.47 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 117.695 -1.614 . . . . 0.0 112.992 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.42 -30.91 70.86 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.542 2.171 . . . . 0.0 110.597 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -49.91 -37.39 31.38 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.985 2.114 . . . . 0.0 111.453 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -55.82 28.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.238 1.015 . . . . 0.0 110.534 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.0 m -62.49 -43.8 97.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.015 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -38.88 77.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.13 0.877 . . . . 0.0 110.302 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' ILE . 14.6 mt -68.67 -51.62 39.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.99 -1.069 . . . . 0.0 111.056 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -55.57 -25.84 40.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.054 1.297 . . . . 0.0 114.3 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -47.4 -36.03 9.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.985 1.314 . . . . 0.0 111.582 168.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -6.22 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.735 0.814 . . . . 0.0 111.973 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.92 85.02 0.23 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -169.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.41 -70.11 0.43 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.602 2.361 . . . . 0.0 109.008 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.58 148.68 51.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 121.081 1.764 . . . . 0.0 107.407 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.247 0.962 0 O-C-N 126.057 2.098 . . . . 0.0 107.37 158.725 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -111.72 81.6 1.48 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -163.07 -60.76 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 116.668 -1.634 . . . . 0.0 110.385 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -50.21 -49.48 52.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.226 1.375 . . . . 0.0 111.217 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.92 -49.46 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.32 -46.86 81.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 t -79.69 10.27 4.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.144 2.178 . . . . 0.0 112.34 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -106.49 -34.61 7.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.712 -1.243 . . . . 0.0 109.862 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.07 148.2 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.53 1.059 . . . . 0.0 108.998 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -135.8 139.13 29.79 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 159.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -63.1 158.47 43.75 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.082 1.855 . . . . 0.0 109.098 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.75 17.36 41.95 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.547 -0.721 . . . . 0.0 113.528 -171.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 156.74 46.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.666 1.987 . . . . 0.0 107.981 172.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -107.85 104.53 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.91 125.7 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.87 112.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -167.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.61 126.79 34.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.78 -178.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 0.0 111.429 -166.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.2 160.55 61.82 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 127.037 2.135 . . . . 0.0 107.086 172.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.67 -17.17 10.0 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.511 2.141 . . . . 0.0 111.638 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -129.16 24.57 5.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.732 2.013 . . . . 0.0 111.041 -163.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -107.17 115.29 60.16 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.16 -18.41 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.915 1.743 . . . . 0.0 111.07 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -74.17 -37.83 63.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.64 -50.35 65.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -49.03 -47.34 44.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.698 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -63.31 1.18 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 119.137 0.88 . . . . 0.0 109.348 173.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.0 58.87 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.143 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.48 -45.78 85.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.019 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.06 -30.95 55.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 121.724 2.056 . . . . 0.0 111.841 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mt -57.3 -55.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.282 1.433 . . . . 0.0 107.456 170.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.92 -56.13 4.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t -65.07 -20.91 66.71 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -160.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -73.62 -21.31 60.34 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.21 0.914 . . . . 0.0 111.914 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.93 149.53 90.01 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.181 0.9 . . . . 0.0 110.498 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.92 109.24 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.108 2.539 . . . . 0.0 108.57 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.416 HD13 HD23 ' A' ' 43' ' ' LEU . 6.2 mt -130.72 147.55 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -174.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.39 155.21 5.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.028 1.331 . . . . 0.0 109.882 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.96 100.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.377 1.871 . . . . 0.0 111.043 -172.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.18 19.55 75.82 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.587 167.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 mt -73.44 -25.88 60.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.31 2.055 . . . . 0.0 110.891 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.09 103.65 13.5 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 120.309 1.413 . . . . 0.0 107.305 178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -115.14 102.29 9.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.039 1.336 . . . . 0.0 107.841 -170.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.13 131.08 34.81 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.0 t -128.14 100.85 6.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 125.542 1.537 . . . . 0.0 108.029 -166.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.61 119.6 22.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.075 0.55 . . . . 0.0 110.957 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.94 -9.15 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 t -117.6 13.71 14.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.58 1.152 . . . . 0.0 109.755 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.16 67.59 0.31 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.087 1.755 . . . . 0.0 108.335 159.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.264 0.3 OUTLIER 68.36 -16.07 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 128.272 2.629 . . . . 0.0 113.286 175.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.23 168.17 16.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 109.981 174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -92.28 72.85 5.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.599 1.16 . . . . 0.0 109.145 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.74 -63.77 0.29 Allowed 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 127.73 2.412 . . . . 0.0 109.961 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.29 -32.76 39.05 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -45.24 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.766 -1.209 . . . . 0.0 111.008 174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 mt -57.34 -38.05 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.462 1.105 . . . . 0.0 110.208 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -63.33 -47.18 83.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.739 2.416 . . . . 0.0 106.934 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.67 -45.93 88.32 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.076 0.95 . . . . 0.0 110.006 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -61.06 -37.19 81.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.265 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.5 mt -55.77 -47.49 76.93 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 121.197 1.817 . . . . 0.0 109.206 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -54.12 -47.53 71.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.963 0.789 . . . . 0.0 111.08 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.91 77.48 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.054 0.542 . . . . 0.0 110.66 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD2' HH12 ' A' ' 72' ' ' ARG . 9.5 tp -75.71 -24.5 56.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.891 0.876 . . . . 0.0 110.022 -168.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.2 p -121.34 -65.92 1.09 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.513 1.051 . . . . 0.0 110.099 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.66 -4.76 0.68 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.564 2.03 . . . . 0.0 112.038 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.31 142.57 32.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.976 1.888 . . . . 0.0 109.518 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -95.63 -15.55 22.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 141.83 55.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.866 0.757 . . . . 0.0 110.755 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 158.22 33.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.994 1.718 . . . . 0.0 108.265 171.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.03 141.17 50.62 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 N-CA-C 110.034 -0.795 . . . . 0.0 110.034 -5.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.407 HH12 ' CD2' ' A' ' 64' ' ' LEU . 21.0 ttp180 -109.56 96.57 6.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.36 126.74 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -122.82 94.01 4.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.49 117.1 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.95 66.33 2.54 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 124.832 1.206 . . . . 0.0 114.016 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt 46.08 31.95 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -143.87 148.41 35.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.684 1.129 . . . . 0.0 110.09 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.3 139.32 30.61 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 119.334 0.97 . . . . 0.0 110.149 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.28 -7.89 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.47 0.577 . . . . 0.0 112.249 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.28 -88.23 0.25 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.76 -80.41 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -39.29 1.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.625 0.77 . . . . 0.0 112.255 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -76.89 -25.85 53.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.648 1.567 . . . . 0.0 111.15 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.74 -43.76 83.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.286 1.035 . . . . 0.0 108.318 165.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.34 -36.61 76.0 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.008 0.523 . . . . 0.0 111.086 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -60.41 -46.22 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 117.435 -1.269 . . . . 0.0 109.65 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -48.43 79.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.431 1.469 . . . . 0.0 107.217 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mt -56.21 -39.69 72.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.999 0.92 . . . . 0.0 109.006 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -58.65 6.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.394 1.452 . . . . 0.0 110.032 172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -50.55 66.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.095 1.358 . . . . 0.0 110.767 -164.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.9 t -75.97 -2.33 29.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.134 1.774 . . . . 0.0 111.562 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.44 5.74 44.92 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.624 -1.654 . . . . 0.0 113.866 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -65.2 -21.45 66.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.905 2.353 . . . . 0.0 110.504 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -49.85 -40.0 40.89 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.471 1.508 . . . . 0.0 111.88 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.87 -50.82 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -56.76 -54.15 49.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.9 1.28 . . . . 0.0 109.721 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -38.63 63.9 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.772 2.029 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.59 -49.68 20.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.073 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -62.51 -23.47 66.97 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.642 1.565 . . . . 0.0 112.765 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -52.35 -20.38 2.72 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.883 1.673 . . . . 0.0 112.955 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.2 8.89 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.015 1.279 . . . . 0.0 113.671 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.38 41.13 31.39 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.383 -0.823 . . . . 0.0 111.6 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -89.14 -74.52 0.47 Allowed 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.285 1.434 . . . . 0.0 111.181 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.33 55.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.249 1.027 0 O-C-N 124.463 1.102 . . . . 0.0 108.933 -163.069 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 121.58 0.705 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -75.92 28.56 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.577 1.951 . . . . 0.0 114.113 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -163.03 -56.93 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -58.6 -45.62 88.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.171 0.896 . . . . 0.0 110.94 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.29 -49.69 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.021 0.828 . . . . 0.0 109.479 171.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.26 -48.19 81.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -164.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -74.16 -21.95 59.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.754 0.822 . . . . 0.0 111.733 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HG2' HG11 ' A' ' 46' ' ' VAL . 2.8 mptp? -64.79 -48.12 75.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.025 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.01 149.8 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -145.27 152.64 50.99 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.29 160.97 28.75 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.225 1.283 . . . . 0.0 109.78 159.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.86 24.33 33.47 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.869 -0.962 . . . . 0.0 113.917 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -141.43 160.11 40.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.531 1.666 . . . . 0.0 107.877 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 75' ' ' ILE . 40.4 t -120.74 87.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.51 129.42 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.86 112.45 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -166.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.92 124.91 29.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.7 178.42 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.929 2.092 . . . . 0.0 110.395 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -133.89 160.31 69.05 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 159.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.5 -30.52 3.13 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.994 1.796 . . . . 0.0 110.848 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -91.21 3.18 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.048 1.339 . . . . 0.0 111.96 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 1.3 m -90.24 110.55 41.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.226 1.011 . . . . 0.0 112.042 173.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -28.51 38.34 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 112.12 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -73.78 -24.08 59.79 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.607 1.094 . . . . 0.0 110.977 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.73 -52.09 48.43 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 166.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -55.04 -37.6 66.9 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.413 1.085 . . . . 0.0 113.544 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -59.32 -61.16 2.84 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 118.428 0.558 . . . . 0.0 110.263 169.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.4 -34.07 46.56 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 124.575 1.172 . . . . 0.0 110.969 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -53.18 60.2 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 126.256 1.822 . . . . 0.0 112.967 171.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -53.62 35.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.96 -50.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.843 1.657 . . . . 0.0 110.905 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.89 -45.26 59.2 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -63.02 -16.37 59.59 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.39 -31.2 63.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.937 1.699 . . . . 0.0 109.939 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.6 136.89 55.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.26 61.45 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.203 3.268 . . . . 0.0 112.719 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.63 150.16 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -53.07 124.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.826 0.85 . . . . 0.0 110.119 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -53.2 128.26 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.48 -23.58 34.63 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.005 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.89 -37.89 64.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 119.823 1.811 . . . . 0.0 110.612 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.19 106.73 16.05 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -129.14 115.12 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.859 0.838 . . . . 0.0 111.426 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -83.9 105.46 14.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.416 HG11 ' HG2' ' A' ' 9' ' ' LYS . 47.6 t -91.84 125.67 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.907 2.083 . . . . 0.0 106.731 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -82.27 128.63 34.38 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.415 -0.803 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -63.09 -23.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.15 -0.969 . . . . 0.0 111.12 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -133.61 47.11 2.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.424 1.89 . . . . 0.0 106.822 -175.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.94 -48.6 67.22 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.2 p -137.14 -55.11 0.71 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.807 1.643 . . . . 0.0 109.466 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -165.76 -161.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.038 1.735 . . . . 0.0 109.264 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 62.33 -3.39 0.28 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -62.71 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 122.225 2.284 . . . . 0.0 111.473 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -48.55 -48.32 38.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.708 0.803 . . . . 0.0 112.101 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -28.81 69.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.526 1.53 . . . . 0.0 113.377 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 mt -81.65 -34.56 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.602 1.961 . . . . 0.0 107.922 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.61 -50.98 25.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.535 2.334 . . . . 0.0 107.851 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -45.51 -53.1 9.41 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.577 1.551 . . . . 0.0 111.013 167.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.09 -42.33 99.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.999 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.26 -40.29 85.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.839 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.63 -50.84 70.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.301 1.04 . . . . 0.0 109.386 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.06 -46.33 89.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 111.864 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.26 -38.4 56.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 109.287 -170.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -112.27 -28.99 7.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.06 -5.02 35.97 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.948 1.261 . . . . 0.0 112.738 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.47 147.06 28.7 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.512 1.656 . . . . 0.0 109.674 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -84.92 -18.44 34.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.085 -0.483 . . . . 0.0 111.914 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -64.72 133.55 52.32 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.345 0.52 . . . . 0.0 110.113 -162.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 165.41 31.94 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.542 0.737 . . . . 0.0 109.475 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -65.47 165.7 56.04 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -15.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.98 96.72 4.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.06 105.21 13.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.006 1.722 . . . . 0.0 106.791 166.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.06 107.22 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 167.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.07 69.38 0.77 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.428 1.49 . . . . 0.0 113.066 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tttm 46.05 31.0 1.03 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.421 1.888 . . . . 0.0 115.985 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -128.96 127.25 41.33 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.626 1.103 . . . . 0.0 108.885 159.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.54 138.48 43.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -114.86 12.92 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.148 0.979 . . . . 0.0 111.223 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -149.06 21.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 -10.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.25 150.83 29.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 t 61.46 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -48.96 69.19 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.005 1.322 . . . . 0.0 109.566 -175.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.3 -46.84 36.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.979 2.112 . . . . 0.0 111.475 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.53 -48.24 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.25 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -47.77 77.07 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.663 1.574 . . . . 0.0 109.128 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.58 -35.46 74.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.45 -56.91 6.79 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.58 1.536 . . . . 0.0 109.639 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -53.84 41.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.32 1.848 . . . . 0.0 111.303 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.5 t -70.6 -15.84 62.79 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.875 2.47 . . . . 0.0 111.019 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.09 1.33 84.63 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 118.393 -1.226 . . . . 0.0 113.617 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.23 -33.27 73.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 120.066 1.933 . . . . 0.0 111.394 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.19 -38.65 73.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.232 1.413 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -55.04 25.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.79 1.236 . . . . 0.0 108.677 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -61.47 -42.51 98.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.643 0.777 . . . . 0.0 110.246 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.91 83.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.692 0.797 . . . . 0.0 111.317 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.09 -48.69 61.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.283 1.033 . . . . 0.0 110.337 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' CG ' ' HB2' ' A' ' 105' ' ' LEU . 11.6 mtpt -57.42 -31.12 65.55 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.788 -1.195 . . . . 0.0 112.979 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -24.54 40.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.737 0.815 . . . . 0.0 111.591 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.01 23.97 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.818 0.847 . . . . 0.0 111.514 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.0 16.34 57.99 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 164.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.96 -70.46 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.402 1.101 . . . . 0.0 111.167 -166.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HB2' ' CG ' ' A' ' 100' ' ' LYS . 3.0 mm? -72.39 146.16 47.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.102 -165.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 112.67 -2.059 . . . . 0.0 109.968 -173.493 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 60' ' ' TYR . . . . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -40.37 -61.9 0.84 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.238 1.015 . . . . 0.0 112.596 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -163.78 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.774 -1.107 . . . . 0.0 108.339 -165.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -55.02 -35.69 64.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.151 1.342 . . . . 0.0 113.59 -166.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.97 -59.75 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 0.0 109.171 170.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.1 -33.73 76.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.091 2.556 . . . . 0.0 110.827 -166.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.23 -51.18 65.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.263 3.425 . . . . 0.0 110.443 172.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 40.7 mmtm -69.8 -17.27 63.39 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.842 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 77' ' ' LYS . 6.9 mm -73.9 129.92 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 119.156 0.889 . . . . 0.0 108.694 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -131.11 159.22 72.57 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 159.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.07 70.05 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.884 3.056 . . . . 0.0 109.789 169.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.7 64.87 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 126.719 2.104 . . . . 0.0 108.464 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -151.11 159.05 44.71 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.622 2.369 . . . . 0.0 105.597 165.174 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.704 HG13 HD12 ' A' ' 75' ' ' ILE . 60.3 t -117.04 87.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 172.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.421 HG11 ' CZ ' ' A' ' 18' ' ' PHE . 64.0 t -85.46 151.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.904 -1.123 . . . . 0.0 108.247 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.36 116.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 160.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' A' ' 16' ' ' VAL . 71.1 m-85 -77.3 125.58 29.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.11 176.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.681 1.993 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 160.46 43.65 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.378 1.871 . . . . 0.0 108.956 171.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -82.19 26.43 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.191 3.261 . . . . 0.0 110.56 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.364 2.9 t -138.2 -106.63 0.18 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.75 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m 32.65 104.21 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 129.916 3.286 . . . . 0.0 113.989 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.23 -16.88 36.37 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.202 1.268 . . . . 0.0 112.211 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -74.36 -47.91 31.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.062 1.345 . . . . 0.0 108.852 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.1 m -63.93 -44.35 93.16 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -53.19 -45.28 68.5 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.353 1.061 . . . . 0.0 110.343 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.66 -60.1 4.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 118.816 -0.612 . . . . 0.0 109.578 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.04 64.57 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.187 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -52.59 64.98 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.167 0.894 . . . . 0.0 112.451 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.18 -40.5 67.87 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.491 0.587 . . . . 0.0 109.753 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.0 mt -53.88 -53.13 29.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.821 1.248 . . . . 0.0 109.584 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.62 -44.47 56.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.132 -0.937 . . . . 0.0 108.564 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.1 m -55.81 -27.92 53.7 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -73.45 -19.71 60.89 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.018 0.826 . . . . 0.0 110.952 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -87.57 133.7 37.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.707 1.139 . . . . 0.0 107.936 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.77 114.55 4.05 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.206 1.938 . . . . 0.0 108.829 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.25 152.13 36.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -54.16 123.6 13.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.94 150.64 48.31 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 -30.03 6.34 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.931 -168.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.51 -47.05 24.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 120.42 2.11 . . . . 0.0 111.533 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -83.57 107.5 16.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.822 1.192 . . . . 0.0 108.433 -164.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.03 111.47 12.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.738 0.78 . . . . 0.0 110.431 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -84.01 102.55 12.56 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.41 121.3 49.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.78 1.632 . . . . 0.0 107.637 -172.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.7 133.68 34.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.593 -170.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -88.18 -12.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.846 1.658 . . . . 0.0 113.843 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 t -141.48 2.93 1.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.923 0.889 . . . . 0.0 110.987 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.16 15.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.737 1.215 . . . . 0.0 112.13 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.9 p -122.7 -77.83 0.59 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 160.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -162.77 -163.12 0.84 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.155 1.382 . . . . 0.0 109.099 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m80 65.26 8.65 5.04 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.145 2.178 . . . . 0.0 115.571 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -63.37 1.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 121.362 1.892 . . . . 0.0 110.236 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.25 -41.47 75.8 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 119.694 -0.194 . . . . 0.0 111.394 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -49.04 77.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.444 1.498 . . . . 0.0 111.65 173.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.43 -39.58 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.296 1.838 . . . . 0.0 108.512 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -80.33 -40.09 27.38 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -164.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -58.01 -53.94 52.57 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.449 1.9 . . . . 0.0 108.903 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' HA ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -53.23 -49.4 66.9 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.896 1.278 . . . . 0.0 109.946 172.227 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.25 -29.29 63.68 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.436 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.93 -59.88 4.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.132 1.333 . . . . 0.0 109.13 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.13 -36.61 82.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.091 0.557 . . . . 0.0 111.23 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.61 -20.05 58.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.889 1.276 . . . . 0.0 110.404 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.4 p -125.84 -76.23 0.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.744 1.611 . . . . 0.0 112.744 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.1 -6.87 0.07 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.66 2.076 . . . . 0.0 113.797 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.09 152.78 35.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.559 1.68 . . . . 0.0 109.078 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -97.46 -3.2 40.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.112 0.965 . . . . 0.0 111.882 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -69.59 141.75 53.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.13 157.81 32.97 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 125.62 1.568 . . . . 0.0 108.931 166.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.7 161.85 52.49 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 CA-C-N 120.256 1.127 . . . . 0.0 111.829 -4.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -132.16 97.61 4.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.5 1.12 . . . . 0.0 108.313 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.9 t -75.03 120.93 25.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.94 96.58 6.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.827 1.651 . . . . 0.0 107.335 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.704 HD12 HG13 ' A' ' 15' ' ' VAL . 1.4 mp -83.85 116.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 161.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.29 87.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.514 2.007 . . . . 0.0 115.374 162.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 10' ' ' ILE . 15.4 mtpp 46.83 -12.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 131.512 3.925 . . . . 0.0 117.434 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -99.06 167.74 10.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 119.529 1.058 . . . . 0.0 109.209 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -120.16 125.49 48.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.401 1.48 . . . . 0.0 107.611 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.62 -23.58 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.567 0.222 . . . . 0.0 111.315 -164.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.85 177.11 15.43 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -159.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.45 -84.12 1.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -167.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.23 -64.15 1.06 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.234 1.014 . . . . 0.0 110.255 -173.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -49.8 64.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.74 1.155 . . . . 0.0 111.166 176.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.0 -36.66 78.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.138 1.775 . . . . 0.0 107.783 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.65 -40.51 84.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.083 0.953 . . . . 0.0 110.074 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.88 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 116.273 -1.822 . . . . 0.0 109.384 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.294 5.1 p -54.1 -47.27 71.96 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 121.987 2.176 . . . . 0.0 114.783 168.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.02 -43.87 70.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.333 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -60.69 -54.95 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.259 2.299 . . . . 0.0 110.693 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -42.99 58.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.486 1.914 . . . . 0.0 114.157 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -14.6 61.29 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 168.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.9 2.69 88.38 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.338 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.49 -17.49 64.83 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.916 1.858 . . . . 0.0 112.236 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -43.6 97.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.436 1.494 . . . . 0.0 109.495 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.22 -44.58 97.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 109.399 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -59.36 -54.08 50.85 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.079 0.552 . . . . 0.0 109.797 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -44.55 65.42 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.257 1.023 . . . . 0.0 111.55 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.5 mt -65.44 -50.59 64.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.56 1.144 . . . . 0.0 110.269 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -23.51 61.22 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.181 -0.949 . . . . 0.0 113.329 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.54 -29.09 9.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.173 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.16 26.6 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.394 1.078 . . . . 0.0 111.936 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.29 19.06 73.87 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.385 1.469 . . . . 0.0 114.725 168.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.34 -57.08 4.18 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 112.108 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.6 133.27 50.81 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -153.084 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.61 -45.77 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -55.79 -50.18 71.18 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.361 0.664 . . . . 0.0 111.34 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.22 -25.72 36.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.941 0.896 . . . . 0.0 111.781 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -65.58 -38.45 89.55 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.811 1.187 . . . . 0.0 110.621 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.91 154.84 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 120.63 1.559 . . . . 0.0 107.9 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.9 166.93 14.89 Favored Pre-proline 0 C--O 1.241 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 107.175 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.56 158.59 52.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 159.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.77 84.24 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 113.968 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.62 151.56 38.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.174 2.19 . . . . 0.0 108.961 163.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.3 t -103.68 79.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.203 1.401 . . . . 0.0 107.476 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.09 140.7 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.02 115.82 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -81.54 131.94 35.29 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 171.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 126.294 1.838 . . . . 0.0 111.235 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -140.15 143.94 35.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 162.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.14 -10.99 24.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.602 1.535 . . . . 0.0 110.985 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 p -89.46 -9.31 50.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.472 1.509 . . . . 0.0 111.882 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.33 123.62 85.78 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.527 1.058 . . . . 0.0 109.092 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.67 -23.67 48.79 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.672 1.581 . . . . 0.0 110.291 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.37 -28.92 62.3 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.673 0.789 . . . . 0.0 110.369 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.0 m -68.02 -32.08 72.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -65.89 -38.28 88.33 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.932 0.787 . . . . 0.0 111.833 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -59.56 4.97 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.91 -35.88 58.86 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 124.051 0.845 . . . . 0.0 111.343 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -45.96 92.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.117 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.93 -50.9 25.12 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -46.05 -50.39 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.738 1.215 . . . . 0.0 110.563 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mt -79.59 -48.39 13.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -70.63 -6.18 34.93 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.8 -21.25 60.22 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.456 1.025 . . . . 0.0 110.725 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.91 142.09 24.58 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.797 . . . . 0.0 109.964 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.11 109.75 2.78 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.64 2.894 . . . . 0.0 110.075 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HD23 ' A' ' 43' ' ' LEU . 12.2 mt -133.68 149.84 31.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -169.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -53.0 127.69 24.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 118.195 0.452 . . . . 0.0 110.995 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.12 131.08 49.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.757 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.86 52.73 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.287 1.422 . . . . 0.0 111.841 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.95 -34.44 64.3 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.951 1.375 . . . . 0.0 110.665 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.36 111.32 18.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -175.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -129.08 108.75 10.63 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -83.93 102.49 12.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.77 137.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.506 1.923 . . . . 0.0 106.965 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.12 149.5 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.728 -0.608 . . . . 0.0 110.816 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.65 10.19 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.102 1.761 . . . . 0.0 112.27 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 CA--C 1.541 0.618 0 CA-C-N 120.581 1.537 . . . . 0.0 111.882 171.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.5 m170 . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 103.016 -2.957 . . . . 0.0 103.016 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -42.14 -63.31 0.77 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -43.85 -33.1 1.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.921 2.488 . . . . 0.0 113.758 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.36 -60.68 1.93 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.76 -33.85 28.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 124.972 1.309 . . . . 0.0 111.173 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -73.63 -40.68 63.6 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.31 -44.63 87.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.077 1.751 . . . . 0.0 110.496 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.53 -48.15 81.81 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.035 -0.416 . . . . 0.0 110.469 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.78 -36.41 69.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.096 0.959 . . . . 0.0 110.288 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -50.47 68.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.509 0.724 . . . . 0.0 110.418 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -68.73 -45.28 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.084 0.553 . . . . 0.0 110.279 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.79 -30.79 59.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 p -123.72 -12.78 7.58 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.65 59.66 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.292 1.405 . . . . 0.0 113.178 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.46 149.47 18.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.357 1.079 . . . . 0.0 109.935 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -102.9 -25.29 13.53 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.811 0.844 . . . . 0.0 112.649 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -71.29 144.31 50.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.95 165.99 11.81 Favored Pre-proline 0 C--O 1.244 0.777 0 C-N-CA 126.372 1.869 . . . . 0.0 109.21 -170.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.58 161.91 51.53 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 119.287 0.781 . . . . 0.0 111.424 -3.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -137.81 97.11 3.35 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.14 127.49 39.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.23 96.03 5.59 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.836 2.454 . . . . 0.0 107.879 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.428 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.61 107.84 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 38.37 81.48 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 127.432 2.444 . . . . 0.0 113.135 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 16.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.37 2.268 . . . . 0.0 116.996 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.96 110.81 18.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 119.024 0.829 . . . . 0.0 108.836 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.28 117.12 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.54 -21.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.53 -155.76 21.3 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.64 -168.75 31.2 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.982 1.753 . . . . 0.0 110.253 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.75 -24.66 64.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.578 -1.201 . . . . 0.0 112.126 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m -60.63 -49.22 78.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 120.231 1.378 . . . . 0.0 109.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -41.29 84.86 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.692 0.797 . . . . 0.0 109.57 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.7 tp -56.59 -39.25 73.22 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.367 0.667 . . . . 0.0 112.004 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -61.92 -46.08 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.044 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.58 -56.47 21.73 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.73 -27.15 68.71 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.912 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -68.05 -54.07 21.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.586 1.539 . . . . 0.0 109.454 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -40.8 77.37 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.702 1.201 . . . . 0.0 111.775 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -70.61 -20.52 62.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.529 2.732 . . . . 0.0 110.262 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.9 6.63 82.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.722 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.61 -31.98 72.91 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 120.273 2.036 . . . . 0.0 109.514 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.43 -40.9 75.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.191 1.796 . . . . 0.0 110.445 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.11 -47.72 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.592 0.633 . . . . 0.0 109.339 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m -60.82 -49.52 77.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.279 0.632 . . . . 0.0 109.351 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -48.77 61.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.598 1.159 . . . . 0.0 110.688 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -49.3 70.88 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.334 1.054 . . . . 0.0 112.734 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -67.43 -25.11 65.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 117.088 -1.845 . . . . 0.0 112.717 -166.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -48.16 -46.22 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.764 0.665 . . . . 0.0 110.448 168.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.71 8.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.903 0.774 . . . . 0.0 112.078 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.67 34.21 44.64 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.602 1.096 . . . . 0.0 111.701 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.31 -74.52 0.38 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.39 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.59 133.75 55.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.773 1.169 . . . . 0.0 110.578 -159.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 131.144 3.778 . . . . 0.0 104.858 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.9 t80 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 118.896 -0.574 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.43 -49.29 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.322 0.51 . . . . 0.0 109.895 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.86 -53.12 55.6 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.547 0.612 . . . . 0.0 111.262 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.9 m -68.76 -5.4 20.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.214 1.406 . . . . 0.0 112.659 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.6 -26.4 45.4 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.508 167.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.26 167.45 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 165.08 18.98 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 128.194 2.598 . . . . 0.0 105.735 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.6 61.47 7.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.709 2.273 . . . . 0.0 111.951 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.74 16.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.745 -1.031 . . . . 0.0 115.513 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -119.05 160.11 22.66 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.486 1.643 . . . . 0.0 108.002 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.1 t -108.96 98.78 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.59 151.68 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.56 115.22 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -74.81 120.42 20.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.07 176.04 7.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 127.462 2.305 . . . . 0.0 110.268 -171.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -122.89 158.69 56.49 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 164.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.95 9.75 2.26 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.759 2.972 . . . . 0.0 112.971 -168.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.306 0.1 OUTLIER -133.35 -106.17 0.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -173.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t 33.83 115.06 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 130.975 3.71 . . . . 0.0 113.702 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -61.75 -20.32 68.62 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.96 1.107 . . . . 0.0 112.602 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -81.8 -42.6 19.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.76 -43.13 99.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -54.35 -53.42 54.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.31 1.044 . . . . 0.0 110.204 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -55.81 27.8 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.1 69.89 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.677 0.611 . . . . 0.0 110.868 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -54.6 -51.98 63.61 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.81 1.244 . . . . 0.0 112.557 172.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.8 -47.61 45.12 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 126.342 1.857 . . . . 0.0 110.178 -171.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -50.21 -56.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.207 1.803 . . . . 0.0 108.079 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.83 -43.25 62.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.268 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.3 m -70.39 -4.43 22.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.8 -26.75 60.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.431 1.469 . . . . 0.0 111.874 172.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.83 150.51 65.88 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 119.137 0.881 . . . . 0.0 110.787 -171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.47 72.95 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.613 2.876 . . . . 0.0 108.731 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.61 147.57 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -50.21 124.21 9.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.941 0.496 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -65.14 140.87 58.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.1 -3.5 85.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.109 -1.384 . . . . 0.0 112.418 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -92.23 -28.88 16.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.201 2.001 . . . . 0.0 112.674 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.63 109.64 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.858 2.117 . . . . 0.0 108.193 -171.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -121.43 112.6 18.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.46 1.027 . . . . 0.0 109.885 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 74.5 m-85 -96.03 91.76 6.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.832 1.253 . . . . 0.0 108.963 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.67 104.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.299 1.84 . . . . 0.0 108.708 -168.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.73 104.79 2.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.69 1.596 . . . . 0.0 112.235 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.23 -8.98 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.639 1.175 . . . . 0.0 113.087 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.453 -0.289 0 CA-C-N 119.427 1.012 . . . . 0.0 110.79 -173.928 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.0 m170 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.87 -63.4 0.98 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 120.397 1.453 . . . . 0.0 109.864 170.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -47.02 -49.7 20.63 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.373 -0.822 . . . . 0.0 113.01 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -60.9 -44.61 96.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.708 1.203 . . . . 0.0 110.06 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -68.31 -42.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.801 1.64 . . . . 0.0 107.32 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -48.92 70.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.567 2.347 . . . . 0.0 105.421 -172.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -52.91 -59.01 5.05 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 126.022 1.729 . . . . 0.0 109.942 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.97 -38.7 79.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.644 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.37 -32.1 72.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.462 1.028 . . . . 0.0 111.213 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -61.72 -38.69 88.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.277 0.944 . . . . 0.0 110.372 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -51.54 12.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.728 0.695 . . . . 0.0 111.395 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.59 -22.76 63.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.611 1.164 . . . . 0.0 110.533 -171.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.9 p -116.09 -71.67 0.73 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.608 1.095 . . . . 0.0 108.083 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.66 0.23 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.108 1.337 . . . . 0.0 110.811 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -134.89 144.95 47.8 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 108.871 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -21.66 51.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.117 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.5 p -63.05 133.37 54.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.493 0.496 . . . . 0.0 110.007 -158.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.76 155.57 61.69 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.39 166.28 64.93 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 CA-C-N 119.927 1.01 . . . . 0.0 111.419 -5.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -133.84 96.11 3.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 169.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 86' ' ' LEU . 54.3 t -74.4 126.31 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -113.99 101.83 9.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.877 1.671 . . . . 0.0 107.477 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.471 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.04 115.26 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.554 -2.388 . . . . 0.0 104.554 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.35 72.38 0.48 Allowed Glycine 0 C--N 1.337 0.611 0 C-N-CA 124.621 1.105 . . . . 0.0 111.873 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 46.67 22.1 0.16 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.58 130.52 38.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.397 1.453 . . . . 0.0 110.854 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 t -71.58 115.96 11.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.776 0.83 . . . . 0.0 110.068 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -84.2 -6.65 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 118.442 0.565 . . . . 0.0 111.256 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.54 -175.93 19.68 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.561 1.553 . . . . 0.0 109.519 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.66 -91.82 1.2 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.43 -55.7 0.96 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.611 0.705 . . . . 0.0 112.457 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -61.18 -33.56 73.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.171 0.896 . . . . 0.0 111.107 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.12 -63.21 1.21 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.098 1.759 . . . . 0.0 107.766 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -49.31 -37.25 23.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.683 2.393 . . . . 0.0 113.126 -176.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.33 -36.03 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.341 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -49.39 66.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 121.3 1.864 . . . . 0.0 107.383 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.54 -37.48 75.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.36 -63.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.465 1.03 . . . . 0.0 109.692 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -51.64 58.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.155 1.782 . . . . 0.0 112.25 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -75.01 -36.73 61.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.594 1.157 . . . . 0.0 109.889 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.21 35.34 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.799 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -63.06 -26.97 69.09 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.621 2.21 . . . . 0.0 110.872 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -39.66 84.94 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 125.206 1.402 . . . . 0.0 109.172 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -39.71 84.93 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.526 0.73 . . . . 0.0 109.234 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 m -59.7 -57.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -34.51 78.3 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.888 -0.508 . . . . 0.0 112.174 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 mt -57.04 -53.73 54.71 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.946 1.298 . . . . 0.0 109.793 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -25.34 68.03 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.368 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -56.55 -30.31 62.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.42 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.74 8.78 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 112.53 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.59 30.95 59.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.305 -0.872 . . . . 0.0 112.858 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.74 -70.47 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 110.195 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.93 134.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -166.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--O 1.247 0.944 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 -174.041 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.0 t80 . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 18' ' ' PHE . 24.8 t -80.6 -56.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -60.47 -28.42 68.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -158.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -109.34 -16.66 13.98 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.398 1.079 . . . . 0.0 112.662 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -65.6 -39.07 91.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 0.0 110.149 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -69.9 144.86 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.26 160.27 37.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 163.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 71.5 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.499 3.466 . . . . 0.0 111.931 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.31 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.922 2.201 . . . . 0.0 110.555 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -151.24 162.92 40.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.76 2.424 . . . . 0.0 106.361 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.44 87.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 165.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -88.16 135.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.58 114.27 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 6' ' ' VAL . 69.3 m-85 -84.11 130.04 34.87 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 167.77 18.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.005 1.322 . . . . 0.0 110.659 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.7 149.33 58.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 161.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.49 -19.68 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.617 2.878 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -75.58 31.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.758 2.423 . . . . 0.0 110.802 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 12.9 t -144.19 121.5 6.6 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.87 1.668 . . . . 0.0 111.289 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.98 -19.97 19.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.018 1.812 . . . . 0.0 111.238 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 26.4 m-85 -76.8 -41.18 45.46 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.38 -46.65 88.07 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.3 ttm-85 -57.17 -42.66 81.52 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.467 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -58.62 -56.91 16.14 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 120.321 1.418 . . . . 0.0 108.529 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.45 -32.7 51.09 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 123.722 0.639 . . . . 0.0 111.141 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -56.7 -60.52 3.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.46 1.504 . . . . 0.0 112.474 169.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -66.11 -45.94 79.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.692 1.133 . . . . 0.0 109.243 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.12 -48.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.424 1.49 . . . . 0.0 110.494 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -74.96 -52.29 11.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -64.42 -14.43 56.75 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.47 1.508 . . . . 0.0 113.531 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.64 -24.25 59.98 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.073 1.306 . . . . 0.0 111.28 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.77 150.83 84.3 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.178 0.899 . . . . 0.0 110.714 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.88 67.69 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.565 2.843 . . . . 0.0 110.47 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -90.33 154.25 3.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -55.38 128.75 35.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.57 1.148 . . . . 0.0 109.469 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.93 136.22 57.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.26 -3.66 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.481 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mt -73.66 -41.15 63.08 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.888 1.844 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.79 110.04 18.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -121.52 120.25 34.33 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 54.0 m-85 -89.79 94.76 9.95 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.585 1.554 . . . . 0.0 107.324 172.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -85.29 107.96 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.895 2.078 . . . . 0.0 107.988 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -70.92 107.86 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.97 1.308 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 pt -68.47 -15.19 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.605 0.762 . . . . 0.0 112.644 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 124.274 1.03 . . . . 0.0 110.952 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.7 m170 . . . . . 0 N--CA 1.456 -0.125 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -63.44 1.11 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.988 0.915 . . . . 0.0 109.53 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -27.24 32.71 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.58 -29.67 15.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.831 1.196 . . . . 0.0 111.448 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.77 -37.16 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -62.89 -51.67 66.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.38 1.872 . . . . 0.0 106.472 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -52.65 -53.84 41.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 111.054 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -41.44 80.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.92 -35.83 81.94 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.749 -1.22 . . . . 0.0 110.321 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.23 -39.02 92.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.373 0.533 . . . . 0.0 111.201 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -63.22 -52.45 62.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.805 . . . . 0.0 110.25 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -75.7 -52.95 9.35 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 p -97.57 -15.95 20.27 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.73 1.67 57.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.079 -0.845 . . . . 0.0 111.748 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.44 151.94 10.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.186 1.493 . . . . 0.0 110.756 169.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -87.9 -26.38 22.76 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 p -58.61 133.35 55.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -158.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.88 22.46 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.896 0.879 . . . . 0.0 110.007 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -60.53 155.33 51.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 CA-C-N 119.833 0.976 . . . . 0.0 110.111 -10.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.83 113.6 20.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.21 123.92 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 119.712 1.142 . . . . 0.0 109.08 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.87 104.09 13.72 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 121.93 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 160.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.4 80.58 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 127.736 2.589 . . . . 0.0 114.934 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 47.26 21.14 0.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.27 125.39 34.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 121.206 1.821 . . . . 0.0 111.722 158.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.6 t -65.56 113.46 4.21 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.592 1.957 . . . . 0.0 109.761 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.68 -21.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 O-C-N 122.935 0.147 . . . . 0.0 110.611 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.39 -165.44 24.72 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.65 -167.11 36.43 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.985 0.802 . . . . 0.0 111.312 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.2 p -60.87 -34.89 75.32 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.303 1.051 . . . . 0.0 111.707 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -74.45 -42.98 58.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.543 0.611 . . . . 0.0 109.524 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.77 -46.97 82.85 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.95 -41.07 67.37 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.318 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.93 -48.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 116.827 -1.559 . . . . 0.0 109.9 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -47.02 87.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.206 1.821 . . . . 0.0 108.037 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.7 -40.56 83.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.933 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.36 -67.01 0.47 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.842 1.655 . . . . 0.0 110.211 172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -43.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.981 2.113 . . . . 0.0 113.294 -170.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.9 -4.17 50.41 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.73 1.212 . . . . 0.0 111.482 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.9 5.53 87.76 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 117.271 -1.849 . . . . 0.0 115.146 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.2 -29.08 69.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 121.495 2.648 . . . . 0.0 110.937 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 33' ' ' LEU . 54.1 tp -53.54 -38.1 63.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.88 1.672 . . . . 0.0 111.619 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.76 -50.67 48.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -172.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.5 m -60.5 -47.36 86.48 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.721 0.808 . . . . 0.0 110.132 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -52.05 41.1 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 110.213 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.3 -46.17 84.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -66.3 -26.84 67.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 117.995 -1.003 . . . . 0.0 113.031 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -54.84 -33.1 61.33 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.504 0.593 . . . . 0.0 110.558 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.45 9.38 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.438 1.017 . . . . 0.0 112.199 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.16 17.8 79.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.311 0.96 . . . . 0.0 114.181 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.32 -61.83 1.63 Allowed 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.123 1.769 . . . . 0.0 111.468 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.35 133.29 46.79 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.249 1.077 0 O-C-N 126.227 2.204 . . . . 0.0 112.195 -152.431 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 CA--C 1.53 0.212 0 CA-C-O 120.579 0.228 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.411 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.4 t -63.75 -33.29 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.96 -30.86 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.861 -0.525 . . . . 0.0 111.541 -162.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -89.18 -19.22 25.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.091 1.757 . . . . 0.0 110.61 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -47.09 82.46 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.493 -1.38 . . . . 0.0 109.012 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -71.28 148.03 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -136.25 145.97 54.24 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.133 0.973 . . . . 0.0 108.878 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 61.21 7.62 Favored 'Trans proline' 0 CA--C 1.537 0.661 1 C-N-CA 125.324 4.016 . . . . 0.0 112.924 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.06 23.09 0.03 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 125.809 1.671 . . . . 0.0 111.723 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -137.94 154.04 49.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 127.003 2.121 . . . . 0.0 107.006 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 75' ' ' ILE . 29.4 t -102.04 93.13 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.58 129.94 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.18 155.98 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE1' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -117.75 125.59 50.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.54 175.63 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.048 2.139 . . . . 0.0 110.005 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -129.73 152.96 80.68 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.11 1.764 . . . . 0.0 106.688 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.79 -13.62 26.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.235 2.623 . . . . 0.0 113.145 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -102.3 -10.68 19.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.816 2.047 . . . . 0.0 112.209 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -90.95 127.57 51.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.653 0.781 . . . . 0.0 109.381 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.89 -23.05 16.78 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.86 1.707 . . . . 0.0 111.293 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.38 -35.04 47.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -58.19 -54.08 51.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.581 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -51.11 -45.15 61.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.306 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -61.59 2.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.96 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.895 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -55.11 -58.74 6.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.38 1.472 . . . . 0.0 112.683 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.87 -41.49 82.75 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 118.549 0.613 . . . . 0.0 109.802 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -53.75 -52.82 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.443 1.497 . . . . 0.0 109.101 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.31 -44.77 64.51 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -55.73 -15.67 3.4 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.5 -23.02 59.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.802 2.092 . . . . 0.0 111.745 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.29 137.12 39.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 119.071 0.851 . . . . 0.0 109.682 -169.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.72 85.17 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.847 3.031 . . . . 0.0 111.032 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 43' ' ' LEU . 14.9 mt -105.34 151.63 7.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.474 1.51 . . . . 0.0 107.196 -165.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -49.24 126.65 13.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.026 0.93 . . . . 0.0 109.988 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.46 130.02 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.67 84.35 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 117.623 -1.654 . . . . 0.0 113.16 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.12 -37.72 64.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.594 2.197 . . . . 0.0 111.022 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.73 110.37 18.26 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.403 1.456 . . . . 0.0 107.589 -175.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -124.53 98.61 5.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.221 1.408 . . . . 0.0 108.549 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -83.97 105.99 15.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.59 127.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.963 1.305 . . . . 0.0 107.568 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.842 1.257 . . . . 0.0 111.119 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 57' ' ' ILE . 47.0 pt -68.6 -16.76 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.722 -1.237 . . . . 0.0 112.243 174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.315 174.514 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.89 -63.28 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.764 2.026 . . . . 0.0 109.96 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -45.19 -48.49 12.47 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.952 1.701 . . . . 0.0 113.719 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -40.19 73.51 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.58 0.627 . . . . 0.0 110.498 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CG2' ' A' ' 48' ' ' ILE . 13.4 mt -63.31 -42.27 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -58.01 -51.32 70.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.17 2.988 . . . . 0.0 109.27 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.23 -62.16 1.9 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.041 1.737 . . . . 0.0 110.442 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -53.17 -41.02 64.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.07 -27.57 69.19 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.753 1.221 . . . . 0.0 112.423 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -44.3 96.66 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.026 0.83 . . . . 0.0 110.049 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.45 -46.76 37.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.211 0.605 . . . . 0.0 110.359 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.69 -23.82 66.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 111.464 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 1.5 p -127.22 -72.22 0.65 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.741 1.609 . . . . 0.0 109.45 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.16 -21.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.492 -1.171 . . . . 0.0 114.864 -172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.71 156.94 45.09 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.861 1.831 . . . . 0.0 110.24 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -71.63 -30.49 65.82 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.692 -0.63 . . . . 0.0 110.01 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 p -61.16 133.54 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -165.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 165.64 22.28 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.354 1.462 . . . . 0.0 107.487 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.4 171.1 18.13 Favored 'Cis proline' 0 C--N 1.345 0.352 0 CA-C-N 120.883 1.351 . . . . 0.0 111.815 -6.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -142.37 108.01 5.1 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.85 133.27 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -114.75 140.4 48.92 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -123.51 113.08 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 177.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.59 58.53 13.94 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.353 -0.842 . . . . 0.0 112.008 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.256 1.0 OUTLIER 46.21 27.73 0.59 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -174.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -129.85 135.23 48.15 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.65 1.114 . . . . 0.0 109.187 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -71.11 150.03 45.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -105.51 -12.46 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 122.924 0.49 . . . . 0.0 111.39 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.18 -165.44 18.34 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -166.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.65 -95.57 2.41 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 119.006 -0.886 . . . . 0.0 110.921 -174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.89 -56.78 2.19 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.133 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -59.35 -39.04 81.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.861 1.664 . . . . 0.0 112.126 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -42.86 81.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.827 0.451 . . . . 0.0 109.871 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.16 -37.0 85.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.558 0.743 . . . . 0.0 110.479 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.39 -49.56 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 115.494 -2.193 . . . . 0.0 109.738 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -61.93 -39.95 93.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 122.939 2.608 . . . . 0.0 112.051 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 80' ' ' ILE . 10.3 mt -54.47 -46.18 73.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.41 -51.95 25.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 121.375 1.898 . . . . 0.0 110.959 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.2 -53.15 53.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.897 1.679 . . . . 0.0 112.01 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.4 t -71.59 -5.19 31.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.845 1.258 . . . . 0.0 110.775 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.93 9.29 59.44 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.016 -1.435 . . . . 0.0 112.968 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.38 -21.6 66.24 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.264 2.032 . . . . 0.0 111.842 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.49 -37.9 65.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 111.047 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.41 -48.69 74.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.667 0.667 . . . . 0.0 109.65 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -46.57 85.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.199 1.0 . . . . 0.0 110.236 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -47.7 -53.51 14.84 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.512 1.525 . . . . 0.0 110.392 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 mp -72.27 -34.85 68.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -58.95 -30.75 68.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.435 1.471 . . . . 0.0 111.419 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -54.62 -19.01 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 112.979 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.01 11.08 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.716 1.143 . . . . 0.0 112.384 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.23 46.9 7.27 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 118.703 0.683 . . . . 0.0 112.431 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.34 -72.49 0.58 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.842 1.257 . . . . 0.0 111.875 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.58 137.19 55.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 120.182 1.355 . . . . 0.0 109.528 -159.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 163.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 C--O 1.226 -0.177 0 CA-C-O 120.02 -0.038 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 40.6 t -68.79 -62.85 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.86 -43.65 98.41 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -159.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.37 -15.13 60.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.273 -0.87 . . . . 0.0 113.296 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -71.99 -38.76 69.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.426 1.466 . . . . 0.0 111.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.05 126.36 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -106.88 162.32 20.07 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 123.42 0.688 . . . . 0.0 109.357 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.5 79.18 0.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.636 2.89 . . . . 0.0 109.658 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.79 19.7 0.49 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 127.313 2.387 . . . . 0.0 113.54 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -111.96 159.02 18.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.782 1.791 . . . . 0.0 108.467 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG13 ' CD1' ' A' ' 75' ' ' ILE . 36.1 t -113.07 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.8 t -84.06 147.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.98 113.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 6' ' ' VAL . 86.1 m-85 -76.52 126.28 30.71 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.11 168.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.791 1.236 . . . . 0.0 110.399 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -117.5 149.57 45.07 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 158.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.28 4.83 5.54 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.188 1.926 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -124.21 -17.25 6.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 132.33 89.12 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 168.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -64.85 -21.26 64.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.766 1.644 . . . . 0.0 109.78 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -74.34 -42.9 58.65 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.953 0.901 . . . . 0.0 109.609 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.64 -45.13 94.25 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -54.55 -44.93 73.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.103 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -57.74 10.27 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 118.793 0.724 . . . . 0.0 109.654 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.96 55.84 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -69.58 -37.62 77.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 117.558 -1.21 . . . . 0.0 114.113 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.51 -49.25 27.56 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 120.111 1.323 . . . . 0.0 108.464 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -49.28 -53.33 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.531 1.532 . . . . 0.0 109.982 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.46 -46.43 17.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -74.79 6.25 4.16 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.156 1.343 . . . . 0.0 114.196 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.1 -12.73 60.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.47 1.508 . . . . 0.0 112.572 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.4 148.66 56.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.55 1.068 . . . . 0.0 111.199 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.64 96.62 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.181 2.588 . . . . 0.0 109.911 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.82 145.98 30.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -47.32 134.34 11.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.272 0.629 . . . . 0.0 111.998 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -49.42 115.39 1.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.381 1.473 . . . . 0.0 109.137 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.92 86.75 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.404 -1.22 . . . . 0.0 114.126 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.73 -33.07 64.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 121.215 2.507 . . . . 0.0 109.962 165.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.46 109.59 17.47 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -171.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -129.25 102.72 6.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.51 90.4 8.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.128 1.371 . . . . 0.0 107.938 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.5 111.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.475 1.51 . . . . 0.0 109.212 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -71.31 115.01 9.97 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.314 1.046 . . . . 0.0 112.929 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG22 HG21 ' A' ' 57' ' ' ILE . 20.2 pt -70.82 -35.0 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.688 1.595 . . . . 0.0 112.494 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.232 0.177 0 C-N-CA 124.297 1.039 . . . . 0.0 111.63 -166.732 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m170 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -63.68 1.2 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -67.7 -23.69 65.32 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.95 -48.62 73.43 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.061 1.744 . . . . 0.0 111.009 165.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.487 HG21 HG22 ' A' ' 48' ' ' ILE . 13.3 mt -60.86 -38.28 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.102 0.961 . . . . 0.0 109.066 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -59.96 -49.86 76.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.02 -44.09 85.74 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.5 1.143 . . . . 0.0 112.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -58.11 -43.64 87.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.624 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 mt -61.89 -33.24 73.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.116 0.966 . . . . 0.0 111.081 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.27 -51.0 69.75 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 119.15 0.886 . . . . 0.0 110.39 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.29 -49.54 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.209 0.528 . . . . 0.0 109.609 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tp -73.53 -17.9 61.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.792 0.837 . . . . 0.0 111.114 -167.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -129.25 -25.91 2.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 114.451 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.51 23.1 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.071 -1.405 . . . . 0.0 112.183 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.86 147.52 22.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 121.069 2.435 . . . . 0.0 110.698 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -21.09 61.05 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 p -70.24 133.75 47.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.806 0.73 . . . . 0.0 110.457 -159.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 161.74 22.54 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.483 1.913 . . . . 0.0 107.813 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.85 125.01 6.2 Favored 'Cis proline' 0 C--N 1.345 0.394 0 CA-C-N 120.344 1.158 . . . . 0.0 111.571 -1.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -95.61 91.25 6.04 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.64 125.07 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 94.03 4.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.142 2.577 . . . . 0.0 107.38 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.477 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -93.27 112.37 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.47 63.39 5.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.291 0.948 . . . . 0.0 113.41 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 46.48 15.28 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.838 2.455 . . . . 0.0 115.703 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -126.96 144.5 50.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 120.074 1.306 . . . . 0.0 109.887 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -86.57 134.96 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.974 0.91 . . . . 0.0 110.896 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pp -83.86 -18.41 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 119.104 0.866 . . . . 0.0 110.556 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.06 -141.3 12.48 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.8 -158.05 14.37 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.898 1.713 . . . . 0.0 108.838 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -22.03 59.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.756 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -65.32 -45.09 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.847 1.203 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.32 -57.62 12.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.162 1.785 . . . . 0.0 107.112 170.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.9 tp -52.0 -40.09 60.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.14 -50.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 117.266 -1.349 . . . . 0.0 108.382 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -43.24 99.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 120.82 1.645 . . . . 0.0 110.28 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -51.82 -47.48 64.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.097 0.862 . . . . 0.0 109.537 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.79 -52.58 42.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.515 1.052 . . . . 0.0 110.785 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -58.73 3.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.947 1.699 . . . . 0.0 111.244 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -11.46 59.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.463 1.505 . . . . 0.0 109.889 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.51 -2.53 49.76 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.569 161.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -59.27 -28.87 67.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.797 1.799 . . . . 0.0 111.435 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 tt -44.17 -57.89 3.17 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.359 1.863 . . . . 0.0 110.514 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.73 -42.09 98.5 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.864 0.756 . . . . 0.0 109.532 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -61.29 -54.23 46.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.791 0.836 . . . . 0.0 110.358 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.52 76.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.436 1.094 . . . . 0.0 111.021 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.66 -47.4 60.19 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.31 -26.34 67.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.174 1.352 . . . . 0.0 112.468 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -52.3 -33.04 40.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.346 1.458 . . . . 0.0 110.738 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.04 11.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.126 0.876 . . . . 0.0 112.674 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 37.9 26.68 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.2 -0.938 . . . . 0.0 112.328 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.99 -69.83 0.56 Allowed 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 112.131 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.84 136.58 52.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.991 0.814 . . . . 0.0 110.839 -158.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.664 3.185 . . . . 0.0 105.219 -175.245 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.96 -55.12 23.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.32 1.448 . . . . 0.0 109.448 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.66 -39.87 95.28 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 t -81.4 38.6 0.49 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.803 2.041 . . . . 0.0 111.772 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -130.91 -47.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.626 0.771 . . . . 0.0 109.647 159.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.17 133.76 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.21 165.07 34.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.58 156.77 40.22 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.008 -1.574 . . . . 0.0 108.008 159.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.69 17.1 77.94 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.191 -0.943 . . . . 0.0 115.08 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -135.78 162.04 33.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.684 1.593 . . . . 0.0 108.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.88 79.58 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.19 132.95 33.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.06 110.79 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.3 130.07 38.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.08 179.73 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 C-N-CA 126.362 1.865 . . . . 0.0 109.843 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -140.37 151.27 63.73 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 158.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.22 -15.01 20.49 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.588 2.192 . . . . 0.0 111.527 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -50.57 43.57 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.703 1.201 . . . . 0.0 110.131 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 20' ' ' LYS . 16.0 m -61.1 109.59 2.25 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.401 1.481 . . . . 0.0 111.398 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.75 -20.84 58.98 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.992 1.795 . . . . 0.0 110.898 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -73.2 -22.32 60.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.926 -1.109 . . . . 0.0 111.294 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.96 -33.12 74.05 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.47 -0.769 . . . . 0.0 109.755 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -63.17 -30.04 71.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.764 0.826 . . . . 0.0 111.774 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.76 4.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.22 51.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 124.365 1.041 . . . . 0.0 111.785 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.6 -56.53 16.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.549 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.46 -41.33 63.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 123.741 0.651 . . . . 0.0 110.263 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -50.21 -57.42 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.732 1.213 . . . . 0.0 108.737 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 33' ' ' LEU . 12.9 mt -75.96 -43.25 45.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.303 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.2 p -65.65 -20.83 66.45 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 120.03 1.286 . . . . 0.0 113.915 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -73.51 -21.77 60.31 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.626 1.103 . . . . 0.0 110.697 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.78 142.24 56.53 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -64.56 127.56 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -146.36 157.61 11.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 128.02 34.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.173 0.989 . . . . 0.0 109.646 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -64.43 126.24 27.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.985 -168.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.92 71.29 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.962 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.68 -37.58 65.19 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 119.847 1.824 . . . . 0.0 109.002 164.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 100.03 10.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -170.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -122.1 101.49 7.57 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 108.92 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -84.55 93.82 8.44 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.774 1.23 . . . . 0.0 108.638 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.56 112.22 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.809 1.244 . . . . 0.0 109.363 -171.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.83 121.29 13.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.506 1.523 . . . . 0.0 112.793 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.5 pt -85.18 -21.35 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.17 1.388 . . . . 0.0 113.382 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 119.071 0.85 . . . . 0.0 110.134 -179.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -37.13 -63.02 0.46 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.417 2.287 . . . . 0.0 109.792 164.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -43.74 -49.34 7.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.031 1.333 . . . . 0.0 113.372 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.68 -43.39 80.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.935 0.894 . . . . 0.0 111.458 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.2 mt -62.87 -31.75 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -69.35 -54.24 15.51 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.9 -55.8 17.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 123.679 1.704 . . . . 0.0 111.004 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 4.67 13.71 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.764 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -91.41 -37.7 13.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 118.122 -2.861 . . . . 0.0 109.907 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.83 -49.79 47.72 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.336 1.455 . . . . 0.0 108.142 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -57.49 5.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.412 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.86 -23.86 67.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 111.01 -163.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.1 p -126.45 -17.31 5.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.75 50.0 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.645 1.111 . . . . 0.0 112.155 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.28 158.16 31.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.336 1.854 . . . . 0.0 107.869 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -22.08 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -55.41 133.54 49.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.41 0.684 . . . . 0.0 111.139 -161.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.82 153.8 39.96 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -60.3 147.17 43.24 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.122 1.079 . . . . 0.0 110.043 -10.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -130.46 103.1 6.46 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 86' ' ' LEU . 69.7 t -87.09 124.45 40.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 123.022 0.529 . . . . 0.0 109.92 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -103.37 105.5 15.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.605 1.562 . . . . 0.0 107.772 160.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.97 116.57 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 161.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 41.46 69.67 0.51 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 126.193 1.854 . . . . 0.0 114.019 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 47.31 21.37 0.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -116.82 120.67 39.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.908 1.283 . . . . 0.0 108.632 165.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -83.99 104.26 13.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.201 0.6 . . . . 0.0 110.088 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -83.85 -8.74 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.462 0.574 . . . . 0.0 112.008 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.97 -167.19 24.15 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.843 0.735 . . . . 0.0 112.606 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.7 -162.15 34.81 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.032 1.301 . . . . 0.0 110.373 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -37.93 71.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.652 1.226 . . . . 0.0 110.104 -165.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 m -68.43 -36.09 78.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.557 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.33 -49.76 58.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.607 1.163 . . . . 0.0 108.618 173.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 73' ' ' VAL . 58.2 tp -51.58 -44.32 62.74 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.016 1.726 . . . . 0.0 111.821 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.17 -44.84 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-O 117.113 -1.422 . . . . 0.0 109.694 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.99 -48.79 75.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -173.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.12 -42.34 85.56 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.222 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -64.1 -56.84 12.04 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.371 0.987 . . . . 0.0 110.305 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -51.52 55.07 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.739 1.616 . . . . 0.0 111.364 -172.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.0 t -71.49 -7.23 46.19 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.325 1.45 . . . . 0.0 110.934 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.09 77.93 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.662 -1.632 . . . . 0.0 114.062 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.04 -33.66 73.64 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.742 2.271 . . . . 0.0 110.707 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -38.18 86.61 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.904 1.282 . . . . 0.0 109.545 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.25 -37.72 86.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.364 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -48.57 72.51 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.589 1.086 . . . . 0.0 109.736 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -50.73 62.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 110.593 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -60.11 -48.21 82.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.49 1.516 . . . . 0.0 110.715 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.59 -35.22 77.23 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.903 -1.123 . . . . 0.0 111.811 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -54.0 -32.42 54.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.007 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.96 5.5 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 119.484 1.038 . . . . 0.0 113.377 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.89 39.44 13.5 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.747 1.158 . . . . 0.0 112.87 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.93 -74.86 0.38 Allowed 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 125.876 1.67 . . . . 0.0 112.602 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -53.13 -23.38 8.0 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.24 1.816 . . . . 0.0 114.872 -159.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 130.377 3.471 . . . . 0.0 110.523 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.51 -60.26 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.524 -0.735 . . . . 0.0 110.263 166.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -63.38 -27.29 69.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -163.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.2 t -87.35 -24.15 24.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.087 0.955 . . . . 0.0 111.349 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -73.95 -37.84 64.43 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 121.074 -1.016 . . . . 0.0 111.406 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -82.61 149.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 160.05 34.92 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 72.0 Cg_endo -75.94 111.36 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.412 2.741 . . . . 0.0 108.733 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 9.12 21.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.42 1.486 . . . . 0.0 113.646 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -123.47 166.04 16.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.09 1.756 . . . . 0.0 109.241 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 47.3 t -124.0 110.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 10' ' ' ILE . 42.4 t -120.01 139.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.43 112.91 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -78.4 119.91 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.42 161.28 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.629 1.172 . . . . 0.0 111.602 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -120.33 141.96 32.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.58 -20.12 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.903 1.736 . . . . 0.0 110.996 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 26.52 0.97 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.798 2.039 . . . . 0.0 111.44 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -130.92 134.97 26.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.622 2.369 . . . . 0.0 108.706 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.98 -25.87 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.179 2.586 . . . . 0.0 112.265 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -74.34 -29.98 61.83 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.37 -48.0 83.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.562 -0.711 . . . . 0.0 109.836 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -59.5 -41.51 90.06 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.518 -0.739 . . . . 0.0 110.164 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -58.67 6.53 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -39.85 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.154 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -56.46 -54.3 47.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.503 172.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -69.47 -41.93 75.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.288 0.949 . . . . 0.0 109.752 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.73 -52.28 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 125.727 1.611 . . . . 0.0 110.159 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.22 -48.97 16.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -69.83 -13.58 62.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.923 0.489 . . . . 0.0 112.269 -169.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.08 -23.33 60.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.035 0.834 . . . . 0.0 110.951 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.08 149.65 85.14 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.12 113.99 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 106.631 -2.103 . . . . 0.0 106.631 164.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.66 138.44 54.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 124.34 7.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.968 1.307 . . . . 0.0 108.687 -169.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.61 122.33 13.81 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -162.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.19 -12.96 58.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.082 1.325 . . . . 0.0 113.875 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.67 -28.29 61.68 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 120.697 2.249 . . . . 0.0 110.458 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.81 120.67 26.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 120.229 1.377 . . . . 0.0 107.482 -177.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -131.61 104.71 7.09 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.473 1.109 . . . . 0.0 109.338 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 20.3 m-85 -84.6 100.76 11.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.07 107.39 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -67.06 104.45 1.41 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 54' ' ' THR . 19.1 pt -69.44 -18.25 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.64 0.776 . . . . 0.0 111.463 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 CA--C 1.535 0.366 0 O-C-N 121.386 -0.821 . . . . 0.0 111.382 179.216 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m170 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -43.41 -63.68 0.78 Allowed 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.558 1.943 . . . . 0.0 109.053 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -52.34 -43.27 64.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.196 1.398 . . . . 0.0 109.801 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.87 -36.1 69.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 112.246 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.7 -51.74 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -57.25 10.04 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.291 0.567 . . . . 0.0 110.822 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.67 -42.33 62.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.242 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -61.13 -43.43 98.9 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.682 0.673 . . . . 0.0 110.709 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.78 -27.51 68.05 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.333 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -63.23 -56.69 14.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 120.739 1.609 . . . . 0.0 109.67 171.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.79 -49.13 71.7 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.839 0.712 . . . . 0.0 109.972 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.3 -29.74 57.48 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.116 1.366 . . . . 0.0 111.606 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 p -125.63 -29.08 3.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.55 13.96 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.179 -1.345 . . . . 0.0 113.982 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.99 150.97 9.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.649 2.224 . . . . 0.0 110.68 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' A' ' 62' ' ' GLN . 2.8 ptt-85 -96.61 -7.87 33.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.738 0.815 . . . . 0.0 112.571 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -65.05 133.98 52.84 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 108.649 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.88 147.0 34.61 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 126.618 1.967 . . . . 0.0 105.794 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -66.35 155.1 81.97 Favored 'Cis proline' 0 N--CA 1.461 -0.436 0 CA-C-N 120.353 1.162 . . . . 0.0 111.666 3.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -140.29 106.48 5.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 86' ' ' LEU . 55.2 t -87.89 127.46 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.73 93.98 4.3 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.598 2.359 . . . . 0.0 106.85 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -86.5 121.6 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.75 63.44 3.84 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.231 0.919 . . . . 0.0 113.425 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HE3' ' HD3' ' A' ' 12' ' ' PRO . 3.5 ttmt 46.13 19.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.369 2.267 . . . . 0.0 117.056 -173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.74 133.38 50.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.069 1.304 . . . . 0.0 110.571 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -81.11 121.99 26.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.106 -0.996 . . . . 0.0 109.899 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.4 pp -84.31 -11.81 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 119.616 1.098 . . . . 0.0 111.502 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.83 -163.69 19.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.322 0.963 . . . . 0.0 111.137 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.19 -155.26 29.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.303 0.954 . . . . 0.0 111.076 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -41.96 95.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.465 0.633 . . . . 0.0 111.269 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -65.94 -44.63 84.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.444 0.566 . . . . 0.0 110.897 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.47 -58.13 9.34 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 73' ' ' VAL . 65.0 tp -50.51 -42.13 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.436 1.094 . . . . 0.0 112.051 -174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.28 -51.02 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 116.347 -1.787 . . . . 0.0 109.229 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.47 54.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.448 1.931 . . . . 0.0 107.14 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.33 -40.98 83.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.111 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -74.67 -47.58 30.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.197 1.362 . . . . 0.0 107.806 -172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -35.85 60.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.373 1.069 . . . . 0.0 111.073 -169.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 t -94.13 -2.8 52.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.838 1.255 . . . . 0.0 111.15 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.76 0.32 87.74 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.082 -1.954 . . . . 0.0 115.075 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.54 -33.63 74.17 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 121.295 2.548 . . . . 0.0 110.37 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 tp -54.69 -37.64 66.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.48 -48.15 57.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -56.58 -49.87 73.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.981 0.913 . . . . 0.0 109.283 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.4 91.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.101 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -50.34 62.79 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.183 173.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.37 1.441 . . . . 0.0 111.801 -164.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.35 -39.08 14.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.304 1.441 . . . . 0.0 113.02 168.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.18 0.58 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 119.304 0.956 . . . . 0.0 111.936 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.34 55.2 2.94 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.7 1.143 . . . . 0.0 110.925 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.46 -75.65 0.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.79 1.636 . . . . 0.0 111.892 -167.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.89 133.73 52.49 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.235 -0.888 . . . . 0.0 108.826 -172.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.8 t80 . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.94 -47.05 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.949 0.9 . . . . 0.0 109.976 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.84 -44.19 86.22 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.006 -0.434 . . . . 0.0 111.355 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.22 -23.52 65.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.703 1.601 . . . . 0.0 112.168 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.05 -44.33 69.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.913 1.233 . . . . 0.0 110.268 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -80.02 136.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.23 153.02 55.51 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.08 80.54 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.178 2.586 . . . . 0.0 109.361 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.51 18.54 0.27 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.074 1.797 . . . . 0.0 115.323 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -132.17 171.82 13.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.568 1.684 . . . . 0.0 108.074 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.8 t -115.87 110.39 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 10' ' ' ILE . 75.0 t -126.73 126.16 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -169.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.81 112.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -81.83 120.16 24.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.22 164.52 34.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.391 1.477 . . . . 0.0 111.402 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -123.55 139.54 32.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 165.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.58 -9.55 21.42 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.373 2.049 . . . . 0.0 112.104 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 p -79.23 -18.81 52.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.581 2.352 . . . . 0.0 113.592 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -122.4 134.54 24.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -158.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.86 -14.25 26.67 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.805 2.337 . . . . 0.0 112.304 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -73.27 -35.17 66.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.566 1.075 . . . . 0.0 108.739 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.27 -47.07 74.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -52.05 -49.96 62.42 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.157 0.983 . . . . 0.0 113.049 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -57.03 14.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.582 1.083 . . . . 0.0 109.02 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -35.94 64.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.412 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -53.65 54.34 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.561 1.144 . . . . 0.0 112.435 174.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.69 -52.26 46.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.1 mt -46.73 -53.64 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.763 2.025 . . . . 0.0 109.413 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.94 -47.16 63.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.9 p -63.45 -19.14 64.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.538 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -73.28 -33.22 65.12 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 120.254 1.388 . . . . 0.0 109.966 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.12 136.05 95.28 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.81 76.98 3.87 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.493 2.795 . . . . 0.0 110.046 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.7 mt -87.76 145.51 7.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -53.25 123.39 11.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -66.3 122.87 18.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 -8.04 40.89 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.192 1.377 . . . . 0.0 111.801 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -78.04 -33.7 50.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.812 1.806 . . . . 0.0 111.489 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 120.73 29.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.433 1.015 . . . . 0.0 109.782 -171.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.67 130.68 47.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.481 0.712 . . . . 0.0 109.605 168.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.0 101.42 11.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.7 113.97 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.005 2.122 . . . . 0.0 108.485 -167.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -69.9 109.97 4.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.529 0.732 . . . . 0.0 110.532 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.43 13.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.316 1.046 . . . . 0.0 112.857 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.234 0.253 0 O-C-N 120.449 -1.407 . . . . 0.0 111.45 179.702 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 CA--C 1.515 -0.383 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -63.53 0.99 Allowed 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 125.465 1.506 . . . . 0.0 107.495 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -44.14 -48.89 9.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.525 1.13 . . . . 0.0 113.013 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -52.64 64.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.552 1.141 . . . . 0.0 111.411 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.96 -31.82 54.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.75 1.22 . . . . 0.0 111.675 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HA ' HH22 ' A' ' 72' ' ' ARG . 7.1 mt-30 -68.31 -45.31 73.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -64.64 -52.27 58.27 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.703 2.801 . . . . 0.0 110.405 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -55.05 -47.82 74.28 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.148 0.979 . . . . 0.0 111.205 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 64' ' ' LEU . 61.8 mt -65.66 -36.95 85.16 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.73 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.71 -44.31 96.76 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.53 1.059 . . . . 0.0 110.725 172.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -42.39 98.83 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.829 0.452 . . . . 0.0 110.597 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -76.05 -29.69 58.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.421 1.089 . . . . 0.0 109.399 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -125.06 -76.03 0.59 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.202 0.91 . . . . 0.0 109.072 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.31 -8.31 0.05 OUTLIER Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.728 -1.596 . . . . 0.0 116.715 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.43 146.26 48.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.572 2.686 . . . . 0.0 111.19 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.12 -28.29 15.15 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.302 1.441 . . . . 0.0 112.238 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 p -61.14 133.82 56.4 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 159.02 56.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.43 170.28 32.85 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 CA-C-N 118.763 0.594 . . . . 0.0 111.88 -11.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.584 HH22 ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -121.11 113.14 19.59 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 159.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.7 t -83.22 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.96 121.93 43.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 164.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -107.88 118.57 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 166.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.65 58.96 11.46 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.387 0.994 . . . . 0.0 112.689 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.285 3.6 tmtt? 45.49 30.73 0.78 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.58 1.952 . . . . 0.0 116.192 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.02 149.95 49.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.71 130.39 34.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.88 -26.08 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.14 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.17 -174.2 21.83 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.636 1.589 . . . . 0.0 112.057 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 -167.67 42.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.31 1.433 . . . . 0.0 112.042 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.42 -38.11 89.89 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.811 1.306 . . . . 0.0 111.598 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -64.99 -40.18 94.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.399 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.84 -51.65 45.97 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.421 1.088 . . . . 0.0 109.316 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.1 tp -51.89 -38.91 57.98 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 125.515 1.526 . . . . 0.0 111.652 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.42 -47.87 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 116.53 -1.7 . . . . 0.0 109.8 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -46.79 88.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.636 2.017 . . . . 0.0 108.615 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.155 -174.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.07 -52.54 23.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.385 1.448 . . . . 0.0 110.234 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.79 49.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.928 1.691 . . . . 0.0 111.399 -170.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -63.66 -33.55 75.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.76 2.024 . . . . 0.0 109.951 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.32 64.81 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.951 -1.472 . . . . 0.0 112.034 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.75 -32.04 65.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.089 1.945 . . . . 0.0 110.835 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.29 -36.23 70.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.846 1.659 . . . . 0.0 110.648 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.77 -50.67 61.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.916 0.487 . . . . 0.0 109.829 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 m -60.41 -49.29 78.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.883 0.873 . . . . 0.0 109.551 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -49.35 60.0 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.433 1.093 . . . . 0.0 110.348 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.4 mt -66.99 -45.09 78.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.32 -24.44 64.84 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.34 -1.475 . . . . 0.0 112.832 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.08 -39.34 59.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.861 0.755 . . . . 0.0 110.323 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.11 10.93 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.919 0.888 . . . . 0.0 111.914 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.45 76.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.411 -0.806 . . . . 0.0 113.571 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.0 -67.7 0.45 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 118.467 1.133 . . . . 0.0 110.142 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.92 134.01 45.75 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 118.163 -1.415 . . . . 0.0 107.669 -162.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 125.11 1.506 . . . . 0.0 108.668 -157.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.85 -54.19 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.851 0.861 . . . . 0.0 109.954 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.81 -38.22 75.16 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.051 0.94 . . . . 0.0 110.971 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.22 -29.76 64.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.736 0.815 . . . . 0.0 111.702 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -76.65 -45.6 29.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.797 1.635 . . . . 0.0 111.484 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.65 148.29 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -144.5 145.96 30.71 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.19 129.44 28.5 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.701 1.601 . . . . 0.0 108.617 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.54 77.88 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.372 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.6 169.91 8.99 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.237 2.019 . . . . 0.0 110.041 172.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.86 109.49 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.63 111.35 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 73' ' ' VAL . 14.3 t -100.82 121.14 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.79 130.14 34.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.48 173.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 110.399 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.41 144.53 43.08 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 161.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.83 -15.04 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.749 1.633 . . . . 0.0 111.433 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -66.65 -49.03 67.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.106 2.162 . . . . 0.0 110.943 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 122.35 87.28 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.806 1.242 . . . . 0.0 110.257 -172.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.29 -11.5 31.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.272 2.648 . . . . 0.0 112.31 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.8 -31.46 63.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.241 -0.912 . . . . 0.0 109.588 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -72.82 -38.77 67.04 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -46.55 67.06 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.138 0.575 . . . . 0.0 110.068 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.92 -56.05 23.84 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.287 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.91 -38.85 65.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.238 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -48.64 79.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.37 0.986 . . . . 0.0 113.644 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.09 -44.57 53.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -49.3 -54.83 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.969 1.307 . . . . 0.0 110.323 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD12 HG21 ' A' ' 17' ' ' VAL . 9.9 mt -81.97 -41.56 20.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.813 -172.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.7 t -70.65 -18.71 62.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.543 1.519 . . . . 0.0 112.498 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.83 -11.01 60.24 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.729 1.149 . . . . 0.0 111.827 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.12 133.06 39.77 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 163.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.44 62.52 8.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.011 2.474 . . . . 0.0 111.791 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.16 147.84 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -55.77 124.31 17.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -62.61 113.38 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.09 -12.9 9.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.744 1.164 . . . . 0.0 111.741 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.15 -39.81 15.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.691 1.745 . . . . 0.0 111.63 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 115.91 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.482 1.113 . . . . 0.0 109.465 -167.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -137.74 107.54 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.52 1.055 . . . . 0.0 109.078 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -85.93 105.12 16.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.842 1.257 . . . . 0.0 108.175 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.08 111.01 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -63.45 127.93 33.52 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 162.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 pt -93.04 -2.23 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 112.195 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 119.847 1.203 . . . . 0.0 111.372 179.323 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.21 -63.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.468 1.507 . . . . 0.0 110.384 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -40.63 59.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.78 0.832 . . . . 0.0 110.969 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.5 -11.91 56.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.615 1.966 . . . . 0.0 114.425 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 mt -85.03 -47.49 16.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 125.379 1.472 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -71.17 -40.98 70.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.521 0.677 . . . . 0.0 110.78 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.89 -36.86 72.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.918 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -66.36 -33.87 76.71 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.311 -1.493 . . . . 0.0 112.703 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.92 -29.62 70.78 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 120.186 1.357 . . . . 0.0 110.135 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.79 -38.5 78.67 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 120.354 1.434 . . . . 0.0 110.681 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -55.54 6.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.405 0.682 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.13 -25.79 55.71 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.1 p -122.9 -36.74 2.83 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.813 -1.18 . . . . 0.0 111.977 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.95 -17.69 5.15 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.378 -1.234 . . . . 0.0 114.211 168.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.91 148.33 38.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.899 1.85 . . . . 0.0 110.216 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -11.95 59.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.59 143.11 25.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.805 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 151.55 43.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.9 1.68 . . . . 0.0 106.573 164.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.28 165.45 43.8 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 CA-C-N 120.139 1.086 . . . . 0.0 111.33 -4.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -142.57 109.11 5.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 86' ' ' LEU . 97.9 t -88.31 126.78 41.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.935 0.494 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -105.06 130.47 53.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.82 111.78 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.43 73.39 0.42 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 125.145 1.355 . . . . 0.0 113.213 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.55 -9.18 0.0 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 130.658 3.583 . . . . 0.0 118.107 -173.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -91.73 163.82 13.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.923 1.238 . . . . 0.0 108.877 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 t -125.02 129.13 49.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.828 1.651 . . . . 0.0 109.006 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -106.48 -16.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.68 178.66 23.96 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.73 -89.54 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 125.206 1.384 . . . . 0.0 110.391 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.45 -62.15 1.05 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 111.642 -169.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.2 t -65.53 -36.79 84.85 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.108 0.867 . . . . 0.0 110.183 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.47 -55.61 29.25 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.53 HD13 HG21 ' A' ' 73' ' ' VAL . 48.5 tp -49.07 -45.49 43.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.995 1.318 . . . . 0.0 111.689 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -46.74 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 116.628 -1.653 . . . . 0.0 109.789 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -49.08 75.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.64 -33.11 69.7 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.489 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -71.4 -51.57 23.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 121.148 1.794 . . . . 0.0 109.784 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -47.73 60.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.015 1.326 . . . . 0.0 110.045 -166.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.98 -34.08 74.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.424 1.89 . . . . 0.0 110.436 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 19.65 57.78 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-O 118.156 -1.358 . . . . 0.0 112.043 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.54 -42.51 83.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.732 2.266 . . . . 0.0 110.381 170.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -35.27 63.55 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.23 1.812 . . . . 0.0 110.473 -174.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.31 -52.58 64.1 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.681 0.793 . . . . 0.0 111.945 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.1 m -65.71 -41.53 92.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.449 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -44.72 73.14 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.771 0.828 . . . . 0.0 110.167 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.93 -44.44 89.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.974 1.31 . . . . 0.0 112.752 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 105' ' ' LEU . 68.0 mttt -63.18 -27.08 69.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.696 1.135 . . . . 0.0 112.434 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -56.03 -15.89 4.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 112.878 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.59 12.3 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.141 1.337 . . . . 0.0 112.351 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.74 36.14 58.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.174 -0.954 . . . . 0.0 113.005 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.72 -66.05 0.96 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.253 1.421 . . . . 0.0 112.757 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . 17.1 mt -75.27 133.57 41.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 121.352 1.887 . . . . 0.0 107.572 -167.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.771 1.229 . . . . 0.0 109.315 -167.269 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.4 t80 . . . . . 0 C--O 1.225 -0.201 0 CA-C-O 119.643 -0.218 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 57' ' ' ILE . 8.9 t -68.99 -59.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.51 -49.41 74.83 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 t -76.76 -26.44 54.54 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.79 0.836 . . . . 0.0 112.367 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -66.47 -39.18 88.64 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.322 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -75.81 132.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.18 155.49 71.07 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.83 26.08 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 125.302 4.001 . . . . 0.0 115.054 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.23 21.16 0.11 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.603 1.573 . . . . 0.0 113.169 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -120.79 168.24 11.65 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.84 120.55 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.07 135.1 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.73 118.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -82.19 124.53 29.99 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.51 177.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.384 1.474 . . . . 0.0 111.257 -166.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 158.98 64.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.009 1.724 . . . . 0.0 107.289 169.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.88 2.09 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.264 2.643 . . . . 0.0 114.592 -163.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -133.04 -25.3 1.82 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -158.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 156.41 77.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.32 1.448 . . . . 0.0 114.12 -158.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.27 -29.5 21.34 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.431 2.087 . . . . 0.0 110.666 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -73.92 -46.74 42.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.7 m -70.09 -44.23 69.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -48.56 -46.71 39.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.217 -0.927 . . . . 0.0 111.969 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -60.4 -60.54 3.64 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.891 0.769 . . . . 0.0 109.572 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.69 69.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 124.244 0.965 . . . . 0.0 111.968 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -60.88 -47.54 85.93 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 117.827 -1.082 . . . . 0.0 111.503 177.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.77 -53.55 31.9 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 119.08 0.855 . . . . 0.0 109.9 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.04 -49.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.442 1.497 . . . . 0.0 109.763 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.27 -51.96 13.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -66.33 -23.44 66.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -73.84 -23.61 59.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.248 0.931 . . . . 0.0 110.044 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.98 138.15 69.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.1 65.79 8.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.303 2.668 . . . . 0.0 111.663 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.02 150.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -55.82 123.97 16.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.502 1.121 . . . . 0.0 109.516 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -65.29 151.31 46.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.322 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.61 -18.83 10.28 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.671 -1.627 . . . . 0.0 112.255 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -46.14 47.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 120.649 2.224 . . . . 0.0 109.803 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 116.08 22.69 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.044 0.84 . . . . 0.0 109.866 -169.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -124.48 150.67 45.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.987 1.315 . . . . 0.0 108.949 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 7.6 m-85 -124.24 130.31 52.31 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.54 101.39 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.801 1.64 . . . . 0.0 107.82 -160.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -64.16 119.67 10.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 pt -89.77 -8.22 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.072 0.949 . . . . 0.0 113.196 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 124.556 1.142 . . . . 0.0 110.964 -175.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.738 0.78 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -62.46 1.56 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 125.377 1.471 . . . . 0.0 107.376 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -47.8 -45.42 29.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.494 1.118 . . . . 0.0 112.537 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.261 9.9 tm-20 -63.87 -44.47 93.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.751 2.02 . . . . 0.0 112.668 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.475 HG23 HG21 ' A' ' 6' ' ' VAL . 11.7 mt -62.99 -37.75 80.18 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 125.243 1.417 . . . . 0.0 110.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.63 -38.56 70.75 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.33 -50.47 72.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.267 1.427 . . . . 0.0 111.057 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.09 -43.31 82.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.429 HD13 ' HG3' ' A' ' 72' ' ' ARG . 23.9 mt -64.15 -34.85 79.01 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -57.89 -46.0 85.56 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -53.73 30.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.63 -29.77 69.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.708 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -121.8 -27.31 4.69 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.34 -33.99 3.97 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.405 1.479 . . . . 0.0 110.867 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.74 43.59 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.729 1.264 . . . . 0.0 112.077 -172.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.49 -5.89 28.52 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.299 1.039 . . . . 0.0 113.175 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.6 p -68.1 133.78 49.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.99 154.56 37.27 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 132.23 14.57 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.169 1.096 . . . . 0.0 111.716 -9.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 61' ' ' LEU . 3.5 mmp_? -93.03 111.1 22.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.37 126.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -111.23 136.76 49.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 159.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.62 115.51 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 102.501 -3.148 . . . . 0.0 102.501 171.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.46 72.35 0.43 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.661 1.601 . . . . 0.0 114.183 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' A' ' 10' ' ' ILE . 2.6 mmtp 46.58 9.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.002 2.521 . . . . 0.0 116.12 -171.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -114.58 113.21 24.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.994 1.27 . . . . 0.0 108.848 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.94 123.93 21.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.71 -26.04 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 118.714 0.688 . . . . 0.0 109.707 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.38 -161.35 24.67 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.328 0.966 . . . . 0.0 111.133 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.42 -161.47 31.42 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.455 1.026 . . . . 0.0 111.444 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -33.59 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.326 1.063 . . . . 0.0 110.119 -165.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 t -71.42 -36.59 71.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.63 -53.8 30.22 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.3 tp -51.72 -46.42 63.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.313 1.445 . . . . 0.0 112.132 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.39 -44.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 117.357 -1.306 . . . . 0.0 108.892 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -50.02 63.9 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.45 -38.88 72.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.13 -57.32 6.99 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.381 1.446 . . . . 0.0 110.505 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -29.7 65.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.49 1.516 . . . . 0.0 112.486 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 t -87.17 -14.5 41.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.434 2.294 . . . . 0.0 110.638 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.3 89.39 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -25.31 67.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.246 2.523 . . . . 0.0 110.77 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.41 -34.32 76.51 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.605 1.962 . . . . 0.0 111.449 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.16 -50.24 66.74 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 m -61.55 -46.49 89.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.188 0.449 . . . . 0.0 109.808 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -47.0 72.26 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.234 0.47 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.44 -53.48 23.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 111.24 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -58.27 -29.19 65.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.655 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -51.34 -42.58 61.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.715 0.689 . . . . 0.0 110.093 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.31 6.05 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.027 0.831 . . . . 0.0 112.354 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.31 38.01 19.41 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.289 0.95 . . . . 0.0 112.821 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.87 -69.47 0.69 Allowed 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.801 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.46 133.84 49.24 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -172.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.253 1.276 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.934 -160.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.07 -58.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.219 1.007 . . . . 0.0 109.549 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -68.41 -17.74 64.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -159.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.3 t -101.97 -26.42 13.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.983 1.313 . . . . 0.0 110.31 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -64.14 -45.75 87.11 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.659 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.2 143.75 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.682 1.128 . . . . 0.0 108.076 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.7 140.36 35.15 Favored Pre-proline 0 C--O 1.238 0.454 0 CA-C-N 119.296 0.953 . . . . 0.0 109.716 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.86 89.94 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.24 2.627 . . . . 0.0 108.714 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.53 17.04 2.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.896 1.712 . . . . 0.0 113.882 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -128.6 162.23 27.77 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.875 2.07 . . . . 0.0 109.636 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.2 t -112.29 81.45 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.43 134.93 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 t -134.3 111.71 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -78.46 128.36 33.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 pt -138.53 179.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.3 1.84 . . . . 0.0 109.24 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -144.79 147.6 36.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 158.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.34 -14.97 38.33 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.579 2.186 . . . . 0.0 113.042 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p -77.16 -28.82 54.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.333 0.97 . . . . 0.0 111.672 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -74.8 121.52 85.44 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.583 0.629 . . . . 0.0 110.382 -164.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.74 -15.62 33.43 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.012 1.808 . . . . 0.0 111.823 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.98 -33.55 24.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.772 1.169 . . . . 0.0 109.341 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.2 m -62.63 -41.52 99.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -53.49 -42.76 67.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.474 0.579 . . . . 0.0 112.29 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -55.82 23.19 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.02 -36.08 62.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.307 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.92 83.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.777 169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.81 -46.58 65.38 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 120.543 1.519 . . . . 0.0 109.414 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -52.09 -58.34 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 126.504 1.921 . . . . 0.0 107.7 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.47 -33.34 58.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.598 -170.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 m -67.33 -35.13 78.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 0.0 112.138 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.98 -9.43 58.63 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.904 1.229 . . . . 0.0 112.079 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.57 135.52 43.41 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.058 1.299 . . . . 0.0 109.392 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.12 75.96 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.515 3.477 . . . . 0.0 110.481 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.494 HD11 HD13 ' A' ' 99' ' ' LEU . 8.1 mt -102.93 151.3 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -169.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -48.25 130.53 16.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.383 1.073 . . . . 0.0 110.485 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.1 140.27 56.01 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.66 -7.81 57.18 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.814 -1.548 . . . . 0.0 113.733 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.57 -37.19 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 121.066 2.433 . . . . 0.0 110.966 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 103.29 13.26 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.26 103.68 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.377 1.071 . . . . 0.0 108.58 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -84.09 117.49 23.48 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.67 109.2 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.995 2.118 . . . . 0.0 108.834 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -64.02 104.95 0.78 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.494 2.318 . . . . 0.0 114.015 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.67 -22.38 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.757 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.262 3.0 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 117.877 -1.058 . . . . 0.0 111.135 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 1.1 m-70 . . . . . 0 C--O 1.232 0.144 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -63.51 1.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.462 1.105 . . . . 0.0 108.914 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 58' ' ' GLN . 7.1 t30 -61.46 -29.96 70.29 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . 3.6 tm-20 -64.24 -46.57 83.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.484 1.114 . . . . 0.0 110.985 171.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -59.26 -38.57 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 55' ' ' ASN . 6.9 mm-40 -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -169.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -49.21 -55.31 12.94 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.211 1.404 . . . . 0.0 110.548 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -56.84 -45.12 82.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.169 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.06 -44.83 96.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.889 1.222 . . . . 0.0 111.032 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.8 -34.75 69.97 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 123.151 0.282 . . . . 0.0 111.034 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -76.29 -48.23 20.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.935 0.494 . . . . 0.0 111.567 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.28 -47.01 63.17 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.941 1.296 . . . . 0.0 108.5 -158.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 p -102.63 -44.9 5.19 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.34 -13.35 4.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.667 1.127 . . . . 0.0 113.001 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.78 160.28 41.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.486 1.643 . . . . 0.0 108.875 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -118.65 -24.16 6.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 117.394 -1.289 . . . . 0.0 114.221 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 p -64.16 133.24 52.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 160.73 56.16 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.783 1.233 . . . . 0.0 108.497 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.16 159.99 61.4 Favored 'Cis proline' 0 C--N 1.344 0.323 0 CA-C-N 120.314 1.148 . . . . 0.0 110.591 -4.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -123.27 101.2 7.24 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.07 126.56 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -114.25 97.86 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -83.79 123.12 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 168.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 42.6 68.79 0.69 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.924 1.25 . . . . 0.0 113.23 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.22 -2.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.813 2.845 . . . . 0.0 118.645 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.4 115.74 28.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.094 1.316 . . . . 0.0 107.87 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -63.74 117.26 6.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.32 -16.89 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.19 -146.79 17.88 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.26 -153.43 18.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.934 0.741 . . . . 0.0 111.783 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.2 p -65.64 -38.47 89.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.044 0.938 . . . . 0.0 110.653 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -75.92 -31.39 59.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.662 0.601 . . . . 0.0 111.62 -176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.05 -52.5 41.54 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 23.0 tp -57.01 -34.36 68.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.451 0.7 . . . . 0.0 111.351 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.65 -48.44 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 115.419 -2.229 . . . . 0.0 109.723 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -55.1 37.64 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.441 1.928 . . . . 0.0 107.256 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.54 -35.86 72.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.689 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -68.47 -47.77 66.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.335 1.425 . . . . 0.0 110.51 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -63.8 1.15 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.999 2.52 . . . . 0.0 109.818 -168.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -79.22 -12.54 59.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 119.253 -0.404 . . . . 0.0 110.523 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.7 18.81 53.92 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-O 117.228 -1.873 . . . . 0.0 113.282 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.52 -23.02 67.13 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 121.099 2.449 . . . . 0.0 111.049 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.44 -38.86 63.94 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.294 1.438 . . . . 0.0 111.09 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.57 -48.38 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.161 0.984 . . . . 0.0 109.182 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.2 m -66.69 -44.66 81.15 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.976 1.31 . . . . 0.0 110.658 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -47.76 64.33 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.6 0.76 . . . . 0.0 109.392 174.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 38' ' ' ILE . 23.4 mt -69.83 -50.67 40.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.126 0.57 . . . . 0.0 111.438 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -57.95 -29.94 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.362 -0.836 . . . . 0.0 112.627 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -47.96 -40.52 22.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.361 1.064 . . . . 0.0 111.601 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.4 8.17 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.646 0.657 . . . . 0.0 112.764 -168.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.4 50.81 5.54 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.694 0.679 . . . . 0.0 111.671 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.86 -74.17 0.65 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 126.508 1.923 . . . . 0.0 112.507 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.74 150.95 43.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.599 1.999 . . . . 0.0 106.93 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.964 -172.294 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.574 0.702 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.26 -48.67 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.726 -0.609 . . . . 0.0 110.033 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -70.95 -32.03 68.8 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.161 -0.962 . . . . 0.0 113.199 -167.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -18.12 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.973 -1.08 . . . . 0.0 110.818 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 44' ' ' GLU . 32.1 mmtm -76.46 -59.87 2.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.479 172.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.05 144.81 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.623 1.101 . . . . 0.0 108.928 -172.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -138.27 157.04 73.35 Favored Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 126.982 2.113 . . . . 0.0 106.559 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.26 66.76 7.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.518 2.812 . . . . 0.0 110.7 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.86 40.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.109 1.814 . . . . 0.0 111.21 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -143.49 168.99 18.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.22 1.808 . . . . 0.0 107.128 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 75' ' ' ILE . 25.3 t -114.7 95.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 165.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.68 144.66 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 t -132.22 117.59 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -77.16 120.79 22.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.29 -178.15 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.745 2.418 . . . . 0.0 109.664 -172.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 11.8 ptpt -136.27 164.48 42.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 126.496 1.918 . . . . 0.0 107.673 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 82.3 Cg_endo -76.74 -1.97 12.14 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.452 2.101 . . . . 0.0 112.773 -165.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -118.67 -99.99 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.794 1.637 . . . . 0.0 107.426 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 t 32.48 100.94 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.599 2.76 . . . . 0.0 114.995 169.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.56 -10.0 26.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.247 1.298 . . . . 0.0 111.637 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.85 -35.1 15.85 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.727 -1.233 . . . . 0.0 108.169 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.7 -55.18 33.08 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -57.58 -41.4 81.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.845 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -56.89 -61.41 2.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 118.865 0.757 . . . . 0.0 109.69 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.13 -33.54 27.03 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.049 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.18 -55.52 33.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.56 1.544 . . . . 0.0 111.968 171.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.43 -38.58 77.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.078 1.763 . . . . 0.0 110.243 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.41 -50.33 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.291 1.436 . . . . 0.0 108.971 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.86 -53.0 9.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -63.21 -24.55 67.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.397 0.679 . . . . 0.0 112.098 -166.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -74.01 0.85 12.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.055 0.843 . . . . 0.0 112.392 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 120.796 -1.19 . . . . 0.0 109.207 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.35 57.24 6.16 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.159 3.24 . . . . 0.0 111.383 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 99' ' ' LEU . 9.2 mt -74.52 151.2 7.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -175.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -53.92 123.93 13.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.06 133.33 50.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -171.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -14.33 63.9 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.571 -1.127 . . . . 0.0 113.005 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.16 -39.5 63.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.706 1.753 . . . . 0.0 110.754 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 104.18 14.14 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -168.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' OE2' ' HE3' ' A' ' 9' ' ' LYS . 42.5 tt0 -122.35 113.9 20.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 22.1 m-85 -83.84 133.28 34.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -125.03 100.2 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.369 1.468 . . . . 0.0 107.052 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -64.65 112.86 3.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.708 1.203 . . . . 0.0 111.131 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.7 pt -68.04 -9.39 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.113 -0.992 . . . . 0.0 112.689 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 CA--C 1.54 0.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.623 172.731 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.86 -63.0 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.674 1.99 . . . . 0.0 110.237 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.62 -22.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.629 1.572 . . . . 0.0 114.81 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.74 -30.71 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.155 1.343 . . . . 0.0 111.522 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mt -69.76 -33.68 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.896 1.279 . . . . 0.0 108.299 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -52.27 54.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -52.48 -54.96 25.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.199 1.8 . . . . 0.0 110.424 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -51.55 -46.0 63.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.608 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.97 -35.46 81.25 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.617 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.53 -54.91 28.79 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.973 1.26 . . . . 0.0 109.412 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -36.76 76.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.137 0.975 . . . . 0.0 110.393 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -76.34 -52.48 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 0.0 109.161 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -97.49 -75.89 0.53 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -168.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.06 -13.93 0.06 OUTLIER Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.022 1.296 . . . . 0.0 114.005 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.68 146.47 41.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.091 1.945 . . . . 0.0 108.97 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -29.43 45.8 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.861 171.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -62.41 133.29 54.83 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -159.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.03 153.91 52.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.32 156.85 80.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.24 0.764 . . . . 0.0 111.684 -7.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.48 106.69 10.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.2 129.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -118.53 93.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.912 2.485 . . . . 0.0 107.479 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.91 118.15 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 40.13 67.97 0.61 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.492 1.996 . . . . 0.0 114.489 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.61 24.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.89 97.75 5.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -67.84 118.1 10.62 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.806 -1.184 . . . . 0.0 108.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 89' ' ' LEU . 1.1 pp -83.76 -21.58 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -167.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -168.77 24.34 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -170.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.14 -85.62 1.79 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 -64.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.813 1.245 . . . . 0.0 108.157 -170.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m -58.77 -39.41 80.94 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.533 0.733 . . . . 0.0 111.721 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.83 -56.73 18.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.0 -39.35 74.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.099 1.36 . . . . 0.0 110.856 -168.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.8 t -64.85 -40.87 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 117.256 -1.354 . . . . 0.0 111.119 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -50.91 69.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 80' ' ' ILE . 4.0 mp -56.06 -37.65 69.58 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 117.743 -1.122 . . . . 0.0 109.613 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -63.64 -57.58 9.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.453 1.479 . . . . 0.0 109.613 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -42.9 83.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.299 1.44 . . . . 0.0 111.57 -166.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.1 t -65.06 -51.99 58.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.593 1.957 . . . . 0.0 107.845 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.73 1.77 27.3 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.259 -1.301 . . . . 0.0 111.475 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.7 -22.66 66.67 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.936 1.868 . . . . 0.0 110.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -54.51 -46.45 73.5 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 110.348 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.68 -51.14 68.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.478 0.711 . . . . 0.0 109.234 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -53.73 -45.62 70.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.009 0.924 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -56.23 21.36 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 110.678 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -75.22 -30.72 60.65 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.944 -1.097 . . . . 0.0 112.15 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.19 -30.15 66.21 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.396 -1.44 . . . . 0.0 112.474 169.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -60.17 -8.8 2.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.157 1.383 . . . . 0.0 113.773 171.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.16 8.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.437 1.895 . . . . 0.0 110.866 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.51 36.86 89.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.968 1.27 . . . . 0.0 112.951 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.45 -62.32 1.48 Allowed 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.71 1.204 . . . . 0.0 110.742 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -72.28 142.62 48.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.464 -161.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.319 -0.741 0 C-N-CA 127.994 2.518 . . . . 0.0 107.5 -178.199 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.7 t80 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.79 -69.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.458 1.503 . . . . 0.0 110.687 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -65.79 -43.56 88.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.1 0.863 . . . . 0.0 111.834 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.1 t -72.83 -18.19 61.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.814 0.445 . . . . 0.0 111.009 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -71.2 -46.86 60.35 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.615 -1.184 . . . . 0.0 112.109 171.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.5 144.21 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 120.245 1.384 . . . . 0.0 108.526 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.74 168.18 14.62 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 125.372 1.469 . . . . 0.0 107.416 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.3 157.55 30.19 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.295 1.141 . . . . 0.0 109.399 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.63 79.55 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.575 -1.125 . . . . 0.0 115.372 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -132.39 158.58 41.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.656 1.728 . . . . 0.0 107.905 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 43' ' ' LEU . 21.2 t -107.05 123.3 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.06 136.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.12 114.58 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -77.68 122.66 25.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -133.71 166.91 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.056 1.342 . . . . 0.0 109.758 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -132.33 125.18 19.66 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 158.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.4 -15.32 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.66 1.573 . . . . 0.0 111.414 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -83.0 -0.17 47.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.914 2.086 . . . . 0.0 113.356 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.13 132.49 21.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.159 1.345 . . . . 0.0 108.23 161.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.91 -17.72 56.2 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.479 2.786 . . . . 0.0 110.952 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -74.04 -38.21 64.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.95 -44.51 96.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 117.72 -1.134 . . . . 0.0 109.027 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -53.43 -50.35 65.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.606 1.094 . . . . 0.0 111.783 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -54.45 -59.21 4.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 119.202 -0.427 . . . . 0.0 110.187 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.06 60.84 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.604 1.19 . . . . 0.0 111.231 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.67 80.62 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 117.855 -1.069 . . . . 0.0 111.206 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -41.33 69.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 120.557 1.526 . . . . 0.0 109.336 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.17 -54.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.429 1.892 . . . . 0.0 109.263 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.43 -42.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -171.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 t -65.91 -25.11 67.0 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.247 0.476 . . . . 0.0 111.131 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.69 -22.72 59.84 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.355 0.98 . . . . 0.0 112.407 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.95 154.47 92.58 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 119.329 0.968 . . . . 0.0 109.496 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.57 77.93 3.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.853 2.369 . . . . 0.0 109.876 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mt -102.43 153.46 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -51.97 124.27 12.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.033 0.933 . . . . 0.0 109.083 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.61 137.83 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.77 -14.07 64.13 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.841 -1.533 . . . . 0.0 112.247 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mt -73.81 -36.8 65.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.802 2.301 . . . . 0.0 111.78 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.04 118.02 23.79 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -170.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -122.04 123.6 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.627 1.171 . . . . 0.0 109.193 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.53 127.26 45.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.96 105.09 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.935 1.294 . . . . 0.0 108.735 -165.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.35 100.76 3.26 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.576 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.488 HG22 HG21 ' A' ' 57' ' ' ILE . 8.9 pt -63.94 -14.46 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 113.18 175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.871 1.268 . . . . 0.0 111.666 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 CA--C 1.513 -0.452 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -63.47 1.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.275 1.43 . . . . 0.0 108.323 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.47 -30.64 60.95 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.61 -52.31 61.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.839 1.199 . . . . 0.0 110.747 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 48' ' ' ILE . 6.4 mt -64.03 -39.24 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -57.2 -50.07 74.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.406 2.282 . . . . 0.0 107.459 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.27 -42.32 93.34 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 110.518 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -58.41 -47.42 83.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.9 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.19 -36.78 84.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.792 0.724 . . . . 0.0 110.581 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.83 -51.04 70.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.538 0.735 . . . . 0.0 109.945 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.91 -49.93 72.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.003 0.521 . . . . 0.0 109.851 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.49 -40.58 66.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.116 0.966 . . . . 0.0 109.373 -166.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 p -108.38 -15.37 14.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.255 0.934 . . . . 0.0 113.356 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.19 6.78 64.5 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.625 -1.097 . . . . 0.0 112.158 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.52 22.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.236 1.518 . . . . 0.0 109.265 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -94.67 -8.89 36.56 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.92 133.82 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.685 1.129 . . . . 0.0 110.66 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.11 161.11 29.27 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 160.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.24 141.79 37.46 Favored 'Cis proline' 0 N--CA 1.463 -0.275 0 N-CA-C 110.158 -0.747 . . . . 0.0 110.158 -13.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.94 93.1 4.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.85 130.79 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.86 109.02 18.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.378 1.871 . . . . 0.0 106.927 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.5 108.66 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 163.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 67.48 1.91 Allowed Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.264 1.411 . . . . 0.0 112.849 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.0 mttt 46.06 20.39 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.166 1.787 . . . . 0.0 115.393 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.29 110.91 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 164.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -67.26 107.99 2.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.5 pp -83.48 -14.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.485 0.584 . . . . 0.0 111.456 -170.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.47 -171.35 22.94 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 124.478 1.037 . . . . 0.0 111.355 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.81 -160.23 31.82 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.896 1.713 . . . . 0.0 110.251 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -37.78 86.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.026 0.913 . . . . 0.0 110.334 -170.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.6 m -67.36 -48.32 67.79 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.987 -172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 -51.94 67.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.7 tp -54.28 -37.33 64.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.074 -0.965 . . . . 0.0 112.231 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -60.85 -53.41 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 116.777 -1.582 . . . . 0.0 108.982 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.22 87.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 121.848 2.113 . . . . 0.0 108.692 -174.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.3 -32.03 71.88 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.745 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.34 -55.11 8.66 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 121.055 1.752 . . . . 0.0 111.087 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -51.91 34.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.635 2.374 . . . . 0.0 110.631 -168.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 t -70.34 -24.59 63.01 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.945 1.298 . . . . 0.0 109.977 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 11.06 65.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.166 173.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.55 -25.93 68.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.36 2.08 . . . . 0.0 111.726 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.73 -32.23 69.02 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.536 1.134 . . . . 0.0 111.513 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.09 -46.52 61.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.65 0.659 . . . . 0.0 109.656 -168.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.9 m -64.45 -40.49 95.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -40.97 85.37 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.54 -0.725 . . . . 0.0 111.687 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.75 -46.09 84.96 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.713 1.205 . . . . 0.0 110.503 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -62.12 -31.02 71.44 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.958 -1.089 . . . . 0.0 112.331 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -63.64 -10.99 21.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.92 11.75 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 119.474 1.034 . . . . 0.0 111.854 170.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.12 26.09 62.69 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.341 0.972 . . . . 0.0 112.887 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.616 1.166 . . . . 0.0 111.487 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.7 mt -77.55 134.32 38.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.802 -1.559 . . . . 0.0 110.944 -158.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 . . . . . 0 N--CA 1.428 -1.526 0 C-N-CA 130.134 3.374 . . . . 0.0 106.161 -179.273 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 . . . . . 0 N--CA 1.461 0.104 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.09 -58.93 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -55.32 -37.39 67.36 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.19 0.996 . . . . 0.0 113.573 -161.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.0 m -101.91 -8.87 21.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.971 0.908 . . . . 0.0 112.815 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.87 -45.26 90.24 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.966 1.257 . . . . 0.0 107.7 159.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.44 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 mt -63.75 155.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 152.52 47.48 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.61 125.22 14.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 N-CA-C 104.763 -2.822 . . . . 0.0 104.763 158.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.49 35.58 25.63 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.737 0.684 . . . . 0.0 113.302 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -142.31 161.31 38.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.099 2.159 . . . . 0.0 109.341 166.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 75' ' ' ILE . 38.3 t -118.33 109.25 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 10' ' ' ILE . 61.6 t -127.56 132.25 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 120.555 -1.341 . . . . 0.0 108.289 -166.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.23 111.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -166.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -79.29 119.26 22.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.86 169.5 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.989 1.716 . . . . 0.0 109.921 -174.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -127.29 141.28 40.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 162.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.06 28.77 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.6 3.533 . . . . 0.0 111.315 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.323 9.6 t -147.23 29.48 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.813 2.045 . . . . 0.0 108.929 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.63 123.84 26.87 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.035 1.734 . . . . 0.0 108.595 167.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.98 -24.92 52.4 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.486 1.457 . . . . 0.0 111.984 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -78.98 -28.72 43.54 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.953 0.797 . . . . 0.0 109.353 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.2 m -66.11 -46.9 75.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -51.92 -48.15 64.33 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.166 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -55.5 -57.87 10.13 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 119.014 0.825 . . . . 0.0 109.938 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.42 62.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.328 1.018 . . . . 0.0 111.472 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -45.69 78.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.388 0.994 . . . . 0.0 113.295 172.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.66 -53.21 16.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt -44.34 -53.22 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.39 1.876 . . . . 0.0 110.442 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.64 -46.47 19.13 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.186 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -6.51 59.26 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.367 0.985 . . . . 0.0 112.608 -167.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -73.83 -16.16 61.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.66 1.118 . . . . 0.0 110.992 167.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -78.0 151.29 78.89 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 120.885 -1.134 . . . . 0.0 108.748 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 42.23 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.303 2.669 . . . . 0.0 111.295 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.1 145.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -58.38 123.06 14.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.27 146.66 54.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.78 10.22 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.589 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.49 -30.5 63.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.883 1.842 . . . . 0.0 109.68 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 119.72 25.18 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 120.515 1.507 . . . . 0.0 107.684 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -128.72 110.41 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.688 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -84.19 103.74 13.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -90.82 114.96 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 126.519 1.927 . . . . 0.0 107.231 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.57 110.58 3.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.591 1.156 . . . . 0.0 110.942 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.6 pt -70.45 -2.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.369 1.068 . . . . 0.0 113.006 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.261 3.3 t . . . . . 0 N--CA 1.443 -0.824 0 CA-C-N 118.775 0.716 . . . . 0.0 110.41 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -63.66 0.86 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.581 1.152 . . . . 0.0 111.817 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -46.63 -54.68 9.02 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.901 0.75 . . . . 0.0 111.15 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -41.66 93.63 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.554 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.4 -39.99 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.03 -41.45 74.25 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -42.05 35.9 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.49 1.916 . . . . 0.0 111.423 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.5 -50.99 66.49 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.753 1.221 . . . . 0.0 110.338 171.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.42 -30.71 65.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.789 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' NE2' HH21 ' A' ' 68' ' ' ARG . 22.7 tt0 -66.56 -37.79 85.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.627 1.558 . . . . 0.0 111.695 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -67.66 -47.54 69.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.53 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.27 -24.33 57.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.211 -168.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 p -133.51 -2.85 3.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.283 1.401 . . . . 0.0 114.101 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.13 -10.23 61.42 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 120.061 1.301 . . . . 0.0 112.857 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.62 137.33 54.48 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.126 -1.22 . . . . 0.0 110.587 -172.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.503 HH21 ' NE2' ' A' ' 62' ' ' GLN . 5.1 ptp85 -102.02 -31.31 10.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.475 174.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 133.33 41.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.285 0.564 . . . . 0.0 109.716 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.27 159.49 39.27 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.369 1.467 . . . . 0.0 108.458 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.54 167.77 22.72 Favored 'Cis proline' 0 C--N 1.347 0.457 0 CA-C-N 120.379 1.171 . . . . 0.0 111.881 -8.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 110.15 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.062 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.9 t -91.98 125.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 119.426 1.012 . . . . 0.0 108.761 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -102.21 114.68 29.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 158.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.41 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -93.18 123.68 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 160.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 43.78 72.43 0.33 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.301 1.429 . . . . 0.0 113.811 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 46.65 14.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.17 120.22 36.44 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.471 1.487 . . . . 0.0 110.658 170.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.71 114.66 4.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.706 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.8 pp -83.52 -12.68 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 119.236 0.925 . . . . 0.0 110.845 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.75 -158.17 18.28 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.65 -157.47 31.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 126.767 2.127 . . . . 0.0 111.108 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -38.44 83.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.923 -0.751 . . . . 0.0 110.335 -169.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -68.85 -44.82 72.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.634 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -65.17 -45.56 84.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.6 tp -53.98 -45.42 71.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.5 0.72 . . . . 0.0 112.057 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.89 -39.16 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 117.112 -1.423 . . . . 0.0 109.536 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -54.54 24.92 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -58.52 -33.54 69.96 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.29 -63.67 1.03 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.935 1.698 . . . . 0.0 110.705 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.26 78.3 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.864 1.266 . . . . 0.0 112.163 -166.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -86.39 -2.24 58.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.457 1.503 . . . . 0.0 110.972 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 -0.37 88.86 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 117.107 -1.941 . . . . 0.0 114.671 168.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.38 -31.54 72.73 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 121.285 2.542 . . . . 0.0 111.168 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.27 -35.65 70.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.987 1.315 . . . . 0.0 110.763 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.19 -44.09 76.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -61.25 -54.14 47.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -40.34 63.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.519 1.128 . . . . 0.0 111.07 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.1 mt -70.11 -57.56 4.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.78 1.632 . . . . 0.0 112.448 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 105' ' ' LEU . 4.5 tttm -65.88 -26.81 67.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.709 1.595 . . . . 0.0 111.913 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -44.95 -36.69 3.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.674 1.59 . . . . 0.0 111.528 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.57 14.3 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.44 1.018 . . . . 0.0 112.552 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.5 40.89 21.85 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.725 0.693 . . . . 0.0 112.286 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.21 -78.21 0.53 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.076 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -60.1 135.0 57.58 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 C--O 1.245 0.831 0 O-C-N 125.499 1.75 . . . . 0.0 108.006 -163.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.9 t80 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.7 -53.12 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.939 0.791 . . . . 0.0 109.937 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.36 -55.71 31.28 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.233 0.924 . . . . 0.0 111.467 -163.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.9 m -82.58 -6.69 59.49 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -65.52 -22.83 66.75 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.915 1.234 . . . . 0.0 110.639 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.8 154.87 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 120.637 1.562 . . . . 0.0 108.561 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -135.65 152.33 75.98 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.79 63.93 8.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.128 3.219 . . . . 0.0 110.976 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.4 31.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.933 1.254 . . . . 0.0 111.781 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -134.44 172.92 12.23 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.142 1.777 . . . . 0.0 107.756 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 21.1 t -116.76 111.51 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.7 t -132.38 115.91 27.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -158.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.69 130.16 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 123.003 0.521 . . . . 0.0 110.305 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.42 125.15 40.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.77 168.5 16.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.854 1.661 . . . . 0.0 110.512 -167.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -125.54 148.42 61.54 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 169.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.28 -39.08 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.701 2.267 . . . . 0.0 110.134 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 p -81.89 48.48 1.23 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.05 2.14 . . . . 0.0 109.966 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -140.67 127.06 11.77 Favored Pre-proline 0 C--O 1.242 0.679 0 C-N-CA 126.516 1.927 . . . . 0.0 109.387 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.56 -19.56 11.39 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.333 2.022 . . . . 0.0 112.038 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -73.59 -35.28 65.39 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 120.428 1.467 . . . . 0.0 108.305 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.27 -40.07 89.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -53.13 -53.95 42.93 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.156 0.434 . . . . 0.0 110.84 171.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -53.19 -59.18 4.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.552 0.741 . . . . 0.0 109.021 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -41.88 72.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 117.515 -1.231 . . . . 0.0 111.481 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -49.64 71.05 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 119.718 1.145 . . . . 0.0 112.162 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.43 -50.05 55.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.205 1.002 . . . . 0.0 110.124 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -46.69 -56.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 127.272 2.229 . . . . 0.0 109.586 170.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.66 -46.76 74.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -65.61 -18.65 65.48 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -73.52 -27.31 61.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.084 1.311 . . . . 0.0 110.397 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.66 135.43 81.13 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -82.25 63.32 8.2 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.089 2.526 . . . . 0.0 112.072 -167.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.57 147.74 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.244 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -46.45 124.54 5.94 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.856 1.662 . . . . 0.0 109.243 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.56 129.51 42.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -3.08 82.71 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 118.083 -1.398 . . . . 0.0 113.279 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.72 -30.99 46.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.813 2.306 . . . . 0.0 112.44 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 116.09 26.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -123.3 133.6 54.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.676 1.19 . . . . 0.0 108.219 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -110.56 139.03 46.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.7 t -135.39 108.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.288 1.035 . . . . 0.0 108.547 -164.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.29 122.76 17.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 111.942 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.427 HG22 HG21 ' A' ' 57' ' ' ILE . 45.2 pt -75.11 -20.47 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.955 1.302 . . . . 0.0 112.449 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 124.472 1.109 . . . . 0.0 110.893 -179.126 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.29 -62.62 1.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.94 -7.41 8.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.096 1.758 . . . . 0.0 113.531 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -36.0 16.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.84 1.655 . . . . 0.0 109.637 161.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 48' ' ' ILE . 11.3 mt -71.36 -50.06 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -167.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.55 76.09 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.009 0.524 . . . . 0.0 110.015 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -55.48 -56.85 15.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.547 1.539 . . . . 0.0 110.946 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -56.84 -29.91 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.84 2.056 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 72' ' ' ARG . 33.9 mt -60.48 -30.42 69.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.015 1.28 . . . . 0.0 111.73 174.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -60.28 -37.04 79.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.945 0.793 . . . . 0.0 109.731 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.16 -49.44 17.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.41 -30.42 57.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.54 -166.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.778 HG21 HH11 ' A' ' 72' ' ' ARG . 34.7 p -120.79 -62.56 1.44 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.904 1.229 . . . . 0.0 110.459 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.19 -34.69 0.2 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.154 -1.359 . . . . 0.0 114.341 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.35 144.88 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.123 1.461 . . . . 0.0 109.739 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -83.54 14.88 3.42 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.618 0.767 . . . . 0.0 112.368 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -105.84 163.76 12.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.578 1.656 . . . . 0.0 110.626 -158.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.99 144.38 46.18 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 127.632 2.373 . . . . 0.0 106.16 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.62 155.33 89.91 Favored 'Cis proline' 0 N--CA 1.454 -0.808 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 -4.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.778 HH11 HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.46 130.24 17.1 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 176.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.17 128.15 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 124.185 0.994 . . . . 0.0 109.559 -163.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -94.23 124.98 38.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.29 113.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 160.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.69 15.27 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.28 -0.887 . . . . 0.0 112.483 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt 46.52 3.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.852 2.461 . . . . 0.0 116.917 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.33 142.02 28.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.171 1.805 . . . . 0.0 107.637 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -101.25 123.5 45.47 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.893 -1.13 . . . . 0.0 112.271 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.62 -23.1 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.359 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.93 -165.22 21.02 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.292 0.949 . . . . 0.0 111.201 -171.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 -163.58 32.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.486 1.517 . . . . 0.0 110.885 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.1 p -65.61 -34.37 78.07 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.409 1.104 . . . . 0.0 110.49 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -62.01 -42.55 99.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.872 0.76 . . . . 0.0 111.113 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.66 -54.52 22.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.2 tp -51.91 -39.24 58.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.92 1.288 . . . . 0.0 111.9 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.6 t -58.56 -59.35 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 117.012 -1.471 . . . . 0.0 108.797 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.2 p -48.65 -54.74 13.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.556 1.98 . . . . 0.0 115.003 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . 6.6 mp -59.75 -32.81 70.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.447 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -72.01 -51.89 19.66 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.893 1.679 . . . . 0.0 110.245 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -58.58 3.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.07 1.748 . . . . 0.0 110.097 -168.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -16.99 64.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.852 1.261 . . . . 0.0 110.895 173.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.64 78.94 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.185 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.49 -22.72 67.05 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.816 2.308 . . . . 0.0 111.68 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 89' ' ' LEU . 5.9 tp -64.8 -24.67 67.62 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.576 174.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.34 -52.32 59.0 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 120.354 1.434 . . . . 0.0 108.632 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.1 m -57.07 -50.88 71.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.727 0.811 . . . . 0.0 109.956 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -47.6 -51.6 20.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.001 0.92 . . . . 0.0 110.712 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.29 -52.06 37.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.175 1.39 . . . . 0.0 111.3 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -62.18 -26.05 68.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.562 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -57.25 -33.1 67.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.072 0.851 . . . . 0.0 112.305 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.1 -14.92 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.905 1.229 . . . . 0.0 112.133 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.04 83.9 0.74 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -166.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.85 -76.41 0.46 Allowed 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.721 -1.609 . . . . 0.0 110.92 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.47 135.29 54.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 121.968 2.167 . . . . 0.0 108.503 -172.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.844 1.34 . . . . 0.0 109.132 -158.364 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.79 -48.92 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -16.32 63.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.37 1.068 . . . . 0.0 112.421 -165.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -103.81 -26.24 12.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.862 1.665 . . . . 0.0 111.751 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -64.05 -43.8 94.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.491 1.042 . . . . 0.0 110.959 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.16 140.9 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.86 157.2 60.75 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.46 16.86 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.023 3.149 . . . . 0.0 114.828 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.57 45.32 0.2 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.8 2.143 . . . . 0.0 110.795 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -141.23 164.08 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.594 HG13 HD12 ' A' ' 75' ' ' ILE . 36.2 t -101.61 100.61 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.96 125.56 61.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 t -126.15 109.08 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -76.47 132.08 39.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -138.65 164.29 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.012 2.125 . . . . 0.0 108.874 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 145.87 34.02 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 158.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.53 16.11 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.923 3.082 . . . . 0.0 114.085 -161.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -129.4 -22.02 3.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.397 1.479 . . . . 0.0 112.665 -160.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -94.74 148.69 35.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -157.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.17 -25.19 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.874 2.382 . . . . 0.0 111.787 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -73.81 -43.39 58.96 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.12 1.768 . . . . 0.0 107.514 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -54.27 -47.12 72.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.476 1.111 . . . . 0.0 111.872 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -59.62 4.55 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.88 -36.69 65.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.356 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -54.91 -57.83 10.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.631 1.173 . . . . 0.0 112.554 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -70.68 -35.65 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.371 0.605 . . . . 0.0 110.815 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.63 -49.83 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.476 1.51 . . . . 0.0 109.796 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.31 -49.17 15.57 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.9 p -67.51 -25.96 66.1 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -162.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -80.83 -9.14 59.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 111.994 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.04 134.84 77.35 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 168.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.09 104.18 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.581 2.187 . . . . 0.0 108.784 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -122.71 151.7 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -57.87 124.27 18.64 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.71 136.51 56.37 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.95 84.6 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.18 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.51 -39.59 31.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.53 2.165 . . . . 0.0 111.675 166.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.7 93.48 8.04 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.035 0.834 . . . . 0.0 110.28 -159.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -110.63 116.05 30.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -84.73 119.18 24.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -113.63 131.42 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 127.591 2.356 . . . . 0.0 107.784 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.66 137.8 34.35 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.955 0.502 . . . . 0.0 110.279 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.8 pt -99.41 5.11 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 123.39 0.676 . . . . 0.0 112.248 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.33 -0.264 0 O-C-N 120.155 -1.59 . . . . 0.0 111.517 -174.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -33.93 -63.82 0.25 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 130.149 3.38 . . . . 0.0 110.059 166.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -49.36 -46.4 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.914 0.759 . . . . 0.0 111.606 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -49.97 59.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 110.973 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 mt -54.63 -43.41 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.706 1.602 . . . . 0.0 110.471 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -71.98 -45.85 59.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -170.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -48.55 76.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 109.888 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.33 -44.99 86.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.672 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.0 -42.61 76.67 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.261 1.024 . . . . 0.0 109.89 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -56.4 21.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.491 174.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.07 -51.23 68.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 123.556 0.535 . . . . 0.0 109.993 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.89 -45.26 95.3 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.306 1.442 . . . . 0.0 109.457 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 p -101.1 -65.19 0.99 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.552 0.614 . . . . 0.0 110.781 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.38 -4.48 2.55 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.638 2.066 . . . . 0.0 111.635 -172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.73 157.92 43.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.269 1.535 . . . . 0.0 109.141 169.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -118.77 -29.12 5.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.123 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 p -61.61 133.22 55.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -161.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.08 58.19 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.46 170.45 42.38 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 CA-C-N 118.649 0.553 . . . . 0.0 111.149 -7.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -130.12 100.33 5.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.15 129.26 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.11 104.87 12.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.768 2.027 . . . . 0.0 106.915 168.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.92 103.06 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 169.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.97 64.77 3.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.882 1.23 . . . . 0.0 113.014 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.72 13.09 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 127.7 2.4 . . . . 0.0 117.219 -168.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -100.69 103.55 14.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 120.454 1.479 . . . . 0.0 107.341 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.6 t -68.85 117.22 10.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.63 -25.8 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.563 0.745 . . . . 0.0 110.631 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.25 -171.29 23.75 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 123.462 0.553 . . . . 0.0 112.023 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.61 -169.01 41.41 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 125.409 1.481 . . . . 0.0 111.463 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 p -63.43 -38.01 89.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.871 0.835 . . . . 0.0 110.507 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.235 0.47 . . . . 0.0 111.804 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.64 -49.51 21.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -52.68 -34.66 53.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.059 1.744 . . . . 0.0 112.605 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.64 -50.84 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.164 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -44.99 92.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.606 1.548 . . . . 0.0 107.691 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.79 -31.65 71.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.04 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -69.18 -61.34 1.83 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.25 1.386 . . . . 0.0 109.085 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -50.7 66.47 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.872 2.069 . . . . 0.0 111.658 -166.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -3.71 32.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.27 1.828 . . . . 0.0 111.778 172.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.97 -0.72 82.19 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.038 -1.424 . . . . 0.0 115.113 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.24 -33.87 72.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.153 1.976 . . . . 0.0 111.442 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.3 tp -60.3 -33.22 72.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.689 0.796 . . . . 0.0 111.125 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.63 -40.03 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -72.48 -48.05 43.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -40.24 58.57 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.945 0.793 . . . . 0.0 111.815 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.76 -56.59 9.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 110.567 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -59.38 -24.31 63.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.829 1.195 . . . . 0.0 112.873 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -48.66 -41.69 32.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.681 1.193 . . . . 0.0 110.705 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.98 -1.63 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.26 59.97 1.79 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.28 -73.04 0.66 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.416 1.486 . . . . 0.0 112.412 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 2.8 mt -62.57 135.4 57.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.28 -153.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.5 t80 . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.59 -60.25 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 109.017 169.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -70.0 -11.86 61.18 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -159.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -106.55 -15.48 14.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.148 0.979 . . . . 0.0 112.931 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -63.93 -57.56 9.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.22 1.373 . . . . 0.0 107.517 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.6 150.48 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -144.34 172.4 5.52 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.189 1.795 . . . . 0.0 106.28 161.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.05 17.18 0.87 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.178 2.585 . . . . 0.0 114.912 -163.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.3 12.07 1.2 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.655 2.55 . . . . 0.0 112.16 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.06 148.67 29.46 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.849 1.824 . . . . 0.0 108.585 170.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 t -102.54 86.62 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.84 147.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 O-C-N 120.829 -1.169 . . . . 0.0 108.539 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.9 116.21 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.12 128.89 34.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.18 175.24 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.276 1.43 . . . . 0.0 110.879 -167.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 70' ' ' VAL . 15.3 ptpt -137.97 144.72 45.01 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 158.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.84 -31.66 47.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.305 2.67 . . . . 0.0 112.268 -168.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -65.78 -35.96 82.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.508 0.723 . . . . 0.0 111.829 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 48.7 t -61.01 118.67 37.97 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 124.557 1.143 . . . . 0.0 109.717 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.93 -20.25 34.26 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.772 1.648 . . . . 0.0 111.073 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.416 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 22.9 m-85 -73.49 -39.35 64.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -60.61 -49.42 77.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -57.24 -46.07 83.34 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.425 0.557 . . . . 0.0 111.636 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -56.52 -54.24 48.14 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 118.833 0.742 . . . . 0.0 109.947 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.2 -39.23 59.87 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.223 0.952 . . . . 0.0 111.43 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.02 66.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.673 171.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -55.03 31.64 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.226 1.01 . . . . 0.0 109.741 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.63 -47.17 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.077 2.151 . . . . 0.0 110.237 176.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.11 -42.73 31.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 m -61.42 -21.87 64.5 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.85 -11.55 60.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.91 . . . . 0.0 111.851 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.3 133.51 21.97 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.85 81.77 2.49 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.633 2.889 . . . . 0.0 110.284 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 99' ' ' LEU . 9.5 mt -102.57 155.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -167.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -50.75 123.31 8.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.659 0.783 . . . . 0.0 109.266 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -66.58 157.05 33.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.099 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.86 -20.66 2.84 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.205 -1.331 . . . . 0.0 112.68 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -73.86 -37.14 64.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.538 2.169 . . . . 0.0 109.795 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -83.92 104.1 13.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -171.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -123.35 113.62 19.09 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 43' ' ' LEU . 14.1 m-85 -84.07 107.2 16.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 171.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.92 106.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 126.427 1.891 . . . . 0.0 107.288 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.78 133.08 52.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 122.649 -0.032 . . . . 0.0 110.953 166.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 pt -106.25 -13.75 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.33 1.452 . . . . 0.0 110.758 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.632 1.173 . . . . 0.0 111.083 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m170 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.77 -63.42 0.91 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.316 -1.325 . . . . 0.0 111.777 168.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -47.36 -51.45 19.57 Favored 'General case' 0 C--O 1.217 -0.629 0 O-C-N 124.452 1.095 . . . . 0.0 109.911 -171.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.11 -50.1 75.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.515 0.598 . . . . 0.0 110.352 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -62.34 -35.66 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.964 0.906 . . . . 0.0 108.816 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.21 -37.2 33.64 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 -168.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.43 -46.18 84.31 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 127.502 2.321 . . . . 0.0 110.475 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -61.51 -44.92 96.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.326 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -57.4 -39.21 75.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.973 1.261 . . . . 0.0 110.524 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -41.78 93.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.502 0.721 . . . . 0.0 110.385 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -63.62 -58.53 6.64 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.508 -0.745 . . . . 0.0 110.053 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 tp -65.32 -30.22 71.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.676 2.39 . . . . 0.0 111.775 -166.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.69 -26.47 2.96 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.192 1.36 . . . . 0.0 112.993 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.96 27.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.934 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.77 144.83 27.28 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.365 2.083 . . . . 0.0 110.414 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -85.84 -18.63 32.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.968 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -70.83 134.08 47.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -163.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.4 m -96.28 166.12 14.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.556 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -58.82 159.01 35.48 Favored 'Cis proline' 0 C--N 1.345 0.36 0 CA-C-N 119.657 0.913 . . . . 0.0 110.305 -15.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 mtp85 -126.39 105.7 8.97 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.58 125.25 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -110.79 99.57 8.47 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 107.065 168.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 109.79 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.28 64.67 2.17 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.016 1.769 . . . . 0.0 111.761 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 tttt 46.14 17.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.458 2.703 . . . . 0.0 117.394 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -98.53 115.56 28.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.26 1.391 . . . . 0.0 107.568 159.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -67.01 108.79 2.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.2 pp -83.55 -11.01 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.656 0.662 . . . . 0.0 110.555 -174.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -165.64 24.44 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.154 1.359 . . . . 0.0 110.008 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.65 -165.36 39.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -39.76 93.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.716 -0.873 . . . . 0.0 110.775 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -66.6 -26.01 66.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.316 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.74 -51.9 6.13 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.6 tp -46.55 -39.68 11.4 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.334 1.853 . . . . 0.0 111.269 172.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.29 -48.39 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 116.434 -1.746 . . . . 0.0 110.802 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -44.7 76.65 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.989 1.722 . . . . 0.0 106.857 -176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.36 -34.28 72.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.044 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.09 -56.37 9.09 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.627 1.558 . . . . 0.0 110.408 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -50.22 55.8 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.499 -1.375 . . . . 0.0 110.261 -167.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 t -70.74 -12.15 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.138 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.49 16.28 71.47 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 117.695 -1.614 . . . . 0.0 112.992 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.42 -30.91 70.86 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.542 2.171 . . . . 0.0 110.597 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -49.91 -37.39 31.38 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.985 2.114 . . . . 0.0 111.453 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -55.82 28.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.238 1.015 . . . . 0.0 110.534 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.0 m -62.49 -43.8 97.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.015 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -38.88 77.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.13 0.877 . . . . 0.0 110.302 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' ILE . 14.6 mt -68.67 -51.62 39.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.99 -1.069 . . . . 0.0 111.056 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -55.57 -25.84 40.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.054 1.297 . . . . 0.0 114.3 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -47.4 -36.03 9.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.985 1.314 . . . . 0.0 111.582 168.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -6.22 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.735 0.814 . . . . 0.0 111.973 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.92 85.02 0.23 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -169.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.41 -70.11 0.43 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.602 2.361 . . . . 0.0 109.008 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.58 148.68 51.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 121.081 1.764 . . . . 0.0 107.407 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.247 0.962 0 O-C-N 126.057 2.098 . . . . 0.0 107.37 158.725 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.626 0.25 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.92 -49.46 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.32 -46.86 81.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 t -79.69 10.27 4.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.144 2.178 . . . . 0.0 112.34 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -106.49 -34.61 7.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.712 -1.243 . . . . 0.0 109.862 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.07 148.2 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.53 1.059 . . . . 0.0 108.998 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -135.8 139.13 29.79 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 159.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -63.1 158.47 43.75 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.082 1.855 . . . . 0.0 109.098 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.75 17.36 41.95 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.547 -0.721 . . . . 0.0 113.528 -171.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 156.74 46.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.666 1.987 . . . . 0.0 107.981 172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -107.85 104.53 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.91 125.7 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.87 112.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -167.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.61 126.79 34.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.78 -178.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 0.0 111.429 -166.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.2 160.55 61.82 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 127.037 2.135 . . . . 0.0 107.086 172.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.67 -17.17 10.0 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.511 2.141 . . . . 0.0 111.638 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -129.16 24.57 5.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.732 2.013 . . . . 0.0 111.041 -163.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -107.17 115.29 60.16 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.16 -18.41 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.915 1.743 . . . . 0.0 111.07 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -74.17 -37.83 63.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.64 -50.35 65.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -49.03 -47.34 44.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.698 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -63.31 1.18 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 119.137 0.88 . . . . 0.0 109.348 173.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.0 58.87 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.143 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.48 -45.78 85.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.019 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.06 -30.95 55.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 121.724 2.056 . . . . 0.0 111.841 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mt -57.3 -55.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.282 1.433 . . . . 0.0 107.456 170.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.92 -56.13 4.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t -65.07 -20.91 66.71 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -160.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -73.62 -21.31 60.34 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.21 0.914 . . . . 0.0 111.914 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.93 149.53 90.01 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.181 0.9 . . . . 0.0 110.498 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.92 109.24 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.108 2.539 . . . . 0.0 108.57 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.416 HD13 HD23 ' A' ' 43' ' ' LEU . 6.2 mt -130.72 147.55 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -174.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.39 155.21 5.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.028 1.331 . . . . 0.0 109.882 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.96 100.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.377 1.871 . . . . 0.0 111.043 -172.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.18 19.55 75.82 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.587 167.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 mt -73.44 -25.88 60.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.31 2.055 . . . . 0.0 110.891 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.09 103.65 13.5 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 120.309 1.413 . . . . 0.0 107.305 178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -115.14 102.29 9.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.039 1.336 . . . . 0.0 107.841 -170.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.13 131.08 34.81 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.0 t -128.14 100.85 6.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 125.542 1.537 . . . . 0.0 108.029 -166.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.61 119.6 22.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.075 0.55 . . . . 0.0 110.957 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.94 -9.15 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 124.58 1.152 . . . . 0.0 109.755 179.82 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.74 -63.77 0.29 Allowed 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 127.73 2.412 . . . . 0.0 109.961 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.29 -32.76 39.05 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -45.24 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.766 -1.209 . . . . 0.0 111.008 174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 mt -57.34 -38.05 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.462 1.105 . . . . 0.0 110.208 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -63.33 -47.18 83.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.739 2.416 . . . . 0.0 106.934 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.67 -45.93 88.32 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.076 0.95 . . . . 0.0 110.006 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -61.06 -37.19 81.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.265 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.5 mt -55.77 -47.49 76.93 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 121.197 1.817 . . . . 0.0 109.206 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -54.12 -47.53 71.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.963 0.789 . . . . 0.0 111.08 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.91 77.48 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.054 0.542 . . . . 0.0 110.66 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD2' HH12 ' A' ' 72' ' ' ARG . 9.5 tp -75.71 -24.5 56.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.891 0.876 . . . . 0.0 110.022 -168.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.2 p -121.34 -65.92 1.09 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.513 1.051 . . . . 0.0 110.099 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.66 -4.76 0.68 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.564 2.03 . . . . 0.0 112.038 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.31 142.57 32.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.976 1.888 . . . . 0.0 109.518 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -95.63 -15.55 22.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 141.83 55.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.866 0.757 . . . . 0.0 110.755 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 158.22 33.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.994 1.718 . . . . 0.0 108.265 171.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.03 141.17 50.62 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 N-CA-C 110.034 -0.795 . . . . 0.0 110.034 -5.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.407 HH12 ' CD2' ' A' ' 64' ' ' LEU . 21.0 ttp180 -109.56 96.57 6.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.36 126.74 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -122.82 94.01 4.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.49 117.1 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.95 66.33 2.54 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 124.832 1.206 . . . . 0.0 114.016 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt 46.08 31.95 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -143.87 148.41 35.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.684 1.129 . . . . 0.0 110.09 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.3 139.32 30.61 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 119.334 0.97 . . . . 0.0 110.149 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.28 -7.89 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.47 0.577 . . . . 0.0 112.249 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.28 -88.23 0.25 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.76 -80.41 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -39.29 1.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.625 0.77 . . . . 0.0 112.255 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -76.89 -25.85 53.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.648 1.567 . . . . 0.0 111.15 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.74 -43.76 83.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.286 1.035 . . . . 0.0 108.318 165.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.34 -36.61 76.0 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.008 0.523 . . . . 0.0 111.086 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -60.41 -46.22 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 117.435 -1.269 . . . . 0.0 109.65 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -48.43 79.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.431 1.469 . . . . 0.0 107.217 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mt -56.21 -39.69 72.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.999 0.92 . . . . 0.0 109.006 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -58.65 6.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.394 1.452 . . . . 0.0 110.032 172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -50.55 66.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.095 1.358 . . . . 0.0 110.767 -164.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.9 t -75.97 -2.33 29.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.134 1.774 . . . . 0.0 111.562 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.44 5.74 44.92 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.624 -1.654 . . . . 0.0 113.866 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -65.2 -21.45 66.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.905 2.353 . . . . 0.0 110.504 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -49.85 -40.0 40.89 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.471 1.508 . . . . 0.0 111.88 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.87 -50.82 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -56.76 -54.15 49.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.9 1.28 . . . . 0.0 109.721 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -38.63 63.9 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.772 2.029 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.59 -49.68 20.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.073 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -62.51 -23.47 66.97 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.642 1.565 . . . . 0.0 112.765 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -52.35 -20.38 2.72 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.883 1.673 . . . . 0.0 112.955 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.2 8.89 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.015 1.279 . . . . 0.0 113.671 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.38 41.13 31.39 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.383 -0.823 . . . . 0.0 111.6 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -89.14 -74.52 0.47 Allowed 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.285 1.434 . . . . 0.0 111.181 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.33 55.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.249 1.027 0 O-C-N 124.463 1.102 . . . . 0.0 108.933 -163.069 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.29 -49.69 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.021 0.828 . . . . 0.0 109.479 171.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.26 -48.19 81.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -164.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -74.16 -21.95 59.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.754 0.822 . . . . 0.0 111.733 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HG2' HG11 ' A' ' 46' ' ' VAL . 2.8 mptp? -64.79 -48.12 75.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.025 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.01 149.8 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -145.27 152.64 50.99 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.29 160.97 28.75 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.225 1.283 . . . . 0.0 109.78 159.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.86 24.33 33.47 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.869 -0.962 . . . . 0.0 113.917 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -141.43 160.11 40.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.531 1.666 . . . . 0.0 107.877 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 75' ' ' ILE . 40.4 t -120.74 87.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.51 129.42 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.86 112.45 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -166.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.92 124.91 29.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.7 178.42 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.929 2.092 . . . . 0.0 110.395 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -133.89 160.31 69.05 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 159.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.5 -30.52 3.13 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.994 1.796 . . . . 0.0 110.848 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -91.21 3.18 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.048 1.339 . . . . 0.0 111.96 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 1.3 m -90.24 110.55 41.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.226 1.011 . . . . 0.0 112.042 173.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -28.51 38.34 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 112.12 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -73.78 -24.08 59.79 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.607 1.094 . . . . 0.0 110.977 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.73 -52.09 48.43 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 166.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -55.04 -37.6 66.9 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.413 1.085 . . . . 0.0 113.544 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -59.32 -61.16 2.84 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 118.428 0.558 . . . . 0.0 110.263 169.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.4 -34.07 46.56 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 124.575 1.172 . . . . 0.0 110.969 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -53.18 60.2 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 126.256 1.822 . . . . 0.0 112.967 171.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -53.62 35.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.96 -50.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.843 1.657 . . . . 0.0 110.905 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.89 -45.26 59.2 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -63.02 -16.37 59.59 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.39 -31.2 63.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.937 1.699 . . . . 0.0 109.939 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.6 136.89 55.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.26 61.45 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.203 3.268 . . . . 0.0 112.719 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.63 150.16 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -53.07 124.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.826 0.85 . . . . 0.0 110.119 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -53.2 128.26 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.48 -23.58 34.63 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.005 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.89 -37.89 64.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 119.823 1.811 . . . . 0.0 110.612 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.19 106.73 16.05 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -129.14 115.12 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.859 0.838 . . . . 0.0 111.426 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -83.9 105.46 14.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.416 HG11 ' HG2' ' A' ' 9' ' ' LYS . 47.6 t -91.84 125.67 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.907 2.083 . . . . 0.0 106.731 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -82.27 128.63 34.38 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.415 -0.803 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -63.09 -23.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.15 -0.969 . . . . 0.0 111.12 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.444 -0.733 0 C-N-CA 126.424 1.89 . . . . 0.0 106.822 -175.068 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -62.71 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 122.225 2.284 . . . . 0.0 111.473 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -48.55 -48.32 38.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.708 0.803 . . . . 0.0 112.101 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -28.81 69.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.526 1.53 . . . . 0.0 113.377 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 mt -81.65 -34.56 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.602 1.961 . . . . 0.0 107.922 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.61 -50.98 25.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.535 2.334 . . . . 0.0 107.851 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -45.51 -53.1 9.41 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.577 1.551 . . . . 0.0 111.013 167.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.09 -42.33 99.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.999 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.26 -40.29 85.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.839 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.63 -50.84 70.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.301 1.04 . . . . 0.0 109.386 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.06 -46.33 89.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 111.864 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.26 -38.4 56.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 109.287 -170.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -112.27 -28.99 7.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.06 -5.02 35.97 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.948 1.261 . . . . 0.0 112.738 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.47 147.06 28.7 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.512 1.656 . . . . 0.0 109.674 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -84.92 -18.44 34.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.085 -0.483 . . . . 0.0 111.914 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -64.72 133.55 52.32 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.345 0.52 . . . . 0.0 110.113 -162.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 165.41 31.94 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.542 0.737 . . . . 0.0 109.475 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -65.47 165.7 56.04 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -15.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.98 96.72 4.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.06 105.21 13.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.006 1.722 . . . . 0.0 106.791 166.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.06 107.22 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 167.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.07 69.38 0.77 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.428 1.49 . . . . 0.0 113.066 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tttm 46.05 31.0 1.03 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.421 1.888 . . . . 0.0 115.985 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -128.96 127.25 41.33 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.626 1.103 . . . . 0.0 108.885 159.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.54 138.48 43.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -114.86 12.92 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.148 0.979 . . . . 0.0 111.223 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -149.06 21.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 -10.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.25 150.83 29.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 t 61.46 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -48.96 69.19 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.005 1.322 . . . . 0.0 109.566 -175.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.3 -46.84 36.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.979 2.112 . . . . 0.0 111.475 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.53 -48.24 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.25 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -47.77 77.07 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.663 1.574 . . . . 0.0 109.128 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.58 -35.46 74.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.45 -56.91 6.79 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.58 1.536 . . . . 0.0 109.639 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -53.84 41.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.32 1.848 . . . . 0.0 111.303 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.5 t -70.6 -15.84 62.79 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.875 2.47 . . . . 0.0 111.019 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.09 1.33 84.63 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 118.393 -1.226 . . . . 0.0 113.617 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.23 -33.27 73.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 120.066 1.933 . . . . 0.0 111.394 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.19 -38.65 73.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.232 1.413 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -55.04 25.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.79 1.236 . . . . 0.0 108.677 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -61.47 -42.51 98.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.643 0.777 . . . . 0.0 110.246 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.91 83.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.692 0.797 . . . . 0.0 111.317 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.09 -48.69 61.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.283 1.033 . . . . 0.0 110.337 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' CG ' ' HB2' ' A' ' 105' ' ' LEU . 11.6 mtpt -57.42 -31.12 65.55 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.788 -1.195 . . . . 0.0 112.979 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -24.54 40.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.737 0.815 . . . . 0.0 111.591 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.01 23.97 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.818 0.847 . . . . 0.0 111.514 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.0 16.34 57.99 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 164.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.96 -70.46 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.402 1.101 . . . . 0.0 111.167 -166.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HB2' ' CG ' ' A' ' 100' ' ' LYS . 3.0 mm? -72.39 146.16 47.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.102 -165.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 112.67 -2.059 . . . . 0.0 109.968 -173.493 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.9 t80 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.97 -59.75 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 0.0 109.171 170.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.1 -33.73 76.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.091 2.556 . . . . 0.0 110.827 -166.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.23 -51.18 65.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.263 3.425 . . . . 0.0 110.443 172.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 40.7 mmtm -69.8 -17.27 63.39 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.842 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 77' ' ' LYS . 6.9 mm -73.9 129.92 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 119.156 0.889 . . . . 0.0 108.694 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -131.11 159.22 72.57 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 159.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.07 70.05 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.884 3.056 . . . . 0.0 109.789 169.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.7 64.87 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 126.719 2.104 . . . . 0.0 108.464 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -151.11 159.05 44.71 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.622 2.369 . . . . 0.0 105.597 165.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.704 HG13 HD12 ' A' ' 75' ' ' ILE . 60.3 t -117.04 87.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 172.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.421 HG11 ' CZ ' ' A' ' 18' ' ' PHE . 64.0 t -85.46 151.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.904 -1.123 . . . . 0.0 108.247 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.36 116.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 160.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' A' ' 16' ' ' VAL . 71.1 m-85 -77.3 125.58 29.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.11 176.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.681 1.993 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 160.46 43.65 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.378 1.871 . . . . 0.0 108.956 171.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -82.19 26.43 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.191 3.261 . . . . 0.0 110.56 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.364 2.9 t -138.2 -106.63 0.18 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.75 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m 32.65 104.21 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 129.916 3.286 . . . . 0.0 113.989 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.23 -16.88 36.37 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.202 1.268 . . . . 0.0 112.211 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -74.36 -47.91 31.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.062 1.345 . . . . 0.0 108.852 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.1 m -63.93 -44.35 93.16 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -53.19 -45.28 68.5 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.353 1.061 . . . . 0.0 110.343 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.66 -60.1 4.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 118.816 -0.612 . . . . 0.0 109.578 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.04 64.57 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.187 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -52.59 64.98 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.167 0.894 . . . . 0.0 112.451 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.18 -40.5 67.87 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.491 0.587 . . . . 0.0 109.753 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.0 mt -53.88 -53.13 29.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.821 1.248 . . . . 0.0 109.584 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.62 -44.47 56.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.132 -0.937 . . . . 0.0 108.564 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.1 m -55.81 -27.92 53.7 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -73.45 -19.71 60.89 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.018 0.826 . . . . 0.0 110.952 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -87.57 133.7 37.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.707 1.139 . . . . 0.0 107.936 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.77 114.55 4.05 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.206 1.938 . . . . 0.0 108.829 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.25 152.13 36.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -54.16 123.6 13.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.94 150.64 48.31 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 -30.03 6.34 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.931 -168.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.51 -47.05 24.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 120.42 2.11 . . . . 0.0 111.533 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -83.57 107.5 16.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.822 1.192 . . . . 0.0 108.433 -164.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.03 111.47 12.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.738 0.78 . . . . 0.0 110.431 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -84.01 102.55 12.56 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.41 121.3 49.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.78 1.632 . . . . 0.0 107.637 -172.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.7 133.68 34.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.593 -170.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -88.18 -12.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.846 1.658 . . . . 0.0 113.843 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 123.923 0.889 . . . . 0.0 110.987 -166.561 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m80 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -63.37 1.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 121.362 1.892 . . . . 0.0 110.236 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.25 -41.47 75.8 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 119.694 -0.194 . . . . 0.0 111.394 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -49.04 77.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.444 1.498 . . . . 0.0 111.65 173.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.43 -39.58 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.296 1.838 . . . . 0.0 108.512 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -80.33 -40.09 27.38 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -164.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -58.01 -53.94 52.57 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.449 1.9 . . . . 0.0 108.903 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -53.23 -49.4 66.9 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.896 1.278 . . . . 0.0 109.946 172.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.25 -29.29 63.68 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.436 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.93 -59.88 4.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.132 1.333 . . . . 0.0 109.13 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.13 -36.61 82.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.091 0.557 . . . . 0.0 111.23 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.61 -20.05 58.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.889 1.276 . . . . 0.0 110.404 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.4 p -125.84 -76.23 0.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.744 1.611 . . . . 0.0 112.744 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.1 -6.87 0.07 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.66 2.076 . . . . 0.0 113.797 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.09 152.78 35.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.559 1.68 . . . . 0.0 109.078 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -97.46 -3.2 40.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.112 0.965 . . . . 0.0 111.882 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -69.59 141.75 53.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.13 157.81 32.97 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 125.62 1.568 . . . . 0.0 108.931 166.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.7 161.85 52.49 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 CA-C-N 120.256 1.127 . . . . 0.0 111.829 -4.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -132.16 97.61 4.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.5 1.12 . . . . 0.0 108.313 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.9 t -75.03 120.93 25.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.94 96.58 6.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.827 1.651 . . . . 0.0 107.335 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.704 HD12 HG13 ' A' ' 15' ' ' VAL . 1.4 mp -83.85 116.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 161.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.29 87.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.514 2.007 . . . . 0.0 115.374 162.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 10' ' ' ILE . 15.4 mtpp 46.83 -12.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 131.512 3.925 . . . . 0.0 117.434 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -99.06 167.74 10.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 119.529 1.058 . . . . 0.0 109.209 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -120.16 125.49 48.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.401 1.48 . . . . 0.0 107.611 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.62 -23.58 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.567 0.222 . . . . 0.0 111.315 -164.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.85 177.11 15.43 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -159.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.45 -84.12 1.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -167.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.23 -64.15 1.06 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.234 1.014 . . . . 0.0 110.255 -173.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -49.8 64.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.74 1.155 . . . . 0.0 111.166 176.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.0 -36.66 78.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.138 1.775 . . . . 0.0 107.783 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.65 -40.51 84.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.083 0.953 . . . . 0.0 110.074 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.88 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 116.273 -1.822 . . . . 0.0 109.384 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.294 5.1 p -54.1 -47.27 71.96 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 121.987 2.176 . . . . 0.0 114.783 168.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.02 -43.87 70.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.333 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -60.69 -54.95 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.259 2.299 . . . . 0.0 110.693 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -42.99 58.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.486 1.914 . . . . 0.0 114.157 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -14.6 61.29 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 168.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.9 2.69 88.38 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.338 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.49 -17.49 64.83 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.916 1.858 . . . . 0.0 112.236 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -43.6 97.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.436 1.494 . . . . 0.0 109.495 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.22 -44.58 97.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 109.399 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -59.36 -54.08 50.85 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.079 0.552 . . . . 0.0 109.797 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -44.55 65.42 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.257 1.023 . . . . 0.0 111.55 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.5 mt -65.44 -50.59 64.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.56 1.144 . . . . 0.0 110.269 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -23.51 61.22 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.181 -0.949 . . . . 0.0 113.329 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.54 -29.09 9.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.173 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.16 26.6 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.394 1.078 . . . . 0.0 111.936 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.29 19.06 73.87 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.385 1.469 . . . . 0.0 114.725 168.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.34 -57.08 4.18 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 112.108 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.6 133.27 50.81 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -153.084 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -112.45 -47.52 3.08 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -57.31 -31.19 65.43 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.38 -60.6 3.6 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.542 1.065 . . . . 0.0 109.165 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.61 -45.77 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -55.79 -50.18 71.18 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.361 0.664 . . . . 0.0 111.34 -171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.22 -25.72 36.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.941 0.896 . . . . 0.0 111.781 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -65.58 -38.45 89.55 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.811 1.187 . . . . 0.0 110.621 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.91 154.84 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 120.63 1.559 . . . . 0.0 107.9 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.9 166.93 14.89 Favored Pre-proline 0 C--O 1.241 0.622 0 C-N-CA 125.572 1.549 . . . . 0.0 107.175 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.56 158.59 52.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 159.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.77 84.24 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 113.968 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.62 151.56 38.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.174 2.19 . . . . 0.0 108.961 163.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.3 t -103.68 79.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.203 1.401 . . . . 0.0 107.476 173.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.09 140.7 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.02 115.82 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -81.54 131.94 35.29 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 171.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 126.294 1.838 . . . . 0.0 111.235 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -140.15 143.94 35.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 162.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.14 -10.99 24.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.602 1.535 . . . . 0.0 110.985 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 p -89.46 -9.31 50.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.472 1.509 . . . . 0.0 111.882 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.33 123.62 85.78 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 119.527 1.058 . . . . 0.0 109.092 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -66.67 -23.67 48.79 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.672 1.581 . . . . 0.0 110.291 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.37 -28.92 62.3 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.673 0.789 . . . . 0.0 110.369 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.0 m -68.02 -32.08 72.21 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -65.89 -38.28 88.33 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.932 0.787 . . . . 0.0 111.833 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -59.56 4.97 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.91 -35.88 58.86 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 124.051 0.845 . . . . 0.0 111.343 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -45.96 92.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.117 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.93 -50.9 25.12 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -46.05 -50.39 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.738 1.215 . . . . 0.0 110.563 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mt -79.59 -48.39 13.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -70.63 -6.18 34.93 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -73.8 -21.25 60.22 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.456 1.025 . . . . 0.0 110.725 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.91 142.09 24.58 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.691 0.797 . . . . 0.0 109.964 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.11 109.75 2.78 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.64 2.894 . . . . 0.0 110.075 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HD23 ' A' ' 43' ' ' LEU . 12.2 mt -133.68 149.84 31.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -169.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -53.0 127.69 24.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 118.195 0.452 . . . . 0.0 110.995 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.12 131.08 49.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.757 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.86 52.73 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.287 1.422 . . . . 0.0 111.841 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 mt -73.95 -34.44 64.3 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.951 1.375 . . . . 0.0 110.665 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.36 111.32 18.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 -175.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -129.08 108.75 10.63 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -83.93 102.49 12.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.77 137.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.506 1.923 . . . . 0.0 106.965 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -93.12 149.5 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.728 -0.608 . . . . 0.0 110.816 -173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.65 10.19 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.102 1.761 . . . . 0.0 112.27 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -133.8 -20.43 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 120.581 1.537 . . . . 0.0 111.882 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.98 74.84 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.405 -1.435 . . . . 0.0 113.99 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.29 20.74 0.95 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -161.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.497 HD22 HD12 ' A' ' 57' ' ' ILE . 11.5 p-10 -156.6 -148.64 0.22 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.229 -0.919 . . . . 0.0 110.396 -162.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -137.06 100.76 4.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.15 2.98 . . . . 0.0 103.016 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -42.14 -63.31 0.77 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -43.85 -33.1 1.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.921 2.488 . . . . 0.0 113.758 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.36 -60.68 1.93 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 52' ' ' ASN . 1.3 mt -54.76 -33.85 28.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 124.972 1.309 . . . . 0.0 111.173 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -73.63 -40.68 63.6 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.31 -44.63 87.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.077 1.751 . . . . 0.0 110.496 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -58.53 -48.15 81.81 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.035 -0.416 . . . . 0.0 110.469 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.78 -36.41 69.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.096 0.959 . . . . 0.0 110.288 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -50.47 68.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.509 0.724 . . . . 0.0 110.418 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -68.73 -45.28 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.084 0.553 . . . . 0.0 110.279 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.79 -30.79 59.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 p -123.72 -12.78 7.58 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.65 59.66 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 120.292 1.405 . . . . 0.0 113.178 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.46 149.47 18.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.357 1.079 . . . . 0.0 109.935 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -102.9 -25.29 13.53 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.811 0.844 . . . . 0.0 112.649 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -71.29 144.31 50.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.95 165.99 11.81 Favored Pre-proline 0 C--O 1.244 0.777 0 C-N-CA 126.372 1.869 . . . . 0.0 109.21 -170.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.58 161.91 51.53 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 119.287 0.781 . . . . 0.0 111.424 -3.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -137.81 97.11 3.35 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.14 127.49 39.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.23 96.03 5.59 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.836 2.454 . . . . 0.0 107.879 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.428 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.61 107.84 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 38.37 81.48 0.02 OUTLIER Glycine 0 C--N 1.337 0.635 0 C-N-CA 127.432 2.444 . . . . 0.0 113.135 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 16.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.37 2.268 . . . . 0.0 116.996 -174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.96 110.81 18.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 119.024 0.829 . . . . 0.0 108.836 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.28 117.12 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.54 -21.83 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.53 -155.76 21.3 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.64 -168.75 31.2 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.982 1.753 . . . . 0.0 110.253 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.7 p -68.75 -24.66 64.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.578 -1.201 . . . . 0.0 112.126 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m -60.63 -49.22 78.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 120.231 1.378 . . . . 0.0 109.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -41.29 84.86 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.692 0.797 . . . . 0.0 109.57 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.7 tp -56.59 -39.25 73.22 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.367 0.667 . . . . 0.0 112.004 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -61.92 -46.08 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.044 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.58 -56.47 21.73 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.73 -27.15 68.71 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.912 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -68.05 -54.07 21.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.586 1.539 . . . . 0.0 109.454 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -40.8 77.37 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.702 1.201 . . . . 0.0 111.775 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -70.61 -20.52 62.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.529 2.732 . . . . 0.0 110.262 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.9 6.63 82.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.722 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.61 -31.98 72.91 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 120.273 2.036 . . . . 0.0 109.514 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.43 -40.9 75.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.191 1.796 . . . . 0.0 110.445 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.11 -47.72 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.592 0.633 . . . . 0.0 109.339 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m -60.82 -49.52 77.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.279 0.632 . . . . 0.0 109.351 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -48.77 61.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.598 1.159 . . . . 0.0 110.688 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -49.3 70.88 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.334 1.054 . . . . 0.0 112.734 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -67.43 -25.11 65.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 117.088 -1.845 . . . . 0.0 112.717 -166.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -48.16 -46.22 34.33 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.764 0.665 . . . . 0.0 110.448 168.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.71 8.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.903 0.774 . . . . 0.0 112.078 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.67 34.21 44.64 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.602 1.096 . . . . 0.0 111.701 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.31 -74.52 0.38 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.39 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 mt -62.59 133.75 55.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.773 1.169 . . . . 0.0 110.578 -159.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 131.144 3.778 . . . . 0.0 104.858 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 116.47 -1.728 . . . . 0.0 115.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -66.67 34.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 122.099 2.227 . . . . 0.0 113.559 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -163.42 -57.41 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.262 2.225 . . . . 0.0 105.502 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -55.81 -51.69 66.59 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.763 1.165 . . . . 0.0 110.923 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.43 -49.29 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.322 0.51 . . . . 0.0 109.895 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.86 -53.12 55.6 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.547 0.612 . . . . 0.0 111.262 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.9 m -68.76 -5.4 20.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.214 1.406 . . . . 0.0 112.659 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -78.6 -26.4 45.4 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.508 167.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.26 167.45 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 165.08 18.98 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 128.194 2.598 . . . . 0.0 105.735 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.6 61.47 7.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.709 2.273 . . . . 0.0 111.951 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.74 16.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.745 -1.031 . . . . 0.0 115.513 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -119.05 160.11 22.66 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.486 1.643 . . . . 0.0 108.002 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 75' ' ' ILE . 41.1 t -108.96 98.78 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.59 151.68 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.56 115.22 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -74.81 120.42 20.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.07 176.04 7.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 127.462 2.305 . . . . 0.0 110.268 -171.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -122.89 158.69 56.49 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 164.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.95 9.75 2.26 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.759 2.972 . . . . 0.0 112.971 -168.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.306 0.1 OUTLIER -133.35 -106.17 0.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -173.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t 33.83 115.06 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 130.975 3.71 . . . . 0.0 113.702 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -61.75 -20.32 68.62 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.96 1.107 . . . . 0.0 112.602 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -81.8 -42.6 19.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.76 -43.13 99.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -54.35 -53.42 54.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.31 1.044 . . . . 0.0 110.204 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -55.81 27.8 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.1 69.89 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.677 0.611 . . . . 0.0 110.868 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -54.6 -51.98 63.61 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.81 1.244 . . . . 0.0 112.557 172.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.8 -47.61 45.12 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 126.342 1.857 . . . . 0.0 110.178 -171.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -50.21 -56.17 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 126.207 1.803 . . . . 0.0 108.079 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.83 -43.25 62.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.268 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.3 m -70.39 -4.43 22.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.8 -26.75 60.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.431 1.469 . . . . 0.0 111.874 172.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.83 150.51 65.88 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 119.137 0.881 . . . . 0.0 110.787 -171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.47 72.95 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.613 2.876 . . . . 0.0 108.731 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.61 147.57 5.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -50.21 124.21 9.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.941 0.496 . . . . 0.0 109.705 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -65.14 140.87 58.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.1 -3.5 85.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.109 -1.384 . . . . 0.0 112.418 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 mt -92.23 -28.88 16.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.201 2.001 . . . . 0.0 112.674 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.63 109.64 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.858 2.117 . . . . 0.0 108.193 -171.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -121.43 112.6 18.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.46 1.027 . . . . 0.0 109.885 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 74.5 m-85 -96.03 91.76 6.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.832 1.253 . . . . 0.0 108.963 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.67 104.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.299 1.84 . . . . 0.0 108.708 -168.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.73 104.79 2.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.69 1.596 . . . . 0.0 112.235 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.1 pt -69.23 -8.98 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.639 1.175 . . . . 0.0 113.087 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -128.25 15.52 6.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.427 1.012 . . . . 0.0 110.79 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.44 -18.33 27.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.465 1.029 . . . . 0.0 113.19 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.251 0.4 OUTLIER -150.97 -43.67 0.12 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.076 158.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -160.3 0.2 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.004 1.274 . . . . 0.0 109.27 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.0 m170 66.3 2.43 2.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.384 2.274 . . . . 0.0 115.041 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.87 -63.4 0.98 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 120.397 1.453 . . . . 0.0 109.864 170.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -47.02 -49.7 20.63 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.373 -0.822 . . . . 0.0 113.01 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -60.9 -44.61 96.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.708 1.203 . . . . 0.0 110.06 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -68.31 -42.43 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.801 1.64 . . . . 0.0 107.32 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -48.92 70.5 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.567 2.347 . . . . 0.0 105.421 -172.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -52.91 -59.01 5.05 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 126.022 1.729 . . . . 0.0 109.942 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.97 -38.7 79.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.644 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.37 -32.1 72.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.462 1.028 . . . . 0.0 111.213 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -61.72 -38.69 88.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.277 0.944 . . . . 0.0 110.372 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -51.54 12.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.728 0.695 . . . . 0.0 111.395 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.59 -22.76 63.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.611 1.164 . . . . 0.0 110.533 -171.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.9 p -116.09 -71.67 0.73 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.608 1.095 . . . . 0.0 108.083 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.66 0.23 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.108 1.337 . . . . 0.0 110.811 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -134.89 144.95 47.8 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.097 0.959 . . . . 0.0 108.871 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -21.66 51.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.117 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.5 p -63.05 133.37 54.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.493 0.496 . . . . 0.0 110.007 -158.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.76 155.57 61.69 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.39 166.28 64.93 Favored 'Cis proline' 0 N--CA 1.461 -0.429 0 CA-C-N 119.927 1.01 . . . . 0.0 111.419 -5.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -133.84 96.11 3.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 169.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 86' ' ' LEU . 54.3 t -74.4 126.31 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -113.99 101.83 9.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.877 1.671 . . . . 0.0 107.477 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.471 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.04 115.26 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 104.554 -2.388 . . . . 0.0 104.554 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.35 72.38 0.48 Allowed Glycine 0 C--N 1.337 0.611 0 C-N-CA 124.621 1.105 . . . . 0.0 111.873 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 46.67 22.1 0.16 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -133.58 130.52 38.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.397 1.453 . . . . 0.0 110.854 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.6 t -71.58 115.96 11.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.776 0.83 . . . . 0.0 110.068 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -84.2 -6.65 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 118.442 0.565 . . . . 0.0 111.256 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.54 -175.93 19.68 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.561 1.553 . . . . 0.0 109.519 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.66 -91.82 1.2 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.43 -55.7 0.96 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.611 0.705 . . . . 0.0 112.457 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -61.18 -33.56 73.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.171 0.896 . . . . 0.0 111.107 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.12 -63.21 1.21 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.098 1.759 . . . . 0.0 107.766 170.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -49.31 -37.25 23.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.683 2.393 . . . . 0.0 113.126 -176.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.33 -36.03 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 117.207 -1.377 . . . . 0.0 110.341 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -49.39 66.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 121.3 1.864 . . . . 0.0 107.383 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.54 -37.48 75.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -62.36 -63.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.465 1.03 . . . . 0.0 109.692 170.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -51.64 58.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.155 1.782 . . . . 0.0 112.25 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -75.01 -36.73 61.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.594 1.157 . . . . 0.0 109.889 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.21 35.34 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.799 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -63.06 -26.97 69.09 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.621 2.21 . . . . 0.0 110.872 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -39.66 84.94 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 125.206 1.402 . . . . 0.0 109.172 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -39.71 84.93 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.526 0.73 . . . . 0.0 109.234 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.9 m -59.7 -57.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -34.51 78.3 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.888 -0.508 . . . . 0.0 112.174 -173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 mt -57.04 -53.73 54.71 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.946 1.298 . . . . 0.0 109.793 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -25.34 68.03 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.368 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -56.55 -30.31 62.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.42 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.74 8.78 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 112.53 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.59 30.95 59.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.305 -0.872 . . . . 0.0 112.858 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.74 -70.47 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 110.195 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.93 134.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -166.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--O 1.247 0.944 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 -174.041 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 4' ' ' GLU . 7.0 pt20 34.22 -91.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.086 2.554 . . . . 0.0 113.02 -174.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -34.85 -43.96 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 130.347 3.459 . . . . 0.0 113.458 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -53.14 -41.1 64.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.491 1.117 . . . . 0.0 111.729 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 18' ' ' PHE . 24.8 t -80.6 -56.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -60.47 -28.42 68.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -158.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -109.34 -16.66 13.98 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.398 1.079 . . . . 0.0 112.662 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -65.6 -39.07 91.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 0.0 110.149 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -69.9 144.86 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.26 160.27 37.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 163.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 71.5 5.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.499 3.466 . . . . 0.0 111.931 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.11 43.31 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.922 2.201 . . . . 0.0 110.555 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -151.24 162.92 40.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.76 2.424 . . . . 0.0 106.361 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.44 87.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 165.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -88.16 135.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.58 114.27 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.419 ' CE2' HG13 ' A' ' 6' ' ' VAL . 69.3 m-85 -84.11 130.04 34.87 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 167.77 18.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 125.005 1.322 . . . . 0.0 110.659 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.7 149.33 58.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 161.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -82.49 -19.68 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.617 2.878 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -75.58 31.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.758 2.423 . . . . 0.0 110.802 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 12.9 t -144.19 121.5 6.6 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.87 1.668 . . . . 0.0 111.289 -175.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.98 -19.97 19.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.018 1.812 . . . . 0.0 111.238 165.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 26.4 m-85 -76.8 -41.18 45.46 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.38 -46.65 88.07 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.3 ttm-85 -57.17 -42.66 81.52 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.467 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -58.62 -56.91 16.14 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 120.321 1.418 . . . . 0.0 108.529 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.45 -32.7 51.09 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 123.722 0.639 . . . . 0.0 111.141 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -56.7 -60.52 3.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.46 1.504 . . . . 0.0 112.474 169.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -66.11 -45.94 79.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.692 1.133 . . . . 0.0 109.243 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.12 -48.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.424 1.49 . . . . 0.0 110.494 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 95' ' ' LEU . 11.5 mt -74.96 -52.29 11.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -64.42 -14.43 56.75 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.47 1.508 . . . . 0.0 113.531 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.64 -24.25 59.98 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.073 1.306 . . . . 0.0 111.28 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.77 150.83 84.3 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.178 0.899 . . . . 0.0 110.714 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.88 67.69 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.565 2.843 . . . . 0.0 110.47 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -90.33 154.25 3.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -55.38 128.75 35.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.57 1.148 . . . . 0.0 109.469 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.93 136.22 57.94 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.26 -3.66 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.61 -1.106 . . . . 0.0 114.481 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mt -73.66 -41.15 63.08 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.888 1.844 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.79 110.04 18.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -121.52 120.25 34.33 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 54.0 m-85 -89.79 94.76 9.95 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.585 1.554 . . . . 0.0 107.324 172.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -85.29 107.96 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.895 2.078 . . . . 0.0 107.988 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -70.92 107.86 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.97 1.308 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.9 pt -68.47 -15.19 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.605 0.762 . . . . 0.0 112.644 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -94.57 -9.33 35.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.274 1.03 . . . . 0.0 110.952 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.07 72.9 6.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.302 1.441 . . . . 0.0 109.085 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.25 35.1 p 60.95 8.29 1.82 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.596 3.159 . . . . 0.0 116.04 161.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -78.63 -106.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 163.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -163.6 93.12 0.73 Allowed 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.04 -63.44 1.11 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.988 0.915 . . . . 0.0 109.53 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -27.24 32.71 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.58 -29.67 15.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.831 1.196 . . . . 0.0 111.448 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.77 -37.16 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -62.89 -51.67 66.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.38 1.872 . . . . 0.0 106.472 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -52.65 -53.84 41.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 111.054 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -41.44 80.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.92 -35.83 81.94 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.749 -1.22 . . . . 0.0 110.321 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.23 -39.02 92.19 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.373 0.533 . . . . 0.0 111.201 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -63.22 -52.45 62.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.805 . . . . 0.0 110.25 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -75.7 -52.95 9.35 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 p -97.57 -15.95 20.27 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.73 1.67 57.48 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.079 -0.845 . . . . 0.0 111.748 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.44 151.94 10.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.186 1.493 . . . . 0.0 110.756 169.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ptt-85 -87.9 -26.38 22.76 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 p -58.61 133.35 55.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -158.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.88 22.46 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.896 0.879 . . . . 0.0 110.007 -174.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -60.53 155.33 51.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 CA-C-N 119.833 0.976 . . . . 0.0 110.111 -10.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.83 113.6 20.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.21 123.92 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 119.712 1.142 . . . . 0.0 109.08 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -105.87 104.09 13.72 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 121.93 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 160.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 30.4 80.58 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 127.736 2.589 . . . . 0.0 114.934 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 47.26 21.14 0.18 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.27 125.39 34.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 121.206 1.821 . . . . 0.0 111.722 158.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.6 t -65.56 113.46 4.21 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.592 1.957 . . . . 0.0 109.761 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.68 -21.53 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 O-C-N 122.935 0.147 . . . . 0.0 110.611 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.39 -165.44 24.72 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.65 -167.11 36.43 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.985 0.802 . . . . 0.0 111.312 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.2 p -60.87 -34.89 75.32 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.303 1.051 . . . . 0.0 111.707 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -74.45 -42.98 58.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.543 0.611 . . . . 0.0 109.524 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.77 -46.97 82.85 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.95 -41.07 67.37 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.318 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.93 -48.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 116.827 -1.559 . . . . 0.0 109.9 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -47.02 87.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.206 1.821 . . . . 0.0 108.037 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.7 -40.56 83.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.933 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.36 -67.01 0.47 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.842 1.655 . . . . 0.0 110.211 172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -43.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.981 2.113 . . . . 0.0 113.294 -170.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.9 -4.17 50.41 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.73 1.212 . . . . 0.0 111.482 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.9 5.53 87.76 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 117.271 -1.849 . . . . 0.0 115.146 169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.2 -29.08 69.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 121.495 2.648 . . . . 0.0 110.937 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 33' ' ' LEU . 54.1 tp -53.54 -38.1 63.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.88 1.672 . . . . 0.0 111.619 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.76 -50.67 48.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -172.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.5 m -60.5 -47.36 86.48 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.721 0.808 . . . . 0.0 110.132 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -52.05 41.1 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 110.213 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.3 -46.17 84.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.134 0.974 . . . . 0.0 110.714 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -66.3 -26.84 67.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 117.995 -1.003 . . . . 0.0 113.031 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -54.84 -33.1 61.33 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.504 0.593 . . . . 0.0 110.558 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.45 9.38 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.438 1.017 . . . . 0.0 112.199 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.16 17.8 79.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.311 0.96 . . . . 0.0 114.181 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.32 -61.83 1.63 Allowed 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.123 1.769 . . . . 0.0 111.468 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.35 133.29 46.79 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.249 1.077 0 O-C-N 126.227 2.204 . . . . 0.0 112.195 -152.431 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 34.74 58.7 0.7 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 128.305 2.642 . . . . 0.0 112.437 163.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 61.79 -34.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.877 2.471 . . . . 0.0 115.674 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.12 -61.99 2.15 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 120.987 1.721 . . . . 0.0 110.522 -171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.411 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.4 t -63.75 -33.29 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -79.96 -30.86 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.861 -0.525 . . . . 0.0 111.541 -162.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -89.18 -19.22 25.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.091 1.757 . . . . 0.0 110.61 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -47.09 82.46 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.493 -1.38 . . . . 0.0 109.012 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -71.28 148.03 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -136.25 145.97 54.24 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.133 0.973 . . . . 0.0 108.878 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 61.21 7.62 Favored 'Trans proline' 0 CA--C 1.537 0.661 1 C-N-CA 125.324 4.016 . . . . 0.0 112.924 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.06 23.09 0.03 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 125.809 1.671 . . . . 0.0 111.723 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -137.94 154.04 49.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 127.003 2.121 . . . . 0.0 107.006 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 75' ' ' ILE . 29.4 t -102.04 93.13 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.58 129.94 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.18 155.98 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE1' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -117.75 125.59 50.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.54 175.63 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.048 2.139 . . . . 0.0 110.005 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -129.73 152.96 80.68 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.11 1.764 . . . . 0.0 106.688 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.79 -13.62 26.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.235 2.623 . . . . 0.0 113.145 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -102.3 -10.68 19.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.816 2.047 . . . . 0.0 112.209 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -90.95 127.57 51.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.653 0.781 . . . . 0.0 109.381 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.89 -23.05 16.78 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.86 1.707 . . . . 0.0 111.293 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.38 -35.04 47.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -58.19 -54.08 51.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.581 167.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -51.11 -45.15 61.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.306 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -61.59 2.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.96 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.895 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -55.11 -58.74 6.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.38 1.472 . . . . 0.0 112.683 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.87 -41.49 82.75 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 118.549 0.613 . . . . 0.0 109.802 -174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -53.75 -52.82 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.443 1.497 . . . . 0.0 109.101 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.31 -44.77 64.51 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -55.73 -15.67 3.4 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.5 -23.02 59.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.802 2.092 . . . . 0.0 111.745 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.29 137.12 39.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 119.071 0.851 . . . . 0.0 109.682 -169.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.72 85.17 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.847 3.031 . . . . 0.0 111.032 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 43' ' ' LEU . 14.9 mt -105.34 151.63 7.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.474 1.51 . . . . 0.0 107.196 -165.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -49.24 126.65 13.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.026 0.93 . . . . 0.0 109.988 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.46 130.02 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.67 84.35 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 117.623 -1.654 . . . . 0.0 113.16 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.12 -37.72 64.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.594 2.197 . . . . 0.0 111.022 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -83.73 110.37 18.26 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.403 1.456 . . . . 0.0 107.589 -175.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -124.53 98.61 5.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.221 1.408 . . . . 0.0 108.549 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -83.97 105.99 15.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.59 127.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.963 1.305 . . . . 0.0 107.568 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.842 1.257 . . . . 0.0 111.119 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.44 ' CG2' HG21 ' A' ' 57' ' ' ILE . 47.0 pt -68.6 -16.76 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.722 -1.237 . . . . 0.0 112.243 174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 p -84.46 -7.35 59.31 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 117.353 -1.308 . . . . 0.0 110.315 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.17 -38.13 24.65 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.98 1.312 . . . . 0.0 112.447 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 p -121.61 9.13 10.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.215 1.006 . . . . 0.0 111.081 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.7 t30 40.92 63.95 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.164 2.585 . . . . 0.0 112.204 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -109.03 19.04 19.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.134 1.373 . . . . 0.0 109.307 160.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.89 -63.28 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.764 2.026 . . . . 0.0 109.96 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -45.19 -48.49 12.47 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.952 1.701 . . . . 0.0 113.719 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -40.19 73.51 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.58 0.627 . . . . 0.0 110.498 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.44 HG21 ' CG2' ' A' ' 48' ' ' ILE . 13.4 mt -63.31 -42.27 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -58.01 -51.32 70.16 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.17 2.988 . . . . 0.0 109.27 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.23 -62.16 1.9 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.041 1.737 . . . . 0.0 110.442 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 2' ' ' ALA . 13.7 t80 -53.17 -41.02 64.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.07 -27.57 69.19 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.753 1.221 . . . . 0.0 112.423 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -44.3 96.66 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.026 0.83 . . . . 0.0 110.049 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.45 -46.76 37.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.211 0.605 . . . . 0.0 110.359 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.69 -23.82 66.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.398 1.479 . . . . 0.0 111.464 -170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 1.5 p -127.22 -72.22 0.65 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.741 1.609 . . . . 0.0 109.45 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.16 -21.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.492 -1.171 . . . . 0.0 114.864 -172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.71 156.94 45.09 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.861 1.831 . . . . 0.0 110.24 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -71.63 -30.49 65.82 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.692 -0.63 . . . . 0.0 110.01 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 p -61.16 133.54 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -165.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 165.64 22.28 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.354 1.462 . . . . 0.0 107.487 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.4 171.1 18.13 Favored 'Cis proline' 0 C--N 1.345 0.352 0 CA-C-N 120.883 1.351 . . . . 0.0 111.815 -6.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -142.37 108.01 5.1 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.85 133.27 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -114.75 140.4 48.92 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -123.51 113.08 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 177.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 56.59 58.53 13.94 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.353 -0.842 . . . . 0.0 112.008 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.256 1.0 OUTLIER 46.21 27.73 0.59 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -174.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -129.85 135.23 48.15 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 119.65 1.114 . . . . 0.0 109.187 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -71.11 150.03 45.86 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -105.51 -12.46 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 122.924 0.49 . . . . 0.0 111.39 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.18 -165.44 18.34 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -166.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.65 -95.57 2.41 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 119.006 -0.886 . . . . 0.0 110.921 -174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.89 -56.78 2.19 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.133 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -59.35 -39.04 81.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.861 1.664 . . . . 0.0 112.126 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -42.86 81.2 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.827 0.451 . . . . 0.0 109.871 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.16 -37.0 85.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.558 0.743 . . . . 0.0 110.479 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.39 -49.56 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 115.494 -2.193 . . . . 0.0 109.738 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -61.93 -39.95 93.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 122.939 2.608 . . . . 0.0 112.051 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 80' ' ' ILE . 10.3 mt -54.47 -46.18 73.3 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.41 -51.95 25.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 121.375 1.898 . . . . 0.0 110.959 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -64.2 -53.15 53.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.897 1.679 . . . . 0.0 112.01 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.4 t -71.59 -5.19 31.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.845 1.258 . . . . 0.0 110.775 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.93 9.29 59.44 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.016 -1.435 . . . . 0.0 112.968 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.38 -21.6 66.24 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.264 2.032 . . . . 0.0 111.842 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.49 -37.9 65.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 111.047 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.41 -48.69 74.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.667 0.667 . . . . 0.0 109.65 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -46.57 85.62 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.199 1.0 . . . . 0.0 110.236 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -47.7 -53.51 14.84 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.512 1.525 . . . . 0.0 110.392 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 mp -72.27 -34.85 68.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -58.95 -30.75 68.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.435 1.471 . . . . 0.0 111.419 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -54.62 -19.01 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 112.979 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.01 11.08 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.716 1.143 . . . . 0.0 112.384 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.23 46.9 7.27 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 118.703 0.683 . . . . 0.0 112.431 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.34 -72.49 0.58 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.842 1.257 . . . . 0.0 111.875 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.58 137.19 55.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 120.182 1.355 . . . . 0.0 109.528 -159.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 163.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -66.95 46.78 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.195 2.598 . . . . 0.0 114.536 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -163.53 -56.41 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.051 -1.031 . . . . 0.0 108.393 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.91 -39.05 87.87 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.061 0.392 . . . . 0.0 111.008 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 40.6 t -68.79 -62.85 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.86 -43.65 98.41 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -159.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -75.37 -15.13 60.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.273 -0.87 . . . . 0.0 113.296 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -71.99 -38.76 69.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.426 1.466 . . . . 0.0 111.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.05 126.36 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -173.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -106.88 162.32 20.07 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 123.42 0.688 . . . . 0.0 109.357 168.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.5 79.18 0.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.636 2.89 . . . . 0.0 109.658 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.79 19.7 0.49 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 127.313 2.387 . . . . 0.0 113.54 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -111.96 159.02 18.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.782 1.791 . . . . 0.0 108.467 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG13 ' CD1' ' A' ' 75' ' ' ILE . 36.1 t -113.07 79.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 52.8 t -84.06 147.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.98 113.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 6' ' ' VAL . 86.1 m-85 -76.52 126.28 30.71 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.11 168.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.791 1.236 . . . . 0.0 110.399 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -117.5 149.57 45.07 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 158.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.28 4.83 5.54 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.188 1.926 . . . . 0.0 112.272 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -124.21 -17.25 6.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 132.33 89.12 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 168.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -64.85 -21.26 64.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.766 1.644 . . . . 0.0 109.78 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -74.34 -42.9 58.65 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.953 0.901 . . . . 0.0 109.609 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.64 -45.13 94.25 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -54.55 -44.93 73.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.103 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -57.74 10.27 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 118.793 0.724 . . . . 0.0 109.654 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.96 55.84 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -69.58 -37.62 77.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 117.558 -1.21 . . . . 0.0 114.113 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.51 -49.25 27.56 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 120.111 1.323 . . . . 0.0 108.464 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -49.28 -53.33 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.531 1.532 . . . . 0.0 109.982 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.46 -46.43 17.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -74.79 6.25 4.16 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.156 1.343 . . . . 0.0 114.196 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.1 -12.73 60.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.47 1.508 . . . . 0.0 112.572 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt -123.4 148.66 56.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.55 1.068 . . . . 0.0 111.199 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.64 96.62 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.181 2.588 . . . . 0.0 109.911 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.82 145.98 30.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -47.32 134.34 11.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.272 0.629 . . . . 0.0 111.998 -171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -49.42 115.39 1.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.381 1.473 . . . . 0.0 109.137 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.92 86.75 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.404 -1.22 . . . . 0.0 114.126 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.73 -33.07 64.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 121.215 2.507 . . . . 0.0 109.962 165.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.46 109.59 17.47 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -171.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -129.25 102.72 6.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.51 90.4 8.36 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.128 1.371 . . . . 0.0 107.938 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.5 111.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.475 1.51 . . . . 0.0 109.212 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -71.31 115.01 9.97 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.314 1.046 . . . . 0.0 112.929 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG22 HG21 ' A' ' 57' ' ' ILE . 20.2 pt -70.82 -35.0 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.688 1.595 . . . . 0.0 112.494 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -101.9 4.16 39.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.297 1.039 . . . . 0.0 111.63 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.04 53.14 0.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.337 1.455 . . . . 0.0 110.702 162.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.321 0.3 OUTLIER 60.9 14.24 5.09 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.886 2.474 . . . . 0.0 112.101 178.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.08 11.06 10.4 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 119.448 -2.032 . . . . 0.0 114.162 -167.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m170 67.62 79.82 0.22 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 128.505 2.722 . . . . 0.0 108.48 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -63.68 1.2 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -67.7 -23.69 65.32 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.95 -48.62 73.43 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.061 1.744 . . . . 0.0 111.009 165.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.487 HG21 HG22 ' A' ' 48' ' ' ILE . 13.3 mt -60.86 -38.28 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.102 0.961 . . . . 0.0 109.066 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -59.96 -49.86 76.01 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.02 -44.09 85.74 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.5 1.143 . . . . 0.0 112.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -58.11 -43.64 87.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.624 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 mt -61.89 -33.24 73.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.116 0.966 . . . . 0.0 111.081 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.27 -51.0 69.75 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 119.15 0.886 . . . . 0.0 110.39 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -64.29 -49.54 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.209 0.528 . . . . 0.0 109.609 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tp -73.53 -17.9 61.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.792 0.837 . . . . 0.0 111.114 -167.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.9 p -129.25 -25.91 2.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 114.451 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 -7.51 23.1 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.071 -1.405 . . . . 0.0 112.183 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.86 147.52 22.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 121.069 2.435 . . . . 0.0 110.698 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -21.09 61.05 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 p -70.24 133.75 47.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.806 0.73 . . . . 0.0 110.457 -159.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 161.74 22.54 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.483 1.913 . . . . 0.0 107.813 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.85 125.01 6.2 Favored 'Cis proline' 0 C--N 1.345 0.394 0 CA-C-N 120.344 1.158 . . . . 0.0 111.571 -1.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -95.61 91.25 6.04 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.64 125.07 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 94.03 4.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.142 2.577 . . . . 0.0 107.38 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.477 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -93.27 112.37 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.47 63.39 5.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.291 0.948 . . . . 0.0 113.41 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 46.48 15.28 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.838 2.455 . . . . 0.0 115.703 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -126.96 144.5 50.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 120.074 1.306 . . . . 0.0 109.887 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -86.57 134.96 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.974 0.91 . . . . 0.0 110.896 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pp -83.86 -18.41 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 119.104 0.866 . . . . 0.0 110.556 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.06 -141.3 12.48 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.8 -158.05 14.37 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.898 1.713 . . . . 0.0 108.838 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -22.03 59.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.756 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -65.32 -45.09 85.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.847 1.203 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.32 -57.62 12.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.162 1.785 . . . . 0.0 107.112 170.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.9 tp -52.0 -40.09 60.44 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.14 -50.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 117.266 -1.349 . . . . 0.0 108.382 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -43.24 99.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 120.82 1.645 . . . . 0.0 110.28 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -51.82 -47.48 64.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.097 0.862 . . . . 0.0 109.537 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.79 -52.58 42.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.515 1.052 . . . . 0.0 110.785 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -58.73 3.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.947 1.699 . . . . 0.0 111.244 -170.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -11.46 59.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.463 1.505 . . . . 0.0 109.889 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.51 -2.53 49.76 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.569 161.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -59.27 -28.87 67.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.797 1.799 . . . . 0.0 111.435 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 tt -44.17 -57.89 3.17 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.359 1.863 . . . . 0.0 110.514 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.73 -42.09 98.5 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.864 0.756 . . . . 0.0 109.532 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -61.29 -54.23 46.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.791 0.836 . . . . 0.0 110.358 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.52 76.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.436 1.094 . . . . 0.0 111.021 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.66 -47.4 60.19 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.31 -26.34 67.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.174 1.352 . . . . 0.0 112.468 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -52.3 -33.04 40.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.346 1.458 . . . . 0.0 110.738 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.04 11.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.126 0.876 . . . . 0.0 112.674 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 37.9 26.68 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.2 -0.938 . . . . 0.0 112.328 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.99 -69.83 0.56 Allowed 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 112.131 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.84 136.58 52.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.991 0.814 . . . . 0.0 110.839 -158.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 129.664 3.185 . . . . 0.0 105.219 -175.245 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.693 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.513 -0.459 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -48.64 158.06 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.188 1.395 . . . . 0.0 111.972 -169.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -49.41 -31.64 10.05 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -158.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -55.4 -37.59 67.81 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.24 1.382 . . . . 0.0 112.766 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 2' ' ' ALA . 2.2 t -63.96 -55.12 23.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.32 1.448 . . . . 0.0 109.448 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.66 -39.87 95.28 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 t -81.4 38.6 0.49 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.803 2.041 . . . . 0.0 111.772 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -130.91 -47.79 1.03 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.626 0.771 . . . . 0.0 109.647 159.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.17 133.76 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -170.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.21 165.07 34.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.58 156.77 40.22 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.008 -1.574 . . . . 0.0 108.008 159.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.69 17.1 77.94 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.191 -0.943 . . . . 0.0 115.08 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -135.78 162.04 33.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.684 1.593 . . . . 0.0 108.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.88 79.58 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.19 132.95 33.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.06 110.79 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.3 130.07 38.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.08 179.73 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 C-N-CA 126.362 1.865 . . . . 0.0 109.843 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -140.37 151.27 63.73 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 158.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.22 -15.01 20.49 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.588 2.192 . . . . 0.0 111.527 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -50.57 43.57 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.703 1.201 . . . . 0.0 110.131 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 20' ' ' LYS . 16.0 m -61.1 109.59 2.25 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.401 1.481 . . . . 0.0 111.398 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.75 -20.84 58.98 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.992 1.795 . . . . 0.0 110.898 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -73.2 -22.32 60.49 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 120.926 -1.109 . . . . 0.0 111.294 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.96 -33.12 74.05 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.47 -0.769 . . . . 0.0 109.755 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -63.17 -30.04 71.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.764 0.826 . . . . 0.0 111.774 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.76 4.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.22 51.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 124.365 1.041 . . . . 0.0 111.785 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -53.6 -56.53 16.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.549 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.46 -41.33 63.32 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 123.741 0.651 . . . . 0.0 110.263 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -50.21 -57.42 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.732 1.213 . . . . 0.0 108.737 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 33' ' ' LEU . 12.9 mt -75.96 -43.25 45.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.303 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.2 p -65.65 -20.83 66.45 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 120.03 1.286 . . . . 0.0 113.915 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -73.51 -21.77 60.31 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.626 1.103 . . . . 0.0 110.697 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.78 142.24 56.53 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -64.56 127.56 19.18 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -146.36 157.61 11.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 128.02 34.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.173 0.989 . . . . 0.0 109.646 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -64.43 126.24 27.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.985 -168.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.92 71.29 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.962 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.68 -37.58 65.19 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 119.847 1.824 . . . . 0.0 109.002 164.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 100.03 10.61 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -170.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -122.1 101.49 7.57 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 108.92 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -84.55 93.82 8.44 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.774 1.23 . . . . 0.0 108.638 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.56 112.22 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.809 1.244 . . . . 0.0 109.363 -171.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -63.83 121.29 13.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.506 1.523 . . . . 0.0 112.793 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.5 pt -85.18 -21.35 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.17 1.388 . . . . 0.0 113.382 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -90.09 -3.71 57.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.071 0.85 . . . . 0.0 110.134 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -40.11 -54.85 2.22 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.475 2.31 . . . . 0.0 113.691 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.03 -27.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.05 0.94 . . . . 0.0 109.41 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.35 -46.83 69.69 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.39 1.876 . . . . 0.0 115.073 -164.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 124.63 82.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 1 C-N-CA 131.941 4.096 . . . . 0.0 109.606 -169.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -37.13 -63.02 0.46 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.417 2.287 . . . . 0.0 109.792 164.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -43.74 -49.34 7.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.031 1.333 . . . . 0.0 113.372 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.68 -43.39 80.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.935 0.894 . . . . 0.0 111.458 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HA ' ' HB1' ' A' ' 2' ' ' ALA . 13.2 mt -62.87 -31.75 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -69.35 -54.24 15.51 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.9 -55.8 17.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 123.679 1.704 . . . . 0.0 111.004 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.693 ' CG ' ' HA ' ' A' ' 2' ' ' ALA . 1.1 t80 -79.0 4.67 13.71 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.764 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -91.41 -37.7 13.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 118.122 -2.861 . . . . 0.0 109.907 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -49.83 -49.79 47.72 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.336 1.455 . . . . 0.0 108.142 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -57.49 5.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.412 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.86 -23.86 67.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.971 0.805 . . . . 0.0 111.01 -163.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.1 p -126.45 -17.31 5.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.75 50.0 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.645 1.111 . . . . 0.0 112.155 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.28 158.16 31.94 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.336 1.854 . . . . 0.0 107.869 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.32 -22.08 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -55.41 133.54 49.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.41 0.684 . . . . 0.0 111.139 -161.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.82 153.8 39.96 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -60.3 147.17 43.24 Favored 'Cis proline' 0 CA--C 1.534 0.507 0 CA-C-N 120.122 1.079 . . . . 0.0 110.043 -10.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -130.46 103.1 6.46 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 86' ' ' LEU . 69.7 t -87.09 124.45 40.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 123.022 0.529 . . . . 0.0 109.92 -171.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -103.37 105.5 15.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.605 1.562 . . . . 0.0 107.772 160.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.97 116.57 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 161.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 41.46 69.67 0.51 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 126.193 1.854 . . . . 0.0 114.019 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 47.31 21.37 0.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -116.82 120.67 39.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.908 1.283 . . . . 0.0 108.632 165.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -83.99 104.26 13.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.201 0.6 . . . . 0.0 110.088 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -83.85 -8.74 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 118.462 0.574 . . . . 0.0 112.008 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.97 -167.19 24.15 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.843 0.735 . . . . 0.0 112.606 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.7 -162.15 34.81 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.032 1.301 . . . . 0.0 110.373 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -37.93 71.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.652 1.226 . . . . 0.0 110.104 -165.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 m -68.43 -36.09 78.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.557 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.33 -49.76 58.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.607 1.163 . . . . 0.0 108.618 173.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 73' ' ' VAL . 58.2 tp -51.58 -44.32 62.74 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.016 1.726 . . . . 0.0 111.821 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.17 -44.84 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-O 117.113 -1.422 . . . . 0.0 109.694 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.99 -48.79 75.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -173.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.12 -42.34 85.56 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.222 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -64.1 -56.84 12.04 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.371 0.987 . . . . 0.0 110.305 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -51.52 55.07 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.739 1.616 . . . . 0.0 111.364 -172.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.0 t -71.49 -7.23 46.19 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.325 1.45 . . . . 0.0 110.934 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.09 77.93 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.662 -1.632 . . . . 0.0 114.062 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.04 -33.66 73.64 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.742 2.271 . . . . 0.0 110.707 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -38.18 86.61 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.904 1.282 . . . . 0.0 109.545 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.25 -37.72 86.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.364 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -48.57 72.51 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.589 1.086 . . . . 0.0 109.736 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.76 -50.73 62.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.275 1.03 . . . . 0.0 110.593 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -60.11 -48.21 82.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.49 1.516 . . . . 0.0 110.715 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.59 -35.22 77.23 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.903 -1.123 . . . . 0.0 111.811 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -54.0 -32.42 54.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.674 0.79 . . . . 0.0 111.007 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.96 5.5 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 119.484 1.038 . . . . 0.0 113.377 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.89 39.44 13.5 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.747 1.158 . . . . 0.0 112.87 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.93 -74.86 0.38 Allowed 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 125.876 1.67 . . . . 0.0 112.602 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -53.13 -23.38 8.0 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.24 1.816 . . . . 0.0 114.872 -159.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 130.377 3.471 . . . . 0.0 110.523 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.101 0.477 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -73.33 -67.43 0.58 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 0.0 110.977 -167.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -72.54 -22.87 60.95 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.54 -0.725 . . . . 0.0 111.261 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -32.66 63.15 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.51 -60.26 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.524 -0.735 . . . . 0.0 110.263 166.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -63.38 -27.29 69.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -163.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.2 t -87.35 -24.15 24.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.087 0.955 . . . . 0.0 111.349 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -73.95 -37.84 64.43 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 121.074 -1.016 . . . . 0.0 111.406 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -82.61 149.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 160.05 34.92 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 72.0 Cg_endo -75.94 111.36 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.412 2.741 . . . . 0.0 108.733 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 9.12 21.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.42 1.486 . . . . 0.0 113.646 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -123.47 166.04 16.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.09 1.756 . . . . 0.0 109.241 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 47.3 t -124.0 110.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 10' ' ' ILE . 42.4 t -120.01 139.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.43 112.91 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -78.4 119.91 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.42 161.28 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.629 1.172 . . . . 0.0 111.602 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -120.33 141.96 32.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 168.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.58 -20.12 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.903 1.736 . . . . 0.0 110.996 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 26.52 0.97 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.798 2.039 . . . . 0.0 111.44 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 t -130.92 134.97 26.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.622 2.369 . . . . 0.0 108.706 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.98 -25.87 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.179 2.586 . . . . 0.0 112.265 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -74.34 -29.98 61.83 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.37 -48.0 83.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.562 -0.711 . . . . 0.0 109.836 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -59.5 -41.51 90.06 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.518 -0.739 . . . . 0.0 110.164 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -58.67 6.53 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -39.85 67.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.154 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -56.46 -54.3 47.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.503 172.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -69.47 -41.93 75.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.288 0.949 . . . . 0.0 109.752 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.73 -52.28 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 125.727 1.611 . . . . 0.0 110.159 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.22 -48.97 16.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -69.83 -13.58 62.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.923 0.489 . . . . 0.0 112.269 -169.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.08 -23.33 60.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.035 0.834 . . . . 0.0 110.951 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.08 149.65 85.14 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.12 113.99 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 106.631 -2.103 . . . . 0.0 106.631 164.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.66 138.44 54.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 124.34 7.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.968 1.307 . . . . 0.0 108.687 -169.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.61 122.33 13.81 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -162.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.19 -12.96 58.79 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.082 1.325 . . . . 0.0 113.875 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.67 -28.29 61.68 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 120.697 2.249 . . . . 0.0 110.458 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.81 120.67 26.33 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 120.229 1.377 . . . . 0.0 107.482 -177.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -131.61 104.71 7.09 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.473 1.109 . . . . 0.0 109.338 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 20.3 m-85 -84.6 100.76 11.63 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.07 107.39 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -67.06 104.45 1.41 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 54' ' ' THR . 19.1 pt -69.44 -18.25 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.64 0.776 . . . . 0.0 111.463 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -84.18 8.61 15.16 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.386 -0.821 . . . . 0.0 111.382 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 -21.89 49.75 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.638 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -132.78 -106.41 0.25 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 161.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -134.03 1.85 3.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.68 1.992 . . . . 0.0 110.556 165.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -62.7 -3.1 1.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.921 -1.112 . . . . 0.0 112.091 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -43.41 -63.68 0.78 Allowed 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.558 1.943 . . . . 0.0 109.053 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -52.34 -43.27 64.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.196 1.398 . . . . 0.0 109.801 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.87 -36.1 69.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.13 0.972 . . . . 0.0 112.246 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.7 -51.74 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -57.25 10.04 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.291 0.567 . . . . 0.0 110.822 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.67 -42.33 62.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.242 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -61.13 -43.43 98.9 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.682 0.673 . . . . 0.0 110.709 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.78 -27.51 68.05 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.333 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -63.23 -56.69 14.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 120.739 1.609 . . . . 0.0 109.67 171.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.79 -49.13 71.7 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.839 0.712 . . . . 0.0 109.972 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -76.3 -29.74 57.48 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.116 1.366 . . . . 0.0 111.606 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.8 p -125.63 -29.08 3.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.55 13.96 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 118.179 -1.345 . . . . 0.0 113.982 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -164.99 150.97 9.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.649 2.224 . . . . 0.0 110.68 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' A' ' 62' ' ' GLN . 2.8 ptt-85 -96.61 -7.87 33.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.738 0.815 . . . . 0.0 112.571 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -65.05 133.98 52.84 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.984 0.897 . . . . 0.0 108.649 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.88 147.0 34.61 Favored Pre-proline 0 N--CA 1.442 -0.84 0 C-N-CA 126.618 1.967 . . . . 0.0 105.794 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -66.35 155.1 81.97 Favored 'Cis proline' 0 N--CA 1.461 -0.436 0 CA-C-N 120.353 1.162 . . . . 0.0 111.666 3.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -140.29 106.48 5.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 86' ' ' LEU . 55.2 t -87.89 127.46 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.73 93.98 4.3 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.598 2.359 . . . . 0.0 106.85 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -86.5 121.6 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.75 63.44 3.84 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.231 0.919 . . . . 0.0 113.425 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HE3' ' HD3' ' A' ' 12' ' ' PRO . 3.5 ttmt 46.13 19.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.369 2.267 . . . . 0.0 117.056 -173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.74 133.38 50.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.069 1.304 . . . . 0.0 110.571 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -81.11 121.99 26.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.106 -0.996 . . . . 0.0 109.899 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.4 pp -84.31 -11.81 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 119.616 1.098 . . . . 0.0 111.502 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.83 -163.69 19.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.322 0.963 . . . . 0.0 111.137 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.19 -155.26 29.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.303 0.954 . . . . 0.0 111.076 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -41.96 95.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.465 0.633 . . . . 0.0 111.269 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -65.94 -44.63 84.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.444 0.566 . . . . 0.0 110.897 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.47 -58.13 9.34 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 73' ' ' VAL . 65.0 tp -50.51 -42.13 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.436 1.094 . . . . 0.0 112.051 -174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.28 -51.02 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 CA-C-O 116.347 -1.787 . . . . 0.0 109.229 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.75 -53.47 54.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.448 1.931 . . . . 0.0 107.14 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.33 -40.98 83.55 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.111 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -74.67 -47.58 30.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.197 1.362 . . . . 0.0 107.806 -172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -35.85 60.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.373 1.069 . . . . 0.0 111.073 -169.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 t -94.13 -2.8 52.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.838 1.255 . . . . 0.0 111.15 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.76 0.32 87.74 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.082 -1.954 . . . . 0.0 115.075 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.54 -33.63 74.17 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 121.295 2.548 . . . . 0.0 110.37 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 tp -54.69 -37.64 66.05 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.48 -48.15 57.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -56.58 -49.87 73.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.981 0.913 . . . . 0.0 109.283 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.4 91.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.101 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -50.34 62.79 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.183 173.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.37 1.441 . . . . 0.0 111.801 -164.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.35 -39.08 14.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.304 1.441 . . . . 0.0 113.02 168.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.18 0.58 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 119.304 0.956 . . . . 0.0 111.936 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.34 55.2 2.94 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.7 1.143 . . . . 0.0 110.925 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.46 -75.65 0.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.79 1.636 . . . . 0.0 111.892 -167.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.89 133.73 52.49 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.235 -0.888 . . . . 0.0 108.826 -172.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.45 48.3 1.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.367 -1.458 . . . . 0.0 110.908 -169.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -163.45 -43.13 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.019 1.328 . . . . 0.0 108.752 -172.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -50.72 -55.0 18.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.483 1.038 . . . . 0.0 109.961 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.94 -47.05 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.949 0.9 . . . . 0.0 109.976 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.84 -44.19 86.22 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.006 -0.434 . . . . 0.0 111.355 -164.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -67.22 -23.52 65.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.703 1.601 . . . . 0.0 112.168 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.05 -44.33 69.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.913 1.233 . . . . 0.0 110.268 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -80.02 136.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.23 153.02 55.51 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.08 80.54 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.178 2.586 . . . . 0.0 109.361 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.51 18.54 0.27 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.074 1.797 . . . . 0.0 115.323 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -132.17 171.82 13.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.568 1.684 . . . . 0.0 108.074 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.8 t -115.87 110.39 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 10' ' ' ILE . 75.0 t -126.73 126.16 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -169.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.81 112.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -81.83 120.16 24.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.22 164.52 34.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 125.391 1.477 . . . . 0.0 111.402 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -123.55 139.54 32.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 165.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.58 -9.55 21.42 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.373 2.049 . . . . 0.0 112.104 -172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 p -79.23 -18.81 52.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.581 2.352 . . . . 0.0 113.592 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -122.4 134.54 24.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -158.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.86 -14.25 26.67 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.805 2.337 . . . . 0.0 112.304 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -73.27 -35.17 66.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.566 1.075 . . . . 0.0 108.739 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.27 -47.07 74.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -52.05 -49.96 62.42 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.157 0.983 . . . . 0.0 113.049 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -57.03 14.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.582 1.083 . . . . 0.0 109.02 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -35.94 64.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.412 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -53.65 54.34 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.561 1.144 . . . . 0.0 112.435 174.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.69 -52.26 46.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.1 mt -46.73 -53.64 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.763 2.025 . . . . 0.0 109.413 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.94 -47.16 63.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.9 p -63.45 -19.14 64.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.064 -0.97 . . . . 0.0 113.538 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -73.28 -33.22 65.12 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 120.254 1.388 . . . . 0.0 109.966 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.12 136.05 95.28 Favored Pre-proline 0 N--CA 1.45 -0.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.81 76.98 3.87 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.493 2.795 . . . . 0.0 110.046 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.7 mt -87.76 145.51 7.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 104.238 -2.505 . . . . 0.0 104.238 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -53.25 123.39 11.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -66.3 122.87 18.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 -8.04 40.89 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.192 1.377 . . . . 0.0 111.801 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -78.04 -33.7 50.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 119.812 1.806 . . . . 0.0 111.489 172.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 120.73 29.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.433 1.015 . . . . 0.0 109.782 -171.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.67 130.68 47.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.481 0.712 . . . . 0.0 109.605 168.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.0 101.42 11.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.7 113.97 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.005 2.122 . . . . 0.0 108.485 -167.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -69.9 109.97 4.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.529 0.732 . . . . 0.0 110.532 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.43 13.18 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.316 1.046 . . . . 0.0 112.857 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -114.69 -44.17 3.09 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.449 -1.407 . . . . 0.0 111.45 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.33 -51.35 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.822 0.849 . . . . 0.0 113.042 -158.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -125.03 4.52 7.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 112.577 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.46 -162.4 1.29 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 0.0 110.384 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -129.46 87.17 2.51 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.388 1.075 . . . . 0.0 108.238 -158.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -63.53 0.99 Allowed 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 125.465 1.506 . . . . 0.0 107.495 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -44.14 -48.89 9.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.525 1.13 . . . . 0.0 113.013 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -52.64 64.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.552 1.141 . . . . 0.0 111.411 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.96 -31.82 54.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.75 1.22 . . . . 0.0 111.675 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HA ' HH22 ' A' ' 72' ' ' ARG . 7.1 mt-30 -68.31 -45.31 73.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -64.64 -52.27 58.27 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.703 2.801 . . . . 0.0 110.405 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -55.05 -47.82 74.28 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.148 0.979 . . . . 0.0 111.205 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 64' ' ' LEU . 61.8 mt -65.66 -36.95 85.16 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.73 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.71 -44.31 96.76 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.53 1.059 . . . . 0.0 110.725 172.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -42.39 98.83 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.829 0.452 . . . . 0.0 110.597 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.427 HD23 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -76.05 -29.69 58.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.421 1.089 . . . . 0.0 109.399 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 p -125.06 -76.03 0.59 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.202 0.91 . . . . 0.0 109.072 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.31 -8.31 0.05 OUTLIER Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.728 -1.596 . . . . 0.0 116.715 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.43 146.26 48.15 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.572 2.686 . . . . 0.0 111.19 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.12 -28.29 15.15 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.302 1.441 . . . . 0.0 112.238 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.4 p -61.14 133.82 56.4 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 159.02 56.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.43 170.28 32.85 Favored 'Cis proline' 0 CA--C 1.536 0.577 0 CA-C-N 118.763 0.594 . . . . 0.0 111.88 -11.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.584 HH22 ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -121.11 113.14 19.59 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 159.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.7 t -83.22 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.96 121.93 43.55 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 164.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -107.88 118.57 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 166.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 55.65 58.96 11.46 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.387 0.994 . . . . 0.0 112.689 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.285 3.6 tmtt? 45.49 30.73 0.78 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.58 1.952 . . . . 0.0 116.192 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.02 149.95 49.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.71 130.39 34.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.88 -26.08 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.14 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.17 -174.2 21.83 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.636 1.589 . . . . 0.0 112.057 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.53 -167.67 42.18 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.31 1.433 . . . . 0.0 112.042 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.42 -38.11 89.89 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.811 1.306 . . . . 0.0 111.598 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -64.99 -40.18 94.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.399 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.84 -51.65 45.97 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.421 1.088 . . . . 0.0 109.316 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.1 tp -51.89 -38.91 57.98 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 125.515 1.526 . . . . 0.0 111.652 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.42 -47.87 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 116.53 -1.7 . . . . 0.0 109.8 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -46.79 88.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.636 2.017 . . . . 0.0 108.615 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.62 -31.24 72.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.155 -174.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.07 -52.54 23.08 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.385 1.448 . . . . 0.0 110.234 170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.79 49.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.928 1.691 . . . . 0.0 111.399 -170.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -63.66 -33.55 75.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.76 2.024 . . . . 0.0 109.951 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.95 10.32 64.81 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.951 -1.472 . . . . 0.0 112.034 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.75 -32.04 65.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.089 1.945 . . . . 0.0 110.835 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.29 -36.23 70.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.846 1.659 . . . . 0.0 110.648 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.77 -50.67 61.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.916 0.487 . . . . 0.0 109.829 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 m -60.41 -49.29 78.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.883 0.873 . . . . 0.0 109.551 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -49.35 60.0 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.433 1.093 . . . . 0.0 110.348 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.4 mt -66.99 -45.09 78.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.63 -0.669 . . . . 0.0 111.783 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -68.32 -24.44 64.84 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.34 -1.475 . . . . 0.0 112.832 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -52.08 -39.34 59.59 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.861 0.755 . . . . 0.0 110.323 168.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.11 10.93 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.919 0.888 . . . . 0.0 111.914 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.45 76.98 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.411 -0.806 . . . . 0.0 113.571 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.0 -67.7 0.45 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 118.467 1.133 . . . . 0.0 110.142 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.92 134.01 45.75 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 118.163 -1.415 . . . . 0.0 107.669 -162.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 125.11 1.506 . . . . 0.0 108.668 -157.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.83 55.41 2.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.802 1.641 . . . . 0.0 110.507 -173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -163.1 -55.88 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.877 -1.14 . . . . 0.0 109.776 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -51.91 -47.38 64.65 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.974 0.806 . . . . 0.0 111.305 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 t -63.85 -54.19 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.851 0.861 . . . . 0.0 109.954 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.81 -38.22 75.16 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.051 0.94 . . . . 0.0 110.971 -172.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.22 -29.76 64.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.736 0.815 . . . . 0.0 111.702 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -76.65 -45.6 29.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.797 1.635 . . . . 0.0 111.484 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.65 148.29 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -144.5 145.96 30.71 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.19 129.44 28.5 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.701 1.601 . . . . 0.0 108.617 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.54 77.88 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.372 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.6 169.91 8.99 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 120.237 2.019 . . . . 0.0 110.041 172.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.86 109.49 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.63 111.35 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 73' ' ' VAL . 14.3 t -100.82 121.14 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 169.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.79 130.14 34.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 168.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.48 173.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 110.399 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -138.41 144.53 43.08 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 161.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.83 -15.04 19.18 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.749 1.633 . . . . 0.0 111.433 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -66.65 -49.03 67.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.106 2.162 . . . . 0.0 110.943 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.0 122.35 87.28 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.806 1.242 . . . . 0.0 110.257 -172.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.29 -11.5 31.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.272 2.648 . . . . 0.0 112.31 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.8 -31.46 63.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.241 -0.912 . . . . 0.0 109.588 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -72.82 -38.77 67.04 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -46.55 67.06 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.138 0.575 . . . . 0.0 110.068 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.92 -56.05 23.84 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.287 174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.91 -38.85 65.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.238 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -48.64 79.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.37 0.986 . . . . 0.0 113.644 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.09 -44.57 53.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -49.3 -54.83 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.969 1.307 . . . . 0.0 110.323 175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD12 HG21 ' A' ' 17' ' ' VAL . 9.9 mt -81.97 -41.56 20.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.813 -172.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.7 t -70.65 -18.71 62.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.543 1.519 . . . . 0.0 112.498 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.83 -11.01 60.24 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.729 1.149 . . . . 0.0 111.827 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.12 133.06 39.77 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 163.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.44 62.52 8.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.011 2.474 . . . . 0.0 111.791 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.16 147.84 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -55.77 124.31 17.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -62.61 113.38 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.09 -12.9 9.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.744 1.164 . . . . 0.0 111.741 -175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.15 -39.81 15.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.691 1.745 . . . . 0.0 111.63 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 115.91 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.482 1.113 . . . . 0.0 109.465 -167.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -137.74 107.54 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.52 1.055 . . . . 0.0 109.078 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -85.93 105.12 16.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.842 1.257 . . . . 0.0 108.175 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.08 111.01 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -63.45 127.93 33.52 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 162.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.1 pt -93.04 -2.23 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 112.195 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -92.98 -40.48 10.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.847 1.203 . . . . 0.0 111.372 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.72 66.58 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.084 1.754 . . . . 0.0 113.487 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.77 161.56 40.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.79 1.636 . . . . 0.0 107.501 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 57.76 -163.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.606 1.162 . . . . 0.0 110.856 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -118.15 80.77 1.57 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -158.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.21 -63.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.468 1.507 . . . . 0.0 110.384 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -40.63 59.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.78 0.832 . . . . 0.0 110.969 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.5 -11.91 56.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.615 1.966 . . . . 0.0 114.425 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 mt -85.03 -47.49 16.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 125.379 1.472 . . . . 0.0 107.834 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -71.17 -40.98 70.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.521 0.677 . . . . 0.0 110.78 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.89 -36.86 72.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.918 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -66.36 -33.87 76.71 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.311 -1.493 . . . . 0.0 112.703 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.92 -29.62 70.78 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 120.186 1.357 . . . . 0.0 110.135 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.79 -38.5 78.67 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 120.354 1.434 . . . . 0.0 110.681 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -55.54 6.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.405 0.682 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.13 -25.79 55.71 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.659 1.184 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.1 p -122.9 -36.74 2.83 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.813 -1.18 . . . . 0.0 111.977 -172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.95 -17.69 5.15 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.378 -1.234 . . . . 0.0 114.211 168.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.91 148.33 38.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.899 1.85 . . . . 0.0 110.216 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -11.95 59.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.59 143.11 25.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.805 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 151.55 43.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 125.9 1.68 . . . . 0.0 106.573 164.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.28 165.45 43.8 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 CA-C-N 120.139 1.086 . . . . 0.0 111.33 -4.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -142.57 109.11 5.34 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 86' ' ' LEU . 97.9 t -88.31 126.78 41.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.935 0.494 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -105.06 130.47 53.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.82 111.78 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.43 73.39 0.42 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 125.145 1.355 . . . . 0.0 113.213 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.55 -9.18 0.0 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 130.658 3.583 . . . . 0.0 118.107 -173.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -91.73 163.82 13.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.923 1.238 . . . . 0.0 108.877 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.3 t -125.02 129.13 49.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.828 1.651 . . . . 0.0 109.006 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.1 pp -106.48 -16.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -162.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.68 178.66 23.96 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.73 -89.54 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 125.206 1.384 . . . . 0.0 110.391 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.45 -62.15 1.05 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 111.642 -169.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.2 t -65.53 -36.79 84.85 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.108 0.867 . . . . 0.0 110.183 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.47 -55.61 29.25 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.53 HD13 HG21 ' A' ' 73' ' ' VAL . 48.5 tp -49.07 -45.49 43.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.995 1.318 . . . . 0.0 111.689 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -46.74 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 116.628 -1.653 . . . . 0.0 109.789 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -49.08 75.64 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.64 -33.11 69.7 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.489 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -71.4 -51.57 23.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 121.148 1.794 . . . . 0.0 109.784 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -47.73 60.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.015 1.326 . . . . 0.0 110.045 -166.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -60.98 -34.08 74.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.424 1.89 . . . . 0.0 110.436 167.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 19.65 57.78 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-O 118.156 -1.358 . . . . 0.0 112.043 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.54 -42.51 83.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.732 2.266 . . . . 0.0 110.381 170.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -35.27 63.55 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.23 1.812 . . . . 0.0 110.473 -174.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.31 -52.58 64.1 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.681 0.793 . . . . 0.0 111.945 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.1 m -65.71 -41.53 92.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.449 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -44.72 73.14 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.771 0.828 . . . . 0.0 110.167 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.93 -44.44 89.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.974 1.31 . . . . 0.0 112.752 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 105' ' ' LEU . 68.0 mttt -63.18 -27.08 69.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.696 1.135 . . . . 0.0 112.434 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -56.03 -15.89 4.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 112.878 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.59 12.3 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 120.141 1.337 . . . . 0.0 112.351 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.74 36.14 58.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.174 -0.954 . . . . 0.0 113.005 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.72 -66.05 0.96 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.253 1.421 . . . . 0.0 112.757 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . 17.1 mt -75.27 133.57 41.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 121.352 1.887 . . . . 0.0 107.572 -167.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.771 1.229 . . . . 0.0 109.315 -167.269 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.463 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 5.2 pm0 -53.67 32.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 1 C-N-CA 133.77 4.828 . . . . 0.0 116.831 178.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -163.44 -58.04 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.512 1.925 . . . . 0.0 106.712 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -62.5 -46.12 89.89 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.903 0.774 . . . . 0.0 110.594 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 57' ' ' ILE . 8.9 t -68.99 -59.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.51 -49.41 74.83 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 t -76.76 -26.44 54.54 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.79 0.836 . . . . 0.0 112.367 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -66.47 -39.18 88.64 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.322 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -75.81 132.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.18 155.49 71.07 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.83 26.08 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 125.302 4.001 . . . . 0.0 115.054 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.23 21.16 0.11 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.603 1.573 . . . . 0.0 113.169 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -120.79 168.24 11.65 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.84 120.55 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.07 135.1 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.73 118.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -82.19 124.53 29.99 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.51 177.37 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.384 1.474 . . . . 0.0 111.257 -166.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 158.98 64.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.009 1.724 . . . . 0.0 107.289 169.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.88 2.09 8.71 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.264 2.643 . . . . 0.0 114.592 -163.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -133.04 -25.3 1.82 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -158.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 156.41 77.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.32 1.448 . . . . 0.0 114.12 -158.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.27 -29.5 21.34 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.431 2.087 . . . . 0.0 110.666 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -73.92 -46.74 42.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.7 m -70.09 -44.23 69.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -48.56 -46.71 39.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.217 -0.927 . . . . 0.0 111.969 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -60.4 -60.54 3.64 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 118.891 0.769 . . . . 0.0 109.572 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.69 69.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 124.244 0.965 . . . . 0.0 111.968 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -60.88 -47.54 85.93 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 117.827 -1.082 . . . . 0.0 111.503 177.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.77 -53.55 31.9 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 119.08 0.855 . . . . 0.0 109.9 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.04 -49.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.442 1.497 . . . . 0.0 109.763 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.27 -51.96 13.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -66.33 -23.44 66.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -73.84 -23.61 59.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.248 0.931 . . . . 0.0 110.044 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.98 138.15 69.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.1 65.79 8.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.303 2.668 . . . . 0.0 111.663 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.02 150.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -55.82 123.97 16.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.502 1.121 . . . . 0.0 109.516 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -65.29 151.31 46.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.322 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.61 -18.83 10.28 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.671 -1.627 . . . . 0.0 112.255 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -46.14 47.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 120.649 2.224 . . . . 0.0 109.803 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 116.08 22.69 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.044 0.84 . . . . 0.0 109.866 -169.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -124.48 150.67 45.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.987 1.315 . . . . 0.0 108.949 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 7.6 m-85 -124.24 130.31 52.31 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.54 101.39 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.801 1.64 . . . . 0.0 107.82 -160.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -64.16 119.67 10.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.908 0.883 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 pt -89.77 -8.22 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.072 0.949 . . . . 0.0 113.196 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 t -124.74 16.8 8.73 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.556 1.142 . . . . 0.0 110.964 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.67 -56.99 7.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 159.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 p -148.8 -39.94 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -164.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.06 19.32 2.21 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -158.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.33 80.92 0.16 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.762 1.225 . . . . 0.0 110.69 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.09 -62.46 1.56 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 125.377 1.471 . . . . 0.0 107.376 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -47.8 -45.42 29.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.494 1.118 . . . . 0.0 112.537 -171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.261 9.9 tm-20 -63.87 -44.47 93.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.751 2.02 . . . . 0.0 112.668 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.475 HG23 HG21 ' A' ' 6' ' ' VAL . 11.7 mt -62.99 -37.75 80.18 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 125.243 1.417 . . . . 0.0 110.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.63 -38.56 70.75 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.33 -50.47 72.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.267 1.427 . . . . 0.0 111.057 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -57.09 -43.31 82.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.429 HD13 ' HG3' ' A' ' 72' ' ' ARG . 23.9 mt -64.15 -34.85 79.01 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -57.89 -46.0 85.56 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -53.73 30.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.63 -29.77 69.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.708 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -121.8 -27.31 4.69 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.34 -33.99 3.97 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.405 1.479 . . . . 0.0 110.867 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.74 43.59 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.729 1.264 . . . . 0.0 112.077 -172.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.49 -5.89 28.52 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.299 1.039 . . . . 0.0 113.175 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.6 p -68.1 133.78 49.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.99 154.56 37.27 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.11 132.23 14.57 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.169 1.096 . . . . 0.0 111.716 -9.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 61' ' ' LEU . 3.5 mmp_? -93.03 111.1 22.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -86.37 126.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -111.23 136.76 49.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 159.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.62 115.51 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 102.501 -3.148 . . . . 0.0 102.501 171.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.46 72.35 0.43 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.661 1.601 . . . . 0.0 114.183 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' A' ' 10' ' ' ILE . 2.6 mmtp 46.58 9.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.002 2.521 . . . . 0.0 116.12 -171.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -114.58 113.21 24.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.994 1.27 . . . . 0.0 108.848 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.94 123.93 21.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.71 -26.04 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 118.714 0.688 . . . . 0.0 109.707 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.38 -161.35 24.67 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.328 0.966 . . . . 0.0 111.133 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.42 -161.47 31.42 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.455 1.026 . . . . 0.0 111.444 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -33.59 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.326 1.063 . . . . 0.0 110.119 -165.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 t -71.42 -36.59 71.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -66.63 -53.8 30.22 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.3 tp -51.72 -46.42 63.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.313 1.445 . . . . 0.0 112.132 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.39 -44.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 117.357 -1.306 . . . . 0.0 108.892 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -50.02 63.9 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.45 -38.88 72.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -67.13 -57.32 6.99 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.381 1.446 . . . . 0.0 110.505 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -29.7 65.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.49 1.516 . . . . 0.0 112.486 -168.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 t -87.17 -14.5 41.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.434 2.294 . . . . 0.0 110.638 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.3 89.39 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 117.604 -1.665 . . . . 0.0 113.705 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -25.31 67.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.246 2.523 . . . . 0.0 110.77 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 tp -62.41 -34.32 76.51 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.605 1.962 . . . . 0.0 111.449 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.16 -50.24 66.74 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 m -61.55 -46.49 89.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.188 0.449 . . . . 0.0 109.808 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -47.0 72.26 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.234 0.47 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.44 -53.48 23.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 111.24 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -58.27 -29.19 65.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.655 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -51.34 -42.58 61.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.715 0.689 . . . . 0.0 110.093 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.31 6.05 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.027 0.831 . . . . 0.0 112.354 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.31 38.01 19.41 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.289 0.95 . . . . 0.0 112.821 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.87 -69.47 0.69 Allowed 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.801 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.46 133.84 49.24 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -172.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.253 1.276 0 CA-C-N 112.21 -2.268 . . . . 0.0 110.934 -160.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 38.59 -62.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 1 C-N-CA 132.612 4.365 . . . . 0.0 117.49 159.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -163.31 -50.69 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.285 -0.884 . . . . 0.0 109.091 -167.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -60.34 -25.39 65.79 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.964 0.347 . . . . 0.0 111.432 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.07 -58.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.219 1.007 . . . . 0.0 109.549 159.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -68.41 -17.74 64.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -159.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.3 t -101.97 -26.42 13.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.983 1.313 . . . . 0.0 110.31 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -64.14 -45.75 87.11 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.659 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mt -64.2 143.75 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.682 1.128 . . . . 0.0 108.076 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.7 140.36 35.15 Favored Pre-proline 0 C--O 1.238 0.454 0 CA-C-N 119.296 0.953 . . . . 0.0 109.716 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.86 89.94 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.24 2.627 . . . . 0.0 108.714 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.53 17.04 2.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.896 1.712 . . . . 0.0 113.882 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -128.6 162.23 27.77 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.875 2.07 . . . . 0.0 109.636 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CD1' ' A' ' 75' ' ' ILE . 15.2 t -112.29 81.45 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.43 134.93 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 t -134.3 111.71 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -78.46 128.36 33.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 pt -138.53 179.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.3 1.84 . . . . 0.0 109.24 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -144.79 147.6 36.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 158.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.34 -14.97 38.33 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.579 2.186 . . . . 0.0 113.042 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p -77.16 -28.82 54.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.333 0.97 . . . . 0.0 111.672 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -74.8 121.52 85.44 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.583 0.629 . . . . 0.0 110.382 -164.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.74 -15.62 33.43 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.012 1.808 . . . . 0.0 111.823 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.98 -33.55 24.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.772 1.169 . . . . 0.0 109.341 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.2 m -62.63 -41.52 99.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -53.49 -42.76 67.6 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.474 0.579 . . . . 0.0 112.29 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -55.82 23.19 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.02 -36.08 62.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.307 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.92 83.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.777 169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.81 -46.58 65.38 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 120.543 1.519 . . . . 0.0 109.414 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -52.09 -58.34 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 126.504 1.921 . . . . 0.0 107.7 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.6 mt -76.47 -33.34 58.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.598 -170.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 m -67.33 -35.13 78.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 0.0 112.138 174.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.98 -9.43 58.63 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.904 1.229 . . . . 0.0 112.079 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.57 135.52 43.41 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.058 1.299 . . . . 0.0 109.392 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.12 75.96 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.515 3.477 . . . . 0.0 110.481 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.494 HD11 HD13 ' A' ' 99' ' ' LEU . 8.1 mt -102.93 151.3 6.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -169.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -48.25 130.53 16.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.383 1.073 . . . . 0.0 110.485 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.1 140.27 56.01 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.66 -7.81 57.18 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.814 -1.548 . . . . 0.0 113.733 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.57 -37.19 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 121.066 2.433 . . . . 0.0 110.966 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 103.29 13.26 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.26 103.68 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.377 1.071 . . . . 0.0 108.58 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -84.09 117.49 23.48 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.67 109.2 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.995 2.118 . . . . 0.0 108.834 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -64.02 104.95 0.78 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.494 2.318 . . . . 0.0 114.015 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.67 -22.38 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.757 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.262 3.0 t -99.38 2.83 45.59 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.877 -1.058 . . . . 0.0 111.135 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -40.19 -67.76 0.21 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.529 1.932 . . . . 0.0 112.0 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 t -160.08 -15.57 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.11 1.364 . . . . 0.0 111.508 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -50.3 -57.49 7.76 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.628 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 1.1 m-70 127.73 105.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 C-N-CA 131.276 3.83 . . . . 0.0 105.997 -158.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -63.51 1.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.462 1.105 . . . . 0.0 108.914 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 58' ' ' GLN . 7.1 t30 -61.46 -29.96 70.29 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . 3.6 tm-20 -64.24 -46.57 83.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.484 1.114 . . . . 0.0 110.985 171.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 mt -59.26 -38.57 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 55' ' ' ASN . 6.9 mm-40 -70.38 -48.88 54.2 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -169.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -49.21 -55.31 12.94 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.211 1.404 . . . . 0.0 110.548 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 2' ' ' ALA . 24.9 t80 -56.84 -45.12 82.6 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.169 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.06 -44.83 96.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.889 1.222 . . . . 0.0 111.032 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.8 -34.75 69.97 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 123.151 0.282 . . . . 0.0 111.034 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -76.29 -48.23 20.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.935 0.494 . . . . 0.0 111.567 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.28 -47.01 63.17 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.941 1.296 . . . . 0.0 108.5 -158.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 p -102.63 -44.9 5.19 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.34 -13.35 4.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.667 1.127 . . . . 0.0 113.001 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.78 160.28 41.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.486 1.643 . . . . 0.0 108.875 173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -118.65 -24.16 6.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 117.394 -1.289 . . . . 0.0 114.221 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 p -64.16 133.24 52.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 160.73 56.16 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.783 1.233 . . . . 0.0 108.497 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.16 159.99 61.4 Favored 'Cis proline' 0 C--N 1.344 0.323 0 CA-C-N 120.314 1.148 . . . . 0.0 110.591 -4.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -123.27 101.2 7.24 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.07 126.56 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -114.25 97.86 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -83.79 123.12 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 168.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 42.6 68.79 0.69 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.924 1.25 . . . . 0.0 113.23 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 46.22 -2.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.813 2.845 . . . . 0.0 118.645 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.4 115.74 28.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.094 1.316 . . . . 0.0 107.87 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 t -63.74 117.26 6.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -83.32 -16.89 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.19 -146.79 17.88 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.26 -153.43 18.87 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.934 0.741 . . . . 0.0 111.783 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.2 p -65.64 -38.47 89.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.044 0.938 . . . . 0.0 110.653 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -75.92 -31.39 59.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.662 0.601 . . . . 0.0 111.62 -176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.05 -52.5 41.54 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 23.0 tp -57.01 -34.36 68.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.451 0.7 . . . . 0.0 111.351 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.65 -48.44 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 115.419 -2.229 . . . . 0.0 109.723 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -55.1 37.64 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 121.441 1.928 . . . . 0.0 107.256 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.54 -35.86 72.96 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.689 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -68.47 -47.77 66.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.335 1.425 . . . . 0.0 110.51 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -63.8 1.15 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.999 2.52 . . . . 0.0 109.818 -168.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -79.22 -12.54 59.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 119.253 -0.404 . . . . 0.0 110.523 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.7 18.81 53.92 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-O 117.228 -1.873 . . . . 0.0 113.282 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.52 -23.02 67.13 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 121.099 2.449 . . . . 0.0 111.049 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.44 -38.86 63.94 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.294 1.438 . . . . 0.0 111.09 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.57 -48.38 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.161 0.984 . . . . 0.0 109.182 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.2 m -66.69 -44.66 81.15 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.976 1.31 . . . . 0.0 110.658 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -47.76 64.33 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.6 0.76 . . . . 0.0 109.392 174.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 38' ' ' ILE . 23.4 mt -69.83 -50.67 40.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.126 0.57 . . . . 0.0 111.438 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -57.95 -29.94 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.362 -0.836 . . . . 0.0 112.627 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -47.96 -40.52 22.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.361 1.064 . . . . 0.0 111.601 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.4 8.17 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 118.646 0.657 . . . . 0.0 112.764 -168.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.4 50.81 5.54 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.694 0.679 . . . . 0.0 111.671 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.86 -74.17 0.65 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 126.508 1.923 . . . . 0.0 112.507 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.74 150.95 43.97 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.599 1.999 . . . . 0.0 106.93 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.964 -172.294 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.378 0 CA-C-O 115.807 -2.044 . . . . 0.0 106.672 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 56.42 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 129.284 3.033 . . . . 0.0 118.045 160.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -163.94 -38.9 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.96 2.104 . . . . 0.0 108.036 -164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -49.49 -48.41 47.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.224 1.374 . . . . 0.0 111.519 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.26 -48.67 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.726 -0.609 . . . . 0.0 110.033 174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -70.95 -32.03 68.8 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.161 -0.962 . . . . 0.0 113.199 -167.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -18.12 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.973 -1.08 . . . . 0.0 110.818 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 44' ' ' GLU . 32.1 mmtm -76.46 -59.87 2.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.479 172.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.05 144.81 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.623 1.101 . . . . 0.0 108.928 -172.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -138.27 157.04 73.35 Favored Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 126.982 2.113 . . . . 0.0 106.559 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.26 66.76 7.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.518 2.812 . . . . 0.0 110.7 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.86 40.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.109 1.814 . . . . 0.0 111.21 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -143.49 168.99 18.54 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.22 1.808 . . . . 0.0 107.128 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 75' ' ' ILE . 25.3 t -114.7 95.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 165.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.68 144.66 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 t -132.22 117.59 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -77.16 120.79 22.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.29 -178.15 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.745 2.418 . . . . 0.0 109.664 -172.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 11.8 ptpt -136.27 164.48 42.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 126.496 1.918 . . . . 0.0 107.673 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 20' ' ' LYS . 82.3 Cg_endo -76.74 -1.97 12.14 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.452 2.101 . . . . 0.0 112.773 -165.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -118.67 -99.99 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.794 1.637 . . . . 0.0 107.426 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 t 32.48 100.94 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 128.599 2.76 . . . . 0.0 114.995 169.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.56 -10.0 26.28 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.247 1.298 . . . . 0.0 111.637 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.85 -35.1 15.85 Favored 'General case' 0 C--N 1.34 0.184 0 O-C-N 120.727 -1.233 . . . . 0.0 108.169 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.7 -55.18 33.08 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -57.58 -41.4 81.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.845 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -56.89 -61.41 2.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 118.865 0.757 . . . . 0.0 109.69 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.13 -33.54 27.03 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.049 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' HG3' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.18 -55.52 33.94 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.56 1.544 . . . . 0.0 111.968 171.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.43 -38.58 77.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.078 1.763 . . . . 0.0 110.243 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.41 -50.33 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.291 1.436 . . . . 0.0 108.971 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.86 -53.0 9.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -63.21 -24.55 67.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.397 0.679 . . . . 0.0 112.098 -166.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -74.01 0.85 12.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.055 0.843 . . . . 0.0 112.392 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 120.796 -1.19 . . . . 0.0 109.207 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.35 57.24 6.16 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.159 3.24 . . . . 0.0 111.383 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 99' ' ' LEU . 9.2 mt -74.52 151.2 7.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -175.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -53.92 123.93 13.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.06 133.33 50.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -171.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -14.33 63.9 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.571 -1.127 . . . . 0.0 113.005 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.16 -39.5 63.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.706 1.753 . . . . 0.0 110.754 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 104.18 14.14 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -168.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' OE2' ' HE3' ' A' ' 9' ' ' LYS . 42.5 tt0 -122.35 113.9 20.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 30' ' ' GLN . 22.1 m-85 -83.84 133.28 34.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -125.03 100.2 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.369 1.468 . . . . 0.0 107.052 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -64.65 112.86 3.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.708 1.203 . . . . 0.0 111.131 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.7 pt -68.04 -9.39 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.113 -0.992 . . . . 0.0 112.689 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 p -89.02 -7.33 56.16 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.623 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.47 62.32 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.786 1.176 . . . . 0.0 113.184 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.4 p -121.02 2.79 10.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.813 1.645 . . . . 0.0 110.843 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.0 t30 54.57 -6.46 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.419 2.688 . . . . 0.0 115.855 -171.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -68.02 17.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.657 1.583 . . . . 0.0 113.341 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.86 -63.0 0.34 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.674 1.99 . . . . 0.0 110.237 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.62 -22.62 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.629 1.572 . . . . 0.0 114.81 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.74 -30.71 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.155 1.343 . . . . 0.0 111.522 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mt -69.76 -33.68 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.896 1.279 . . . . 0.0 108.299 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -52.27 54.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -52.48 -54.96 25.56 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.199 1.8 . . . . 0.0 110.424 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -51.55 -46.0 63.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.608 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.4 mt -64.97 -35.46 81.25 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.617 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.53 -54.91 28.79 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.973 1.26 . . . . 0.0 109.412 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -36.76 76.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.137 0.975 . . . . 0.0 110.393 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -76.34 -52.48 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 0.0 109.161 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -97.49 -75.89 0.53 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -168.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 169.06 -13.93 0.06 OUTLIER Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.022 1.296 . . . . 0.0 114.005 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.68 146.47 41.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.091 1.945 . . . . 0.0 108.97 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -29.43 45.8 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.861 171.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -62.41 133.29 54.83 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -159.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.03 153.91 52.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.32 156.85 80.9 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.24 0.764 . . . . 0.0 111.684 -7.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -124.48 106.69 10.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.2 129.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -118.53 93.99 4.31 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.912 2.485 . . . . 0.0 107.479 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.91 118.15 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 40.13 67.97 0.61 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.492 1.996 . . . . 0.0 114.489 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.61 24.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -123.89 97.75 5.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -67.84 118.1 10.62 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.806 -1.184 . . . . 0.0 108.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 89' ' ' LEU . 1.1 pp -83.76 -21.58 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -167.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.57 -168.77 24.34 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -170.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.14 -85.62 1.79 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 -64.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.813 1.245 . . . . 0.0 108.157 -170.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m -58.77 -39.41 80.94 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.533 0.733 . . . . 0.0 111.721 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.83 -56.73 18.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.0 -39.35 74.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.099 1.36 . . . . 0.0 110.856 -168.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.8 t -64.85 -40.87 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 117.256 -1.354 . . . . 0.0 111.119 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.21 -50.91 69.9 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 80' ' ' ILE . 4.0 mp -56.06 -37.65 69.58 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 117.743 -1.122 . . . . 0.0 109.613 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -63.64 -57.58 9.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.453 1.479 . . . . 0.0 109.613 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -42.9 83.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.299 1.44 . . . . 0.0 111.57 -166.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 38.1 t -65.06 -51.99 58.31 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.593 1.957 . . . . 0.0 107.845 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.73 1.77 27.3 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.259 -1.301 . . . . 0.0 111.475 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.7 -22.66 66.67 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.936 1.868 . . . . 0.0 110.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -54.51 -46.45 73.5 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 124.626 1.17 . . . . 0.0 110.348 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.68 -51.14 68.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.478 0.711 . . . . 0.0 109.234 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -53.73 -45.62 70.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.009 0.924 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -56.23 21.36 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.16 0.984 . . . . 0.0 110.678 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -75.22 -30.72 60.65 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.944 -1.097 . . . . 0.0 112.15 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -58.19 -30.15 66.21 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.396 -1.44 . . . . 0.0 112.474 169.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -60.17 -8.8 2.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.157 1.383 . . . . 0.0 113.773 171.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.16 8.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.437 1.895 . . . . 0.0 110.866 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.51 36.86 89.23 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.968 1.27 . . . . 0.0 112.951 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.45 -62.32 1.48 Allowed 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.71 1.204 . . . . 0.0 110.742 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 mt -72.28 142.62 48.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.464 -161.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.319 -0.741 0 C-N-CA 127.994 2.518 . . . . 0.0 107.5 -178.199 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.571 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 1.4 pm0 -67.4 -99.4 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 125.505 1.753 . . . . 0.0 106.755 159.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.06 -31.22 65.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -159.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.25 -26.91 63.48 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.841 -0.6 . . . . 0.0 111.476 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.79 -69.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.458 1.503 . . . . 0.0 110.687 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -65.79 -43.56 88.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.1 0.863 . . . . 0.0 111.834 -164.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.1 t -72.83 -18.19 61.48 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.814 0.445 . . . . 0.0 111.009 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -71.2 -46.86 60.35 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.615 -1.184 . . . . 0.0 112.109 171.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.5 144.21 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 120.245 1.384 . . . . 0.0 108.526 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.74 168.18 14.62 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 125.372 1.469 . . . . 0.0 107.416 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.3 157.55 30.19 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.295 1.141 . . . . 0.0 109.399 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 10.63 79.55 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.575 -1.125 . . . . 0.0 115.372 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -132.39 158.58 41.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.656 1.728 . . . . 0.0 107.905 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' HB ' HD22 ' A' ' 43' ' ' LEU . 21.2 t -107.05 123.3 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 172.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.06 136.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.12 114.58 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -77.68 122.66 25.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.8 pt -133.71 166.91 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.056 1.342 . . . . 0.0 109.758 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -132.33 125.18 19.66 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 158.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.4 -15.32 47.64 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.66 1.573 . . . . 0.0 111.414 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -83.0 -0.17 47.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.914 2.086 . . . . 0.0 113.356 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.13 132.49 21.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.159 1.345 . . . . 0.0 108.23 161.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.91 -17.72 56.2 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.479 2.786 . . . . 0.0 110.952 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -74.04 -38.21 64.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.95 -44.51 96.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 117.72 -1.134 . . . . 0.0 109.027 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -53.43 -50.35 65.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.606 1.094 . . . . 0.0 111.783 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -54.45 -59.21 4.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 119.202 -0.427 . . . . 0.0 110.187 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.06 60.84 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.604 1.19 . . . . 0.0 111.231 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.67 80.62 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 117.855 -1.069 . . . . 0.0 111.206 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -41.33 69.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 120.557 1.526 . . . . 0.0 109.336 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.17 -54.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.429 1.892 . . . . 0.0 109.263 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.43 -42.87 42.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -171.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 t -65.91 -25.11 67.0 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.247 0.476 . . . . 0.0 111.131 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.69 -22.72 59.84 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.355 0.98 . . . . 0.0 112.407 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.9 mt -71.95 154.47 92.58 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 119.329 0.968 . . . . 0.0 109.496 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.57 77.93 3.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.853 2.369 . . . . 0.0 109.876 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mt -102.43 153.46 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -51.97 124.27 12.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.033 0.933 . . . . 0.0 109.083 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.61 137.83 58.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.77 -14.07 64.13 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 117.841 -1.533 . . . . 0.0 112.247 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mt -73.81 -36.8 65.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 120.802 2.301 . . . . 0.0 111.78 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.04 118.02 23.79 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -170.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -122.04 123.6 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.627 1.171 . . . . 0.0 109.193 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.53 127.26 45.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.96 105.09 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.935 1.294 . . . . 0.0 108.735 -165.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.35 100.76 3.26 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.576 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.488 HG22 HG21 ' A' ' 57' ' ' ILE . 8.9 pt -63.94 -14.46 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 113.18 175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -114.69 10.5 16.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.871 1.268 . . . . 0.0 111.666 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.53 68.3 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.528 1.058 . . . . 0.0 109.5 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -157.61 -40.13 0.07 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.216 171.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -41.8 -63.43 0.72 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.739 1.215 . . . . 0.0 113.106 -158.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 144.24 103.57 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 130.409 3.484 . . . . 0.0 106.316 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -63.47 1.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.275 1.43 . . . . 0.0 108.323 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.47 -30.64 60.95 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.61 -52.31 61.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.839 1.199 . . . . 0.0 110.747 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 48' ' ' ILE . 6.4 mt -64.03 -39.24 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -57.2 -50.07 74.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.406 2.282 . . . . 0.0 107.459 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.27 -42.32 93.34 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.153 0.981 . . . . 0.0 110.518 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -58.41 -47.42 83.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.9 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.19 -36.78 84.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.792 0.724 . . . . 0.0 110.581 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.83 -51.04 70.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.538 0.735 . . . . 0.0 109.945 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.91 -49.93 72.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.003 0.521 . . . . 0.0 109.851 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.49 -40.58 66.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.116 0.966 . . . . 0.0 109.373 -166.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.1 p -108.38 -15.37 14.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.255 0.934 . . . . 0.0 113.356 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.19 6.78 64.5 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.625 -1.097 . . . . 0.0 112.158 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.52 22.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.236 1.518 . . . . 0.0 109.265 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -94.67 -8.89 36.56 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.92 133.82 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.685 1.129 . . . . 0.0 110.66 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.11 161.11 29.27 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 160.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.24 141.79 37.46 Favored 'Cis proline' 0 N--CA 1.463 -0.275 0 N-CA-C 110.158 -0.747 . . . . 0.0 110.158 -13.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.94 93.1 4.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.85 130.79 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.86 109.02 18.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.378 1.871 . . . . 0.0 106.927 160.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.5 108.66 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 163.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.88 67.48 1.91 Allowed Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.264 1.411 . . . . 0.0 112.849 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.0 mttt 46.06 20.39 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.166 1.787 . . . . 0.0 115.393 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.29 110.91 21.41 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 164.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.1 t -67.26 107.99 2.56 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.5 pp -83.48 -14.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.485 0.584 . . . . 0.0 111.456 -170.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.47 -171.35 22.94 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 124.478 1.037 . . . . 0.0 111.355 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.81 -160.23 31.82 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.896 1.713 . . . . 0.0 110.251 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -37.78 86.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.026 0.913 . . . . 0.0 110.334 -170.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.6 m -67.36 -48.32 67.79 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.987 -172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 -51.94 67.68 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.7 tp -54.28 -37.33 64.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.074 -0.965 . . . . 0.0 112.231 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -60.85 -53.41 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 116.777 -1.582 . . . . 0.0 108.982 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -47.22 87.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 121.848 2.113 . . . . 0.0 108.692 -174.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 mp -61.3 -32.03 71.88 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.745 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.34 -55.11 8.66 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 121.055 1.752 . . . . 0.0 111.087 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -51.91 34.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.635 2.374 . . . . 0.0 110.631 -168.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 t -70.34 -24.59 63.01 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.945 1.298 . . . . 0.0 109.977 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 11.06 65.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.166 173.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.55 -25.93 68.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.36 2.08 . . . . 0.0 111.726 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.73 -32.23 69.02 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.536 1.134 . . . . 0.0 111.513 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.09 -46.52 61.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.65 0.659 . . . . 0.0 109.656 -168.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.9 m -64.45 -40.49 95.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -40.97 85.37 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.54 -0.725 . . . . 0.0 111.687 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.75 -46.09 84.96 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.713 1.205 . . . . 0.0 110.503 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -62.12 -31.02 71.44 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.958 -1.089 . . . . 0.0 112.331 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -63.64 -10.99 21.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.92 11.75 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 119.474 1.034 . . . . 0.0 111.854 170.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.12 26.09 62.69 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.341 0.972 . . . . 0.0 112.887 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.616 1.166 . . . . 0.0 111.487 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.7 mt -77.55 134.32 38.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.802 -1.559 . . . . 0.0 110.944 -158.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 . . . . . 0 N--CA 1.428 -1.526 0 C-N-CA 130.134 3.374 . . . . 0.0 106.161 -179.273 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 75.22 -173.31 0.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 128.122 2.569 . . . . 0.0 113.487 170.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 7' ' ' ASN . 0.5 OUTLIER -48.76 -10.04 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.807 2.443 . . . . 0.0 114.62 163.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -45.11 -57.03 4.17 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.371 1.441 . . . . 0.0 110.507 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.09 -58.93 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 4' ' ' GLU . 54.3 m-80 -55.32 -37.39 67.36 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.19 0.996 . . . . 0.0 113.573 -161.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.0 m -101.91 -8.87 21.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.971 0.908 . . . . 0.0 112.815 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.87 -45.26 90.24 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.966 1.257 . . . . 0.0 107.7 159.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.44 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 mt -63.75 155.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 152.52 47.48 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.61 125.22 14.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 N-CA-C 104.763 -2.822 . . . . 0.0 104.763 158.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.49 35.58 25.63 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.737 0.684 . . . . 0.0 113.302 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -142.31 161.31 38.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.099 2.159 . . . . 0.0 109.341 166.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 75' ' ' ILE . 38.3 t -118.33 109.25 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 10' ' ' ILE . 61.6 t -127.56 132.25 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 120.555 -1.341 . . . . 0.0 108.289 -166.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.23 111.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -166.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -79.29 119.26 22.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.86 169.5 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.989 1.716 . . . . 0.0 109.921 -174.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -127.29 141.28 40.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 162.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.06 28.77 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.6 3.533 . . . . 0.0 111.315 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.323 9.6 t -147.23 29.48 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.813 2.045 . . . . 0.0 108.929 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.63 123.84 26.87 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.035 1.734 . . . . 0.0 108.595 167.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.98 -24.92 52.4 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.486 1.457 . . . . 0.0 111.984 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -78.98 -28.72 43.54 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.953 0.797 . . . . 0.0 109.353 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.2 m -66.11 -46.9 75.94 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -51.92 -48.15 64.33 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.166 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -55.5 -57.87 10.13 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 119.014 0.825 . . . . 0.0 109.938 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.42 62.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.328 1.018 . . . . 0.0 111.472 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -45.69 78.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.388 0.994 . . . . 0.0 113.295 172.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.66 -53.21 16.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt -44.34 -53.22 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.39 1.876 . . . . 0.0 110.442 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.64 -46.47 19.13 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.186 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -6.51 59.26 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.367 0.985 . . . . 0.0 112.608 -167.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -73.83 -16.16 61.15 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.66 1.118 . . . . 0.0 110.992 167.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -78.0 151.29 78.89 Favored Pre-proline 0 C--O 1.236 0.371 0 O-C-N 120.885 -1.134 . . . . 0.0 108.748 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 42.23 1.19 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.303 2.669 . . . . 0.0 111.295 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.1 145.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -58.38 123.06 14.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.27 146.66 54.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 -27.78 10.22 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.589 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.49 -30.5 63.18 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 119.883 1.842 . . . . 0.0 109.68 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 119.72 25.18 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 120.515 1.507 . . . . 0.0 107.684 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -128.72 110.41 12.16 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.688 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -84.19 103.74 13.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -90.82 114.96 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 126.519 1.927 . . . . 0.0 107.231 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -66.57 110.58 3.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.591 1.156 . . . . 0.0 110.942 171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.6 pt -70.45 -2.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.369 1.068 . . . . 0.0 113.006 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.261 3.3 t -137.12 35.64 2.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 118.775 0.716 . . . . 0.0 110.41 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.06 55.73 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.333 0.653 . . . . 0.0 109.363 159.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.6 p 53.54 65.65 1.46 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 127.965 2.506 . . . . 0.0 111.15 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -143.48 -93.64 0.11 Allowed 'General case' 0 C--O 1.23 0.07 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.008 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -160.22 57.28 0.35 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.422 1.464 . . . . 0.0 113.678 -163.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.66 -63.66 0.86 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.581 1.152 . . . . 0.0 111.817 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -46.63 -54.68 9.02 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.901 0.75 . . . . 0.0 111.15 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -41.66 93.63 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.554 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -59.4 -39.99 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.03 -41.45 74.25 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.69 -42.05 35.9 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.49 1.916 . . . . 0.0 111.423 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.5 -50.99 66.49 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.753 1.221 . . . . 0.0 110.338 171.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.42 -30.71 65.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.789 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' NE2' HH21 ' A' ' 68' ' ' ARG . 22.7 tt0 -66.56 -37.79 85.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.627 1.558 . . . . 0.0 111.695 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -67.66 -47.54 69.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.53 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.27 -24.33 57.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.211 -168.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 p -133.51 -2.85 3.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.283 1.401 . . . . 0.0 114.101 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.13 -10.23 61.42 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 120.061 1.301 . . . . 0.0 112.857 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.62 137.33 54.48 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 121.126 -1.22 . . . . 0.0 110.587 -172.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.503 HH21 ' NE2' ' A' ' 62' ' ' GLN . 5.1 ptp85 -102.02 -31.31 10.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.475 174.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 133.33 41.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.285 0.564 . . . . 0.0 109.716 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.27 159.49 39.27 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.369 1.467 . . . . 0.0 108.458 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.54 167.77 22.72 Favored 'Cis proline' 0 C--N 1.347 0.457 0 CA-C-N 120.379 1.171 . . . . 0.0 111.881 -8.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 110.15 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.062 175.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.9 t -91.98 125.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 119.426 1.012 . . . . 0.0 108.761 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -102.21 114.68 29.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 158.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.41 ' CD1' HG13 ' A' ' 15' ' ' VAL . 1.1 mp -93.18 123.68 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 160.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 43.78 72.43 0.33 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.301 1.429 . . . . 0.0 113.811 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 46.65 14.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.17 120.22 36.44 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.471 1.487 . . . . 0.0 110.658 170.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.8 t -64.71 114.66 4.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.706 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.8 pp -83.52 -12.68 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 119.236 0.925 . . . . 0.0 110.845 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.75 -158.17 18.28 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.65 -157.47 31.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 126.767 2.127 . . . . 0.0 111.108 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -38.44 83.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.923 -0.751 . . . . 0.0 110.335 -169.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -68.85 -44.82 72.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.634 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -65.17 -45.56 84.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.6 tp -53.98 -45.42 71.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.5 0.72 . . . . 0.0 112.057 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.89 -39.16 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 117.112 -1.423 . . . . 0.0 109.536 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -54.54 24.92 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -58.52 -33.54 69.96 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -66.29 -63.67 1.03 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 120.935 1.698 . . . . 0.0 110.705 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.26 78.3 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.864 1.266 . . . . 0.0 112.163 -166.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.7 t -86.39 -2.24 58.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.457 1.503 . . . . 0.0 110.972 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 -0.37 88.86 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 117.107 -1.941 . . . . 0.0 114.671 168.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.38 -31.54 72.73 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 121.285 2.542 . . . . 0.0 111.168 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.27 -35.65 70.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.987 1.315 . . . . 0.0 110.763 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.19 -44.09 76.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -61.25 -54.14 47.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -40.34 63.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.519 1.128 . . . . 0.0 111.07 -176.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.1 mt -70.11 -57.56 4.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.78 1.632 . . . . 0.0 112.448 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 105' ' ' LEU . 4.5 tttm -65.88 -26.81 67.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.709 1.595 . . . . 0.0 111.913 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -44.95 -36.69 3.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.674 1.59 . . . . 0.0 111.528 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.57 14.3 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.44 1.018 . . . . 0.0 112.552 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.5 40.89 21.85 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.725 0.693 . . . . 0.0 112.286 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.21 -78.21 0.53 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.076 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -60.1 135.0 57.58 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 C--O 1.245 0.831 0 O-C-N 125.499 1.75 . . . . 0.0 108.006 -163.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 60' ' ' TYR . . . . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 57.4 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 126.09 2.119 . . . . 0.0 113.747 -165.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.34 -19.2 65.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.658 -0.651 . . . . 0.0 111.073 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -47.08 -49.94 20.72 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.718 1.207 . . . . 0.0 110.111 168.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 t -70.7 -53.12 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.939 0.791 . . . . 0.0 109.937 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.36 -55.71 31.28 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.233 0.924 . . . . 0.0 111.467 -163.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.9 m -82.58 -6.69 59.49 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -65.52 -22.83 66.75 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.915 1.234 . . . . 0.0 110.639 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.8 154.87 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 120.637 1.562 . . . . 0.0 108.561 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -135.65 152.33 75.98 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 165.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.79 63.93 8.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.128 3.219 . . . . 0.0 110.976 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.4 31.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.933 1.254 . . . . 0.0 111.781 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -134.44 172.92 12.23 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.142 1.777 . . . . 0.0 107.756 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' ILE . 21.1 t -116.76 111.51 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.7 t -132.38 115.91 27.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -158.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.69 130.16 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 123.003 0.521 . . . . 0.0 110.305 -173.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.42 125.15 40.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.77 168.5 16.45 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.854 1.661 . . . . 0.0 110.512 -167.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -125.54 148.42 61.54 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 169.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.28 -39.08 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.701 2.267 . . . . 0.0 110.134 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 p -81.89 48.48 1.23 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.05 2.14 . . . . 0.0 109.966 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -140.67 127.06 11.77 Favored Pre-proline 0 C--O 1.242 0.679 0 C-N-CA 126.516 1.927 . . . . 0.0 109.387 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.56 -19.56 11.39 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.333 2.022 . . . . 0.0 112.038 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -73.59 -35.28 65.39 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 120.428 1.467 . . . . 0.0 108.305 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.27 -40.07 89.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -53.13 -53.95 42.93 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.156 0.434 . . . . 0.0 110.84 171.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -53.19 -59.18 4.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.552 0.741 . . . . 0.0 109.021 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -41.88 72.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 117.515 -1.231 . . . . 0.0 111.481 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -49.64 71.05 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 119.718 1.145 . . . . 0.0 112.162 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.43 -50.05 55.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.205 1.002 . . . . 0.0 110.124 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -46.69 -56.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 127.272 2.229 . . . . 0.0 109.586 170.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.66 -46.76 74.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -65.61 -18.65 65.48 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -73.52 -27.31 61.29 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.084 1.311 . . . . 0.0 110.397 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.66 135.43 81.13 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -82.25 63.32 8.2 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.089 2.526 . . . . 0.0 112.072 -167.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.57 147.74 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.244 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -46.45 124.54 5.94 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 125.856 1.662 . . . . 0.0 109.243 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.56 129.51 42.42 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -3.08 82.71 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-O 118.083 -1.398 . . . . 0.0 113.279 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.72 -30.99 46.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.813 2.306 . . . . 0.0 112.44 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 116.09 26.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -123.3 133.6 54.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.676 1.19 . . . . 0.0 108.219 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -110.56 139.03 46.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.7 t -135.39 108.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.288 1.035 . . . . 0.0 108.547 -164.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.29 122.76 17.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 111.942 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.427 HG22 HG21 ' A' ' 57' ' ' ILE . 45.2 pt -75.11 -20.47 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.955 1.302 . . . . 0.0 112.449 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 p -88.28 -2.9 58.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.472 1.109 . . . . 0.0 110.893 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -58.43 6.01 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 124.992 1.317 . . . . 0.0 111.201 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.4 OUTLIER -149.47 -70.12 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.428 169.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -34.1 -86.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.834 2.054 . . . . 0.0 114.285 -158.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -164.18 99.91 0.85 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.213 1.805 . . . . 0.0 106.844 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.29 -62.62 1.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.94 -7.41 8.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.096 1.758 . . . . 0.0 113.531 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -36.0 16.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.84 1.655 . . . . 0.0 109.637 161.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 2' ' ' ALA . 11.3 mt -71.36 -50.06 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -167.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.55 76.09 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.009 0.524 . . . . 0.0 110.015 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -55.48 -56.85 15.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.547 1.539 . . . . 0.0 110.946 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 12.4 t80 -56.84 -29.91 63.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.84 2.056 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 72' ' ' ARG . 33.9 mt -60.48 -30.42 69.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.015 1.28 . . . . 0.0 111.73 174.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -60.28 -37.04 79.25 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.945 0.793 . . . . 0.0 109.731 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.16 -49.44 17.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.41 -30.42 57.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.54 -166.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.778 HG21 HH11 ' A' ' 72' ' ' ARG . 34.7 p -120.79 -62.56 1.44 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.904 1.229 . . . . 0.0 110.459 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.19 -34.69 0.2 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.154 -1.359 . . . . 0.0 114.341 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.35 144.88 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.123 1.461 . . . . 0.0 109.739 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -83.54 14.88 3.42 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.618 0.767 . . . . 0.0 112.368 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -105.84 163.76 12.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.578 1.656 . . . . 0.0 110.626 -158.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.99 144.38 46.18 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 127.632 2.373 . . . . 0.0 106.16 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.62 155.33 89.91 Favored 'Cis proline' 0 N--CA 1.454 -0.808 0 N-CA-C 109.359 -1.054 . . . . 0.0 109.359 -4.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.778 HH11 HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.46 130.24 17.1 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 176.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.17 128.15 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 124.185 0.994 . . . . 0.0 109.559 -163.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -94.23 124.98 38.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 158.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.29 113.22 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 160.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.69 15.27 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.28 -0.887 . . . . 0.0 112.483 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt 46.52 3.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.852 2.461 . . . . 0.0 116.917 -169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.33 142.02 28.96 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.171 1.805 . . . . 0.0 107.637 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -101.25 123.5 45.47 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.893 -1.13 . . . . 0.0 112.271 -171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -83.62 -23.1 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.359 -173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.93 -165.22 21.02 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.292 0.949 . . . . 0.0 111.201 -171.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 -163.58 32.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.486 1.517 . . . . 0.0 110.885 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.1 p -65.61 -34.37 78.07 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.409 1.104 . . . . 0.0 110.49 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -62.01 -42.55 99.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.872 0.76 . . . . 0.0 111.113 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.66 -54.52 22.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.2 tp -51.91 -39.24 58.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.92 1.288 . . . . 0.0 111.9 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.6 t -58.56 -59.35 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 117.012 -1.471 . . . . 0.0 108.797 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.2 p -48.65 -54.74 13.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.556 1.98 . . . . 0.0 115.003 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' LEU . 6.6 mp -59.75 -32.81 70.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.447 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -72.01 -51.89 19.66 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.893 1.679 . . . . 0.0 110.245 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -58.58 3.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.07 1.748 . . . . 0.0 110.097 -168.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -16.99 64.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.852 1.261 . . . . 0.0 110.895 173.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.64 78.94 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 117.988 -1.451 . . . . 0.0 113.185 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -64.49 -22.72 67.05 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.816 2.308 . . . . 0.0 111.68 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 89' ' ' LEU . 5.9 tp -64.8 -24.67 67.62 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.576 174.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.34 -52.32 59.0 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 120.354 1.434 . . . . 0.0 108.632 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.1 m -57.07 -50.88 71.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.727 0.811 . . . . 0.0 109.956 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -47.6 -51.6 20.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.001 0.92 . . . . 0.0 110.712 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.29 -52.06 37.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.175 1.39 . . . . 0.0 111.3 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -62.18 -26.05 68.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.562 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -57.25 -33.1 67.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.072 0.851 . . . . 0.0 112.305 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.1 -14.92 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.905 1.229 . . . . 0.0 112.133 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.04 83.9 0.74 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -166.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.85 -76.41 0.46 Allowed 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.721 -1.609 . . . . 0.0 110.92 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.47 135.29 54.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 121.968 2.167 . . . . 0.0 108.503 -172.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.844 1.34 . . . . 0.0 109.132 -158.364 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.206 0.527 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -81.49 63.08 5.64 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.618 -1.301 . . . . 0.0 110.194 172.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -163.04 -58.63 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.65 -57.89 10.99 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.628 1.558 . . . . 0.0 109.639 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.79 -48.92 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -16.32 63.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.37 1.068 . . . . 0.0 112.421 -165.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -103.81 -26.24 12.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.862 1.665 . . . . 0.0 111.751 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -64.05 -43.8 94.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.491 1.042 . . . . 0.0 110.959 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.16 140.9 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -122.86 157.2 60.75 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.46 16.86 0.57 Allowed 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.023 3.149 . . . . 0.0 114.828 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.57 45.32 0.2 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.8 2.143 . . . . 0.0 110.795 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -141.23 164.08 31.21 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.594 HG13 HD12 ' A' ' 75' ' ' ILE . 36.2 t -101.61 100.61 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.96 125.56 61.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.6 t -126.15 109.08 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -76.47 132.08 39.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -138.65 164.29 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.012 2.125 . . . . 0.0 108.874 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.11 145.87 34.02 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 158.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.53 16.11 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.923 3.082 . . . . 0.0 114.085 -161.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -129.4 -22.02 3.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.397 1.479 . . . . 0.0 112.665 -160.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -94.74 148.69 35.25 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -157.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.17 -25.19 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.874 2.382 . . . . 0.0 111.787 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -73.81 -43.39 58.96 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.12 1.768 . . . . 0.0 107.514 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -54.27 -47.12 72.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.476 1.111 . . . . 0.0 111.872 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -59.62 4.55 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.88 -36.69 65.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.356 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -54.91 -57.83 10.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.631 1.173 . . . . 0.0 112.554 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -70.68 -35.65 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.371 0.605 . . . . 0.0 110.815 -172.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.63 -49.83 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.476 1.51 . . . . 0.0 109.796 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.31 -49.17 15.57 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.9 p -67.51 -25.96 66.1 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -162.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -80.83 -9.14 59.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.78 0.718 . . . . 0.0 111.994 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.04 134.84 77.35 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 168.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.09 104.18 1.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.581 2.187 . . . . 0.0 108.784 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.9 mt -122.71 151.7 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -57.87 124.27 18.64 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.71 136.51 56.37 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 1.95 84.6 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.18 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.51 -39.59 31.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 120.53 2.165 . . . . 0.0 111.675 166.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.7 93.48 8.04 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.035 0.834 . . . . 0.0 110.28 -159.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -110.63 116.05 30.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -84.73 119.18 24.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -113.63 131.42 65.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 127.591 2.356 . . . . 0.0 107.784 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.66 137.8 34.35 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.955 0.502 . . . . 0.0 110.279 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.8 pt -99.41 5.11 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 C-N-CA 123.39 0.676 . . . . 0.0 112.248 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 p -117.51 -26.92 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.155 -1.59 . . . . 0.0 111.517 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.01 -55.5 32.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.783 -164.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 p -147.11 5.18 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.648 0.779 . . . . 0.0 112.375 -158.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -146.62 -0.54 0.74 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -157.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 69.9 88.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.719 1.608 . . . . 0.0 114.91 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -33.93 -63.82 0.25 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 130.149 3.38 . . . . 0.0 110.059 166.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -49.36 -46.4 47.05 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.914 0.759 . . . . 0.0 111.606 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -49.97 59.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 110.973 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.9 mt -54.63 -43.41 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.706 1.602 . . . . 0.0 110.471 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -71.98 -45.85 59.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -170.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -48.55 76.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 109.888 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.33 -44.99 86.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.672 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.0 -42.61 76.67 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.261 1.024 . . . . 0.0 109.89 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -56.4 21.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.491 174.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -56.07 -51.23 68.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 123.556 0.535 . . . . 0.0 109.993 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.89 -45.26 95.3 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.306 1.442 . . . . 0.0 109.457 -172.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 p -101.1 -65.19 0.99 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.552 0.614 . . . . 0.0 110.781 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.38 -4.48 2.55 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.638 2.066 . . . . 0.0 111.635 -172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.73 157.92 43.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.269 1.535 . . . . 0.0 109.141 169.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ptt180 -118.77 -29.12 5.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.123 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 p -61.61 133.22 55.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -161.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.08 58.19 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.46 170.45 42.38 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 CA-C-N 118.649 0.553 . . . . 0.0 111.149 -7.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -130.12 100.33 5.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.15 129.26 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.11 104.87 12.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.768 2.027 . . . . 0.0 106.915 168.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -83.92 103.06 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 169.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.97 64.77 3.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.882 1.23 . . . . 0.0 113.014 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.72 13.09 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 127.7 2.4 . . . . 0.0 117.219 -168.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -100.69 103.55 14.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 120.454 1.479 . . . . 0.0 107.341 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.6 t -68.85 117.22 10.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -83.63 -25.8 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.563 0.745 . . . . 0.0 110.631 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.25 -171.29 23.75 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 123.462 0.553 . . . . 0.0 112.023 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.61 -169.01 41.41 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 125.409 1.481 . . . . 0.0 111.463 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 p -63.43 -38.01 89.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.871 0.835 . . . . 0.0 110.507 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.235 0.47 . . . . 0.0 111.804 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.64 -49.51 21.2 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -52.68 -34.66 53.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.059 1.744 . . . . 0.0 112.605 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.64 -50.84 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.164 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -44.99 92.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.606 1.548 . . . . 0.0 107.691 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.79 -31.65 71.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.04 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -69.18 -61.34 1.83 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 120.25 1.386 . . . . 0.0 109.085 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -50.7 66.47 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.872 2.069 . . . . 0.0 111.658 -166.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -3.71 32.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.27 1.828 . . . . 0.0 111.778 172.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.97 -0.72 82.19 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.038 -1.424 . . . . 0.0 115.113 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.24 -33.87 72.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.153 1.976 . . . . 0.0 111.442 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.3 tp -60.3 -33.22 72.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.689 0.796 . . . . 0.0 111.125 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.63 -40.03 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 m -72.48 -48.05 43.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -40.24 58.57 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.945 0.793 . . . . 0.0 111.815 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.5 mt -66.76 -56.59 9.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 110.567 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -59.38 -24.31 63.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.829 1.195 . . . . 0.0 112.873 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -48.66 -41.69 32.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.681 1.193 . . . . 0.0 110.705 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.98 -1.63 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.26 59.97 1.79 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.28 -73.04 0.66 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.416 1.486 . . . . 0.0 112.412 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 2.8 mt -62.57 135.4 57.38 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.28 -153.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -136.98 -56.6 0.72 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.094 0.957 . . . . 0.0 108.816 163.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.11 -17.69 62.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.583 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -52.51 -45.02 66.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.298 1.408 . . . . 0.0 109.339 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.59 -60.25 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 109.017 169.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -70.0 -11.86 61.18 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -159.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 t -106.55 -15.48 14.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.148 0.979 . . . . 0.0 112.931 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -63.93 -57.56 9.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.22 1.373 . . . . 0.0 107.517 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.6 150.48 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -144.34 172.4 5.52 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.189 1.795 . . . . 0.0 106.28 161.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.05 17.18 0.87 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.178 2.585 . . . . 0.0 114.912 -163.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.3 12.07 1.2 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.655 2.55 . . . . 0.0 112.16 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.06 148.67 29.46 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.849 1.824 . . . . 0.0 108.585 170.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.5 t -102.54 86.62 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.84 147.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 O-C-N 120.829 -1.169 . . . . 0.0 108.539 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.9 116.21 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.12 128.89 34.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.18 175.24 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.276 1.43 . . . . 0.0 110.879 -167.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE3' HG21 ' A' ' 70' ' ' VAL . 15.3 ptpt -137.97 144.72 45.01 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 158.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.84 -31.66 47.51 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.305 2.67 . . . . 0.0 112.268 -168.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -65.78 -35.96 82.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.508 0.723 . . . . 0.0 111.829 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 25' ' ' TYR . 48.7 t -61.01 118.67 37.97 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 124.557 1.143 . . . . 0.0 109.717 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.93 -20.25 34.26 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.772 1.648 . . . . 0.0 111.073 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 22.9 m-85 -73.49 -39.35 64.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.1 m -60.61 -49.42 77.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -57.24 -46.07 83.34 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.425 0.557 . . . . 0.0 111.636 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -56.52 -54.24 48.14 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 118.833 0.742 . . . . 0.0 109.947 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.2 -39.23 59.87 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.223 0.952 . . . . 0.0 111.43 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.02 66.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.673 171.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -55.03 31.64 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.226 1.01 . . . . 0.0 109.741 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -47.63 -47.17 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.077 2.151 . . . . 0.0 110.237 176.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.11 -42.73 31.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 m -61.42 -21.87 64.5 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.85 -11.55 60.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.91 . . . . 0.0 111.851 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.3 133.51 21.97 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.85 81.77 2.49 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.633 2.889 . . . . 0.0 110.284 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 99' ' ' LEU . 9.5 mt -102.57 155.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -167.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -50.75 123.31 8.74 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.659 0.783 . . . . 0.0 109.266 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -66.58 157.05 33.35 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.099 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.86 -20.66 2.84 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.205 -1.331 . . . . 0.0 112.68 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.7 mt -73.86 -37.14 64.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.538 2.169 . . . . 0.0 109.795 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -83.92 104.1 13.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -171.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -123.35 113.62 19.09 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE1' HD12 ' A' ' 43' ' ' LEU . 14.1 m-85 -84.07 107.2 16.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 171.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.92 106.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 126.427 1.891 . . . . 0.0 107.288 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.78 133.08 52.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 122.649 -0.032 . . . . 0.0 110.953 166.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 pt -106.25 -13.75 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.33 1.452 . . . . 0.0 110.758 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.92 -6.45 58.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.632 1.173 . . . . 0.0 111.083 174.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.62 68.79 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 129.338 3.055 . . . . 0.0 108.966 163.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p 55.99 -4.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 131.442 3.897 . . . . 0.0 116.51 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 14.95 29.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 113.182 -159.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m170 78.25 87.58 0.07 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.709 3.204 . . . . 0.0 110.121 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.77 -63.42 0.91 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 117.316 -1.325 . . . . 0.0 111.777 168.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -47.36 -51.45 19.57 Favored 'General case' 0 C--O 1.217 -0.629 0 O-C-N 124.452 1.095 . . . . 0.0 109.911 -171.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.11 -50.1 75.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.515 0.598 . . . . 0.0 110.352 -177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 mt -62.34 -35.66 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.964 0.906 . . . . 0.0 108.816 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -80.21 -37.2 33.64 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 -168.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.43 -46.18 84.31 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 127.502 2.321 . . . . 0.0 110.475 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -61.51 -44.92 96.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.326 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.4 mt -57.4 -39.21 75.64 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.973 1.261 . . . . 0.0 110.524 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.12 -41.78 93.37 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.502 0.721 . . . . 0.0 110.385 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -63.62 -58.53 6.64 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.508 -0.745 . . . . 0.0 110.053 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 tp -65.32 -30.22 71.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.676 2.39 . . . . 0.0 111.775 -166.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.69 -26.47 2.96 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.192 1.36 . . . . 0.0 112.993 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.96 27.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.612 -1.104 . . . . 0.0 113.934 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.77 144.83 27.28 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.365 2.083 . . . . 0.0 110.414 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -85.84 -18.63 32.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.195 0.598 . . . . 0.0 111.968 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -70.83 134.08 47.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -163.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG21 ' HE3' ' A' ' 20' ' ' LYS . 1.4 m -96.28 166.12 14.89 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.556 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -58.82 159.01 35.48 Favored 'Cis proline' 0 C--N 1.345 0.36 0 CA-C-N 119.657 0.913 . . . . 0.0 110.305 -15.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 mtp85 -126.39 105.7 8.97 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.58 125.25 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -110.79 99.57 8.47 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 107.065 168.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.79 109.79 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.28 64.67 2.17 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 126.016 1.769 . . . . 0.0 111.761 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 tttt 46.14 17.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.458 2.703 . . . . 0.0 117.394 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -98.53 115.56 28.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.26 1.391 . . . . 0.0 107.568 159.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.4 t -67.01 108.79 2.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 80' ' ' ILE . 1.2 pp -83.55 -11.01 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.656 0.662 . . . . 0.0 110.555 -174.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -165.64 24.44 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.154 1.359 . . . . 0.0 110.008 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.65 -165.36 39.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 174.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -39.76 93.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.716 -0.873 . . . . 0.0 110.775 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -66.6 -26.01 66.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.316 -174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.74 -51.9 6.13 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.6 tp -46.55 -39.68 11.4 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 126.334 1.853 . . . . 0.0 111.269 172.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.29 -48.39 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 116.434 -1.746 . . . . 0.0 110.802 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.82 -44.7 76.65 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.989 1.722 . . . . 0.0 106.857 -176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.36 -34.28 72.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.044 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.09 -56.37 9.09 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.627 1.558 . . . . 0.0 110.408 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -50.22 55.8 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.499 -1.375 . . . . 0.0 110.261 -167.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 t -70.74 -12.15 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.138 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.49 16.28 71.47 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 117.695 -1.614 . . . . 0.0 112.992 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.42 -30.91 70.86 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.542 2.171 . . . . 0.0 110.597 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -49.91 -37.39 31.38 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.985 2.114 . . . . 0.0 111.453 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -55.82 28.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.238 1.015 . . . . 0.0 110.534 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.0 m -62.49 -43.8 97.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.015 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -38.88 77.78 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 119.13 0.877 . . . . 0.0 110.302 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' ILE . 14.6 mt -68.67 -51.62 39.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.99 -1.069 . . . . 0.0 111.056 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -55.57 -25.84 40.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.054 1.297 . . . . 0.0 114.3 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -47.4 -36.03 9.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.985 1.314 . . . . 0.0 111.582 168.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.55 -6.22 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.735 0.814 . . . . 0.0 111.973 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.92 85.02 0.23 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -169.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.41 -70.11 0.43 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.602 2.361 . . . . 0.0 109.008 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.58 148.68 51.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 121.081 1.764 . . . . 0.0 107.407 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--O 1.247 0.962 0 O-C-N 126.057 2.098 . . . . 0.0 107.37 158.725 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -111.72 81.6 1.48 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -163.07 -60.76 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 116.668 -1.634 . . . . 0.0 110.385 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -50.21 -49.48 52.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.226 1.375 . . . . 0.0 111.217 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.92 -49.46 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -64.32 -46.86 81.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 t -79.69 10.27 4.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.144 2.178 . . . . 0.0 112.34 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -106.49 -34.61 7.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.712 -1.243 . . . . 0.0 109.862 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.07 148.2 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 119.53 1.059 . . . . 0.0 108.998 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -135.8 139.13 29.79 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 159.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -63.1 158.47 43.75 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.082 1.855 . . . . 0.0 109.098 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.75 17.36 41.95 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.547 -0.721 . . . . 0.0 113.528 -171.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 156.74 46.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.666 1.987 . . . . 0.0 107.981 172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -107.85 104.53 17.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.91 125.7 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.87 112.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -167.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.61 126.79 34.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.78 -178.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.99 1.316 . . . . 0.0 111.429 -166.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.2 160.55 61.82 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 127.037 2.135 . . . . 0.0 107.086 172.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.67 -17.17 10.0 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.511 2.141 . . . . 0.0 111.638 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -129.16 24.57 5.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.732 2.013 . . . . 0.0 111.041 -163.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -107.17 115.29 60.16 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.16 -18.41 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.915 1.743 . . . . 0.0 111.07 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -74.17 -37.83 63.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.64 -50.35 65.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -49.03 -47.34 44.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.698 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -63.31 1.18 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 119.137 0.88 . . . . 0.0 109.348 173.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.0 58.87 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.143 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.48 -45.78 85.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.199 -1.382 . . . . 0.0 113.019 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.06 -30.95 55.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 121.724 2.056 . . . . 0.0 111.841 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mt -57.3 -55.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.282 1.433 . . . . 0.0 107.456 170.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.92 -56.13 4.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t -65.07 -20.91 66.71 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -160.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -73.62 -21.31 60.34 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.21 0.914 . . . . 0.0 111.914 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.93 149.53 90.01 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.181 0.9 . . . . 0.0 110.498 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.92 109.24 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.108 2.539 . . . . 0.0 108.57 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.416 HD13 HD23 ' A' ' 43' ' ' LEU . 6.2 mt -130.72 147.55 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -174.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.39 155.21 5.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.028 1.331 . . . . 0.0 109.882 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.96 100.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.377 1.871 . . . . 0.0 111.043 -172.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.18 19.55 75.82 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.587 167.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 mt -73.44 -25.88 60.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.31 2.055 . . . . 0.0 110.891 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 HD23 HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -84.09 103.65 13.5 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 120.309 1.413 . . . . 0.0 107.305 178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -115.14 102.29 9.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.039 1.336 . . . . 0.0 107.841 -170.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -84.13 131.08 34.81 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.0 t -128.14 100.85 6.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 125.542 1.537 . . . . 0.0 108.029 -166.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -78.61 119.6 22.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.075 0.55 . . . . 0.0 110.957 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.94 -9.15 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.0 t -117.6 13.71 14.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.58 1.152 . . . . 0.0 109.755 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.16 67.59 0.31 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.087 1.755 . . . . 0.0 108.335 159.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.264 0.3 OUTLIER 68.36 -16.07 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 128.272 2.629 . . . . 0.0 113.286 175.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.23 168.17 16.37 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 109.981 174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -92.28 72.85 5.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.599 1.16 . . . . 0.0 109.145 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -34.74 -63.77 0.29 Allowed 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 127.73 2.412 . . . . 0.0 109.961 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -52.29 -32.76 39.05 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -45.24 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.766 -1.209 . . . . 0.0 111.008 174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 mt -57.34 -38.05 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.462 1.105 . . . . 0.0 110.208 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -63.33 -47.18 83.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.739 2.416 . . . . 0.0 106.934 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.67 -45.93 88.32 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.076 0.95 . . . . 0.0 110.006 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -61.06 -37.19 81.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.265 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.5 mt -55.77 -47.49 76.93 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 121.197 1.817 . . . . 0.0 109.206 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -54.12 -47.53 71.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.963 0.789 . . . . 0.0 111.08 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.91 77.48 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.054 0.542 . . . . 0.0 110.66 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD2' HH12 ' A' ' 72' ' ' ARG . 9.5 tp -75.71 -24.5 56.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.891 0.876 . . . . 0.0 110.022 -168.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.2 p -121.34 -65.92 1.09 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.513 1.051 . . . . 0.0 110.099 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.66 -4.76 0.68 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.564 2.03 . . . . 0.0 112.038 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.31 142.57 32.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.976 1.888 . . . . 0.0 109.518 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -95.63 -15.55 22.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 141.83 55.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.866 0.757 . . . . 0.0 110.755 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.6 158.22 33.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.994 1.718 . . . . 0.0 108.265 171.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.03 141.17 50.62 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 N-CA-C 110.034 -0.795 . . . . 0.0 110.034 -5.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.407 HH12 ' CD2' ' A' ' 64' ' ' LEU . 21.0 ttp180 -109.56 96.57 6.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -73.36 126.74 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -122.82 94.01 4.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.49 117.1 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 104.249 -2.501 . . . . 0.0 104.249 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 50.95 66.33 2.54 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 124.832 1.206 . . . . 0.0 114.016 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt 46.08 31.95 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -143.87 148.41 35.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.684 1.129 . . . . 0.0 110.09 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.3 139.32 30.61 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 119.334 0.97 . . . . 0.0 110.149 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.28 -7.89 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.47 0.577 . . . . 0.0 112.249 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.28 -88.23 0.25 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.76 -80.41 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -39.29 1.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.625 0.77 . . . . 0.0 112.255 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -76.89 -25.85 53.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.648 1.567 . . . . 0.0 111.15 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.74 -43.76 83.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.286 1.035 . . . . 0.0 108.318 165.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.34 -36.61 76.0 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.008 0.523 . . . . 0.0 111.086 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -60.41 -46.22 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 117.435 -1.269 . . . . 0.0 109.65 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -48.43 79.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.431 1.469 . . . . 0.0 107.217 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.6 mt -56.21 -39.69 72.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.999 0.92 . . . . 0.0 109.006 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -58.65 6.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.394 1.452 . . . . 0.0 110.032 172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -50.55 66.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.095 1.358 . . . . 0.0 110.767 -164.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.9 t -75.97 -2.33 29.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.134 1.774 . . . . 0.0 111.562 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.44 5.74 44.92 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 117.624 -1.654 . . . . 0.0 113.866 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -65.2 -21.45 66.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.905 2.353 . . . . 0.0 110.504 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -49.85 -40.0 40.89 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.471 1.508 . . . . 0.0 111.88 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.87 -50.82 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -56.76 -54.15 49.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.9 1.28 . . . . 0.0 109.721 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -38.63 63.9 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 126.772 2.029 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.59 -49.68 20.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.073 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -62.51 -23.47 66.97 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.642 1.565 . . . . 0.0 112.765 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -52.35 -20.38 2.72 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.883 1.673 . . . . 0.0 112.955 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.2 8.89 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.015 1.279 . . . . 0.0 113.671 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.38 41.13 31.39 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.383 -0.823 . . . . 0.0 111.6 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 42' ' ' LEU . . . -89.14 -74.52 0.47 Allowed 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.285 1.434 . . . . 0.0 111.181 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.52 133.33 55.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.249 1.027 0 O-C-N 124.463 1.102 . . . . 0.0 108.933 -163.069 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 121.58 0.705 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -75.92 28.56 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.577 1.951 . . . . 0.0 114.113 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -163.03 -56.93 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -58.6 -45.62 88.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.171 0.896 . . . . 0.0 110.94 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.29 -49.69 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.021 0.828 . . . . 0.0 109.479 171.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.26 -48.19 81.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -164.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -74.16 -21.95 59.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.754 0.822 . . . . 0.0 111.733 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HG2' HG11 ' A' ' 46' ' ' VAL . 2.8 mptp? -64.79 -48.12 75.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.025 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.01 149.8 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -145.27 152.64 50.99 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.29 160.97 28.75 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.225 1.283 . . . . 0.0 109.78 159.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 54.86 24.33 33.47 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.869 -0.962 . . . . 0.0 113.917 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -141.43 160.11 40.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.531 1.666 . . . . 0.0 107.877 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 75' ' ' ILE . 40.4 t -120.74 87.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.51 129.42 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.86 112.45 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -166.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.92 124.91 29.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.7 178.42 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.929 2.092 . . . . 0.0 110.395 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -133.89 160.31 69.05 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 121.655 -0.653 . . . . 0.0 109.377 159.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.5 -30.52 3.13 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.994 1.796 . . . . 0.0 110.848 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -91.21 3.18 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.048 1.339 . . . . 0.0 111.96 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 1.3 m -90.24 110.55 41.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.226 1.011 . . . . 0.0 112.042 173.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.51 -28.51 38.34 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.557 2.171 . . . . 0.0 112.12 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -73.78 -24.08 59.79 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.607 1.094 . . . . 0.0 110.977 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.73 -52.09 48.43 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 166.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -55.04 -37.6 66.9 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.413 1.085 . . . . 0.0 113.544 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -59.32 -61.16 2.84 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 118.428 0.558 . . . . 0.0 110.263 169.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.4 -34.07 46.56 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 124.575 1.172 . . . . 0.0 110.969 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -53.18 60.2 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 126.256 1.822 . . . . 0.0 112.967 171.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.17 -53.62 35.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.96 -50.62 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.843 1.657 . . . . 0.0 110.905 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.89 -45.26 59.2 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -63.02 -16.37 59.59 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.39 -31.2 63.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.937 1.699 . . . . 0.0 109.939 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.6 136.89 55.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.26 61.45 7.3 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.203 3.268 . . . . 0.0 112.719 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.63 150.16 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -53.07 124.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.826 0.85 . . . . 0.0 110.119 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -53.2 128.26 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.48 -23.58 34.63 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.005 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.89 -37.89 64.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 119.823 1.811 . . . . 0.0 110.612 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.19 106.73 16.05 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -129.14 115.12 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.859 0.838 . . . . 0.0 111.426 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -83.9 105.46 14.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.416 HG11 ' HG2' ' A' ' 9' ' ' LYS . 47.6 t -91.84 125.67 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 126.907 2.083 . . . . 0.0 106.731 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -82.27 128.63 34.38 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.415 -0.803 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -63.09 -23.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.15 -0.969 . . . . 0.0 111.12 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -133.61 47.11 2.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.424 1.89 . . . . 0.0 106.822 -175.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.94 -48.6 67.22 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.2 p -137.14 -55.11 0.71 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.807 1.643 . . . . 0.0 109.466 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -165.76 -161.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.038 1.735 . . . . 0.0 109.264 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 62.33 -3.39 0.28 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -62.71 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 122.225 2.284 . . . . 0.0 111.473 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -48.55 -48.32 38.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.708 0.803 . . . . 0.0 112.101 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -28.81 69.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.526 1.53 . . . . 0.0 113.377 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 mt -81.65 -34.56 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.602 1.961 . . . . 0.0 107.922 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -71.61 -50.98 25.74 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.535 2.334 . . . . 0.0 107.851 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -45.51 -53.1 9.41 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.577 1.551 . . . . 0.0 111.013 167.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.09 -42.33 99.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.999 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.26 -40.29 85.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.839 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.63 -50.84 70.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.301 1.04 . . . . 0.0 109.386 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.06 -46.33 89.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 111.864 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 tp -76.26 -38.4 56.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.753 0.821 . . . . 0.0 109.287 -170.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -112.27 -28.99 7.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.06 -5.02 35.97 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.948 1.261 . . . . 0.0 112.738 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.47 147.06 28.7 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.512 1.656 . . . . 0.0 109.674 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -84.92 -18.44 34.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 119.085 -0.483 . . . . 0.0 111.914 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -64.72 133.55 52.32 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.345 0.52 . . . . 0.0 110.113 -162.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 165.41 31.94 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.542 0.737 . . . . 0.0 109.475 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -65.47 165.7 56.04 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -15.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.98 96.72 4.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.06 105.21 13.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.006 1.722 . . . . 0.0 106.791 166.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 15' ' ' VAL . 1.1 mp -84.06 107.22 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 167.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.07 69.38 0.77 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.428 1.49 . . . . 0.0 113.066 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tttm 46.05 31.0 1.03 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.421 1.888 . . . . 0.0 115.985 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -128.96 127.25 41.33 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.626 1.103 . . . . 0.0 108.885 159.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.54 138.48 43.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -114.86 12.92 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.148 0.979 . . . . 0.0 111.223 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.41 -149.06 21.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 -10.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.25 150.83 29.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 t 61.46 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -48.96 69.19 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.005 1.322 . . . . 0.0 109.566 -175.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.3 -46.84 36.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.979 2.112 . . . . 0.0 111.475 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.53 -48.24 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.25 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -47.77 77.07 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.663 1.574 . . . . 0.0 109.128 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.58 -35.46 74.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.45 -56.91 6.79 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.58 1.536 . . . . 0.0 109.639 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -53.84 41.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.32 1.848 . . . . 0.0 111.303 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.5 t -70.6 -15.84 62.79 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.875 2.47 . . . . 0.0 111.019 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.09 1.33 84.63 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 118.393 -1.226 . . . . 0.0 113.617 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.23 -33.27 73.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 120.066 1.933 . . . . 0.0 111.394 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.19 -38.65 73.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.232 1.413 . . . . 0.0 109.892 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -55.04 25.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.79 1.236 . . . . 0.0 108.677 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 m -61.47 -42.51 98.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.643 0.777 . . . . 0.0 110.246 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.91 83.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.692 0.797 . . . . 0.0 111.317 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.09 -48.69 61.97 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.283 1.033 . . . . 0.0 110.337 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' CG ' ' HB2' ' A' ' 105' ' ' LEU . 11.6 mtpt -57.42 -31.12 65.55 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.788 -1.195 . . . . 0.0 112.979 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -24.54 40.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.737 0.815 . . . . 0.0 111.591 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.01 23.97 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.818 0.847 . . . . 0.0 111.514 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.0 16.34 57.99 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 164.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.96 -70.46 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.402 1.101 . . . . 0.0 111.167 -166.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HB2' ' CG ' ' A' ' 100' ' ' LYS . 3.0 mm? -72.39 146.16 47.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.102 -165.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 112.67 -2.059 . . . . 0.0 109.968 -173.493 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 60' ' ' TYR . . . . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.91 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -40.37 -61.9 0.84 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.238 1.015 . . . . 0.0 112.596 172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -163.78 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.774 -1.107 . . . . 0.0 108.339 -165.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -55.02 -35.69 64.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.151 1.342 . . . . 0.0 113.59 -166.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.97 -59.75 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 0.0 109.171 170.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -64.1 -33.73 76.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.091 2.556 . . . . 0.0 110.827 -166.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.23 -51.18 65.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.263 3.425 . . . . 0.0 110.443 172.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 40.7 mmtm -69.8 -17.27 63.39 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.842 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 77' ' ' LYS . 6.9 mm -73.9 129.92 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 119.156 0.889 . . . . 0.0 108.694 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -131.11 159.22 72.57 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 159.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.07 70.05 6.14 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.884 3.056 . . . . 0.0 109.789 169.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.7 64.87 0.09 OUTLIER Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 126.719 2.104 . . . . 0.0 108.464 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -151.11 159.05 44.71 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.622 2.369 . . . . 0.0 105.597 165.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.704 HG13 HD12 ' A' ' 75' ' ' ILE . 60.3 t -117.04 87.23 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 172.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.421 HG11 ' CZ ' ' A' ' 18' ' ' PHE . 64.0 t -85.46 151.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.904 -1.123 . . . . 0.0 108.247 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.36 116.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 160.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' A' ' 16' ' ' VAL . 71.1 m-85 -77.3 125.58 29.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.11 176.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.681 1.993 . . . . 0.0 111.255 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 160.46 43.65 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.378 1.871 . . . . 0.0 108.956 171.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -82.19 26.43 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.191 3.261 . . . . 0.0 110.56 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.364 2.9 t -138.2 -106.63 0.18 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.75 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m 32.65 104.21 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 129.916 3.286 . . . . 0.0 113.989 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.23 -16.88 36.37 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.202 1.268 . . . . 0.0 112.211 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -74.36 -47.91 31.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.062 1.345 . . . . 0.0 108.852 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.1 m -63.93 -44.35 93.16 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -53.19 -45.28 68.5 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 124.353 1.061 . . . . 0.0 110.343 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.66 -60.1 4.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 118.816 -0.612 . . . . 0.0 109.578 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -37.04 64.57 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.187 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -52.59 64.98 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.167 0.894 . . . . 0.0 112.451 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -72.18 -40.5 67.87 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.491 0.587 . . . . 0.0 109.753 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.0 mt -53.88 -53.13 29.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.821 1.248 . . . . 0.0 109.584 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.62 -44.47 56.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.132 -0.937 . . . . 0.0 108.564 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.1 m -55.81 -27.92 53.7 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -73.45 -19.71 60.89 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.018 0.826 . . . . 0.0 110.952 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -87.57 133.7 37.53 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 119.707 1.139 . . . . 0.0 107.936 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.77 114.55 4.05 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.206 1.938 . . . . 0.0 108.829 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.25 152.13 36.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -54.16 123.6 13.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.94 150.64 48.31 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 -30.03 6.34 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.931 -168.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.51 -47.05 24.06 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 120.42 2.11 . . . . 0.0 111.533 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -83.57 107.5 16.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.822 1.192 . . . . 0.0 108.433 -164.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.03 111.47 12.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.738 0.78 . . . . 0.0 110.431 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -84.01 102.55 12.56 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.41 121.3 49.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.78 1.632 . . . . 0.0 107.637 -172.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.7 133.68 34.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.593 -170.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.8 pt -88.18 -12.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.846 1.658 . . . . 0.0 113.843 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.5 t -141.48 2.93 1.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.923 0.889 . . . . 0.0 110.987 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.16 15.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.737 1.215 . . . . 0.0 112.13 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.9 p -122.7 -77.83 0.59 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 160.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -162.77 -163.12 0.84 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.155 1.382 . . . . 0.0 109.099 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.5 m80 65.26 8.65 5.04 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.145 2.178 . . . . 0.0 115.571 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -63.37 1.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 121.362 1.892 . . . . 0.0 110.236 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.25 -41.47 75.8 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 119.694 -0.194 . . . . 0.0 111.394 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -49.04 77.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.444 1.498 . . . . 0.0 111.65 173.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.43 -39.58 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.296 1.838 . . . . 0.0 108.512 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -80.33 -40.09 27.38 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -164.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -58.01 -53.94 52.57 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.449 1.9 . . . . 0.0 108.903 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' HA ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -53.23 -49.4 66.9 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.896 1.278 . . . . 0.0 109.946 172.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.4 mt -57.25 -29.29 63.68 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.36 -1.305 . . . . 0.0 111.436 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.93 -59.88 4.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.132 1.333 . . . . 0.0 109.13 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.13 -36.61 82.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.091 0.557 . . . . 0.0 111.23 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.0 tp -75.61 -20.05 58.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.889 1.276 . . . . 0.0 110.404 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.4 p -125.84 -76.23 0.59 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.744 1.611 . . . . 0.0 112.744 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.1 -6.87 0.07 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.66 2.076 . . . . 0.0 113.797 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.09 152.78 35.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.559 1.68 . . . . 0.0 109.078 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -97.46 -3.2 40.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.112 0.965 . . . . 0.0 111.882 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -69.59 141.75 53.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.13 157.81 32.97 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 125.62 1.568 . . . . 0.0 108.931 166.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.7 161.85 52.49 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 CA-C-N 120.256 1.127 . . . . 0.0 111.829 -4.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -132.16 97.61 4.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.5 1.12 . . . . 0.0 108.313 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.9 t -75.03 120.93 25.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.94 96.58 6.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.827 1.651 . . . . 0.0 107.335 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.704 HD12 HG13 ' A' ' 15' ' ' VAL . 1.4 mp -83.85 116.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 161.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.29 87.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.514 2.007 . . . . 0.0 115.374 162.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 10' ' ' ILE . 15.4 mtpp 46.83 -12.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 131.512 3.925 . . . . 0.0 117.434 -171.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -99.06 167.74 10.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 119.529 1.058 . . . . 0.0 109.209 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.0 t -120.16 125.49 48.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.401 1.48 . . . . 0.0 107.611 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.5 pp -83.62 -23.58 8.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.567 0.222 . . . . 0.0 111.315 -164.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.85 177.11 15.43 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -159.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.45 -84.12 1.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -167.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.23 -64.15 1.06 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.234 1.014 . . . . 0.0 110.255 -173.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -49.8 64.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.74 1.155 . . . . 0.0 111.166 176.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.0 -36.66 78.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.138 1.775 . . . . 0.0 107.783 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.65 -40.51 84.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.083 0.953 . . . . 0.0 110.074 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.88 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 116.273 -1.822 . . . . 0.0 109.384 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.294 5.1 p -54.1 -47.27 71.96 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 121.987 2.176 . . . . 0.0 114.783 168.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.02 -43.87 70.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.333 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -60.69 -54.95 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.259 2.299 . . . . 0.0 110.693 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -42.99 58.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.486 1.914 . . . . 0.0 114.157 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -14.6 61.29 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 168.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.9 2.69 88.38 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.338 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -66.49 -17.49 64.83 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 119.916 1.858 . . . . 0.0 112.236 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -43.6 97.9 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.436 1.494 . . . . 0.0 109.495 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.22 -44.58 97.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 109.399 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -59.36 -54.08 50.85 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.079 0.552 . . . . 0.0 109.797 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -44.55 65.42 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.257 1.023 . . . . 0.0 111.55 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.5 mt -65.44 -50.59 64.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.56 1.144 . . . . 0.0 110.269 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -23.51 61.22 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.181 -0.949 . . . . 0.0 113.329 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.54 -29.09 9.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.173 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.16 26.6 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.394 1.078 . . . . 0.0 111.936 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.29 19.06 73.87 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.385 1.469 . . . . 0.0 114.725 168.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.34 -57.08 4.18 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 112.108 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.6 133.27 50.81 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -153.084 . . . . . . . . 0 0 . 1 stop_ save_